data_2klm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2klm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.223 -0.323 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.4 p -42.22 121.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 m -113.92 -24.76 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.09 129.68 24.29 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.978 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 9.0 p -120.8 109.78 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.577 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.45 89.82 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.015 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -84.6 117.31 23.66 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 124.073 0.858 . . . . 0.0 109.704 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.92 -178.66 0.44 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.649 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.434 ' N ' ' NE2' ' A' ' 11' ' ' GLN . 0.7 OUTLIER -91.8 160.43 15.32 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 mt -151.53 133.93 8.5 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -80.79 119.04 3.54 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.108 1.074 . . . . 0.0 114.213 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.97 137.9 25.9 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 53.56 -154.03 7.65 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 -176.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 15' ' ' GLY . 40.7 tttp 40.73 22.55 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.369 1.085 . . . . 0.0 111.008 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -96.84 159.58 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.13 167.31 8.73 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.144 -178.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.37 40.26 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.464 1.443 . . . . 0.0 112.159 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.536 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -146.14 53.31 1.76 Allowed Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.708 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 34.8 Cg_endo -80.17 165.6 21.29 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 120.901 1.067 . . . . 0.0 112.043 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -61.41 -24.88 79.21 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 120.827 1.018 . . . . 0.0 111.099 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.7 t -83.72 -66.66 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.676 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.02 -98.75 0.01 OUTLIER Glycine 0 N--CA 1.468 0.799 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 27' ' ' LEU . 2.7 Cg_endo -53.1 -57.17 2.16 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 CA-C-N 120.698 2.249 . . . . 0.0 110.334 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -43.29 -16.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 25' ' ' PRO . 1.3 tp -112.2 -38.02 4.86 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.09 -49.71 75.57 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.682 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -41.19 -29.49 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.022 0.911 . . . . 0.0 110.662 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -44.76 -37.43 3.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.551 0.691 . . . . 0.0 109.379 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 99.56 -23.23 37.02 Favored Glycine 0 C--O 1.225 -0.41 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.574 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -47.1 -135.94 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.223 0.609 . . . . 0.0 112.492 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -137.46 106.89 6.11 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.72 -0.613 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 37' ' ' PHE . 4.6 mm -52.52 -70.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 34' ' ' ILE . 10.0 tpt -39.56 -40.45 0.87 Allowed 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.2 -0.312 . . . . 0.0 110.498 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.28 -46.92 88.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' ILE . 57.5 t80 -50.7 -65.06 0.62 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 122.371 1.082 . . . . 0.0 109.504 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 42' ' ' ASN . 97.4 t -57.42 -44.29 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.169 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -46.27 -64.8 0.66 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.9 -38.94 70.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.249 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -64.2 -76.38 0.07 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 46' ' ' ALA . 20.4 t-20 -41.06 -45.49 2.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.586 0.708 . . . . 0.0 112.035 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.5 -35.99 73.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.305 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.21 -43.02 13.33 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.702 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 49' ' ' GLY . 47.1 p -67.47 -21.23 65.54 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -82.45 -37.51 25.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -65.51 -21.57 66.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.446 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.4 ptm -107.5 -29.27 9.31 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 117.62 171.04 15.35 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 51.1 p-10 -75.63 142.28 42.65 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -174.34 -150.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.903 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.473 HD11 HG21 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -139.87 135.81 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.1 t -144.27 133.28 11.26 Favored Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.905 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.24 131.96 12.19 Favored 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 120.766 0.978 . . . . 0.0 109.646 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 1.5 p -140.53 156.98 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.862 0.839 . . . . 0.0 111.928 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 21.5 mt-10 -131.34 82.37 2.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.331 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.9 mt -53.04 95.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.282 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.41 101.94 5.76 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.38 123.67 58.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.45 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -99.98 144.3 29.18 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.666 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -54.65 -22.29 13.18 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.042 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -66.03 6.42 0.39 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.666 ' H ' ' C ' ' A' ' 61' ' ' ALA . 84.0 mtm180 64.44 71.02 0.48 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.921 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 t -147.92 126.24 12.3 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.526 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -103.58 102.31 12.19 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -90.49 123.91 34.56 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.426 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 0.8 OUTLIER 173.47 118.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.565 -177.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -151.2 131.92 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.694 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.5 p -135.23 150.89 50.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.473 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 71' ' ' THR . 46.5 pttt -174.27 -158.3 0.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.504 ' O ' ' O ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER 80.34 60.0 0.14 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.912 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 71' ' ' THR . 19.7 Cg_exo -43.53 177.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.747 1.631 . . . . 0.0 112.916 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -54.67 -55.37 3.35 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.398 1.399 . . . . 0.0 114.924 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.646 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -146.54 -66.63 0.28 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.0 p -36.64 -20.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.891 0.377 . . . . 0.0 110.43 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.646 ' N ' ' O ' ' A' ' 74' ' ' ALA . 1.8 t80 -40.29 -67.11 0.25 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.276 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.429 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 6.9 tt -110.15 -19.94 12.85 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 82' ' ' ALA . 1.2 mt -55.67 -42.21 68.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.031 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -44.54 -39.27 4.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.592 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -81.89 -60.42 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.49 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.73 13.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.43 . . . . 0.0 110.766 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -85.43 -78.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.39 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.34 41.43 0.23 Allowed Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 mt -94.59 112.86 24.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 . . . . . 0 C--N 1.33 -0.28 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.499 -179.649 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.2 mttp . . . . . 0 N--CA 1.462 0.154 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 p -138.84 159.01 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.733 0.302 . . . . 0.0 110.25 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.54 84.38 1.76 Allowed Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.401 HH21 HG23 ' A' ' 139' ' ' VAL . 43.5 ttt180 -135.77 104.77 5.87 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.142 0.496 . . . . 0.0 111.219 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 pt -109.41 148.51 13.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.1 160.28 17.11 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.164 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -60.4 -54.17 48.85 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.605 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -59.97 -43.5 95.04 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.913 -1.117 . . . . 0.0 111.388 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -59.1 -45.53 90.64 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.978 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.8 m -64.88 -31.66 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 118.249 -1.381 . . . . 0.0 109.672 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 108' ' ' ALA . 76.1 mt -61.74 -67.32 0.42 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.662 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -44.38 -41.59 6.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.198 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.13 -29.12 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.104 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -91.77 -3.3 56.34 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.749 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 111' ' ' LYS . 44.1 mtpt -85.74 -72.73 0.48 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.866 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.58 -0.89 0.3 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.027 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 109' ' ' LYS . 1.4 pptp? -68.9 -16.72 63.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.616 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.481 ' SD ' ' NZ ' ' A' ' 111' ' ' LYS . 5.9 ptt? -123.91 70.15 48.85 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.444 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 15.2 Cg_exo -53.84 -40.52 80.07 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 120.653 0.902 . . . . 0.0 112.082 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 113' ' ' PRO . 80.6 m-20 -149.78 14.93 0.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.58 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.6 mp -71.32 160.53 32.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.2 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.539 ' C ' HD21 ' A' ' 116' ' ' ASN . 0.2 OUTLIER -70.56 64.72 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.096 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.0 m -162.04 140.04 8.87 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.374 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.74 -2.76 0.35 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.99 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.87 124.41 34.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.298 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 36.0 mt -62.09 -42.95 99.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.576 0.703 . . . . 0.0 110.266 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.4 -36.63 71.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.983 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.61 -69.4 0.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.591 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.13 -33.09 4.76 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.133 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.13 -66.58 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.1 mtt180 -46.35 -33.78 4.08 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.793 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.491 ' O ' ' N ' ' A' ' 130' ' ' SER . 34.4 ttp -59.57 -73.83 0.08 Allowed 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 127' ' ' ILE . 38.9 mm -50.56 -48.31 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.739 0.304 . . . . 0.0 110.826 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -68.15 -70.82 0.24 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.05 -45.8 6.17 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 126' ' ' MET . 67.5 m -56.41 -42.45 78.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -55.85 -46.65 78.13 Favored 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.509 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -54.67 -44.11 73.02 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 t -51.96 -69.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 74.4 mtp -41.96 -66.39 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.674 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.22 55.05 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 49.2 t -134.6 161.14 40.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 96.2 mt-10 -124.3 152.9 42.5 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.1 t -104.07 133.37 48.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.401 HG23 HH21 ' A' ' 98' ' ' ARG . 1.6 p -70.37 -3.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.799 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.452 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.556 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 tttt . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 12.9 p -64.76 119.92 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.03 -24.49 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 119.211 -0.423 . . . . 0.0 109.88 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.55 134.83 27.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.588 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.453 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 13.4 p -124.98 125.51 69.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.207 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.61 93.47 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 119.644 1.111 . . . . 0.0 111.556 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -84.05 118.12 23.86 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.836 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.417 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -171.41 -173.79 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.648 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -90.18 149.29 22.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.59 93.39 8.69 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 123.154 0.284 . . . . 0.0 110.315 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -67.47 123.18 10.51 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.141 1.227 . . . . 0.0 114.224 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.459 ' CB ' ' H ' ' A' ' 51' ' ' ALA . . . -54.49 136.73 44.17 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 54.89 -155.78 8.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 15' ' ' GLY . 97.3 mttt 41.47 20.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.118 0.959 . . . . 0.0 111.165 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -97.04 158.52 15.39 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.61 167.68 7.89 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.245 -179.145 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.79 42.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.136 1.224 . . . . 0.0 112.024 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.522 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -150.53 55.58 1.82 Allowed Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.599 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 32.5 Cg_endo -79.47 164.8 23.57 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 120.819 1.013 . . . . 0.0 112.105 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -63.18 -24.37 72.75 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.768 0.979 . . . . 0.0 111.359 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.01 -64.67 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 44.04 -99.01 0.01 OUTLIER Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 28' ' ' GLY . 14.4 Cg_exo -48.95 -59.63 1.17 Allowed 'Trans proline' 0 C--N 1.32 -0.971 0 CA-C-N 119.991 1.896 . . . . 0.0 110.561 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.36 -24.01 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.381 -0.527 . . . . 0.0 109.886 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.545 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 39.4 tp -119.91 31.96 6.28 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.907 0.86 . . . . 0.0 109.495 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' PRO . . . -126.24 -64.34 0.16 Allowed Glycine 0 C--N 1.319 -0.363 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 28' ' ' GLY . 65.6 tp60 -42.29 -25.26 0.07 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.734 0.767 . . . . 0.0 109.699 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.483 ' N ' ' C ' ' A' ' 28' ' ' GLY . 37.6 t-80 -42.63 -39.14 2.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.44 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 97.68 -24.43 31.63 Favored Glycine 0 C--N 1.331 0.28 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -48.94 -135.68 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.093 0.557 . . . . 0.0 112.272 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -136.88 130.31 31.52 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.096 -0.377 . . . . 0.0 110.874 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 37' ' ' PHE . 3.5 mm -82.16 -72.24 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.3 tpt -39.57 -40.51 0.88 Allowed 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.14 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -60.78 -49.81 76.0 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.255 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 34' ' ' ILE . 87.6 t80 -47.02 -60.54 2.38 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.099 0.952 . . . . 0.0 109.795 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 42' ' ' ASN . 59.9 t -59.85 -44.05 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.348 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 84.5 tttt -46.66 -66.12 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.99 76.11 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.627 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -62.97 -75.8 0.07 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' VAL . 6.3 t-20 -40.53 -45.33 2.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.389 0.614 . . . . 0.0 111.974 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.446 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -57.44 -34.84 69.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.037 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.42 -44.79 12.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.371 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 49' ' ' GLY . 45.8 p -65.36 -21.61 66.71 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -77.0 -45.15 28.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 43' ' ' ALA . 5.1 m120 -62.48 -16.11 53.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.4 mmm -106.8 -70.92 0.77 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.268 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 160.15 -162.22 33.04 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 40.0 p-10 -99.86 122.3 42.59 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.459 ' H ' ' CB ' ' A' ' 14' ' ' ALA . . . -156.8 -153.14 0.4 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.28 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mm -137.71 127.79 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.708 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.7 t -144.26 124.97 7.69 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.774 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -73.94 147.93 39.68 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 120.745 0.963 . . . . 0.0 110.639 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.0 m -143.19 160.83 17.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.257 0.551 . . . . 0.0 111.246 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 58' ' ' THR . 93.8 mt-10 -129.38 76.74 1.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.5 mt -50.87 86.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.874 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -72.99 95.17 1.96 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.417 HD11 HG23 ' A' ' 59' ' ' ILE . 60.8 mt -95.6 125.13 48.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.693 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 63' ' ' ARG . 3.4 m-85 -100.63 140.35 35.03 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.633 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.63 -23.33 2.52 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 124.584 1.178 . . . . 0.0 112.366 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -66.89 5.82 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.633 ' H ' ' C ' ' A' ' 61' ' ' ALA . 59.8 mtp180 63.88 69.69 0.53 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.341 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.9 p -146.47 127.55 14.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.959 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -105.04 103.44 13.0 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.622 -177.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.512 ' O ' ' OG1' ' A' ' 58' ' ' THR . 41.1 p -95.21 122.91 38.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.518 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.5 p90 176.32 -152.74 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 48.9 t 80.35 117.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 124.408 1.067 . . . . 0.0 111.381 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -124.58 127.56 47.56 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -143.8 -170.33 3.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.678 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 m 66.0 52.07 0.83 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.586 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.678 ' HD3' ' N ' ' A' ' 71' ' ' THR . 1.4 Cg_endo -73.73 162.57 39.26 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 120.859 1.039 . . . . 0.0 112.553 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -73.75 91.24 0.91 Allowed 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.552 1.502 . . . . 0.0 113.189 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.641 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 179.69 -171.53 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.511 ' OG ' ' NH1' ' A' ' 79' ' ' ARG . 2.5 m -38.91 -17.32 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.641 ' N ' ' O ' ' A' ' 74' ' ' ALA . 74.9 m-85 -45.69 -42.24 11.43 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.297 0.373 . . . . 0.0 110.392 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -130.74 -13.98 3.64 Favored 'General case' 0 C--O 1.254 1.318 0 CA-C-O 122.304 1.049 . . . . 0.0 108.891 178.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 82' ' ' ALA . 17.4 mt -65.34 -41.74 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.987 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.548 ' HG2' HH11 ' A' ' 79' ' ' ARG . 0.0 OUTLIER -51.76 -41.61 61.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.661 179.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -63.21 -63.18 1.27 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.27 69.6 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.491 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -79.52 -83.84 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.553 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 137.6 -76.87 0.35 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.9 mt 42.34 -160.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 C--N 1.329 -0.292 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.466 178.854 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.427 0.156 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -144.96 150.61 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 137' ' ' GLU . . . 82.4 75.96 1.12 Allowed Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -131.0 116.94 18.49 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.621 0.248 . . . . 0.0 110.624 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 mt -109.71 150.11 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.446 ' CG2' ' NE2' ' A' ' 103' ' ' GLN . 3.0 p -82.0 149.35 28.18 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.912 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -57.7 -52.05 67.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.092 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -58.77 -40.94 85.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.329 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.446 ' NE2' ' CG2' ' A' ' 100' ' ' THR . 58.3 mt-30 -60.62 -48.47 81.63 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.9 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.87 -32.78 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.658 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 108' ' ' ALA . 50.5 mt -59.5 -68.37 0.29 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.655 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -44.59 -46.2 9.89 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.284 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.57 -29.24 38.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.946 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -101.66 -8.23 21.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.651 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 105' ' ' LEU . 75.0 tttt -77.6 -75.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.007 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -59.58 -20.96 59.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.631 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -97.75 102.02 13.67 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.721 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 115' ' ' LEU . 6.6 mmt -140.05 55.34 6.35 Favored Pre-proline 0 C--O 1.236 0.373 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.129 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 112' ' ' MET . 14.5 Cg_exo -50.57 -54.8 4.85 Favored 'Trans proline' 0 N--CA 1.488 1.206 0 C-N-CA 120.671 0.914 . . . . 0.0 112.067 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -126.92 -29.27 2.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.345 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.497 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -75.14 38.99 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.072 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.661 ' N ' HD21 ' A' ' 116' ' ' ASN . 0.1 OUTLIER -84.85 46.82 1.3 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.704 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 119' ' ' ASP . 5.5 p -73.33 32.54 0.07 Allowed 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.855 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.505 ' H ' ' C ' ' A' ' 116' ' ' ASN . 9.8 t 39.43 29.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.26 0.35 . . . . 0.0 110.73 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 117' ' ' THR . 74.9 m-20 -150.95 125.37 9.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.458 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 124' ' ' ALA . 83.8 mt -62.95 -34.47 77.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.258 0.552 . . . . 0.0 110.788 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.67 -37.17 62.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.512 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.39 -69.4 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.056 -1.058 . . . . 0.0 109.35 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.6 -32.72 19.61 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.192 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -60.91 -70.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 129' ' ' GLY . 62.7 ttt180 -42.95 -30.78 0.44 Allowed 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.508 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 4.7 tmm? -58.38 -73.08 0.08 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 88.0 mt -50.69 -51.3 20.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.023 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -63.66 -71.55 0.17 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.73 -45.76 4.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.508 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 67.2 m -58.75 -44.65 90.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -51.59 -47.83 63.42 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -55.26 -42.28 73.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.4 t -55.26 -72.13 0.07 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.4 mtm -42.17 -34.71 0.79 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.773 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.38 49.11 0.57 Allowed Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 43.0 t -136.05 164.93 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.488 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 81.9 tt0 -130.13 158.72 38.9 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 140' ' ' GLY . 53.9 t -111.56 160.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.431 ' N ' ' CG1' ' A' ' 138' ' ' VAL . 9.8 p -64.48 8.45 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.091 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HG3' ' H ' ' A' ' 4' ' ' VAL . 7.7 tptm . . . . . 0 C--O 1.233 0.205 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.403 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 7.2 p -88.63 138.23 19.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 m -118.82 -25.44 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.188 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.44 143.04 29.82 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.853 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.0 p -133.84 133.03 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.563 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.42 92.67 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 120.067 1.303 . . . . 0.0 111.757 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -82.81 116.07 21.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -167.85 -173.78 2.22 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.536 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -90.76 143.78 26.38 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.68 86.84 52.73 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -65.71 114.91 3.12 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.54 1.493 . . . . 0.0 114.642 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.425 ' HB1' ' C ' ' A' ' 51' ' ' ALA . . . -74.9 146.54 41.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 174.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.73 58.33 10.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt 173.61 -24.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.91 150.29 45.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -160.39 167.54 13.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.115 -178.167 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -59.32 48.07 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.618 1.546 . . . . 0.0 112.711 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -169.53 53.87 0.23 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.504 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 20' ' ' ALA . 18.2 Cg_endo -68.1 166.1 26.12 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.032 1.155 . . . . 0.0 112.247 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -65.33 -22.18 60.41 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.803 1.002 . . . . 0.0 111.239 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.7 t -72.49 -64.32 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.554 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 25' ' ' PRO . . . 59.2 -137.48 50.23 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 118.619 -1.753 . . . . 0.0 109.485 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.702 ' C ' ' H ' ' A' ' 27' ' ' LEU . 28.2 Cg_exo -38.23 -41.32 1.35 Allowed 'Trans proline' 0 N--CA 1.486 1.06 0 CA-C-N 120.607 2.204 . . . . 0.0 110.853 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.47 13.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.811 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.702 ' H ' ' C ' ' A' ' 25' ' ' PRO . 3.5 tt -172.27 -48.7 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 30' ' ' HIS . . . -59.01 -48.9 83.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -73.96 35.55 0.09 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.471 0.653 . . . . 0.0 110.272 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.844 ' HD1' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -84.88 -19.93 31.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.258 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.844 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . 106.2 -43.85 1.59 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -49.35 -131.32 0.0 OUTLIER 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.335 0.654 . . . . 0.0 111.79 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -137.91 143.44 40.83 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.762 -0.586 . . . . 0.0 110.525 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' PHE . 6.7 mt -88.88 -70.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 39' ' ' LYS . 11.1 tpt -40.85 -39.6 1.17 Allowed 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -57.11 -49.32 76.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.631 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 64.2 t80 -48.78 -59.89 3.19 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.452 1.12 . . . . 0.0 109.501 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' ASN . 57.4 t -61.59 -42.73 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 113.391 -1.731 . . . . 0.0 111.281 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 35' ' ' MET . 2.0 tppp? -46.25 -57.9 4.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.65 95.08 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 119.921 -0.711 . . . . 0.0 110.127 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -62.81 -74.78 0.09 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -40.01 -43.32 1.54 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 121.558 0.694 . . . . 0.0 111.779 -177.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.39 75.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.261 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.12 -46.8 10.09 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.113 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.5 p -60.87 -37.77 83.28 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -65.22 -36.74 85.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -63.88 -18.6 64.34 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.756 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -103.79 -42.98 5.45 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.634 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 116.75 74.29 0.53 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.399 -0.667 . . . . 0.0 111.868 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.634 ' O ' ' O ' ' A' ' 49' ' ' GLY . 2.9 p30 44.93 159.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.883 0.373 . . . . 0.0 111.482 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 50' ' ' ASP . . . 170.81 -163.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.293 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.5 mt -141.06 131.23 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.99 125.52 4.94 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.833 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.42 149.78 31.49 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 CA-C-N 119.485 0.852 . . . . 0.0 110.86 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 m -144.64 161.92 14.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.434 0.635 . . . . 0.0 111.416 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 58' ' ' THR . 95.2 mt-10 -127.33 80.93 1.99 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.1 mt -54.04 88.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.043 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -66.21 110.53 3.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.4 mt -107.91 125.0 64.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.363 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -104.12 140.13 38.22 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.73 -21.78 1.79 Allowed 'General case' 0 C--N 1.341 0.232 0 O-C-N 124.226 0.954 . . . . 0.0 112.218 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -68.33 6.12 0.85 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.624 ' H ' ' C ' ' A' ' 61' ' ' ALA . 87.4 mtm180 64.62 67.8 0.55 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.355 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.7 m -143.21 127.14 17.29 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.854 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -108.39 102.49 11.59 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.606 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.418 ' OG1' ' OH ' ' A' ' 60' ' ' TYR . 44.4 p -93.95 126.06 38.93 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.631 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 5.6 p90 -174.96 130.99 0.31 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.918 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.5 t -137.05 156.06 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -177.71 121.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.949 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.454 ' O ' ' OG1' ' A' ' 71' ' ' THR . 42.6 pttt -177.51 -179.65 0.85 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.317 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.497 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 21.9 p 55.93 61.01 8.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.054 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 71' ' ' THR . 3.7 Cg_endo -75.27 164.1 33.5 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 120.897 1.065 . . . . 0.0 112.418 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 13.8 Cg_endo -72.2 176.51 8.43 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 121.899 1.732 . . . . 0.0 112.178 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 79.56 -174.54 0.06 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.909 0.322 . . . . 0.0 111.051 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.466 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.7 OUTLIER -39.99 -19.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.088 -178.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.552 ' N ' ' O ' ' A' ' 74' ' ' ALA . 10.1 m-85 -45.48 -35.95 4.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.697 0.623 . . . . 0.0 111.057 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.91 -25.52 1.83 Allowed 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.8 0.81 . . . . 0.0 109.021 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 73.7 mt -55.5 -35.47 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.666 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -53.73 -43.96 69.5 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.223 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 82' ' ' ALA . 62.8 tttp -64.55 -65.34 0.69 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.35 -13.45 0.56 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.979 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 80' ' ' LYS . . . -88.67 -76.62 0.39 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.765 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.48 48.84 0.58 Allowed Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.0 mt -98.7 124.05 43.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.3 mttm . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -145.24 144.13 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.634 0.254 . . . . 0.0 110.35 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 46.95 87.18 0.01 OUTLIER Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -116.39 106.25 13.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.977 0.418 . . . . 0.0 111.23 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.4 pt -100.94 144.91 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -85.45 156.87 20.64 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.439 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -63.73 -51.06 66.64 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.615 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.23 -43.4 98.95 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.152 -0.967 . . . . 0.0 111.533 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -61.33 -46.96 88.08 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.696 -0.801 . . . . 0.0 111.227 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.5 m -65.2 -33.56 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 118.235 -1.386 . . . . 0.0 109.414 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 109' ' ' LYS . 40.8 mt -59.48 -65.69 0.63 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.392 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -44.86 -51.15 9.87 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.049 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.34 -31.46 46.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.787 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -91.55 -8.07 48.48 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.675 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 105' ' ' LEU . 45.3 tttm -85.56 -71.57 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 109.919 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.63 -40.72 60.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.395 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -69.89 66.08 0.24 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.384 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.436 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 38.8 mtm -157.65 54.84 0.84 Allowed Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.568 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 112' ' ' MET . 9.8 Cg_endo -65.13 -55.7 0.45 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 120.805 1.003 . . . . 0.0 111.85 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 113' ' ' PRO . 57.5 m-20 -160.01 15.5 0.14 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.398 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.9 mt -46.61 -86.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.319 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -170.8 -18.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.25 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 70.1 p -83.33 167.51 17.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.1 0.476 . . . . 0.0 111.15 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.409 ' OG1' ' N ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -140.59 -85.83 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.401 -178.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.409 ' N ' ' OG1' ' A' ' 118' ' ' THR . 90.9 m-20 -58.67 159.55 6.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 124' ' ' ALA . 37.5 mt -61.77 -37.27 83.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 0.0 110.161 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -52.9 -37.79 61.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.281 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.17 -69.0 0.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 118.981 -1.087 . . . . 0.0 109.067 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.51 -35.52 20.26 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.227 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -59.09 -69.83 0.18 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.0 mtt180 -43.76 -30.57 0.67 Allowed 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.758 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.459 ' O ' ' CB ' ' A' ' 130' ' ' SER . 2.9 tmm? -59.31 -73.07 0.09 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.0 mm -51.69 -48.98 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.032 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -67.71 -70.44 0.26 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.61 -43.22 4.97 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 126' ' ' MET . 68.8 m -58.64 -42.64 88.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -56.07 -48.99 75.01 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -51.39 -41.38 60.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.578 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.6 t -54.77 -66.77 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 86.5 mtp -50.75 -4.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.812 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.578 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 91.21 -27.72 8.96 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 55.1 t -47.38 164.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.455 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 97.7 mt-10 -141.23 161.9 36.77 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.056 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 140' ' ' GLY . 83.0 t -88.09 152.44 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.3 2.68 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.285 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.524 0.617 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.224 -0.259 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.428 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 14.2 p -51.9 112.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.639 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.8 -24.18 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.89 132.4 23.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.102 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 8.6 p -122.56 105.29 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.687 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -76.64 91.66 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 118.741 -1.184 . . . . 0.0 109.626 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -89.32 106.43 18.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.511 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -175.32 -173.77 0.68 Allowed 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.024 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -100.95 163.23 12.39 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.479 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 mt -153.51 137.3 10.48 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -87.53 125.27 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 CA-C-N 120.366 1.166 . . . . 0.0 114.114 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.543 ' O ' ' O ' ' A' ' 15' ' ' GLY . . . -59.33 139.17 57.27 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . 57.79 152.8 0.01 OUTLIER Glycine 0 CA--C 1.536 1.345 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 50.4 tttt 77.34 13.97 1.91 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.797 1.799 . . . . 0.0 111.373 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.19 157.97 16.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.99 167.56 4.87 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.653 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.09 39.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.709 1.606 . . . . 0.0 112.61 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 18' ' ' THR . . . -146.52 54.08 1.99 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.043 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 38.9 Cg_endo -82.49 164.24 16.61 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 120.972 1.114 . . . . 0.0 112.142 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -62.33 -25.7 76.63 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 120.8 1.0 . . . . 0.0 111.024 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.04 -71.57 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.034 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 46.47 -101.24 0.03 OUTLIER Glycine 0 C--O 1.214 -1.151 0 CA-C-O 118.574 -1.125 . . . . 0.0 111.099 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 27' ' ' LEU . 19.4 Cg_exo -43.57 -56.29 2.46 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 CA-C-N 121.479 2.639 . . . . 0.0 110.728 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.71 23.9 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.599 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.63 ' H ' ' C ' ' A' ' 25' ' ' PRO . 12.7 tp -169.98 -47.37 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -59.35 -51.39 59.44 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.529 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -73.57 41.28 0.11 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.014 0.907 . . . . 0.0 109.9 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.817 ' HD1' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -89.35 -21.29 23.18 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.817 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . 106.86 -38.82 3.13 Favored Glycine 0 N--CA 1.462 0.431 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.555 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -50.87 -134.98 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -137.14 125.93 24.01 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.484 -0.76 . . . . 0.0 110.4 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.571 ' O ' ' N ' ' A' ' 37' ' ' PHE . 10.9 mm -67.92 -70.55 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.409 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -39.53 -36.93 0.43 Allowed 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.505 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -61.89 -47.1 86.51 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.64 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 59.0 t80 -51.05 -65.1 0.61 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.412 1.101 . . . . 0.0 109.201 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 42' ' ' ASN . 96.4 t -57.07 -42.45 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.276 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 88.2 tttt -49.81 -60.94 2.44 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.685 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.72 79.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.355 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.64 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 8.8 m-85 -64.9 -76.44 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' VAL . 8.9 t-20 -39.3 -49.42 1.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.358 0.599 . . . . 0.0 111.973 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -57.32 -34.01 68.31 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.864 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.83 -46.91 9.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.054 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 49' ' ' GLY . 76.7 p -62.94 -24.01 67.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -84.89 -35.74 21.97 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -60.45 -25.63 66.14 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.501 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 6.6 ptm -107.14 -55.65 2.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.383 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.501 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 152.68 170.9 19.6 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.298 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -73.56 141.26 46.68 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 122.475 -0.426 . . . . 0.0 110.028 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -172.56 -152.26 0.06 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.155 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.8 mm -139.07 130.5 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.3 t -145.02 134.68 11.52 Favored Pre-proline 0 C--O 1.246 0.893 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.188 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -76.1 148.5 31.25 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 120.589 0.859 . . . . 0.0 110.384 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.6 m -146.06 137.04 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.504 0.669 . . . . 0.0 111.967 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 78.0 mt-10 -117.76 75.07 0.97 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.4 mt -58.26 93.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.944 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.36 95.29 1.72 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.9 mt -95.12 120.99 45.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -98.15 142.02 30.36 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.668 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.33 -20.18 1.01 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.846 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 93.3 m-20 -73.23 30.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.668 ' H ' ' C ' ' A' ' 61' ' ' ALA . 5.2 ptm180 40.31 69.77 0.29 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 122.305 1.05 . . . . 0.0 110.888 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 99.4 p -144.84 125.61 14.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.052 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -102.85 101.83 11.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.382 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 1.2 p -93.77 178.08 5.79 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CB ' ' O ' ' A' ' 66' ' ' THR . 1.9 t80 82.17 -154.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -177.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 t 82.25 72.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 123.871 0.732 . . . . 0.0 111.791 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.0 t -68.49 154.14 42.43 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.397 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.401 ' O ' ' OG1' ' A' ' 71' ' ' THR . 18.4 pttp -175.7 178.57 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.652 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 24.7 p 51.61 82.68 0.24 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.766 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.87 177.08 2.53 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.438 1.425 . . . . 0.0 112.441 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -74.98 4.6 4.58 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.398 1.399 . . . . 0.0 113.825 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -72.18 -152.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.832 0.349 . . . . 0.0 110.758 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -39.38 -15.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.691 0.397 . . . . 0.0 111.431 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.59 ' N ' ' O ' ' A' ' 74' ' ' ALA . 2.5 t80 -40.37 -47.75 2.59 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.976 0.798 . . . . 0.0 110.604 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.494 ' C ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -133.42 -14.92 2.52 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.787 0.803 . . . . 0.0 108.885 179.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 82' ' ' ALA . 22.9 mt -60.45 -38.12 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -50.29 -44.66 54.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.265 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -66.42 -61.07 2.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.66 -21.7 7.42 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.089 -0.645 . . . . 0.0 110.597 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -87.49 -77.91 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.807 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.63 19.41 3.76 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.3 mt -69.11 139.05 54.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.701 -179.863 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.831 0.348 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -145.36 163.31 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.23 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.76 75.51 1.29 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -136.82 119.29 15.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.129 0.49 . . . . 0.0 111.25 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.6 pt -108.65 148.3 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.261 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.436 ' CG2' ' NE2' ' A' ' 103' ' ' GLN . 1.2 p -80.73 145.86 31.33 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.454 0.645 . . . . 0.0 110.832 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -53.26 -70.53 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.374 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -43.78 -38.09 3.06 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.216 -0.928 . . . . 0.0 111.482 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.436 ' NE2' ' CG2' ' A' ' 100' ' ' THR . 42.1 mt-30 -61.44 -48.5 80.87 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.821 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 m -63.78 -27.77 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 117.711 -1.596 . . . . 0.0 109.099 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 109' ' ' LYS . 35.9 mt -62.43 -70.86 0.18 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.654 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -45.87 -48.4 15.95 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.39 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.88 -30.39 47.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.934 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.521 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -98.9 -2.53 37.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.026 -0.421 . . . . 0.0 110.681 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 105' ' ' LEU . 68.7 tttt -89.08 -75.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.333 . . . . 0.0 111.026 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.29 -36.6 71.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.649 0.261 . . . . 0.0 111.46 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.43 48.68 0.11 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.049 0.452 . . . . 0.0 111.745 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.521 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 1.3 ptt? -171.64 58.04 0.25 Allowed Pre-proline 0 C--N 1.322 -0.628 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.615 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 112' ' ' MET . 14.0 Cg_exo -54.13 -38.59 87.61 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 120.508 0.805 . . . . 0.0 111.808 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -168.07 34.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.994 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 tt -61.36 -52.19 65.65 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.239 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.547 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -174.38 -6.99 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.332 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.9 p -140.61 175.21 9.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.146 0.498 . . . . 0.0 111.758 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.33 -37.56 0.42 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.432 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -76.55 145.32 39.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.985 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 124' ' ' ALA . 1.1 mm? -61.24 -45.47 94.39 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 121.505 0.669 . . . . 0.0 110.254 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.48 -36.75 69.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.451 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.45 -69.08 0.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.772 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.14 -40.21 45.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.173 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -54.39 -68.99 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.2 mtt180 -44.09 -28.8 0.53 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.081 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.484 ' O ' ' N ' ' A' ' 130' ' ' SER . 5.6 tmm? -59.83 -71.06 0.14 Allowed 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.5 mt -51.41 -50.48 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.728 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -64.63 -71.74 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.25 -45.27 5.16 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 126' ' ' MET . 62.5 m -60.26 -41.07 92.48 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -54.86 -47.19 74.52 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -54.5 -41.77 70.01 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 135' ' ' GLY . 1.9 t -57.01 -71.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 80.1 mtp -43.73 -13.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.329 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 90.66 46.14 4.07 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 131' ' ' ALA . 53.2 t -137.58 142.66 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.43 167.8 10.41 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 140' ' ' GLY . 12.0 t -89.9 144.52 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.03 0.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.291 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.524 0.604 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 4' ' ' VAL . 99.2 mttt . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 3' ' ' LYS . 7.0 p -40.55 124.72 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.1 m -113.88 -24.07 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.64 135.86 32.12 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.869 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 12.6 p -124.65 123.62 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.195 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.63 92.05 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.638 1.108 . . . . 0.0 111.004 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -75.16 112.93 11.94 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -170.45 -173.85 1.53 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.383 0.611 . . . . 0.0 110.583 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -99.49 157.61 16.32 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 mt -133.8 89.05 31.19 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -58.09 135.09 66.31 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.446 1.431 . . . . 0.0 114.442 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.547 ' CB ' ' H ' ' A' ' 51' ' ' ALA . . . -91.83 144.43 25.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.59 40.84 33.03 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -170.26 8.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.237 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.21 150.12 21.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -158.05 164.89 19.91 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.021 -178.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -61.69 47.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.658 1.572 . . . . 0.0 112.456 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.473 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -169.85 54.17 0.23 Allowed Pre-proline 0 C--N 1.322 -0.627 0 O-C-N 122.153 -0.342 . . . . 0.0 110.696 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 22.2 Cg_endo -73.57 172.27 16.08 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 121.066 1.177 . . . . 0.0 112.24 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -57.51 -21.46 46.01 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 120.525 0.817 . . . . 0.0 111.056 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.93 -64.11 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.794 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 45.7 -100.48 0.02 OUTLIER Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.71 -1.05 . . . . 0.0 110.72 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.5 Cg_exo -50.64 -57.92 1.99 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 CA-C-N 120.678 2.239 . . . . 0.0 111.054 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.49 -17.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.596 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -113.96 -39.6 3.92 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.18 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.64 51.0 3.26 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -142.33 -13.25 0.8 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.367 0.603 . . . . 0.0 109.794 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.732 ' HD1' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -70.66 -15.48 62.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.938 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.732 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . 100.88 -32.99 6.8 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.604 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -46.43 -133.8 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.393 0.677 . . . . 0.0 112.357 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -136.2 144.97 45.2 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.904 -0.498 . . . . 0.0 110.483 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 37' ' ' PHE . 4.5 mm -94.03 -73.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 39' ' ' LYS . 3.7 ppp? -41.14 -35.82 0.64 Allowed 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.23 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -59.72 -52.64 64.64 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 90.1 t80 -47.84 -58.94 3.73 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.469 1.128 . . . . 0.0 109.241 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 42' ' ' ASN . 75.3 t -60.76 -44.65 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.156 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 35' ' ' MET . 88.3 tttt -45.21 -64.68 0.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.04 74.13 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.433 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -62.15 -76.36 0.06 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -40.28 -43.4 1.71 Allowed 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 121.311 0.577 . . . . 0.0 111.822 -177.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.05 -34.17 69.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.93 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.19 -47.11 10.43 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.829 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 49' ' ' GLY . 71.8 p -62.57 -32.33 73.29 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -69.17 -41.02 77.77 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -63.66 -18.49 64.02 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 70.8 mtm -107.22 -86.67 0.49 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.788 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -174.7 -165.72 31.54 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.359 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 34.1 p-10 -93.5 130.18 39.44 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.547 ' H ' ' CB ' ' A' ' 14' ' ' ALA . . . -162.41 -152.45 0.23 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.296 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.4 mt -141.99 132.1 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.7 108.07 28.77 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -74.02 112.09 3.46 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 120.793 0.995 . . . . 0.0 109.698 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.526 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 6.5 p -144.35 164.61 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 121.488 0.661 . . . . 0.0 112.2 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 12.7 mt-10 -123.19 115.93 22.58 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.2 mt -74.92 94.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.917 0.389 . . . . 0.0 111.757 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -69.42 102.21 1.73 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 mt -100.73 123.62 53.81 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-O 120.844 0.354 . . . . 0.0 111.163 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -99.3 143.17 29.86 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.505 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.658 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -53.74 -24.44 14.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 124.717 1.261 . . . . 0.0 112.375 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 41.0 t0 -67.72 7.57 0.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.658 ' H ' ' C ' ' A' ' 61' ' ' ALA . 98.5 mtt180 62.5 70.37 0.57 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.252 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 p -145.3 134.08 22.33 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.947 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -111.55 103.81 12.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.651 -178.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.7 p -96.8 123.22 40.44 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 5.9 p90 177.98 -150.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -175.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 53.2 t 80.56 104.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 124.344 1.028 . . . . 0.0 111.766 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 p -122.59 112.72 18.33 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.495 ' O ' ' CG2' ' A' ' 71' ' ' THR . 12.4 mmtt -143.8 -150.29 0.31 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.634 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 4.8 t 47.0 53.47 13.83 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 123.699 0.624 . . . . 0.0 110.442 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.634 ' HD3' ' N ' ' A' ' 71' ' ' THR . 6.5 Cg_endo -79.36 175.79 10.37 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 120.727 0.952 . . . . 0.0 112.399 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.466 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 1.7 Cg_endo -64.7 -172.22 0.19 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.608 1.538 . . . . 0.0 111.246 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 78.99 -176.72 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.578 0.228 . . . . 0.0 110.729 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 p -40.92 -20.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.474 -0.141 . . . . 0.0 110.652 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 74' ' ' ALA . 11.9 m-85 -43.28 -44.26 5.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.366 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.58 -25.4 3.43 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 122.068 0.937 . . . . 0.0 109.018 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 82' ' ' ALA . 26.9 mt -54.05 -33.38 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.438 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 83' ' ' GLY . 19.6 mmm-85 -51.54 -48.34 63.07 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.091 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -64.74 -61.84 1.94 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.57 -21.8 4.26 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.639 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -91.68 -77.05 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.639 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 113.93 54.84 0.42 Allowed Glycine 0 N--CA 1.469 0.85 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 85' ' ' GLU . 10.0 mt -94.58 15.06 18.98 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.853 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' LEU . 64.9 tt0 . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.9 mttm . . . . . 0 N--CA 1.463 0.19 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.3 p -136.44 157.86 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 118.35 80.78 0.73 Allowed Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -126.48 94.4 4.05 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.948 0.404 . . . . 0.0 111.962 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 pt -100.93 149.78 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.452 ' OG1' ' OE1' ' A' ' 103' ' ' GLN . 0.2 OUTLIER -90.78 156.53 17.98 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.478 0.656 . . . . 0.0 110.333 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.431 ' O ' ' CG2' ' A' ' 104' ' ' VAL . 61.3 t-105 -61.56 -71.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.325 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -46.46 -39.14 10.16 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 120.761 -1.212 . . . . 0.0 111.905 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.452 ' OE1' ' OG1' ' A' ' 100' ' ' THR . 32.3 mt-30 -60.8 -47.19 87.45 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.308 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 101' ' ' TRP . 15.9 m -63.62 -29.0 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.371 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 108' ' ' ALA . 59.7 mt -63.23 -72.61 0.13 Allowed 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.998 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -44.88 -45.04 10.07 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.2 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.63 -25.22 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.127 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -106.27 -1.02 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.704 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 105' ' ' LEU . 43.8 tttp -85.18 -74.68 0.39 Allowed 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.253 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -62.42 -43.61 98.4 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.548 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -76.45 76.15 3.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.799 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.449 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -135.98 54.85 10.67 Favored Pre-proline 0 N--CA 1.468 0.432 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.009 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 112' ' ' MET . 4.3 Cg_endo -59.84 -30.97 93.16 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 120.701 0.934 . . . . 0.0 111.662 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' A' ' 116' ' ' ASN . 36.8 t70 -154.05 -86.08 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.992 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.1 mt 51.69 0.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.634 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.609 ' H ' ' C ' ' A' ' 114' ' ' ASP . 4.0 t30 54.38 26.95 7.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.47 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.3 p -143.79 161.62 38.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.293 0.568 . . . . 0.0 111.728 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.3 -32.48 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.09 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -75.02 146.04 41.93 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.74 -45.71 93.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.355 0.598 . . . . 0.0 110.406 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -59.19 -38.85 80.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.702 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.95 -68.98 0.34 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.016 -1.073 . . . . 0.0 108.805 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.18 -37.49 22.67 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.075 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.85 -66.25 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.1 mtt180 -46.16 -36.0 5.56 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.507 ' O ' ' N ' ' A' ' 130' ' ' SER . 5.7 tmm? -55.57 -73.47 0.06 Allowed 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.1 mm -51.15 -50.33 26.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.962 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -62.67 -72.55 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.15 -47.41 5.41 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 126' ' ' MET . 66.4 m -56.79 -43.0 80.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -52.52 -46.85 66.89 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.552 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -55.55 -34.25 64.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 130' ' ' SER . 3.1 t -65.37 -76.45 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 6.7 ptm -40.2 -25.73 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.636 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 104.38 60.52 0.67 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' A' ' 131' ' ' ALA . 27.4 t -145.29 162.99 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.462 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 98.1 mt-10 -128.94 156.22 44.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.73 152.11 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 46.1 t -96.74 -11.8 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.718 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.619 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.57 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 48.4 tttt . . . . . 0 CA--C 1.506 -0.725 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.67 158.71 30.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.621 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.98 -26.16 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.13 116.55 4.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 119.044 -1.062 . . . . 0.0 111.103 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 9.4 p -110.12 112.24 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.335 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.89 90.41 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 118.563 -1.255 . . . . 0.0 110.693 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -76.26 120.17 21.16 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.411 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -173.68 -174.65 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.38 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.414 ' N ' ' NE2' ' A' ' 11' ' ' GLN . 2.7 mp0 -95.87 159.38 15.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.61 92.89 14.6 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.36 146.5 94.63 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.26 1.307 . . . . 0.0 114.414 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.32 143.2 31.66 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.44 44.59 36.43 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -167.46 -6.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.238 -0.481 . . . . 0.0 109.811 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.09 149.62 30.57 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -158.97 168.03 13.23 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.115 -178.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -60.14 41.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.475 1.45 . . . . 0.0 112.427 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -172.34 58.79 0.25 Allowed Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.919 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 20.5 Cg_endo -78.75 172.21 15.44 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.218 1.279 . . . . 0.0 112.136 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -55.88 -23.82 44.4 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 120.552 0.834 . . . . 0.0 111.013 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.4 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.2 t -83.04 -64.55 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 43.43 -96.86 0.01 OUTLIER Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 14.2 Cg_exo -47.13 -60.06 1.02 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 CA-C-N 119.927 1.863 . . . . 0.0 110.669 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.33 -23.84 0.65 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.847 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.96 26.88 9.49 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.48 41.32 0.63 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -141.69 -11.17 0.9 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.438 0.637 . . . . 0.0 109.619 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.616 ' HD1' ' H ' ' A' ' 32' ' ' ALA . 1.4 p80 -67.18 -15.34 63.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.466 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 102.22 -26.33 24.63 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.616 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -51.37 -132.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.142 0.577 . . . . 0.0 112.089 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -133.45 -169.28 2.25 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 37' ' ' PHE . 3.4 mm -131.65 -76.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.582 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -40.2 -42.28 1.46 Allowed 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.875 179.048 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -52.81 -51.47 60.7 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.101 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 34' ' ' ILE . 2.0 t80 -50.37 -66.09 0.45 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.599 1.19 . . . . 0.0 109.845 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 42' ' ' ASN . 54.0 t -57.51 -48.61 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 112.889 -1.959 . . . . 0.0 110.939 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.582 ' N ' ' O ' ' A' ' 35' ' ' MET . 79.1 mttt -44.14 -58.49 2.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.43 -44.33 84.57 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.048 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 44' ' ' ALA . 1.8 t80 -61.13 -73.96 0.09 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -39.85 -41.29 1.12 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.688 0.756 . . . . 0.0 111.681 -177.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -61.9 -35.0 77.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.083 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -86.4 -43.49 12.78 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.749 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 49' ' ' GLY . 70.4 p -63.61 -34.93 78.92 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -67.96 -42.07 81.45 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -62.95 -20.14 64.95 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.0 ttp -106.08 -85.28 0.5 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.954 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 170.78 170.3 34.84 Favored Glycine 0 N--CA 1.465 0.617 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.108 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 47.7 p-10 -65.39 137.05 57.24 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -176.09 -154.0 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.857 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.7 mm -141.68 130.99 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.88 127.93 16.47 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.626 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -71.05 148.62 57.14 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.804 1.003 . . . . 0.0 110.751 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.68 160.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.485 0.659 . . . . 0.0 111.434 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -139.47 103.17 4.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.1 mt -68.17 87.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.582 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 m -70.99 103.16 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 mt -103.74 126.0 58.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.173 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 3' ' ' LYS . 4.4 m-85 -104.07 141.09 36.82 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.652 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -51.09 -22.11 2.26 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 124.18 0.925 . . . . 0.0 112.079 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -67.51 9.12 0.27 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.652 ' H ' ' C ' ' A' ' 61' ' ' ALA . 99.5 mtt180 60.96 68.97 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.923 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -146.22 132.36 19.37 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.135 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -109.56 102.39 11.25 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.161 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 8.4 m -95.56 119.66 34.44 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER 172.19 115.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 O-C-N 124.4 1.062 . . . . 0.0 111.092 -176.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.8 t -154.43 136.6 6.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 p -141.47 147.05 37.25 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -141.76 171.06 14.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.251 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -40.17 98.08 0.16 Allowed Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.793 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.493 ' O ' ' O ' ' A' ' 71' ' ' THR . 16.2 Cg_exo -43.26 177.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 121.256 1.304 . . . . 0.0 113.119 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -51.14 113.54 1.15 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.427 1.418 . . . . 0.0 112.759 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 172.38 -152.0 0.01 OUTLIER 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.629 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 80.2 p -36.94 -22.96 0.01 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.985 0.421 . . . . 0.0 110.44 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.604 ' N ' ' O ' ' A' ' 74' ' ' ALA . 11.6 t80 -47.37 -36.75 10.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.68 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.9 -34.22 3.98 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.67 0.747 . . . . 0.0 109.884 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.629 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 69.0 mt -48.2 -38.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.418 ' NH1' ' O ' ' A' ' 84' ' ' LEU . 13.1 mmm180 -51.67 -45.99 63.63 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.329 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -66.54 -63.31 1.1 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.33 -19.27 2.0 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.293 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -89.96 -77.62 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.607 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.33 45.1 0.63 Allowed Glycine 0 N--CA 1.47 0.902 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.418 ' O ' ' NH1' ' A' ' 79' ' ' ARG . 24.5 mt -98.89 115.36 28.67 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.753 0.311 . . . . 0.0 110.559 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.532 0.206 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.18 155.93 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.247 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.53 82.48 0.07 OUTLIER Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -135.1 104.19 5.84 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.8 pt -104.37 150.21 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.451 ' CG2' ' NE2' ' A' ' 103' ' ' GLN . 1.8 p -87.96 155.72 19.69 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.397 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -60.97 -54.59 43.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.083 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 1.3 tp10 -59.1 -40.37 85.1 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.059 -1.025 . . . . 0.0 111.123 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.451 ' NE2' ' CG2' ' A' ' 100' ' ' THR . 41.0 mt-30 -59.38 -47.14 86.55 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.811 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.4 m -65.52 -29.06 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 118.494 -1.282 . . . . 0.0 109.467 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 109' ' ' LYS . 64.7 mt -64.52 -74.03 0.11 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.522 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -44.2 -48.76 9.3 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.464 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.6 -25.28 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.107 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -105.54 -0.34 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.479 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.9 tmtt? -89.2 -74.74 0.46 Allowed 'General case' 0 N--CA 1.461 0.083 0 CA-C-O 120.751 0.31 . . . . 0.0 110.187 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -72.53 -40.99 66.35 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.843 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -74.85 73.59 2.11 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.57 61.71 0.17 Allowed Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.407 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -52.75 -43.15 58.07 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 120.594 0.863 . . . . 0.0 112.051 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 116' ' ' ASN . 27.0 t70 -142.4 -61.79 0.44 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.272 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.405 ' HB3' ' H ' ' A' ' 116' ' ' ASN . 1.4 tt 45.64 -85.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.933 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 114' ' ' ASP . 4.3 t30 -174.77 9.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.943 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 46.5 p -141.83 171.19 14.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.401 0.619 . . . . 0.0 111.749 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.37 -40.86 0.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.894 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -83.48 153.31 24.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 124' ' ' ALA . 35.8 mt -60.24 -46.18 90.66 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.314 0.578 . . . . 0.0 109.931 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -54.81 -42.09 71.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.916 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.56 -66.84 0.53 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.116 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.63 36.67 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.941 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -53.03 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.602 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.4 mtt180 -43.3 -31.22 0.6 Allowed 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.001 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 130' ' ' SER . 5.5 ttp -59.33 -73.48 0.08 Allowed 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.9 mp -48.99 -49.39 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.581 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -65.98 -71.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.34 -49.29 5.64 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 126' ' ' MET . 49.5 m -54.47 -42.99 71.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -56.05 -47.8 77.21 Favored 'General case' 0 C--O 1.228 -0.069 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -55.14 -41.51 71.86 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 t -53.31 -71.26 0.07 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.1 mtm -41.58 -62.07 0.95 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.942 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.18 50.0 0.04 OUTLIER Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 54.4 t -133.92 164.82 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.477 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 98.0 mt-10 -133.78 159.27 41.1 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.2 t -96.34 155.12 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.0 p -83.44 -2.71 6.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.647 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.261 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.354 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? . . . . . 0 C--O 1.223 -0.333 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.91 121.67 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 m -113.33 -25.32 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.778 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.94 135.59 39.74 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.271 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 7.4 p -126.37 126.95 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.226 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.96 91.03 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.826 1.194 . . . . 0.0 111.539 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -82.15 116.32 21.66 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -168.47 -171.51 1.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.403 -178.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -94.44 154.16 17.58 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.445 ' CD1' ' CZ ' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -135.66 92.35 17.14 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -71.65 114.32 3.91 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.264 1.309 . . . . 0.0 114.775 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.455 ' CB ' ' H ' ' A' ' 51' ' ' ALA . . . -61.94 143.83 55.9 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . 61.49 150.53 0.02 OUTLIER Glycine 0 C--N 1.336 0.57 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.4 tttp 72.88 10.52 5.4 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.126 0.963 . . . . 0.0 110.564 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.15 151.93 20.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.6 170.81 3.97 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.041 -178.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -58.79 42.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.363 1.375 . . . . 0.0 112.23 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -160.91 54.26 0.55 Allowed Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-O 120.474 0.178 . . . . 0.0 110.533 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 25.6 Cg_endo -77.07 168.37 23.43 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.091 1.194 . . . . 0.0 112.21 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -56.51 -31.37 86.02 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 120.639 0.893 . . . . 0.0 111.284 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.7 t -75.02 -61.28 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 44.48 -99.61 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -47.87 -60.31 0.92 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 CA-C-N 119.816 1.808 . . . . 0.0 110.998 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -45.9 -26.83 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.366 -0.533 . . . . 0.0 109.824 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 25.6 tp -119.69 23.06 11.34 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.603 0.716 . . . . 0.0 109.172 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -152.56 37.93 0.77 Allowed Glycine 0 C--N 1.322 -0.221 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.668 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 29' ' ' GLN . 0.8 OUTLIER -141.57 -3.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.619 ' HD1' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -78.5 -11.96 59.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.264 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.619 ' N ' ' HD1' ' A' ' 30' ' ' HIS . . . 97.83 -26.1 24.72 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.588 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -47.66 -134.37 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.987 0.515 . . . . 0.0 112.287 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -136.76 143.58 43.33 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 122.093 -0.38 . . . . 0.0 111.015 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.6 mm -93.14 -73.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.483 ' O ' ' N ' ' A' ' 39' ' ' LYS . 11.4 tpt -39.72 -39.44 0.77 Allowed 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -59.49 -52.44 65.57 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.822 -0.751 . . . . 0.0 108.993 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' A' ' 34' ' ' ILE . 90.2 t80 -47.11 -62.43 1.42 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.165 0.983 . . . . 0.0 109.724 177.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 42' ' ' ASN . 86.9 t -58.71 -44.02 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 113.309 -1.769 . . . . 0.0 111.178 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 35' ' ' MET . 88.4 tttt -45.44 -67.79 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.75 -41.02 66.67 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.491 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 12' ' ' LEU . 54.9 t80 -62.9 -77.03 0.06 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.29 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -40.24 -44.73 1.94 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.314 0.578 . . . . 0.0 112.182 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.06 -34.81 70.52 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.113 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.17 -46.05 11.45 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.618 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 49' ' ' GLY . 32.4 p -63.76 -31.69 72.94 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -70.03 -41.02 74.82 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -62.4 -20.02 64.03 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.2 mtm -106.51 -78.85 0.57 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.259 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 169.17 166.49 28.29 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.362 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 36.9 p-10 -62.63 125.51 24.17 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.455 ' H ' ' CB ' ' A' ' 14' ' ' ALA . . . -162.41 -153.88 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.285 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 99.3 mt -142.03 132.15 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.72 120.46 6.03 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.249 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -65.37 140.71 65.03 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 120.746 0.964 . . . . 0.0 110.862 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.4 m -137.53 159.62 34.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.234 0.54 . . . . 0.0 110.861 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 58' ' ' THR . 32.4 tt0 -129.89 85.7 2.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mt -60.36 82.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.216 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -72.74 97.16 2.15 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.2 mt -97.31 126.25 50.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.008 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -98.86 144.65 27.83 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.672 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -54.25 -24.12 17.46 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.44 1.088 . . . . 0.0 112.331 -176.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -68.45 10.44 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.672 ' H ' ' C ' ' A' ' 61' ' ' ALA . 87.2 mtm180 61.27 69.2 0.68 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.496 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.3 m -142.9 126.94 17.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.843 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -107.58 103.76 13.15 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.058 -177.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' A' ' 58' ' ' THR . 77.3 p -95.71 121.58 37.57 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.543 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.4 p90 176.46 -152.54 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 51.7 t 80.69 152.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.304 0 O-C-N 124.329 1.018 . . . . 0.0 110.564 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t -146.68 173.36 12.43 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.45 ' O ' ' CG2' ' A' ' 71' ' ' THR . 58.0 pttt -170.6 -159.85 0.19 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.565 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 t 43.25 56.38 11.84 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.956 0.408 . . . . 0.0 111.431 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 71' ' ' THR . 9.8 Cg_endo -77.82 157.57 31.35 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 C-N-CA 120.064 0.509 . . . . 0.0 112.04 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.51 ' O ' ' HD2' ' A' ' 76' ' ' TYR . 11.3 Cg_endo -70.13 176.2 7.38 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 121.952 1.768 . . . . 0.0 112.293 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 79.71 -177.24 0.08 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.897 0.317 . . . . 0.0 110.279 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.552 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.1 OUTLIER -40.51 -20.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.312 -0.242 . . . . 0.0 110.521 -179.031 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' A' ' 74' ' ' ALA . 26.0 m-85 -42.73 -35.96 1.3 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.651 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -133.51 -25.55 1.7 Allowed 'General case' 0 C--O 1.253 1.253 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.552 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 45.6 mt -54.56 -35.02 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.573 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -53.37 -42.84 67.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.277 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 82' ' ' ALA . 3.1 tmtm? -67.84 -65.32 0.71 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.9 -11.64 0.25 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.999 -0.681 . . . . 0.0 110.65 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.458 ' H ' ' C ' ' A' ' 80' ' ' LYS . . . -87.42 -77.63 0.33 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.851 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 137.74 63.09 0.05 OUTLIER Glycine 0 N--CA 1.464 0.537 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.9 mt -115.06 135.87 53.74 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.233 0.214 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.61 159.5 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.68 68.19 1.07 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.28 99.29 6.27 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.706 0.253 . . . . 0.0 111.034 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.7 pt -95.63 139.29 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.61 155.99 25.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.753 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.458 ' O ' ' CG2' ' A' ' 104' ' ' VAL . 57.2 t-105 -61.75 -69.13 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -48.29 -42.17 30.07 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 120.916 -1.115 . . . . 0.0 112.147 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -59.86 -46.08 90.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.451 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 101' ' ' TRP . 19.2 m -63.44 -29.78 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 118.286 -1.366 . . . . 0.0 109.283 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 108' ' ' ALA . 36.7 mt -62.38 -70.68 0.19 Allowed 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.339 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -43.63 -46.29 7.21 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.568 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.46 -26.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.378 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.554 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -101.66 -2.39 30.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.364 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.517 ' O ' ' SD ' ' A' ' 112' ' ' MET . 87.5 tttt -88.76 -75.45 0.43 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.857 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.4 -40.3 73.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.04 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.15 84.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.456 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.554 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 3.1 ptt? -179.51 58.24 0.1 OUTLIER Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.505 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 112' ' ' MET . 13.6 Cg_endo -75.81 -55.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 120.618 0.879 . . . . 0.0 112.337 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -88.85 -31.45 18.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.772 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 117' ' ' THR . 10.3 mt -45.42 134.07 7.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -65.98 70.24 0.06 Allowed 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.298 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LEU . 82.6 p -143.71 159.35 42.65 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.212 0.53 . . . . 0.0 111.994 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.64 -43.32 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.935 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -91.94 148.35 22.27 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -46.82 87.5 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.689 0.757 . . . . 0.0 110.124 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.65 -35.68 68.66 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.66 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.92 -64.73 0.81 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.937 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.87 -22.92 27.97 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.923 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.95 -73.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.2 mtt180 -43.09 -31.95 0.63 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.658 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 130' ' ' SER . 38.9 ttp -57.36 -72.95 0.08 Allowed 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.0 mm -51.33 -50.28 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.328 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -64.28 -72.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.13 -45.58 3.99 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 126' ' ' MET . 67.7 m -56.74 -44.69 81.95 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -56.22 -50.43 71.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.583 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -48.88 -42.88 38.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.399 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.608 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.4 t -54.13 -65.07 0.64 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.8 mtp -52.45 -2.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.605 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.1 -29.27 6.61 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 68.1 t -46.05 164.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.462 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 79.2 mt-10 -143.05 164.76 29.22 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.093 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.23 155.03 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -100.18 -7.54 9.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.703 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.464 0 CA-C-O 119.131 -0.816 . . . . 0.0 111.553 -178.432 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.418 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 17.9 ttmt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.775 0.322 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.59 126.39 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -112.07 -24.77 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.41 119.6 14.61 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.292 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 7.6 p -111.6 104.82 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.842 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.68 92.41 2.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 117.985 -1.486 . . . . 0.0 110.295 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -85.23 109.49 18.37 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.437 0.461 . . . . 0.0 110.304 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.43 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -171.89 -174.51 1.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.191 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -102.18 173.57 6.32 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.61 139.31 5.93 Favored Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.974 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -82.2 149.54 15.3 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.125 1.217 . . . . 0.0 114.722 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.33 144.73 25.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.17 58.86 8.95 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm 172.63 21.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.336 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.16 150.68 21.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -162.42 168.54 10.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.075 -178.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -62.23 42.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.29 1.327 . . . . 0.0 111.963 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -155.53 59.31 2.13 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.994 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 27.8 Cg_endo -79.72 166.47 21.57 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.286 1.324 . . . . 0.0 111.888 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.37 -30.71 88.83 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 120.8 1.0 . . . . 0.0 111.102 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.98 -58.06 6.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.812 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 41.08 -99.64 0.01 OUTLIER Glycine 0 C--O 1.207 -1.555 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.3 Cg_exo -48.41 -62.49 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 CA-C-N 120.308 2.054 . . . . 0.0 110.789 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -42.95 -16.82 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.059 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.614 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 29.5 tp -117.53 -27.56 6.3 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.699 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -57.59 -54.83 34.18 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -88.99 43.22 1.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.565 0.697 . . . . 0.0 110.496 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.668 ' CD2' ' H ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -86.87 -31.74 20.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.668 ' H ' ' CD2' ' A' ' 30' ' ' HIS . . . 109.86 -48.83 0.9 Allowed Glycine 0 N--CA 1.472 1.085 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.546 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -50.33 -131.23 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.973 0.509 . . . . 0.0 111.865 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -138.71 128.33 24.76 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.89 -0.506 . . . . 0.0 111.205 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.9 mm -71.96 -72.25 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.453 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -38.55 -39.44 0.48 Allowed 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -58.93 -48.94 79.68 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.074 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 60.7 t80 -48.42 -65.66 0.53 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.527 1.156 . . . . 0.0 109.622 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 42' ' ' ASN . 89.8 t -56.87 -44.03 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.383 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -47.06 -53.03 13.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.87 -37.8 87.12 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.227 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 7.8 m-85 -65.43 -74.11 0.11 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -37.16 -45.69 0.65 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.516 0.674 . . . . 0.0 111.514 -177.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.17 79.31 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.55 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -88.73 -45.23 9.96 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.519 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.3 p -60.63 -18.54 53.92 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -86.69 -42.72 13.15 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -60.23 -17.04 38.88 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.786 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 49' ' ' GLY . 1.7 ppp? -120.11 126.41 50.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.132 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.501 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -40.93 161.9 0.01 OUTLIER Glycine 0 CA--C 1.543 1.835 0 C-N-CA 119.533 -1.317 . . . . 0.0 111.584 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 53.6 p-10 -62.6 151.46 37.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.06 0.93 . . . . 0.0 109.928 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 179.6 -150.48 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.809 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.0 mt -143.24 134.9 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 m -147.43 145.83 23.0 Favored Pre-proline 0 C--O 1.243 0.723 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.3 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -76.42 149.09 30.69 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 121.064 1.176 . . . . 0.0 110.961 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 m -142.54 143.28 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.133 0.492 . . . . 0.0 111.017 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.71 85.6 2.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 mt -64.52 83.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.916 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 m -69.23 93.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.437 HG22 HD13 ' A' ' 59' ' ' ILE . 88.8 mt -93.56 125.72 46.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.218 -178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.418 ' CD2' ' C ' ' A' ' 3' ' ' LYS . 7.7 m-85 -100.27 142.66 31.44 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.675 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.7 -22.87 2.29 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 124.651 1.219 . . . . 0.0 112.165 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.25 5.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.675 ' H ' ' C ' ' A' ' 61' ' ' ALA . 51.2 mtp180 62.54 72.78 0.48 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.104 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.1 p -152.45 132.36 13.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.314 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -101.36 101.69 12.38 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.41 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.7 132.0 41.36 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 67' ' ' PHE . 51.5 p90 -172.26 123.54 0.49 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.479 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.8 t -107.32 108.01 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.507 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 25.6 p -156.21 -164.27 1.65 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 69' ' ' THR . 9.3 pttt 76.78 -178.95 0.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.511 ' CG2' ' CE2' ' A' ' 76' ' ' TYR . 6.4 m 64.9 68.61 0.73 Allowed Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.558 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.531 ' O ' ' CD1' ' A' ' 76' ' ' TYR . 10.8 Cg_endo -78.53 155.5 28.04 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 120.934 1.089 . . . . 0.0 112.289 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.46 112.67 2.89 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.699 1.599 . . . . 0.0 112.367 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 169.61 -167.46 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.596 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -41.51 -16.19 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 O-C-N 122.0 -0.437 . . . . 0.0 110.571 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -43.97 -30.12 0.67 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -140.7 -27.14 0.73 Allowed 'General case' 0 C--O 1.255 1.358 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.596 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 66.4 mt -51.67 -35.59 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.455 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -53.51 -45.37 69.68 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.702 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.07 -63.63 1.19 Allowed 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.32 -19.44 5.42 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.725 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.19 -78.75 0.25 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.069 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 134.03 23.52 0.68 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.17 132.64 36.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 . . . . . 0 C--N 1.333 -0.139 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.306 -179.838 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 CA--C 1.53 0.202 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.4 p -159.8 152.95 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.308 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.88 82.86 0.14 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.647 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -140.35 123.06 16.33 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 121.035 0.445 . . . . 0.0 111.003 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 pt -128.8 157.28 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 p -91.01 166.79 12.82 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.134 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -59.34 -54.39 47.33 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.27 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -55.73 -40.94 73.15 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.585 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -61.03 -47.86 84.48 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.858 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.0 m -66.42 -28.63 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 118.414 -1.314 . . . . 0.0 109.783 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 109' ' ' LYS . 53.0 mt -63.1 -71.47 0.16 Allowed 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.521 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -43.79 -47.45 8.03 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.141 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.83 -27.48 41.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.244 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.566 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -104.63 0.62 28.69 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.693 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 105' ' ' LEU . 77.8 tttt -84.91 -73.78 0.42 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.541 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -57.18 -35.98 70.24 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -70.59 48.74 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.456 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.566 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 91.9 mtp -143.32 54.1 2.95 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.411 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 112' ' ' MET . 3.5 Cg_endo -57.8 -46.67 25.04 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 120.651 0.901 . . . . 0.0 112.088 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -173.93 26.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.9 mt -43.42 -73.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.454 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.529 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -172.1 0.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.226 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.6 p -141.73 177.53 8.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 111.903 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.2 p -141.6 -22.26 0.73 Allowed 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.996 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -82.07 143.06 31.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.198 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.2 -40.72 97.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 110.876 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -56.1 -35.16 66.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.18 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.77 -68.88 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.861 -1.136 . . . . 0.0 108.967 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.06 -39.08 26.19 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.976 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.38 -66.55 0.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 129' ' ' GLY . 98.8 mtt180 -44.27 -31.91 1.14 Allowed 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.479 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 4.4 tmm? -59.24 -72.35 0.1 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.6 mm -51.1 -50.34 25.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.218 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -66.26 -70.82 0.22 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.39 -44.4 3.99 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.479 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 66.4 m -58.71 -44.85 90.51 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -54.62 -50.32 68.39 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.527 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -49.36 -44.59 44.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.564 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.5 t -52.47 -65.72 0.51 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 83.5 mtp -51.82 -5.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.303 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.57 -25.56 12.87 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 45.7 t -47.64 163.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.465 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 75.8 mt-10 -131.62 153.24 50.13 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 65.2 t -117.25 130.49 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 38.7 t -94.76 -4.88 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.487 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.528 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.538 0.208 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 8.2 p -58.05 123.07 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.5 t -114.36 -24.09 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.03 130.05 18.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.608 0.718 . . . . 0.0 111.101 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.4 t -119.92 103.56 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.058 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.25 93.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 118.164 -1.415 . . . . 0.0 110.045 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -76.01 110.81 10.78 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -169.91 -172.6 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.944 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 11' ' ' GLN . 26.4 mp0 -109.59 171.94 7.15 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.412 ' CD1' ' CZ ' ' A' ' 41' ' ' PHE . 8.0 mt -143.15 136.02 13.73 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -82.49 159.85 17.02 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.222 1.281 . . . . 0.0 113.722 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.35 142.53 47.43 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.66 35.53 38.15 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -177.38 59.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.896 -0.652 . . . . 0.0 110.468 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.07 156.24 47.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -167.68 169.02 5.81 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.286 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.84 39.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.357 1.371 . . . . 0.0 112.171 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.556 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -147.0 52.57 1.39 Allowed Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.629 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 31.2 Cg_endo -79.78 166.28 21.6 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.027 1.151 . . . . 0.0 111.885 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.08 -29.2 86.3 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 120.93 1.087 . . . . 0.0 111.087 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.62 -63.49 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 42.97 -99.58 0.01 OUTLIER Glycine 0 C--O 1.212 -1.252 0 CA-C-O 118.58 -1.122 . . . . 0.0 110.418 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.3 Cg_exo -47.55 -60.51 0.85 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 CA-C-N 120.968 2.384 . . . . 0.0 110.986 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.48 -16.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.429 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.632 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -117.82 -38.23 3.29 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 110.901 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.533 ' O ' ' ND1' ' A' ' 30' ' ' HIS . . . -56.68 -52.01 53.2 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -76.5 42.19 0.28 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.382 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.769 ' HD1' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -92.35 -30.38 15.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.726 177.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.769 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . 109.27 -43.19 1.76 Allowed Glycine 0 N--CA 1.464 0.529 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -51.44 -132.01 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.103 0.561 . . . . 0.0 111.849 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -138.68 123.73 19.01 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.909 -0.495 . . . . 0.0 110.736 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.6 mm -63.18 -71.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 39' ' ' LYS . 96.7 mmm -39.43 -43.19 1.19 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.26 -48.26 79.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.272 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 34' ' ' ILE . 29.5 t80 -50.05 -67.67 0.24 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 122.364 1.078 . . . . 0.0 109.358 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 42' ' ' ASN . 93.8 t -56.93 -42.51 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.174 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 35' ' ' MET . 88.4 tttt -48.59 -60.69 2.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.52 -41.32 80.65 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.683 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.435 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 10.3 m-85 -62.97 -76.0 0.07 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 38' ' ' VAL . 8.0 t-20 -39.29 -46.34 1.54 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.524 0.678 . . . . 0.0 111.744 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -57.8 -35.24 70.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.302 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -88.07 -44.42 10.97 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.983 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 49' ' ' GLY . 14.8 p -65.26 -21.12 66.69 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -87.82 -33.66 18.53 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.426 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 62.4 t-20 -64.45 -24.53 67.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.486 ' CG ' ' N ' ' A' ' 49' ' ' GLY . 7.1 ptt? -105.65 -47.2 3.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.644 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.486 ' N ' ' CG ' ' A' ' 48' ' ' MET . . . 142.62 178.57 18.69 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 40.7 p-10 -74.82 147.98 40.69 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 52' ' ' ILE . . . 176.04 -154.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.754 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.42 ' H ' ' HB2' ' A' ' 51' ' ' ALA . 32.1 mm -143.3 136.46 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.5 131.13 12.7 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.741 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -72.26 153.23 56.39 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 120.76 0.974 . . . . 0.0 110.369 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 10' ' ' LEU . 5.3 p -155.52 145.53 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.426 0.632 . . . . 0.0 111.897 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -121.93 95.68 4.76 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.4 mt -69.72 89.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.712 -175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.24 98.93 1.81 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.9 mt -99.28 131.44 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.806 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 63' ' ' ARG . 4.1 m-85 -106.83 142.15 36.93 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.573 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.91 -27.34 7.31 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 124.388 1.055 . . . . 0.0 111.841 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -60.33 -5.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.573 ' H ' ' C ' ' A' ' 61' ' ' ALA . 25.7 ttm180 76.79 70.01 0.06 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.212 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.0 p -144.77 125.33 14.05 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.237 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -104.64 103.28 12.91 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.556 0.217 . . . . 0.0 110.555 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.7 p -95.55 134.46 38.4 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.559 ' CZ ' ' O ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -124.73 175.34 7.3 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.97 86.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.9 t -177.15 139.03 0.26 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.211 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.585 ' O ' ' O ' ' A' ' 71' ' ' THR . 0.6 OUTLIER -176.92 117.25 0.11 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.672 0.749 . . . . 0.0 110.336 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.585 ' O ' ' O ' ' A' ' 70' ' ' LYS . 49.8 p 51.85 140.45 0.02 OUTLIER Pre-proline 0 C--N 1.292 -1.914 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.468 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -78.21 168.57 21.56 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 120.551 1.232 . . . . 0.0 112.821 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.46 90.67 0.33 Allowed 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.983 1.789 . . . . 0.0 111.959 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.72 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -176.7 -143.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.537 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.5 OUTLIER -37.25 -14.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.72 ' N ' ' O ' ' A' ' 74' ' ' ALA . 3.2 t80 -46.52 -41.27 13.95 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 123.53 0.518 . . . . 0.0 110.385 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -130.1 -15.25 3.79 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.547 ' N ' HD22 ' A' ' 77' ' ' LEU . 26.2 mt -65.02 -40.68 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.997 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -50.25 -41.82 50.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.063 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -71.58 -61.19 1.87 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.313 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.18 -22.43 6.55 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.319 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -86.61 -78.08 0.3 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.765 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.39 56.61 0.77 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.8 mt -92.48 114.49 27.06 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 C--N 1.331 -0.22 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.648 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.5 p -152.64 164.56 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.59 84.55 1.25 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -138.81 128.39 24.66 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.07 0.462 . . . . 0.0 110.88 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.0 pt -119.19 151.61 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.6 p -78.72 154.78 29.79 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.237 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -58.49 -54.63 44.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.019 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -58.31 -42.8 87.5 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 121.439 -0.788 . . . . 0.0 111.396 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -58.33 -46.11 86.83 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.638 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.9 -30.6 50.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.044 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 109' ' ' LYS . 58.3 mt -61.69 -71.77 0.14 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.153 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -45.66 -49.77 14.1 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.39 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.501 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 93.1 mt -57.53 -26.69 27.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -105.64 2.44 28.16 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.398 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 105' ' ' LEU . 77.3 tttt -86.16 -73.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -65.52 -40.51 93.06 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.725 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 107' ' ' ILE . 49.7 mmtt -60.43 93.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.712 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.422 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 48.8 mtt -154.82 56.0 1.35 Allowed Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.403 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 112' ' ' MET . 14.7 Cg_exo -50.46 -46.67 28.17 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 120.778 0.985 . . . . 0.0 112.154 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 66.8 t0 -170.92 40.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.245 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 117' ' ' THR . 3.6 mm? -74.41 143.66 44.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.74 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.563 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 10.2 t30 -69.37 35.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.444 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.549 ' H ' ' C ' ' A' ' 115' ' ' LEU . 69.5 p -139.46 162.79 34.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.228 0.537 . . . . 0.0 111.756 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.7 p -142.46 -45.07 0.32 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.779 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -72.5 151.51 42.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 35.9 mt -59.3 -42.19 90.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.358 0.599 . . . . 0.0 109.948 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.85 -44.53 86.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.093 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.85 -71.23 0.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.279 -0.969 . . . . 0.0 108.528 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.577 ' O ' ' HG3' ' A' ' 126' ' ' MET . . . -44.22 -55.0 5.17 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.896 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -44.69 -62.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.295 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 129' ' ' GLY . 64.8 ttt180 -44.41 -32.36 1.34 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.82 ' HG3' ' H ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER -58.95 -66.71 0.46 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.82 ' H ' ' HG3' ' A' ' 126' ' ' MET . 4.9 mm -56.11 -48.68 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.317 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -66.84 -69.83 0.28 Allowed 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.09 -47.43 5.35 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 126' ' ' MET . 70.3 m -57.82 -42.84 85.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -53.86 -48.18 70.28 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.516 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -50.75 -41.1 56.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.536 ' C ' ' H ' ' A' ' 135' ' ' GLY . 2.3 t -59.57 -72.64 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.3 ptm -45.27 -13.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.527 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 89.31 66.17 1.26 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 37.1 t -157.16 141.61 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -116.17 172.44 7.18 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 140' ' ' GLY . 7.3 t -96.33 149.02 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 p -62.08 4.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.313 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.523 0.588 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt . . . . . 0 CA--C 1.521 -0.142 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -55.01 104.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.213 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -80.79 -46.33 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.204 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.84 142.1 32.79 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.263 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 7.7 p -132.58 99.91 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.595 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.12 90.34 3.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.031 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -78.99 117.2 19.84 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.43 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -170.67 -173.91 1.49 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.537 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -98.25 162.7 13.06 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mt -148.88 96.83 3.73 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -54.23 147.88 43.36 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.239 1.292 . . . . 0.0 114.769 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.61 142.45 27.44 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 45.06 31.38 2.9 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -154.07 34.34 0.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.145 -0.527 . . . . 0.0 110.522 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.82 151.55 36.28 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -156.32 167.98 13.27 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.121 -178.078 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -61.5 36.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.305 1.337 . . . . 0.0 112.207 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.541 ' H ' ' C ' ' A' ' 18' ' ' THR . . . -159.33 57.39 1.04 Allowed Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.687 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 23.4 Cg_endo -80.22 169.62 17.26 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.157 1.238 . . . . 0.0 112.123 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -55.01 -28.41 59.65 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 120.705 0.936 . . . . 0.0 111.146 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.6 t -84.7 -61.9 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 43.25 -98.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.809 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -47.15 -60.71 0.78 Allowed 'Trans proline' 0 C--N 1.317 -1.106 0 CA-C-N 119.736 1.768 . . . . 0.0 110.559 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.49 -26.29 2.07 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.834 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 36.8 tp -113.23 26.35 10.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 122.124 0.964 . . . . 0.0 109.354 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.42 42.38 0.5 Allowed Glycine 0 C--N 1.313 -0.73 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.259 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.407 ' C ' ' H ' ' A' ' 31' ' ' GLY . 84.1 mt-30 -141.13 -16.28 0.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.186 0.517 . . . . 0.0 109.638 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.497 ' ND1' ' O ' ' A' ' 30' ' ' HIS . 16.2 t-80 -59.01 -11.11 3.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.197 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 29' ' ' GLN . . . 99.99 -15.81 58.99 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.39 -131.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.304 0.642 . . . . 0.0 112.071 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -134.09 -165.56 1.66 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mm -138.46 -74.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 39' ' ' LYS . 11.3 tpt -41.4 -37.41 1.03 Allowed 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -59.83 -54.36 47.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 68.7 t80 -45.38 -58.15 3.53 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 122.863 1.315 . . . . 0.0 109.755 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' ASN . 48.8 t -63.19 -43.4 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.577 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 35' ' ' MET . 88.8 tttt -44.64 -58.67 2.9 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.41 95.83 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.342 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -74.22 0.09 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -39.74 -44.58 1.58 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.72 0.772 . . . . 0.0 111.738 -177.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.17 72.92 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.219 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.71 -46.09 9.8 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.186 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.8 p -62.76 -19.46 64.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -89.12 -34.14 16.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -61.41 -26.05 67.6 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.626 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -106.08 -85.87 0.49 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.067 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.626 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -176.2 169.23 41.75 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.338 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 42.9 p-10 -69.48 137.66 52.77 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -174.93 -150.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.861 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 52' ' ' ILE . 35.4 mm -138.19 125.0 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.4 t -125.9 120.94 24.19 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.206 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -75.32 141.69 26.03 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.011 1.141 . . . . 0.0 110.631 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.501 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 7.5 p -159.74 162.91 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.329 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.501 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 9.7 mt-10 -129.44 114.82 16.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.9 mt -76.54 88.23 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.097 0.475 . . . . 0.0 111.73 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -74.37 113.49 11.65 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.6 mt -118.55 135.94 57.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.004 0.431 . . . . 0.0 111.401 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.642 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -110.17 147.72 33.18 Favored 'General case' 0 C--O 1.253 1.274 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.27 176.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.706 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -53.48 -22.55 8.19 Favored 'General case' 0 C--N 1.346 0.423 0 O-C-N 124.985 1.428 . . . . 0.0 112.177 -175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -63.43 8.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.706 ' H ' ' C ' ' A' ' 61' ' ' ALA . 89.0 mtm180 59.7 72.33 0.53 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.992 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.478 ' CB ' ' CE2' ' A' ' 60' ' ' TYR . 1.4 m -149.96 147.56 28.03 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.604 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.648 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -124.48 106.56 10.27 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.284 0.365 . . . . 0.0 111.452 -177.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.599 ' OG1' ' OH ' ' A' ' 60' ' ' TYR . 15.3 m -94.11 122.09 36.27 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 4.0 p90 177.1 -151.78 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 47.3 t 80.69 159.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.202 0 O-C-N 124.006 0.816 . . . . 0.0 110.344 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.64 119.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.033 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.541 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -148.73 147.83 29.3 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.292 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.48 ' OG1' ' C ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER 173.7 141.6 0.16 Allowed Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.359 177.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.71 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 10.8 Cg_endo -72.62 169.38 22.02 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.588 0.859 . . . . 0.0 111.955 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 72' ' ' PRO . 12.1 Cg_exo -46.61 -157.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.814 2.343 . . . . 0.0 112.359 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.718 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -36.31 -34.01 0.05 Allowed 'General case' 0 C--O 1.255 1.364 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -40.15 -10.35 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.123 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.718 ' N ' ' O ' ' A' ' 74' ' ' ALA . 31.1 m-85 -32.76 -81.55 0.01 OUTLIER 'General case' 0 C--N 1.35 0.628 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.759 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -108.49 -5.35 16.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 82' ' ' ALA . 6.5 mm -63.08 -42.42 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.347 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -52.2 -36.58 52.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.17 -66.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.842 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.62 -13.98 0.46 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.726 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 78' ' ' ILE . . . -89.83 -77.06 0.4 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.637 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.75 37.86 0.49 Allowed Glycine 0 N--CA 1.466 0.648 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.2 mt -90.68 104.88 17.42 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 C--N 1.33 -0.241 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.742 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.2 mttt . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -158.86 151.25 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.167 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.88 84.3 0.59 Allowed Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -141.82 103.15 4.3 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.086 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.5 pt -106.56 159.91 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.36 152.01 19.4 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.257 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.43 ' O ' ' CG2' ' A' ' 104' ' ' VAL . 70.4 t-105 -60.32 -51.26 70.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.778 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.85 -41.93 92.5 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 120.62 -1.3 . . . . 0.0 111.751 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.22 -44.51 95.11 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.105 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 101' ' ' TRP . 17.5 m -62.92 -33.71 62.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 118.257 -1.377 . . . . 0.0 109.411 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 108' ' ' ALA . 96.2 mt -61.47 -72.21 0.13 Allowed 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.19 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -43.77 -56.23 3.96 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.488 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.482 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 95.1 mt -50.61 -25.68 3.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.879 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -88.89 -44.6 10.34 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.604 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -43.9 -68.32 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.373 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.751 ' N ' HE21 ' A' ' 110' ' ' GLN . 0.0 OUTLIER -57.32 -66.37 0.47 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.328 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -47.16 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.973 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.561 ' N ' ' O ' ' A' ' 110' ' ' GLN . 37.6 mtt -157.51 51.34 0.48 Allowed Pre-proline 0 C--O 1.234 0.248 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.664 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 112' ' ' MET . 10.7 Cg_endo -66.05 -33.37 41.53 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 120.748 0.965 . . . . 0.0 111.867 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 115' ' ' LEU . 63.9 m-20 -160.75 -77.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.942 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 115' ' ' LEU . 3.9 mm? 44.0 -169.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.296 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.532 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -121.98 35.56 4.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.762 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.3 p -135.83 168.41 19.35 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.395 0.617 . . . . 0.0 111.902 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.443 ' OG1' ' N ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -138.67 -85.52 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.511 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.443 ' N ' ' OG1' ' A' ' 118' ' ' THR . 97.7 m-20 -55.42 164.22 1.04 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 124' ' ' ALA . 4.4 mm? -61.66 -40.62 95.57 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-O 121.469 0.652 . . . . 0.0 110.42 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -50.31 -46.08 55.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.129 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.73 -66.27 0.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.174 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.05 -48.02 44.31 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.928 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -47.06 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' A' ' 129' ' ' GLY . 42.2 ttm180 -42.15 -37.63 1.49 Allowed 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.498 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.2 tmm? -54.9 -73.48 0.05 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.484 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.1 mt -51.77 -51.71 26.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.847 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -62.81 -70.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.16 -42.39 3.12 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 133' ' ' SER . 23.9 m -57.49 -46.16 84.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -51.28 -50.29 59.57 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.571 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -49.97 -36.03 26.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.2 t -63.23 -71.15 0.17 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 81.3 mtp -47.65 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.82 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.626 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 80.43 55.68 3.38 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 39.8 t -138.15 161.72 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.449 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 76.3 mt-10 -133.01 159.35 40.28 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.921 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.2 t -99.49 156.99 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 p -84.48 -3.33 7.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.651 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.286 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.376 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.91 -167.64 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.831 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.54 -161.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.4 p -42.22 121.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 m -113.92 -24.76 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.09 129.68 24.29 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.978 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 9.0 p -120.8 109.78 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.577 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.45 89.82 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.015 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -84.6 117.31 23.66 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 124.073 0.858 . . . . 0.0 109.704 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.92 -178.66 0.44 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.649 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.434 ' N ' ' NE2' ' A' ' 11' ' ' GLN . 0.7 OUTLIER -91.8 160.43 15.32 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 mt -151.53 133.93 8.5 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -80.79 119.04 3.54 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.108 1.074 . . . . 0.0 114.213 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.97 137.9 25.9 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 53.56 -154.03 7.65 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 -176.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 15' ' ' GLY . 40.7 tttp 40.73 22.55 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.369 1.085 . . . . 0.0 111.008 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -96.84 159.58 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.13 167.31 8.73 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.144 -178.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.37 40.26 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.464 1.443 . . . . 0.0 112.159 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.536 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -146.14 53.31 1.76 Allowed Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.708 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 34.8 Cg_endo -80.17 165.6 21.29 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 120.901 1.067 . . . . 0.0 112.043 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -61.41 -24.88 79.21 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 120.827 1.018 . . . . 0.0 111.099 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.7 t -83.72 -66.66 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.676 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.02 -98.75 0.01 OUTLIER Glycine 0 N--CA 1.468 0.799 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 27' ' ' LEU . 2.7 Cg_endo -53.1 -57.17 2.16 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 CA-C-N 120.698 2.249 . . . . 0.0 110.334 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -43.29 -16.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 25' ' ' PRO . 1.3 tp -112.2 -38.02 4.86 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.09 -49.71 75.57 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.682 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -41.19 -29.49 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.022 0.911 . . . . 0.0 110.662 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -44.76 -37.43 3.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.551 0.691 . . . . 0.0 109.379 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 99.56 -23.23 37.02 Favored Glycine 0 C--O 1.225 -0.41 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.574 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -47.1 -135.94 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.223 0.609 . . . . 0.0 112.492 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -137.46 106.89 6.11 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.72 -0.613 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 37' ' ' PHE . 4.6 mm -52.52 -70.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 34' ' ' ILE . 10.0 tpt -39.56 -40.45 0.87 Allowed 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.2 -0.312 . . . . 0.0 110.498 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.28 -46.92 88.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' ILE . 57.5 t80 -50.7 -65.06 0.62 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 122.371 1.082 . . . . 0.0 109.504 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 42' ' ' ASN . 97.4 t -57.42 -44.29 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.169 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -46.27 -64.8 0.66 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.9 -38.94 70.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.249 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -64.2 -76.38 0.07 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 46' ' ' ALA . 20.4 t-20 -41.06 -45.49 2.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.586 0.708 . . . . 0.0 112.035 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.5 -35.99 73.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.305 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.21 -43.02 13.33 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.702 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 49' ' ' GLY . 47.1 p -67.47 -21.23 65.54 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -82.45 -37.51 25.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -65.51 -21.57 66.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.446 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.4 ptm -107.5 -29.27 9.31 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 117.62 171.04 15.35 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 51.1 p-10 -75.63 142.28 42.65 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -174.34 -150.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.903 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.473 HD11 HG21 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -139.87 135.81 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.1 t -144.27 133.28 11.26 Favored Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.905 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.24 131.96 12.19 Favored 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 120.766 0.978 . . . . 0.0 109.646 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 1.5 p -140.53 156.98 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.862 0.839 . . . . 0.0 111.928 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 21.5 mt-10 -131.34 82.37 2.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.331 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.9 mt -53.04 95.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.282 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.41 101.94 5.76 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.38 123.67 58.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.45 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -99.98 144.3 29.18 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.666 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -54.65 -22.29 13.18 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.042 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -66.03 6.42 0.39 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.666 ' H ' ' C ' ' A' ' 61' ' ' ALA . 84.0 mtm180 64.44 71.02 0.48 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.921 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 t -147.92 126.24 12.3 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.526 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -103.58 102.31 12.19 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -90.49 123.91 34.56 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.426 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 0.8 OUTLIER 173.47 118.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.565 -177.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -151.2 131.92 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.694 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.5 p -135.23 150.89 50.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.473 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 71' ' ' THR . 46.5 pttt -174.27 -158.3 0.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.504 ' O ' ' O ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER 80.34 60.0 0.14 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.912 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 71' ' ' THR . 19.7 Cg_exo -43.53 177.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.747 1.631 . . . . 0.0 112.916 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -54.67 -55.37 3.35 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.398 1.399 . . . . 0.0 114.924 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.646 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -146.54 -66.63 0.28 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.0 p -36.64 -20.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.891 0.377 . . . . 0.0 110.43 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.646 ' N ' ' O ' ' A' ' 74' ' ' ALA . 1.8 t80 -40.29 -67.11 0.25 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.276 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.429 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 6.9 tt -110.15 -19.94 12.85 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 82' ' ' ALA . 1.2 mt -55.67 -42.21 68.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.031 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -44.54 -39.27 4.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.592 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -81.89 -60.42 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.49 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.73 13.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.43 . . . . 0.0 110.766 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -85.43 -78.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.39 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.34 41.43 0.23 Allowed Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 mt -94.59 112.86 24.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -91.18 -85.21 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.499 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -63.38 -43.72 96.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.861 0.362 . . . . 0.0 110.282 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 131.59 -155.41 21.37 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.5 158.7 20.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -158.05 -173.13 4.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.103 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -49.66 154.35 1.73 Allowed Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.97 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.84 144.51 35.12 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.656 0.904 . . . . 0.0 111.786 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -151.79 164.27 30.29 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -96.13 5.73 50.41 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.595 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 1.5 pm0 -65.55 -35.46 80.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.39 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 94' ' ' GLU . 58.2 mttp 56.49 114.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 p -138.84 159.01 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.733 0.302 . . . . 0.0 110.25 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.54 84.38 1.76 Allowed Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.401 HH21 HG23 ' A' ' 139' ' ' VAL . 43.5 ttt180 -135.77 104.77 5.87 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.142 0.496 . . . . 0.0 111.219 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 pt -109.41 148.51 13.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.1 160.28 17.11 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.164 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -60.4 -54.17 48.85 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.605 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -59.97 -43.5 95.04 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.913 -1.117 . . . . 0.0 111.388 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -59.1 -45.53 90.64 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.978 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.8 m -64.88 -31.66 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 118.249 -1.381 . . . . 0.0 109.672 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 108' ' ' ALA . 76.1 mt -61.74 -67.32 0.42 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.662 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -44.38 -41.59 6.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.198 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.13 -29.12 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.104 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -91.77 -3.3 56.34 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.749 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 111' ' ' LYS . 44.1 mtpt -85.74 -72.73 0.48 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.866 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.58 -0.89 0.3 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.027 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 109' ' ' LYS . 1.4 pptp? -68.9 -16.72 63.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.616 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.481 ' SD ' ' NZ ' ' A' ' 111' ' ' LYS . 5.9 ptt? -123.91 70.15 48.85 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.444 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 15.2 Cg_exo -53.84 -40.52 80.07 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 120.653 0.902 . . . . 0.0 112.082 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 113' ' ' PRO . 80.6 m-20 -149.78 14.93 0.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.58 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.6 mp -71.32 160.53 32.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.2 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.539 ' C ' HD21 ' A' ' 116' ' ' ASN . 0.2 OUTLIER -70.56 64.72 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.096 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.0 m -162.04 140.04 8.87 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.374 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.74 -2.76 0.35 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.99 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.87 124.41 34.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.298 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 36.0 mt -62.09 -42.95 99.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.576 0.703 . . . . 0.0 110.266 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.4 -36.63 71.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.983 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.61 -69.4 0.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.591 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.13 -33.09 4.76 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.133 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.13 -66.58 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.1 mtt180 -46.35 -33.78 4.08 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.793 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.491 ' O ' ' N ' ' A' ' 130' ' ' SER . 34.4 ttp -59.57 -73.83 0.08 Allowed 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 127' ' ' ILE . 38.9 mm -50.56 -48.31 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.739 0.304 . . . . 0.0 110.826 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -68.15 -70.82 0.24 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.05 -45.8 6.17 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 126' ' ' MET . 67.5 m -56.41 -42.45 78.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -55.85 -46.65 78.13 Favored 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.509 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -54.67 -44.11 73.02 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 t -51.96 -69.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 74.4 mtp -41.96 -66.39 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.674 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.22 55.05 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 49.2 t -134.6 161.14 40.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 96.2 mt-10 -124.3 152.9 42.5 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.1 t -104.07 133.37 48.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.401 HG23 HH21 ' A' ' 98' ' ' ARG . 1.6 p -70.37 -3.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.799 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -131.58 112.31 1.18 Allowed Glycine 0 N--CA 1.463 0.452 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -179.59 68.37 0.17 Allowed Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -55.57 133.44 58.08 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.029 1.153 . . . . 0.0 111.804 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 174.74 23.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.899 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.55 133.6 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.774 0.321 . . . . 0.0 110.619 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -74.35 142.88 45.08 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -85.16 -2.04 57.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.683 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.9 -179.76 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 mmt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -153.06 130.52 11.4 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 tttt 71.75 -164.65 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 12.9 p -64.76 119.92 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.03 -24.49 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 119.211 -0.423 . . . . 0.0 109.88 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.55 134.83 27.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.588 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.453 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 13.4 p -124.98 125.51 69.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.207 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.61 93.47 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 119.644 1.111 . . . . 0.0 111.556 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -84.05 118.12 23.86 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.836 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.417 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -171.41 -173.79 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.648 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -90.18 149.29 22.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.59 93.39 8.69 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 123.154 0.284 . . . . 0.0 110.315 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -67.47 123.18 10.51 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.141 1.227 . . . . 0.0 114.224 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.459 ' CB ' ' H ' ' A' ' 51' ' ' ALA . . . -54.49 136.73 44.17 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 54.89 -155.78 8.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 15' ' ' GLY . 97.3 mttt 41.47 20.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.118 0.959 . . . . 0.0 111.165 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -97.04 158.52 15.39 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.61 167.68 7.89 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.245 -179.145 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.79 42.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.136 1.224 . . . . 0.0 112.024 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.522 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -150.53 55.58 1.82 Allowed Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.599 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 32.5 Cg_endo -79.47 164.8 23.57 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 120.819 1.013 . . . . 0.0 112.105 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -63.18 -24.37 72.75 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.768 0.979 . . . . 0.0 111.359 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.01 -64.67 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 44.04 -99.01 0.01 OUTLIER Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 28' ' ' GLY . 14.4 Cg_exo -48.95 -59.63 1.17 Allowed 'Trans proline' 0 C--N 1.32 -0.971 0 CA-C-N 119.991 1.896 . . . . 0.0 110.561 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.36 -24.01 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.381 -0.527 . . . . 0.0 109.886 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.545 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 39.4 tp -119.91 31.96 6.28 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.907 0.86 . . . . 0.0 109.495 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' PRO . . . -126.24 -64.34 0.16 Allowed Glycine 0 C--N 1.319 -0.363 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 28' ' ' GLY . 65.6 tp60 -42.29 -25.26 0.07 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.734 0.767 . . . . 0.0 109.699 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.483 ' N ' ' C ' ' A' ' 28' ' ' GLY . 37.6 t-80 -42.63 -39.14 2.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.44 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 97.68 -24.43 31.63 Favored Glycine 0 C--N 1.331 0.28 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -48.94 -135.68 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.093 0.557 . . . . 0.0 112.272 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -136.88 130.31 31.52 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.096 -0.377 . . . . 0.0 110.874 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 37' ' ' PHE . 3.5 mm -82.16 -72.24 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.3 tpt -39.57 -40.51 0.88 Allowed 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.14 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -60.78 -49.81 76.0 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.255 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 34' ' ' ILE . 87.6 t80 -47.02 -60.54 2.38 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.099 0.952 . . . . 0.0 109.795 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 42' ' ' ASN . 59.9 t -59.85 -44.05 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.348 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 84.5 tttt -46.66 -66.12 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.99 76.11 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.627 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -62.97 -75.8 0.07 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' VAL . 6.3 t-20 -40.53 -45.33 2.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.389 0.614 . . . . 0.0 111.974 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.446 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -57.44 -34.84 69.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.037 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.42 -44.79 12.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.371 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 49' ' ' GLY . 45.8 p -65.36 -21.61 66.71 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -77.0 -45.15 28.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 43' ' ' ALA . 5.1 m120 -62.48 -16.11 53.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.4 mmm -106.8 -70.92 0.77 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.268 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 160.15 -162.22 33.04 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 40.0 p-10 -99.86 122.3 42.59 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.459 ' H ' ' CB ' ' A' ' 14' ' ' ALA . . . -156.8 -153.14 0.4 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.28 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mm -137.71 127.79 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.708 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.7 t -144.26 124.97 7.69 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.774 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -73.94 147.93 39.68 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 120.745 0.963 . . . . 0.0 110.639 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.0 m -143.19 160.83 17.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.257 0.551 . . . . 0.0 111.246 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 58' ' ' THR . 93.8 mt-10 -129.38 76.74 1.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.5 mt -50.87 86.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.874 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -72.99 95.17 1.96 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.417 HD11 HG23 ' A' ' 59' ' ' ILE . 60.8 mt -95.6 125.13 48.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.693 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 63' ' ' ARG . 3.4 m-85 -100.63 140.35 35.03 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.633 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.63 -23.33 2.52 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 124.584 1.178 . . . . 0.0 112.366 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -66.89 5.82 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.633 ' H ' ' C ' ' A' ' 61' ' ' ALA . 59.8 mtp180 63.88 69.69 0.53 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.341 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.9 p -146.47 127.55 14.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.959 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -105.04 103.44 13.0 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.622 -177.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.512 ' O ' ' OG1' ' A' ' 58' ' ' THR . 41.1 p -95.21 122.91 38.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.518 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.5 p90 176.32 -152.74 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 48.9 t 80.35 117.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 124.408 1.067 . . . . 0.0 111.381 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -124.58 127.56 47.56 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -143.8 -170.33 3.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.678 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 m 66.0 52.07 0.83 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.586 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.678 ' HD3' ' N ' ' A' ' 71' ' ' THR . 1.4 Cg_endo -73.73 162.57 39.26 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 120.859 1.039 . . . . 0.0 112.553 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -73.75 91.24 0.91 Allowed 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.552 1.502 . . . . 0.0 113.189 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.641 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 179.69 -171.53 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.511 ' OG ' ' NH1' ' A' ' 79' ' ' ARG . 2.5 m -38.91 -17.32 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.641 ' N ' ' O ' ' A' ' 74' ' ' ALA . 74.9 m-85 -45.69 -42.24 11.43 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.297 0.373 . . . . 0.0 110.392 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -130.74 -13.98 3.64 Favored 'General case' 0 C--O 1.254 1.318 0 CA-C-O 122.304 1.049 . . . . 0.0 108.891 178.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 82' ' ' ALA . 17.4 mt -65.34 -41.74 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.987 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.548 ' HG2' HH11 ' A' ' 79' ' ' ARG . 0.0 OUTLIER -51.76 -41.61 61.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.661 179.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -63.21 -63.18 1.27 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.27 69.6 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.491 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -79.52 -83.84 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.553 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 137.6 -76.87 0.35 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.9 mt 42.34 -160.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 86' ' ' LYS . 1.4 pt-20 -164.37 -87.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.466 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.42 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 31.5 ttpt -145.38 106.87 4.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.57 -100.0 0.02 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -163.75 121.4 1.83 Allowed 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.534 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -72.7 -63.4 1.17 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.446 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -142.31 151.27 57.79 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.639 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.11 142.44 54.81 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 120.747 0.964 . . . . 0.0 111.436 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.39 -118.06 2.46 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -139.22 -86.77 0.23 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.642 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -178.98 67.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.875 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -155.71 54.97 0.61 Allowed 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.157 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -144.96 150.61 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 137' ' ' GLU . . . 82.4 75.96 1.12 Allowed Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -131.0 116.94 18.49 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.621 0.248 . . . . 0.0 110.624 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 mt -109.71 150.11 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.446 ' CG2' ' NE2' ' A' ' 103' ' ' GLN . 3.0 p -82.0 149.35 28.18 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.912 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -57.7 -52.05 67.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.092 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -58.77 -40.94 85.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.329 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.446 ' NE2' ' CG2' ' A' ' 100' ' ' THR . 58.3 mt-30 -60.62 -48.47 81.63 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.9 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.87 -32.78 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.658 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 108' ' ' ALA . 50.5 mt -59.5 -68.37 0.29 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.655 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -44.59 -46.2 9.89 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.284 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.57 -29.24 38.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.946 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -101.66 -8.23 21.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.651 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 105' ' ' LEU . 75.0 tttt -77.6 -75.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.007 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -59.58 -20.96 59.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.631 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -97.75 102.02 13.67 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.721 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 115' ' ' LEU . 6.6 mmt -140.05 55.34 6.35 Favored Pre-proline 0 C--O 1.236 0.373 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.129 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 112' ' ' MET . 14.5 Cg_exo -50.57 -54.8 4.85 Favored 'Trans proline' 0 N--CA 1.488 1.206 0 C-N-CA 120.671 0.914 . . . . 0.0 112.067 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -126.92 -29.27 2.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.345 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.497 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -75.14 38.99 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.072 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.661 ' N ' HD21 ' A' ' 116' ' ' ASN . 0.1 OUTLIER -84.85 46.82 1.3 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.704 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 119' ' ' ASP . 5.5 p -73.33 32.54 0.07 Allowed 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.855 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.505 ' H ' ' C ' ' A' ' 116' ' ' ASN . 9.8 t 39.43 29.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.26 0.35 . . . . 0.0 110.73 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 117' ' ' THR . 74.9 m-20 -150.95 125.37 9.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.458 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 124' ' ' ALA . 83.8 mt -62.95 -34.47 77.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.258 0.552 . . . . 0.0 110.788 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.67 -37.17 62.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.512 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.39 -69.4 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.056 -1.058 . . . . 0.0 109.35 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.6 -32.72 19.61 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.192 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -60.91 -70.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 129' ' ' GLY . 62.7 ttt180 -42.95 -30.78 0.44 Allowed 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.508 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 4.7 tmm? -58.38 -73.08 0.08 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 88.0 mt -50.69 -51.3 20.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.023 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -63.66 -71.55 0.17 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.73 -45.76 4.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.508 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 67.2 m -58.75 -44.65 90.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -51.59 -47.83 63.42 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -55.26 -42.28 73.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.4 t -55.26 -72.13 0.07 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.4 mtm -42.17 -34.71 0.79 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.773 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.38 49.11 0.57 Allowed Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 43.0 t -136.05 164.93 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.488 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 81.9 tt0 -130.13 158.72 38.9 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 140' ' ' GLY . 53.9 t -111.56 160.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.431 ' N ' ' CG1' ' A' ' 138' ' ' VAL . 9.8 p -64.48 8.45 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.091 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . 61.03 157.33 0.06 OUTLIER Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.91 71.1 56.96 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 117.087 0.443 . . . . 0.0 110.818 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -63.91 154.41 70.08 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.33 1.354 . . . . 0.0 111.849 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -54.15 -177.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.51 ' O ' ' O ' ' A' ' 145' ' ' LYS . 2.8 t -137.17 109.3 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 144' ' ' VAL . 97.7 mttt 53.95 117.22 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.139 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 147' ' ' ALA . 31.9 p30 -63.71 -30.26 71.39 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.904 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.524 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.647 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptp . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 67.9 mttm -94.71 41.87 1.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.379 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 7.7 tptm 74.61 175.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.403 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 7.2 p -88.63 138.23 19.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 m -118.82 -25.44 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.188 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.44 143.04 29.82 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.853 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.0 p -133.84 133.03 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.563 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.42 92.67 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 120.067 1.303 . . . . 0.0 111.757 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -82.81 116.07 21.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -167.85 -173.78 2.22 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.536 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -90.76 143.78 26.38 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.68 86.84 52.73 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -65.71 114.91 3.12 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.54 1.493 . . . . 0.0 114.642 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.425 ' HB1' ' C ' ' A' ' 51' ' ' ALA . . . -74.9 146.54 41.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 174.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.73 58.33 10.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt 173.61 -24.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.91 150.29 45.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -160.39 167.54 13.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.115 -178.167 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -59.32 48.07 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.618 1.546 . . . . 0.0 112.711 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -169.53 53.87 0.23 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.504 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 20' ' ' ALA . 18.2 Cg_endo -68.1 166.1 26.12 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.032 1.155 . . . . 0.0 112.247 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -65.33 -22.18 60.41 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.803 1.002 . . . . 0.0 111.239 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.7 t -72.49 -64.32 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.554 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 25' ' ' PRO . . . 59.2 -137.48 50.23 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 118.619 -1.753 . . . . 0.0 109.485 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.702 ' C ' ' H ' ' A' ' 27' ' ' LEU . 28.2 Cg_exo -38.23 -41.32 1.35 Allowed 'Trans proline' 0 N--CA 1.486 1.06 0 CA-C-N 120.607 2.204 . . . . 0.0 110.853 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.47 13.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.811 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.702 ' H ' ' C ' ' A' ' 25' ' ' PRO . 3.5 tt -172.27 -48.7 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 30' ' ' HIS . . . -59.01 -48.9 83.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -73.96 35.55 0.09 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.471 0.653 . . . . 0.0 110.272 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.844 ' HD1' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -84.88 -19.93 31.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.258 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.844 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . 106.2 -43.85 1.59 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -49.35 -131.32 0.0 OUTLIER 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.335 0.654 . . . . 0.0 111.79 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -137.91 143.44 40.83 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.762 -0.586 . . . . 0.0 110.525 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' PHE . 6.7 mt -88.88 -70.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 39' ' ' LYS . 11.1 tpt -40.85 -39.6 1.17 Allowed 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -57.11 -49.32 76.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.631 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 64.2 t80 -48.78 -59.89 3.19 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.452 1.12 . . . . 0.0 109.501 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' ASN . 57.4 t -61.59 -42.73 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 113.391 -1.731 . . . . 0.0 111.281 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 35' ' ' MET . 2.0 tppp? -46.25 -57.9 4.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.65 95.08 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 119.921 -0.711 . . . . 0.0 110.127 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -62.81 -74.78 0.09 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -40.01 -43.32 1.54 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 121.558 0.694 . . . . 0.0 111.779 -177.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.39 75.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.261 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.12 -46.8 10.09 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.113 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.5 p -60.87 -37.77 83.28 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -65.22 -36.74 85.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -63.88 -18.6 64.34 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.756 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -103.79 -42.98 5.45 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.634 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 116.75 74.29 0.53 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.399 -0.667 . . . . 0.0 111.868 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.634 ' O ' ' O ' ' A' ' 49' ' ' GLY . 2.9 p30 44.93 159.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.883 0.373 . . . . 0.0 111.482 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 50' ' ' ASP . . . 170.81 -163.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.293 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.5 mt -141.06 131.23 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.99 125.52 4.94 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.833 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.42 149.78 31.49 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 CA-C-N 119.485 0.852 . . . . 0.0 110.86 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 m -144.64 161.92 14.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.434 0.635 . . . . 0.0 111.416 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 58' ' ' THR . 95.2 mt-10 -127.33 80.93 1.99 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.1 mt -54.04 88.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.043 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -66.21 110.53 3.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.4 mt -107.91 125.0 64.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.363 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -104.12 140.13 38.22 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.73 -21.78 1.79 Allowed 'General case' 0 C--N 1.341 0.232 0 O-C-N 124.226 0.954 . . . . 0.0 112.218 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -68.33 6.12 0.85 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.624 ' H ' ' C ' ' A' ' 61' ' ' ALA . 87.4 mtm180 64.62 67.8 0.55 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.355 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.7 m -143.21 127.14 17.29 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.854 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -108.39 102.49 11.59 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.606 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.418 ' OG1' ' OH ' ' A' ' 60' ' ' TYR . 44.4 p -93.95 126.06 38.93 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.631 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 5.6 p90 -174.96 130.99 0.31 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.918 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.5 t -137.05 156.06 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -177.71 121.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.949 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.454 ' O ' ' OG1' ' A' ' 71' ' ' THR . 42.6 pttt -177.51 -179.65 0.85 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.317 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.497 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 21.9 p 55.93 61.01 8.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.054 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 71' ' ' THR . 3.7 Cg_endo -75.27 164.1 33.5 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 120.897 1.065 . . . . 0.0 112.418 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 13.8 Cg_endo -72.2 176.51 8.43 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 121.899 1.732 . . . . 0.0 112.178 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 79.56 -174.54 0.06 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.909 0.322 . . . . 0.0 111.051 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.466 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.7 OUTLIER -39.99 -19.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.088 -178.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.552 ' N ' ' O ' ' A' ' 74' ' ' ALA . 10.1 m-85 -45.48 -35.95 4.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.697 0.623 . . . . 0.0 111.057 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.91 -25.52 1.83 Allowed 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.8 0.81 . . . . 0.0 109.021 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 73.7 mt -55.5 -35.47 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.666 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -53.73 -43.96 69.5 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.223 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 82' ' ' ALA . 62.8 tttp -64.55 -65.34 0.69 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.35 -13.45 0.56 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.979 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 80' ' ' LYS . . . -88.67 -76.62 0.39 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.765 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.48 48.84 0.58 Allowed Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.0 mt -98.7 124.05 43.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -100.85 118.8 37.62 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 45.57 32.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.522 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.09 -135.23 40.11 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.85 59.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.937 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -59.3 -41.99 90.29 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.627 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -87.06 147.05 41.82 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.685 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -62.15 142.17 91.0 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 120.599 0.866 . . . . 0.0 111.848 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -111.26 -121.36 4.11 Favored Glycine 0 N--CA 1.465 0.601 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.4 mtt-85 -136.68 -86.83 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.651 0.262 . . . . 0.0 110.639 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -150.07 176.96 10.33 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.3 mttm 54.94 100.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.936 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -145.24 144.13 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.634 0.254 . . . . 0.0 110.35 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 46.95 87.18 0.01 OUTLIER Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -116.39 106.25 13.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.977 0.418 . . . . 0.0 111.23 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.4 pt -100.94 144.91 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -85.45 156.87 20.64 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.439 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -63.73 -51.06 66.64 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.615 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.23 -43.4 98.95 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.152 -0.967 . . . . 0.0 111.533 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -61.33 -46.96 88.08 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.696 -0.801 . . . . 0.0 111.227 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.5 m -65.2 -33.56 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 118.235 -1.386 . . . . 0.0 109.414 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 109' ' ' LYS . 40.8 mt -59.48 -65.69 0.63 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.392 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -44.86 -51.15 9.87 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.049 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.34 -31.46 46.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.787 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -91.55 -8.07 48.48 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.675 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 105' ' ' LEU . 45.3 tttm -85.56 -71.57 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 109.919 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.63 -40.72 60.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.395 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -69.89 66.08 0.24 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.384 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.436 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 38.8 mtm -157.65 54.84 0.84 Allowed Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.568 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 112' ' ' MET . 9.8 Cg_endo -65.13 -55.7 0.45 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 120.805 1.003 . . . . 0.0 111.85 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 113' ' ' PRO . 57.5 m-20 -160.01 15.5 0.14 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.398 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.9 mt -46.61 -86.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.319 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -170.8 -18.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.25 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 70.1 p -83.33 167.51 17.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.1 0.476 . . . . 0.0 111.15 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.409 ' OG1' ' N ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -140.59 -85.83 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.401 -178.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.409 ' N ' ' OG1' ' A' ' 118' ' ' THR . 90.9 m-20 -58.67 159.55 6.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 124' ' ' ALA . 37.5 mt -61.77 -37.27 83.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 0.0 110.161 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -52.9 -37.79 61.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.281 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.17 -69.0 0.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 118.981 -1.087 . . . . 0.0 109.067 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.51 -35.52 20.26 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.227 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -59.09 -69.83 0.18 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.0 mtt180 -43.76 -30.57 0.67 Allowed 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.758 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.459 ' O ' ' CB ' ' A' ' 130' ' ' SER . 2.9 tmm? -59.31 -73.07 0.09 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.0 mm -51.69 -48.98 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.032 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -67.71 -70.44 0.26 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.61 -43.22 4.97 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 126' ' ' MET . 68.8 m -58.64 -42.64 88.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -56.07 -48.99 75.01 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -51.39 -41.38 60.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.578 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.6 t -54.77 -66.77 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 86.5 mtp -50.75 -4.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.812 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.578 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 91.21 -27.72 8.96 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 55.1 t -47.38 164.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.455 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 97.7 mt-10 -141.23 161.9 36.77 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.056 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 140' ' ' GLY . 83.0 t -88.09 152.44 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.3 2.68 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.285 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . 113.9 154.23 11.17 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -141.92 68.02 23.16 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.69 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.067 1.178 . . . . 0.0 112.048 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -173.7 23.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.776 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.8 t -137.45 134.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.216 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -88.24 130.51 35.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -145.75 -55.71 0.29 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.993 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.104 -0.95 . . . . 0.0 110.324 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 ptt? . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 3' ' ' LYS . 50.5 tttt -171.05 177.96 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 2' ' ' LYS . 98.4 mttt 52.34 -162.41 0.09 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.143 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.428 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 14.2 p -51.9 112.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.639 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.8 -24.18 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.89 132.4 23.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.102 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 8.6 p -122.56 105.29 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.687 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -76.64 91.66 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 118.741 -1.184 . . . . 0.0 109.626 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -89.32 106.43 18.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.511 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -175.32 -173.77 0.68 Allowed 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.024 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -100.95 163.23 12.39 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.479 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 mt -153.51 137.3 10.48 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -87.53 125.27 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 CA-C-N 120.366 1.166 . . . . 0.0 114.114 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.543 ' O ' ' O ' ' A' ' 15' ' ' GLY . . . -59.33 139.17 57.27 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . 57.79 152.8 0.01 OUTLIER Glycine 0 CA--C 1.536 1.345 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 50.4 tttt 77.34 13.97 1.91 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.797 1.799 . . . . 0.0 111.373 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.19 157.97 16.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.99 167.56 4.87 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.653 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.09 39.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.709 1.606 . . . . 0.0 112.61 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 18' ' ' THR . . . -146.52 54.08 1.99 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.043 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 38.9 Cg_endo -82.49 164.24 16.61 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 120.972 1.114 . . . . 0.0 112.142 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -62.33 -25.7 76.63 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 120.8 1.0 . . . . 0.0 111.024 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.04 -71.57 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.034 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 46.47 -101.24 0.03 OUTLIER Glycine 0 C--O 1.214 -1.151 0 CA-C-O 118.574 -1.125 . . . . 0.0 111.099 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 27' ' ' LEU . 19.4 Cg_exo -43.57 -56.29 2.46 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 CA-C-N 121.479 2.639 . . . . 0.0 110.728 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.71 23.9 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.599 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.63 ' H ' ' C ' ' A' ' 25' ' ' PRO . 12.7 tp -169.98 -47.37 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -59.35 -51.39 59.44 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.529 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -73.57 41.28 0.11 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.014 0.907 . . . . 0.0 109.9 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.817 ' HD1' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -89.35 -21.29 23.18 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.817 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . 106.86 -38.82 3.13 Favored Glycine 0 N--CA 1.462 0.431 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.555 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -50.87 -134.98 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -137.14 125.93 24.01 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.484 -0.76 . . . . 0.0 110.4 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.571 ' O ' ' N ' ' A' ' 37' ' ' PHE . 10.9 mm -67.92 -70.55 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.409 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -39.53 -36.93 0.43 Allowed 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.505 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -61.89 -47.1 86.51 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.64 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 59.0 t80 -51.05 -65.1 0.61 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.412 1.101 . . . . 0.0 109.201 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 42' ' ' ASN . 96.4 t -57.07 -42.45 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.276 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 88.2 tttt -49.81 -60.94 2.44 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.685 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.72 79.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.355 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.64 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 8.8 m-85 -64.9 -76.44 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' VAL . 8.9 t-20 -39.3 -49.42 1.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.358 0.599 . . . . 0.0 111.973 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -57.32 -34.01 68.31 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.864 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.83 -46.91 9.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.054 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 49' ' ' GLY . 76.7 p -62.94 -24.01 67.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -84.89 -35.74 21.97 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -60.45 -25.63 66.14 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.501 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 6.6 ptm -107.14 -55.65 2.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.383 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.501 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 152.68 170.9 19.6 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.298 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -73.56 141.26 46.68 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 122.475 -0.426 . . . . 0.0 110.028 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -172.56 -152.26 0.06 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.155 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.8 mm -139.07 130.5 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.3 t -145.02 134.68 11.52 Favored Pre-proline 0 C--O 1.246 0.893 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.188 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -76.1 148.5 31.25 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 120.589 0.859 . . . . 0.0 110.384 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.6 m -146.06 137.04 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.504 0.669 . . . . 0.0 111.967 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 78.0 mt-10 -117.76 75.07 0.97 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.4 mt -58.26 93.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.944 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.36 95.29 1.72 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.9 mt -95.12 120.99 45.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -98.15 142.02 30.36 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.668 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.33 -20.18 1.01 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.846 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 93.3 m-20 -73.23 30.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.668 ' H ' ' C ' ' A' ' 61' ' ' ALA . 5.2 ptm180 40.31 69.77 0.29 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 122.305 1.05 . . . . 0.0 110.888 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 99.4 p -144.84 125.61 14.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.052 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -102.85 101.83 11.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.382 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 1.2 p -93.77 178.08 5.79 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CB ' ' O ' ' A' ' 66' ' ' THR . 1.9 t80 82.17 -154.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -177.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 t 82.25 72.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 123.871 0.732 . . . . 0.0 111.791 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.0 t -68.49 154.14 42.43 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.397 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.401 ' O ' ' OG1' ' A' ' 71' ' ' THR . 18.4 pttp -175.7 178.57 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.652 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 24.7 p 51.61 82.68 0.24 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.766 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.87 177.08 2.53 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.438 1.425 . . . . 0.0 112.441 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -74.98 4.6 4.58 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.398 1.399 . . . . 0.0 113.825 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -72.18 -152.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.832 0.349 . . . . 0.0 110.758 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -39.38 -15.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.691 0.397 . . . . 0.0 111.431 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.59 ' N ' ' O ' ' A' ' 74' ' ' ALA . 2.5 t80 -40.37 -47.75 2.59 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.976 0.798 . . . . 0.0 110.604 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.494 ' C ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -133.42 -14.92 2.52 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.787 0.803 . . . . 0.0 108.885 179.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 82' ' ' ALA . 22.9 mt -60.45 -38.12 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -50.29 -44.66 54.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.265 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -66.42 -61.07 2.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.66 -21.7 7.42 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.089 -0.645 . . . . 0.0 110.597 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -87.49 -77.91 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.807 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.63 19.41 3.76 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.3 mt -69.11 139.05 54.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -94.02 -45.48 7.57 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.701 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -173.17 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.018 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.26 40.79 54.85 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.11 72.25 1.25 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 110.651 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -151.46 162.95 40.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.919 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -55.31 154.2 11.89 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.172 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -53.42 144.67 49.38 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 120.491 0.794 . . . . 0.0 111.787 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -147.05 -75.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.3 110.75 6.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.718 0.294 . . . . 0.0 110.608 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -74.59 76.3 2.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.139 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -164.62 71.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.871 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -145.36 163.31 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.23 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.76 75.51 1.29 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -136.82 119.29 15.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.129 0.49 . . . . 0.0 111.25 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.6 pt -108.65 148.3 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.261 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.436 ' CG2' ' NE2' ' A' ' 103' ' ' GLN . 1.2 p -80.73 145.86 31.33 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.454 0.645 . . . . 0.0 110.832 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -53.26 -70.53 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.374 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -43.78 -38.09 3.06 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.216 -0.928 . . . . 0.0 111.482 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.436 ' NE2' ' CG2' ' A' ' 100' ' ' THR . 42.1 mt-30 -61.44 -48.5 80.87 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.821 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 m -63.78 -27.77 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 117.711 -1.596 . . . . 0.0 109.099 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 109' ' ' LYS . 35.9 mt -62.43 -70.86 0.18 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.654 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -45.87 -48.4 15.95 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.39 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.88 -30.39 47.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.934 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.521 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -98.9 -2.53 37.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.026 -0.421 . . . . 0.0 110.681 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 105' ' ' LEU . 68.7 tttt -89.08 -75.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.333 . . . . 0.0 111.026 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.29 -36.6 71.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.649 0.261 . . . . 0.0 111.46 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.43 48.68 0.11 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.049 0.452 . . . . 0.0 111.745 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.521 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 1.3 ptt? -171.64 58.04 0.25 Allowed Pre-proline 0 C--N 1.322 -0.628 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.615 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 112' ' ' MET . 14.0 Cg_exo -54.13 -38.59 87.61 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 120.508 0.805 . . . . 0.0 111.808 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -168.07 34.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.994 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 tt -61.36 -52.19 65.65 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.239 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.547 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -174.38 -6.99 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.332 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.9 p -140.61 175.21 9.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.146 0.498 . . . . 0.0 111.758 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.33 -37.56 0.42 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.432 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -76.55 145.32 39.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.985 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 124' ' ' ALA . 1.1 mm? -61.24 -45.47 94.39 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 121.505 0.669 . . . . 0.0 110.254 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.48 -36.75 69.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.451 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.45 -69.08 0.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.772 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.14 -40.21 45.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.173 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -54.39 -68.99 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.2 mtt180 -44.09 -28.8 0.53 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.081 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.484 ' O ' ' N ' ' A' ' 130' ' ' SER . 5.6 tmm? -59.83 -71.06 0.14 Allowed 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.5 mt -51.41 -50.48 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.728 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -64.63 -71.74 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.25 -45.27 5.16 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 126' ' ' MET . 62.5 m -60.26 -41.07 92.48 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -54.86 -47.19 74.52 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -54.5 -41.77 70.01 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 135' ' ' GLY . 1.9 t -57.01 -71.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 80.1 mtp -43.73 -13.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.329 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 90.66 46.14 4.07 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 131' ' ' ALA . 53.2 t -137.58 142.66 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.43 167.8 10.41 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 140' ' ' GLY . 12.0 t -89.9 144.52 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.03 0.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.291 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . 99.15 156.82 29.03 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -133.8 72.45 73.16 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 117.033 0.417 . . . . 0.0 110.798 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.97 149.16 91.36 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.444 1.429 . . . . 0.0 112.099 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 143' ' ' GLU . 0.7 OUTLIER -168.57 37.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.82 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.7 t -136.95 159.1 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.416 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.73 98.92 3.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.3 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 146' ' ' ASP . 44.9 p-10 -172.18 134.32 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.559 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.255 179.671 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtm . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt 51.98 -166.51 0.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.304 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 4' ' ' VAL . 99.2 mttt -104.32 -159.12 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 3' ' ' LYS . 7.0 p -40.55 124.72 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.1 m -113.88 -24.07 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.64 135.86 32.12 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.869 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 12.6 p -124.65 123.62 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.195 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.63 92.05 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.638 1.108 . . . . 0.0 111.004 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -75.16 112.93 11.94 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -170.45 -173.85 1.53 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.383 0.611 . . . . 0.0 110.583 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -99.49 157.61 16.32 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 mt -133.8 89.05 31.19 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -58.09 135.09 66.31 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.446 1.431 . . . . 0.0 114.442 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.547 ' CB ' ' H ' ' A' ' 51' ' ' ALA . . . -91.83 144.43 25.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.59 40.84 33.03 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -170.26 8.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.237 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.21 150.12 21.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -158.05 164.89 19.91 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.021 -178.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -61.69 47.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.658 1.572 . . . . 0.0 112.456 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.473 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -169.85 54.17 0.23 Allowed Pre-proline 0 C--N 1.322 -0.627 0 O-C-N 122.153 -0.342 . . . . 0.0 110.696 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 22.2 Cg_endo -73.57 172.27 16.08 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 121.066 1.177 . . . . 0.0 112.24 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -57.51 -21.46 46.01 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 120.525 0.817 . . . . 0.0 111.056 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.93 -64.11 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.794 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 45.7 -100.48 0.02 OUTLIER Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.71 -1.05 . . . . 0.0 110.72 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.5 Cg_exo -50.64 -57.92 1.99 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 CA-C-N 120.678 2.239 . . . . 0.0 111.054 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.49 -17.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.596 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -113.96 -39.6 3.92 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.18 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.64 51.0 3.26 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -142.33 -13.25 0.8 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.367 0.603 . . . . 0.0 109.794 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.732 ' HD1' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -70.66 -15.48 62.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.938 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.732 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . 100.88 -32.99 6.8 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.604 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -46.43 -133.8 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.393 0.677 . . . . 0.0 112.357 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -136.2 144.97 45.2 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.904 -0.498 . . . . 0.0 110.483 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 37' ' ' PHE . 4.5 mm -94.03 -73.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 39' ' ' LYS . 3.7 ppp? -41.14 -35.82 0.64 Allowed 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.23 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -59.72 -52.64 64.64 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 90.1 t80 -47.84 -58.94 3.73 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.469 1.128 . . . . 0.0 109.241 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 42' ' ' ASN . 75.3 t -60.76 -44.65 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.156 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 35' ' ' MET . 88.3 tttt -45.21 -64.68 0.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.04 74.13 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.433 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -62.15 -76.36 0.06 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -40.28 -43.4 1.71 Allowed 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 121.311 0.577 . . . . 0.0 111.822 -177.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.05 -34.17 69.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.93 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.19 -47.11 10.43 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.829 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 49' ' ' GLY . 71.8 p -62.57 -32.33 73.29 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -69.17 -41.02 77.77 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -63.66 -18.49 64.02 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 70.8 mtm -107.22 -86.67 0.49 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.788 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -174.7 -165.72 31.54 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.359 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 34.1 p-10 -93.5 130.18 39.44 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.547 ' H ' ' CB ' ' A' ' 14' ' ' ALA . . . -162.41 -152.45 0.23 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.296 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.4 mt -141.99 132.1 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.7 108.07 28.77 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -74.02 112.09 3.46 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 120.793 0.995 . . . . 0.0 109.698 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.526 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 6.5 p -144.35 164.61 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 121.488 0.661 . . . . 0.0 112.2 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 12.7 mt-10 -123.19 115.93 22.58 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.2 mt -74.92 94.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.917 0.389 . . . . 0.0 111.757 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -69.42 102.21 1.73 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 mt -100.73 123.62 53.81 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-O 120.844 0.354 . . . . 0.0 111.163 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -99.3 143.17 29.86 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.505 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.658 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -53.74 -24.44 14.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 124.717 1.261 . . . . 0.0 112.375 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 41.0 t0 -67.72 7.57 0.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.658 ' H ' ' C ' ' A' ' 61' ' ' ALA . 98.5 mtt180 62.5 70.37 0.57 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.252 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 p -145.3 134.08 22.33 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.947 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -111.55 103.81 12.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.651 -178.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.7 p -96.8 123.22 40.44 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 5.9 p90 177.98 -150.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -175.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 53.2 t 80.56 104.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 124.344 1.028 . . . . 0.0 111.766 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 p -122.59 112.72 18.33 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.495 ' O ' ' CG2' ' A' ' 71' ' ' THR . 12.4 mmtt -143.8 -150.29 0.31 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.634 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 4.8 t 47.0 53.47 13.83 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 123.699 0.624 . . . . 0.0 110.442 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.634 ' HD3' ' N ' ' A' ' 71' ' ' THR . 6.5 Cg_endo -79.36 175.79 10.37 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 120.727 0.952 . . . . 0.0 112.399 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.466 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 1.7 Cg_endo -64.7 -172.22 0.19 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.608 1.538 . . . . 0.0 111.246 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 78.99 -176.72 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.578 0.228 . . . . 0.0 110.729 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 p -40.92 -20.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.474 -0.141 . . . . 0.0 110.652 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 74' ' ' ALA . 11.9 m-85 -43.28 -44.26 5.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.366 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.58 -25.4 3.43 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 122.068 0.937 . . . . 0.0 109.018 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 82' ' ' ALA . 26.9 mt -54.05 -33.38 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.438 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 83' ' ' GLY . 19.6 mmm-85 -51.54 -48.34 63.07 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.091 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -64.74 -61.84 1.94 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.57 -21.8 4.26 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.639 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -91.68 -77.05 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.639 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 113.93 54.84 0.42 Allowed Glycine 0 N--CA 1.469 0.85 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 85' ' ' GLU . 10.0 mt -94.58 15.06 18.98 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.853 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' LEU . 64.9 tt0 -44.26 164.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.458 ' CG ' ' N ' ' A' ' 87' ' ' GLY . 18.9 ptmt -48.49 -42.76 33.79 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.505 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.458 ' N ' ' CG ' ' A' ' 86' ' ' LYS . . . 144.03 170.03 13.27 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 90' ' ' LYS . . . -108.03 109.74 21.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 66.33 -67.36 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -148.91 152.32 36.66 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.81 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -52.39 140.08 53.98 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 120.76 0.974 . . . . 0.0 111.647 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.48 -77.45 1.35 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -140.19 151.18 45.01 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 95' ' ' LYS . 96.0 mt-10 -60.32 -165.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 94' ' ' GLU . 61.9 mttm 52.95 105.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.013 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.3 p -136.44 157.86 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 118.35 80.78 0.73 Allowed Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -126.48 94.4 4.05 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.948 0.404 . . . . 0.0 111.962 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 pt -100.93 149.78 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.452 ' OG1' ' OE1' ' A' ' 103' ' ' GLN . 0.2 OUTLIER -90.78 156.53 17.98 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.478 0.656 . . . . 0.0 110.333 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.431 ' O ' ' CG2' ' A' ' 104' ' ' VAL . 61.3 t-105 -61.56 -71.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.325 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -46.46 -39.14 10.16 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 120.761 -1.212 . . . . 0.0 111.905 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.452 ' OE1' ' OG1' ' A' ' 100' ' ' THR . 32.3 mt-30 -60.8 -47.19 87.45 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.308 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 101' ' ' TRP . 15.9 m -63.62 -29.0 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.371 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 108' ' ' ALA . 59.7 mt -63.23 -72.61 0.13 Allowed 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.998 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -44.88 -45.04 10.07 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.2 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.63 -25.22 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.127 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -106.27 -1.02 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.704 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 105' ' ' LEU . 43.8 tttp -85.18 -74.68 0.39 Allowed 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.253 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -62.42 -43.61 98.4 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.548 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -76.45 76.15 3.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.799 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.449 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -135.98 54.85 10.67 Favored Pre-proline 0 N--CA 1.468 0.432 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.009 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 112' ' ' MET . 4.3 Cg_endo -59.84 -30.97 93.16 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 120.701 0.934 . . . . 0.0 111.662 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' A' ' 116' ' ' ASN . 36.8 t70 -154.05 -86.08 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.992 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.1 mt 51.69 0.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.634 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.609 ' H ' ' C ' ' A' ' 114' ' ' ASP . 4.0 t30 54.38 26.95 7.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.47 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.3 p -143.79 161.62 38.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.293 0.568 . . . . 0.0 111.728 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.3 -32.48 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.09 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -75.02 146.04 41.93 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.74 -45.71 93.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.355 0.598 . . . . 0.0 110.406 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -59.19 -38.85 80.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.702 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.95 -68.98 0.34 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.016 -1.073 . . . . 0.0 108.805 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.18 -37.49 22.67 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.075 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.85 -66.25 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.1 mtt180 -46.16 -36.0 5.56 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.507 ' O ' ' N ' ' A' ' 130' ' ' SER . 5.7 tmm? -55.57 -73.47 0.06 Allowed 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.1 mm -51.15 -50.33 26.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.962 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -62.67 -72.55 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.15 -47.41 5.41 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 126' ' ' MET . 66.4 m -56.79 -43.0 80.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -52.52 -46.85 66.89 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.552 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -55.55 -34.25 64.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 130' ' ' SER . 3.1 t -65.37 -76.45 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 6.7 ptm -40.2 -25.73 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.636 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 104.38 60.52 0.67 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' A' ' 131' ' ' ALA . 27.4 t -145.29 162.99 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.462 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 98.1 mt-10 -128.94 156.22 44.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.73 152.11 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 46.1 t -96.74 -11.8 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.718 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -131.54 69.22 0.54 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.12 69.56 18.15 Favored Pre-proline 0 CA--C 1.532 0.256 0 O-C-N 122.793 -0.24 . . . . 0.0 110.502 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.8 148.16 93.69 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.344 1.363 . . . . 0.0 111.976 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.54 151.26 47.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 145' ' ' LYS . 12.7 m -90.56 31.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.734 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 144' ' ' VAL . 98.3 mttt 48.35 -174.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -152.57 -85.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.587 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.194 179.787 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptp . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 14.3 mptt -97.39 -179.89 4.65 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.57 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 48.4 tttt 71.97 173.72 0.3 Allowed 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.884 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.67 158.71 30.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.621 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.98 -26.16 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.13 116.55 4.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 119.044 -1.062 . . . . 0.0 111.103 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 9.4 p -110.12 112.24 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.335 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.89 90.41 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 118.563 -1.255 . . . . 0.0 110.693 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -76.26 120.17 21.16 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.411 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -173.68 -174.65 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.38 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.414 ' N ' ' NE2' ' A' ' 11' ' ' GLN . 2.7 mp0 -95.87 159.38 15.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.61 92.89 14.6 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.36 146.5 94.63 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.26 1.307 . . . . 0.0 114.414 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.32 143.2 31.66 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.44 44.59 36.43 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -167.46 -6.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.238 -0.481 . . . . 0.0 109.811 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.09 149.62 30.57 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -158.97 168.03 13.23 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.115 -178.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -60.14 41.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.475 1.45 . . . . 0.0 112.427 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -172.34 58.79 0.25 Allowed Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.919 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 20.5 Cg_endo -78.75 172.21 15.44 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.218 1.279 . . . . 0.0 112.136 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -55.88 -23.82 44.4 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 120.552 0.834 . . . . 0.0 111.013 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.4 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.2 t -83.04 -64.55 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 43.43 -96.86 0.01 OUTLIER Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 14.2 Cg_exo -47.13 -60.06 1.02 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 CA-C-N 119.927 1.863 . . . . 0.0 110.669 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.33 -23.84 0.65 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.847 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.96 26.88 9.49 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.48 41.32 0.63 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -141.69 -11.17 0.9 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.438 0.637 . . . . 0.0 109.619 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.616 ' HD1' ' H ' ' A' ' 32' ' ' ALA . 1.4 p80 -67.18 -15.34 63.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.466 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 102.22 -26.33 24.63 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.616 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -51.37 -132.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.142 0.577 . . . . 0.0 112.089 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -133.45 -169.28 2.25 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 37' ' ' PHE . 3.4 mm -131.65 -76.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.582 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -40.2 -42.28 1.46 Allowed 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.875 179.048 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -52.81 -51.47 60.7 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.101 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 34' ' ' ILE . 2.0 t80 -50.37 -66.09 0.45 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.599 1.19 . . . . 0.0 109.845 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 42' ' ' ASN . 54.0 t -57.51 -48.61 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 112.889 -1.959 . . . . 0.0 110.939 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.582 ' N ' ' O ' ' A' ' 35' ' ' MET . 79.1 mttt -44.14 -58.49 2.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.43 -44.33 84.57 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.048 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 44' ' ' ALA . 1.8 t80 -61.13 -73.96 0.09 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -39.85 -41.29 1.12 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.688 0.756 . . . . 0.0 111.681 -177.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -61.9 -35.0 77.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.083 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -86.4 -43.49 12.78 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.749 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 49' ' ' GLY . 70.4 p -63.61 -34.93 78.92 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -67.96 -42.07 81.45 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -62.95 -20.14 64.95 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.0 ttp -106.08 -85.28 0.5 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.954 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 170.78 170.3 34.84 Favored Glycine 0 N--CA 1.465 0.617 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.108 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 47.7 p-10 -65.39 137.05 57.24 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -176.09 -154.0 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.857 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.7 mm -141.68 130.99 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.88 127.93 16.47 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.626 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -71.05 148.62 57.14 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.804 1.003 . . . . 0.0 110.751 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.68 160.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.485 0.659 . . . . 0.0 111.434 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -139.47 103.17 4.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.1 mt -68.17 87.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.582 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 m -70.99 103.16 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 mt -103.74 126.0 58.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.173 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 3' ' ' LYS . 4.4 m-85 -104.07 141.09 36.82 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.652 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -51.09 -22.11 2.26 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 124.18 0.925 . . . . 0.0 112.079 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -67.51 9.12 0.27 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.652 ' H ' ' C ' ' A' ' 61' ' ' ALA . 99.5 mtt180 60.96 68.97 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.923 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -146.22 132.36 19.37 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.135 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -109.56 102.39 11.25 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.161 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 8.4 m -95.56 119.66 34.44 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER 172.19 115.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 O-C-N 124.4 1.062 . . . . 0.0 111.092 -176.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.8 t -154.43 136.6 6.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 p -141.47 147.05 37.25 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -141.76 171.06 14.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.251 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -40.17 98.08 0.16 Allowed Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.793 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.493 ' O ' ' O ' ' A' ' 71' ' ' THR . 16.2 Cg_exo -43.26 177.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 121.256 1.304 . . . . 0.0 113.119 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -51.14 113.54 1.15 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.427 1.418 . . . . 0.0 112.759 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 172.38 -152.0 0.01 OUTLIER 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.629 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 80.2 p -36.94 -22.96 0.01 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.985 0.421 . . . . 0.0 110.44 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.604 ' N ' ' O ' ' A' ' 74' ' ' ALA . 11.6 t80 -47.37 -36.75 10.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.68 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.9 -34.22 3.98 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.67 0.747 . . . . 0.0 109.884 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.629 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 69.0 mt -48.2 -38.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.418 ' NH1' ' O ' ' A' ' 84' ' ' LEU . 13.1 mmm180 -51.67 -45.99 63.63 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.329 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -66.54 -63.31 1.1 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.33 -19.27 2.0 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.293 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -89.96 -77.62 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.607 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.33 45.1 0.63 Allowed Glycine 0 N--CA 1.47 0.902 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.418 ' O ' ' NH1' ' A' ' 79' ' ' ARG . 24.5 mt -98.89 115.36 28.67 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -89.92 -46.06 8.8 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.753 0.311 . . . . 0.0 110.559 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 88' ' ' ALA . 21.1 ptmt -149.81 152.08 34.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.085 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.07 -6.07 3.66 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.43 ' O ' ' CG ' ' A' ' 89' ' ' HIS . . . 53.59 -179.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 88' ' ' ALA . 71.7 m80 -154.09 -60.53 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -80.45 147.41 63.81 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.333 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.36 146.74 49.74 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.808 1.006 . . . . 0.0 111.766 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.92 -101.46 0.33 Allowed Glycine 0 N--CA 1.466 0.64 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.459 ' C ' ' H ' ' A' ' 95' ' ' LYS . 7.4 tpt180 -97.62 135.22 39.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -77.88 29.36 0.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.817 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 93' ' ' ARG . 52.8 mtmt -144.81 101.27 3.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.557 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.18 155.93 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.247 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.53 82.48 0.07 OUTLIER Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -135.1 104.19 5.84 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.8 pt -104.37 150.21 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.451 ' CG2' ' NE2' ' A' ' 103' ' ' GLN . 1.8 p -87.96 155.72 19.69 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.397 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -60.97 -54.59 43.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.083 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 1.3 tp10 -59.1 -40.37 85.1 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.059 -1.025 . . . . 0.0 111.123 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.451 ' NE2' ' CG2' ' A' ' 100' ' ' THR . 41.0 mt-30 -59.38 -47.14 86.55 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.811 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.4 m -65.52 -29.06 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 118.494 -1.282 . . . . 0.0 109.467 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 109' ' ' LYS . 64.7 mt -64.52 -74.03 0.11 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.522 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -44.2 -48.76 9.3 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.464 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.6 -25.28 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.107 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -105.54 -0.34 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.479 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.9 tmtt? -89.2 -74.74 0.46 Allowed 'General case' 0 N--CA 1.461 0.083 0 CA-C-O 120.751 0.31 . . . . 0.0 110.187 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -72.53 -40.99 66.35 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.843 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -74.85 73.59 2.11 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.57 61.71 0.17 Allowed Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.407 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -52.75 -43.15 58.07 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 120.594 0.863 . . . . 0.0 112.051 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 116' ' ' ASN . 27.0 t70 -142.4 -61.79 0.44 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.272 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.405 ' HB3' ' H ' ' A' ' 116' ' ' ASN . 1.4 tt 45.64 -85.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.933 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 114' ' ' ASP . 4.3 t30 -174.77 9.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.943 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 46.5 p -141.83 171.19 14.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.401 0.619 . . . . 0.0 111.749 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.37 -40.86 0.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.894 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -83.48 153.31 24.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 124' ' ' ALA . 35.8 mt -60.24 -46.18 90.66 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.314 0.578 . . . . 0.0 109.931 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -54.81 -42.09 71.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.916 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.56 -66.84 0.53 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.116 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.63 36.67 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.941 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -53.03 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.602 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.4 mtt180 -43.3 -31.22 0.6 Allowed 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.001 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 130' ' ' SER . 5.5 ttp -59.33 -73.48 0.08 Allowed 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.9 mp -48.99 -49.39 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.581 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -65.98 -71.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.34 -49.29 5.64 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 126' ' ' MET . 49.5 m -54.47 -42.99 71.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -56.05 -47.8 77.21 Favored 'General case' 0 C--O 1.228 -0.069 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -55.14 -41.51 71.86 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 t -53.31 -71.26 0.07 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.1 mtm -41.58 -62.07 0.95 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.942 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.18 50.0 0.04 OUTLIER Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 54.4 t -133.92 164.82 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.477 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 98.0 mt-10 -133.78 159.27 41.1 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.2 t -96.34 155.12 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.0 p -83.44 -2.71 6.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.647 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.12 103.21 0.24 Allowed Glycine 0 CA--C 1.518 0.261 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -157.76 68.11 3.89 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.489 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -60.28 143.73 99.5 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.276 1.318 . . . . 0.0 111.804 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -82.63 152.94 25.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 145' ' ' LYS . 10.5 t -75.26 121.91 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 144' ' ' VAL . 68.4 mttm 51.08 178.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -152.59 -85.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.644 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.921 179.637 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 3' ' ' LYS . 22.4 tptt -93.48 -163.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 1.5 mptm? -64.59 -164.05 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.91 121.67 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.3 m -113.33 -25.32 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.778 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.94 135.59 39.74 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.271 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 7.4 p -126.37 126.95 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.226 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.96 91.03 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.826 1.194 . . . . 0.0 111.539 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -82.15 116.32 21.66 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -168.47 -171.51 1.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.403 -178.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -94.44 154.16 17.58 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' CD1' ' CZ ' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -135.66 92.35 17.14 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -71.65 114.32 3.91 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.264 1.309 . . . . 0.0 114.775 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.455 ' CB ' ' H ' ' A' ' 51' ' ' ALA . . . -61.94 143.83 55.9 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . 61.49 150.53 0.02 OUTLIER Glycine 0 C--N 1.336 0.57 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.4 tttp 72.88 10.52 5.4 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.126 0.963 . . . . 0.0 110.564 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.15 151.93 20.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.6 170.81 3.97 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.041 -178.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -58.79 42.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.363 1.375 . . . . 0.0 112.23 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -160.91 54.26 0.55 Allowed Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-O 120.474 0.178 . . . . 0.0 110.533 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 25.6 Cg_endo -77.07 168.37 23.43 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.091 1.194 . . . . 0.0 112.21 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -56.51 -31.37 86.02 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 120.639 0.893 . . . . 0.0 111.284 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.7 t -75.02 -61.28 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 44.48 -99.61 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -47.87 -60.31 0.92 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 CA-C-N 119.816 1.808 . . . . 0.0 110.998 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -45.9 -26.83 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.366 -0.533 . . . . 0.0 109.824 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 25.6 tp -119.69 23.06 11.34 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.603 0.716 . . . . 0.0 109.172 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -152.56 37.93 0.77 Allowed Glycine 0 C--N 1.322 -0.221 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.668 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 29' ' ' GLN . 0.8 OUTLIER -141.57 -3.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.619 ' HD1' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -78.5 -11.96 59.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.264 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.619 ' N ' ' HD1' ' A' ' 30' ' ' HIS . . . 97.83 -26.1 24.72 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.588 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -47.66 -134.37 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.987 0.515 . . . . 0.0 112.287 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -136.76 143.58 43.33 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 122.093 -0.38 . . . . 0.0 111.015 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.6 mm -93.14 -73.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.483 ' O ' ' N ' ' A' ' 39' ' ' LYS . 11.4 tpt -39.72 -39.44 0.77 Allowed 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -59.49 -52.44 65.57 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.822 -0.751 . . . . 0.0 108.993 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' A' ' 34' ' ' ILE . 90.2 t80 -47.11 -62.43 1.42 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.165 0.983 . . . . 0.0 109.724 177.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 42' ' ' ASN . 86.9 t -58.71 -44.02 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 113.309 -1.769 . . . . 0.0 111.178 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 35' ' ' MET . 88.4 tttt -45.44 -67.79 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.75 -41.02 66.67 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.491 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 12' ' ' LEU . 54.9 t80 -62.9 -77.03 0.06 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.29 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -40.24 -44.73 1.94 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.314 0.578 . . . . 0.0 112.182 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.06 -34.81 70.52 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.113 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.17 -46.05 11.45 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.618 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 49' ' ' GLY . 32.4 p -63.76 -31.69 72.94 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -70.03 -41.02 74.82 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -62.4 -20.02 64.03 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.2 mtm -106.51 -78.85 0.57 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.259 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 169.17 166.49 28.29 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.362 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 36.9 p-10 -62.63 125.51 24.17 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.455 ' H ' ' CB ' ' A' ' 14' ' ' ALA . . . -162.41 -153.88 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.285 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 99.3 mt -142.03 132.15 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.72 120.46 6.03 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.249 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -65.37 140.71 65.03 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 120.746 0.964 . . . . 0.0 110.862 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.4 m -137.53 159.62 34.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.234 0.54 . . . . 0.0 110.861 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 58' ' ' THR . 32.4 tt0 -129.89 85.7 2.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mt -60.36 82.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.216 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -72.74 97.16 2.15 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.2 mt -97.31 126.25 50.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.008 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -98.86 144.65 27.83 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.672 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -54.25 -24.12 17.46 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.44 1.088 . . . . 0.0 112.331 -176.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -68.45 10.44 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.672 ' H ' ' C ' ' A' ' 61' ' ' ALA . 87.2 mtm180 61.27 69.2 0.68 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.496 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.3 m -142.9 126.94 17.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.843 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -107.58 103.76 13.15 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.058 -177.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' A' ' 58' ' ' THR . 77.3 p -95.71 121.58 37.57 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.543 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.4 p90 176.46 -152.54 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 51.7 t 80.69 152.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.304 0 O-C-N 124.329 1.018 . . . . 0.0 110.564 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t -146.68 173.36 12.43 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.45 ' O ' ' CG2' ' A' ' 71' ' ' THR . 58.0 pttt -170.6 -159.85 0.19 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.565 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 t 43.25 56.38 11.84 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.956 0.408 . . . . 0.0 111.431 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 71' ' ' THR . 9.8 Cg_endo -77.82 157.57 31.35 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 C-N-CA 120.064 0.509 . . . . 0.0 112.04 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.51 ' O ' ' HD2' ' A' ' 76' ' ' TYR . 11.3 Cg_endo -70.13 176.2 7.38 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 121.952 1.768 . . . . 0.0 112.293 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 79.71 -177.24 0.08 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.897 0.317 . . . . 0.0 110.279 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.552 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.1 OUTLIER -40.51 -20.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.312 -0.242 . . . . 0.0 110.521 -179.031 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' A' ' 74' ' ' ALA . 26.0 m-85 -42.73 -35.96 1.3 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.651 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -133.51 -25.55 1.7 Allowed 'General case' 0 C--O 1.253 1.253 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.552 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 45.6 mt -54.56 -35.02 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.573 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -53.37 -42.84 67.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.277 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 82' ' ' ALA . 3.1 tmtm? -67.84 -65.32 0.71 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.9 -11.64 0.25 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.999 -0.681 . . . . 0.0 110.65 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.458 ' H ' ' C ' ' A' ' 80' ' ' LYS . . . -87.42 -77.63 0.33 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.851 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 137.74 63.09 0.05 OUTLIER Glycine 0 N--CA 1.464 0.537 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.9 mt -115.06 135.87 53.74 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -140.92 -175.3 4.25 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.83 126.36 26.61 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.91 -143.36 11.84 Favored Glycine 0 N--CA 1.466 0.646 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 51.29 31.25 6.75 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.586 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -79.44 -83.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.271 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -89.21 153.57 48.85 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.332 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -53.45 142.51 58.44 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 120.842 1.028 . . . . 0.0 111.667 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.47 -107.85 0.2 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -71.43 149.12 46.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -127.31 57.82 1.48 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.687 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -139.66 74.13 1.46 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.492 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.61 159.5 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.68 68.19 1.07 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.28 99.29 6.27 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.706 0.253 . . . . 0.0 111.034 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.7 pt -95.63 139.29 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.61 155.99 25.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.753 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.458 ' O ' ' CG2' ' A' ' 104' ' ' VAL . 57.2 t-105 -61.75 -69.13 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -48.29 -42.17 30.07 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 120.916 -1.115 . . . . 0.0 112.147 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -59.86 -46.08 90.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.451 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 101' ' ' TRP . 19.2 m -63.44 -29.78 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 118.286 -1.366 . . . . 0.0 109.283 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 108' ' ' ALA . 36.7 mt -62.38 -70.68 0.19 Allowed 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.339 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -43.63 -46.29 7.21 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.568 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.46 -26.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.378 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.554 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -101.66 -2.39 30.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.364 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.517 ' O ' ' SD ' ' A' ' 112' ' ' MET . 87.5 tttt -88.76 -75.45 0.43 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.857 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.4 -40.3 73.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.04 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.15 84.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.456 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.554 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 3.1 ptt? -179.51 58.24 0.1 OUTLIER Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.505 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 112' ' ' MET . 13.6 Cg_endo -75.81 -55.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 120.618 0.879 . . . . 0.0 112.337 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -88.85 -31.45 18.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.772 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 117' ' ' THR . 10.3 mt -45.42 134.07 7.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -65.98 70.24 0.06 Allowed 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.298 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LEU . 82.6 p -143.71 159.35 42.65 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.212 0.53 . . . . 0.0 111.994 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.64 -43.32 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.935 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -91.94 148.35 22.27 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -46.82 87.5 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.689 0.757 . . . . 0.0 110.124 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.65 -35.68 68.66 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.66 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.92 -64.73 0.81 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.937 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.87 -22.92 27.97 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.923 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.95 -73.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.2 mtt180 -43.09 -31.95 0.63 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.658 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 130' ' ' SER . 38.9 ttp -57.36 -72.95 0.08 Allowed 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.0 mm -51.33 -50.28 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.328 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -64.28 -72.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.13 -45.58 3.99 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 126' ' ' MET . 67.7 m -56.74 -44.69 81.95 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -56.22 -50.43 71.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.583 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -48.88 -42.88 38.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.399 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.608 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.4 t -54.13 -65.07 0.64 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.8 mtp -52.45 -2.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.605 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.1 -29.27 6.61 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 68.1 t -46.05 164.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.462 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 79.2 mt-10 -143.05 164.76 29.22 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.093 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.23 155.03 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -100.18 -7.54 9.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.703 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 142' ' ' PRO . . . -115.48 -22.28 4.83 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-O 119.131 -0.816 . . . . 0.0 111.553 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 140' ' ' GLY . . . -35.74 91.1 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 124.045 0.497 . . . . 0.0 110.197 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.5 ' N ' ' O ' ' A' ' 140' ' ' GLY . 2.9 Cg_exo -63.2 149.85 90.23 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.36 1.373 . . . . 0.0 111.895 -177.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.466 ' HG2' ' H ' ' A' ' 145' ' ' LYS . 72.2 tt0 -59.36 132.1 52.98 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 145' ' ' LYS . 4.9 m -66.8 -6.12 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.894 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.466 ' H ' ' HG2' ' A' ' 143' ' ' GLU . 2.5 tmtp? 54.16 104.89 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -131.6 116.12 16.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.601 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.851 -179.808 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptt? . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? 49.62 91.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.884 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 17.9 ttmt -107.84 178.03 4.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.775 0.322 . . . . 0.0 110.455 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.59 126.39 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -112.07 -24.77 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.41 119.6 14.61 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.292 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 7.6 p -111.6 104.82 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.842 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.68 92.41 2.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 117.985 -1.486 . . . . 0.0 110.295 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -85.23 109.49 18.37 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.437 0.461 . . . . 0.0 110.304 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.43 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -171.89 -174.51 1.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.191 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -102.18 173.57 6.32 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.61 139.31 5.93 Favored Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.974 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -82.2 149.54 15.3 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.125 1.217 . . . . 0.0 114.722 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.33 144.73 25.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.17 58.86 8.95 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm 172.63 21.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.336 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.16 150.68 21.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -162.42 168.54 10.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.075 -178.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -62.23 42.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.29 1.327 . . . . 0.0 111.963 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -155.53 59.31 2.13 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.994 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 27.8 Cg_endo -79.72 166.47 21.57 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.286 1.324 . . . . 0.0 111.888 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.37 -30.71 88.83 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 120.8 1.0 . . . . 0.0 111.102 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.98 -58.06 6.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.812 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 41.08 -99.64 0.01 OUTLIER Glycine 0 C--O 1.207 -1.555 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.3 Cg_exo -48.41 -62.49 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 CA-C-N 120.308 2.054 . . . . 0.0 110.789 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -42.95 -16.82 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.059 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.614 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 29.5 tp -117.53 -27.56 6.3 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.699 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -57.59 -54.83 34.18 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -88.99 43.22 1.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.565 0.697 . . . . 0.0 110.496 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.668 ' CD2' ' H ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -86.87 -31.74 20.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.668 ' H ' ' CD2' ' A' ' 30' ' ' HIS . . . 109.86 -48.83 0.9 Allowed Glycine 0 N--CA 1.472 1.085 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.546 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -50.33 -131.23 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.973 0.509 . . . . 0.0 111.865 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -138.71 128.33 24.76 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.89 -0.506 . . . . 0.0 111.205 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.9 mm -71.96 -72.25 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.453 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -38.55 -39.44 0.48 Allowed 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -58.93 -48.94 79.68 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.074 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 60.7 t80 -48.42 -65.66 0.53 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.527 1.156 . . . . 0.0 109.622 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 42' ' ' ASN . 89.8 t -56.87 -44.03 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.383 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -47.06 -53.03 13.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.87 -37.8 87.12 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.227 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 7.8 m-85 -65.43 -74.11 0.11 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -37.16 -45.69 0.65 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.516 0.674 . . . . 0.0 111.514 -177.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.17 79.31 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.55 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -88.73 -45.23 9.96 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.519 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.3 p -60.63 -18.54 53.92 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -86.69 -42.72 13.15 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -60.23 -17.04 38.88 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.786 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 49' ' ' GLY . 1.7 ppp? -120.11 126.41 50.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.132 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.501 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -40.93 161.9 0.01 OUTLIER Glycine 0 CA--C 1.543 1.835 0 C-N-CA 119.533 -1.317 . . . . 0.0 111.584 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 53.6 p-10 -62.6 151.46 37.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.06 0.93 . . . . 0.0 109.928 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 179.6 -150.48 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.809 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.0 mt -143.24 134.9 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 m -147.43 145.83 23.0 Favored Pre-proline 0 C--O 1.243 0.723 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.3 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -76.42 149.09 30.69 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 121.064 1.176 . . . . 0.0 110.961 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 m -142.54 143.28 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.133 0.492 . . . . 0.0 111.017 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.71 85.6 2.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 mt -64.52 83.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.916 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 m -69.23 93.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.437 HG22 HD13 ' A' ' 59' ' ' ILE . 88.8 mt -93.56 125.72 46.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.218 -178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.418 ' CD2' ' C ' ' A' ' 3' ' ' LYS . 7.7 m-85 -100.27 142.66 31.44 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.675 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.7 -22.87 2.29 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 124.651 1.219 . . . . 0.0 112.165 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.25 5.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.675 ' H ' ' C ' ' A' ' 61' ' ' ALA . 51.2 mtp180 62.54 72.78 0.48 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.104 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.1 p -152.45 132.36 13.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.314 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -101.36 101.69 12.38 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.41 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.7 132.0 41.36 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 67' ' ' PHE . 51.5 p90 -172.26 123.54 0.49 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.479 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.8 t -107.32 108.01 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.507 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 25.6 p -156.21 -164.27 1.65 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 69' ' ' THR . 9.3 pttt 76.78 -178.95 0.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.511 ' CG2' ' CE2' ' A' ' 76' ' ' TYR . 6.4 m 64.9 68.61 0.73 Allowed Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.558 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.531 ' O ' ' CD1' ' A' ' 76' ' ' TYR . 10.8 Cg_endo -78.53 155.5 28.04 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 120.934 1.089 . . . . 0.0 112.289 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.46 112.67 2.89 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.699 1.599 . . . . 0.0 112.367 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 169.61 -167.46 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.596 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -41.51 -16.19 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 O-C-N 122.0 -0.437 . . . . 0.0 110.571 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -43.97 -30.12 0.67 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -140.7 -27.14 0.73 Allowed 'General case' 0 C--O 1.255 1.358 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.596 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 66.4 mt -51.67 -35.59 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.455 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -53.51 -45.37 69.68 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.702 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.07 -63.63 1.19 Allowed 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.32 -19.44 5.42 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.725 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.19 -78.75 0.25 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.069 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 134.03 23.52 0.68 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.17 132.64 36.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -88.49 -80.39 0.28 Allowed 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.306 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -144.48 -19.34 0.54 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.709 0.29 . . . . 0.0 111.012 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.06 -137.74 2.29 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.05 0.38 0.1 Allowed 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.191 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 49.49 -173.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -48.97 154.18 1.34 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.096 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.09 141.87 46.52 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 120.909 1.072 . . . . 0.0 111.714 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.61 -103.9 0.22 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -86.02 135.13 33.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -94.18 8.94 39.87 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.939 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -91.54 97.82 11.29 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.4 p -159.8 152.95 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.308 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.88 82.86 0.14 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.647 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -140.35 123.06 16.33 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 121.035 0.445 . . . . 0.0 111.003 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 pt -128.8 157.28 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 p -91.01 166.79 12.82 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.134 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -59.34 -54.39 47.33 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.27 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -55.73 -40.94 73.15 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.585 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -61.03 -47.86 84.48 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.858 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.0 m -66.42 -28.63 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 118.414 -1.314 . . . . 0.0 109.783 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 109' ' ' LYS . 53.0 mt -63.1 -71.47 0.16 Allowed 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.521 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -43.79 -47.45 8.03 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.141 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.83 -27.48 41.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.244 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.566 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -104.63 0.62 28.69 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.693 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 105' ' ' LEU . 77.8 tttt -84.91 -73.78 0.42 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.541 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -57.18 -35.98 70.24 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -70.59 48.74 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.456 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.566 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 91.9 mtp -143.32 54.1 2.95 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.411 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 112' ' ' MET . 3.5 Cg_endo -57.8 -46.67 25.04 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 120.651 0.901 . . . . 0.0 112.088 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -173.93 26.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.9 mt -43.42 -73.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.454 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.529 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -172.1 0.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.226 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.6 p -141.73 177.53 8.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 111.903 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.2 p -141.6 -22.26 0.73 Allowed 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.996 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -82.07 143.06 31.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.198 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.2 -40.72 97.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 110.876 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -56.1 -35.16 66.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.18 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.77 -68.88 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.861 -1.136 . . . . 0.0 108.967 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.06 -39.08 26.19 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.976 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.38 -66.55 0.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 129' ' ' GLY . 98.8 mtt180 -44.27 -31.91 1.14 Allowed 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.479 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 4.4 tmm? -59.24 -72.35 0.1 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.6 mm -51.1 -50.34 25.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.218 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -66.26 -70.82 0.22 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.39 -44.4 3.99 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.479 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 66.4 m -58.71 -44.85 90.51 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -54.62 -50.32 68.39 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.527 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -49.36 -44.59 44.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.564 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.5 t -52.47 -65.72 0.51 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 83.5 mtp -51.82 -5.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.303 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.57 -25.56 12.87 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 45.7 t -47.64 163.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.465 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 75.8 mt-10 -131.62 153.24 50.13 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 65.2 t -117.25 130.49 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 38.7 t -94.76 -4.88 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.487 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 141' ' ' ALA . . . -59.33 156.11 26.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 140' ' ' GLY . . . 73.68 64.32 0.31 Allowed Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 117.403 0.602 . . . . 0.0 110.186 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 9.5 Cg_endo -71.85 178.41 5.86 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.339 1.359 . . . . 0.0 111.759 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.1 140.16 56.13 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 75.7 t -126.19 127.75 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -140.15 141.66 36.04 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -103.19 -76.03 0.6 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.616 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.106 -0.949 . . . . 0.0 110.505 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 ttp . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.67 139.77 53.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -145.29 168.59 20.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.482 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 8.2 p -58.05 123.07 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.5 t -114.36 -24.09 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.03 130.05 18.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.608 0.718 . . . . 0.0 111.101 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.4 t -119.92 103.56 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.058 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.25 93.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 118.164 -1.415 . . . . 0.0 110.045 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -76.01 110.81 10.78 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -169.91 -172.6 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.944 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 11' ' ' GLN . 26.4 mp0 -109.59 171.94 7.15 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.412 ' CD1' ' CZ ' ' A' ' 41' ' ' PHE . 8.0 mt -143.15 136.02 13.73 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -82.49 159.85 17.02 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.222 1.281 . . . . 0.0 113.722 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.35 142.53 47.43 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.66 35.53 38.15 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -177.38 59.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.896 -0.652 . . . . 0.0 110.468 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.07 156.24 47.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -167.68 169.02 5.81 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.286 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.84 39.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.357 1.371 . . . . 0.0 112.171 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.556 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -147.0 52.57 1.39 Allowed Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.629 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 31.2 Cg_endo -79.78 166.28 21.6 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.027 1.151 . . . . 0.0 111.885 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.08 -29.2 86.3 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 120.93 1.087 . . . . 0.0 111.087 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.62 -63.49 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 42.97 -99.58 0.01 OUTLIER Glycine 0 C--O 1.212 -1.252 0 CA-C-O 118.58 -1.122 . . . . 0.0 110.418 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.3 Cg_exo -47.55 -60.51 0.85 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 CA-C-N 120.968 2.384 . . . . 0.0 110.986 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.48 -16.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.429 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.632 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -117.82 -38.23 3.29 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 110.901 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.533 ' O ' ' ND1' ' A' ' 30' ' ' HIS . . . -56.68 -52.01 53.2 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -76.5 42.19 0.28 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.382 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.769 ' HD1' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -92.35 -30.38 15.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.726 177.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.769 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . 109.27 -43.19 1.76 Allowed Glycine 0 N--CA 1.464 0.529 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -51.44 -132.01 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.103 0.561 . . . . 0.0 111.849 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -138.68 123.73 19.01 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.909 -0.495 . . . . 0.0 110.736 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.6 mm -63.18 -71.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 39' ' ' LYS . 96.7 mmm -39.43 -43.19 1.19 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.26 -48.26 79.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.272 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 34' ' ' ILE . 29.5 t80 -50.05 -67.67 0.24 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 122.364 1.078 . . . . 0.0 109.358 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 42' ' ' ASN . 93.8 t -56.93 -42.51 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.174 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 35' ' ' MET . 88.4 tttt -48.59 -60.69 2.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.52 -41.32 80.65 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.683 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.435 ' CD2' ' CE1' ' A' ' 37' ' ' PHE . 10.3 m-85 -62.97 -76.0 0.07 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 38' ' ' VAL . 8.0 t-20 -39.29 -46.34 1.54 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.524 0.678 . . . . 0.0 111.744 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -57.8 -35.24 70.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.302 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -88.07 -44.42 10.97 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.983 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 49' ' ' GLY . 14.8 p -65.26 -21.12 66.69 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -87.82 -33.66 18.53 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.426 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 62.4 t-20 -64.45 -24.53 67.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.486 ' CG ' ' N ' ' A' ' 49' ' ' GLY . 7.1 ptt? -105.65 -47.2 3.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.644 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.486 ' N ' ' CG ' ' A' ' 48' ' ' MET . . . 142.62 178.57 18.69 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 40.7 p-10 -74.82 147.98 40.69 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 52' ' ' ILE . . . 176.04 -154.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.754 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.42 ' H ' ' HB2' ' A' ' 51' ' ' ALA . 32.1 mm -143.3 136.46 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.5 131.13 12.7 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.741 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -72.26 153.23 56.39 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 120.76 0.974 . . . . 0.0 110.369 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 10' ' ' LEU . 5.3 p -155.52 145.53 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.426 0.632 . . . . 0.0 111.897 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -121.93 95.68 4.76 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.4 mt -69.72 89.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.712 -175.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.24 98.93 1.81 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.9 mt -99.28 131.44 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.806 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 63' ' ' ARG . 4.1 m-85 -106.83 142.15 36.93 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.573 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.91 -27.34 7.31 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 124.388 1.055 . . . . 0.0 111.841 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -60.33 -5.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.573 ' H ' ' C ' ' A' ' 61' ' ' ALA . 25.7 ttm180 76.79 70.01 0.06 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.212 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.0 p -144.77 125.33 14.05 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.237 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -104.64 103.28 12.91 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.556 0.217 . . . . 0.0 110.555 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.7 p -95.55 134.46 38.4 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.559 ' CZ ' ' O ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -124.73 175.34 7.3 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.97 86.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.9 t -177.15 139.03 0.26 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.211 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.585 ' O ' ' O ' ' A' ' 71' ' ' THR . 0.6 OUTLIER -176.92 117.25 0.11 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.672 0.749 . . . . 0.0 110.336 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.585 ' O ' ' O ' ' A' ' 70' ' ' LYS . 49.8 p 51.85 140.45 0.02 OUTLIER Pre-proline 0 C--N 1.292 -1.914 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.468 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -78.21 168.57 21.56 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 120.551 1.232 . . . . 0.0 112.821 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.46 90.67 0.33 Allowed 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.983 1.789 . . . . 0.0 111.959 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.72 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -176.7 -143.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.537 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.5 OUTLIER -37.25 -14.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.72 ' N ' ' O ' ' A' ' 74' ' ' ALA . 3.2 t80 -46.52 -41.27 13.95 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 123.53 0.518 . . . . 0.0 110.385 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -130.1 -15.25 3.79 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.547 ' N ' HD22 ' A' ' 77' ' ' LEU . 26.2 mt -65.02 -40.68 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.997 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -50.25 -41.82 50.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.063 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -71.58 -61.19 1.87 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.313 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.18 -22.43 6.55 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.319 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -86.61 -78.08 0.3 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.765 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.39 56.61 0.77 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.8 mt -92.48 114.49 27.06 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -81.52 -178.97 7.18 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -79.65 144.67 33.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.06 106.64 0.65 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.22 3.05 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.305 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -64.38 -47.28 79.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.37 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -88.11 148.09 42.13 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.669 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.31 142.92 67.27 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 120.628 0.886 . . . . 0.0 111.616 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.08 136.44 4.13 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 62.26 -175.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 95' ' ' LYS . 79.8 mm-40 -90.5 84.96 6.01 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.189 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 94' ' ' GLU . 58.4 mttp 53.52 169.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.5 p -152.64 164.56 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.59 84.55 1.25 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -138.81 128.39 24.66 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.07 0.462 . . . . 0.0 110.88 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.0 pt -119.19 151.61 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.6 p -78.72 154.78 29.79 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.237 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -58.49 -54.63 44.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.019 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -58.31 -42.8 87.5 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 121.439 -0.788 . . . . 0.0 111.396 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -58.33 -46.11 86.83 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.638 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.9 -30.6 50.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.044 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 109' ' ' LYS . 58.3 mt -61.69 -71.77 0.14 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.153 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -45.66 -49.77 14.1 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.39 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.501 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 93.1 mt -57.53 -26.69 27.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -105.64 2.44 28.16 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.398 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 105' ' ' LEU . 77.3 tttt -86.16 -73.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -65.52 -40.51 93.06 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.725 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 107' ' ' ILE . 49.7 mmtt -60.43 93.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.712 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.422 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 48.8 mtt -154.82 56.0 1.35 Allowed Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.403 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 112' ' ' MET . 14.7 Cg_exo -50.46 -46.67 28.17 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 120.778 0.985 . . . . 0.0 112.154 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 66.8 t0 -170.92 40.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.245 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 117' ' ' THR . 3.6 mm? -74.41 143.66 44.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.74 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.563 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 10.2 t30 -69.37 35.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.444 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.549 ' H ' ' C ' ' A' ' 115' ' ' LEU . 69.5 p -139.46 162.79 34.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.228 0.537 . . . . 0.0 111.756 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.7 p -142.46 -45.07 0.32 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.779 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -72.5 151.51 42.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 35.9 mt -59.3 -42.19 90.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.358 0.599 . . . . 0.0 109.948 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.85 -44.53 86.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.093 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.85 -71.23 0.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.279 -0.969 . . . . 0.0 108.528 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.577 ' O ' ' HG3' ' A' ' 126' ' ' MET . . . -44.22 -55.0 5.17 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.896 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -44.69 -62.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.295 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 129' ' ' GLY . 64.8 ttt180 -44.41 -32.36 1.34 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.82 ' HG3' ' H ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER -58.95 -66.71 0.46 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.82 ' H ' ' HG3' ' A' ' 126' ' ' MET . 4.9 mm -56.11 -48.68 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.317 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -66.84 -69.83 0.28 Allowed 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.09 -47.43 5.35 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 126' ' ' MET . 70.3 m -57.82 -42.84 85.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -53.86 -48.18 70.28 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.516 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -50.75 -41.1 56.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.536 ' C ' ' H ' ' A' ' 135' ' ' GLY . 2.3 t -59.57 -72.64 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.3 ptm -45.27 -13.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.527 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 89.31 66.17 1.26 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 37.1 t -157.16 141.61 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -116.17 172.44 7.18 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 140' ' ' GLY . 7.3 t -96.33 149.02 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 p -62.08 4.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.313 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . 100.27 155.41 27.75 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -145.73 67.87 12.78 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.868 0.334 . . . . 0.0 110.4 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.57 150.74 69.73 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.383 1.388 . . . . 0.0 112.114 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 143' ' ' GLU . 1.2 tm-20 -169.91 24.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.242 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.9 t -132.9 133.42 58.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -105.21 83.3 1.95 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -162.63 93.83 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.713 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.451 179.63 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' N ' ' CB ' ' A' ' 61' ' ' ALA . 7.7 ptt? . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.514 ' H ' ' CG ' ' A' ' 1' ' ' MET . 89.0 tttt -173.58 159.4 3.59 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt 62.09 153.11 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.262 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -55.01 104.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.213 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -80.79 -46.33 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.204 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.84 142.1 32.79 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.263 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 7' ' ' VAL . 7.7 p -132.58 99.91 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.595 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.12 90.34 3.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.031 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -78.99 117.2 19.84 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.43 ' CD1' ' C ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -170.67 -173.91 1.49 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.537 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -98.25 162.7 13.06 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mt -148.88 96.83 3.73 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -54.23 147.88 43.36 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.239 1.292 . . . . 0.0 114.769 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.61 142.45 27.44 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 45.06 31.38 2.9 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -154.07 34.34 0.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.145 -0.527 . . . . 0.0 110.522 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.82 151.55 36.28 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -156.32 167.98 13.27 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.121 -178.078 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -61.5 36.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.305 1.337 . . . . 0.0 112.207 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.541 ' H ' ' C ' ' A' ' 18' ' ' THR . . . -159.33 57.39 1.04 Allowed Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.687 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 23.4 Cg_endo -80.22 169.62 17.26 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.157 1.238 . . . . 0.0 112.123 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -55.01 -28.41 59.65 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 120.705 0.936 . . . . 0.0 111.146 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.6 t -84.7 -61.9 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 43.25 -98.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.809 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -47.15 -60.71 0.78 Allowed 'Trans proline' 0 C--N 1.317 -1.106 0 CA-C-N 119.736 1.768 . . . . 0.0 110.559 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.49 -26.29 2.07 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.834 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 36.8 tp -113.23 26.35 10.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 122.124 0.964 . . . . 0.0 109.354 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.42 42.38 0.5 Allowed Glycine 0 C--N 1.313 -0.73 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.259 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.407 ' C ' ' H ' ' A' ' 31' ' ' GLY . 84.1 mt-30 -141.13 -16.28 0.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.186 0.517 . . . . 0.0 109.638 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.497 ' ND1' ' O ' ' A' ' 30' ' ' HIS . 16.2 t-80 -59.01 -11.11 3.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.197 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 29' ' ' GLN . . . 99.99 -15.81 58.99 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.39 -131.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.304 0.642 . . . . 0.0 112.071 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -134.09 -165.56 1.66 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mm -138.46 -74.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 39' ' ' LYS . 11.3 tpt -41.4 -37.41 1.03 Allowed 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -59.83 -54.36 47.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 68.7 t80 -45.38 -58.15 3.53 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 122.863 1.315 . . . . 0.0 109.755 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' ASN . 48.8 t -63.19 -43.4 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.577 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 35' ' ' MET . 88.8 tttt -44.64 -58.67 2.9 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.41 95.83 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.342 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -74.22 0.09 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -39.74 -44.58 1.58 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.72 0.772 . . . . 0.0 111.738 -177.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.17 72.92 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.219 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.71 -46.09 9.8 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.186 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.8 p -62.76 -19.46 64.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -89.12 -34.14 16.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -61.41 -26.05 67.6 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.626 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -106.08 -85.87 0.49 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.067 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.626 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -176.2 169.23 41.75 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.338 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 42.9 p-10 -69.48 137.66 52.77 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -174.93 -150.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.861 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 52' ' ' ILE . 35.4 mm -138.19 125.0 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.4 t -125.9 120.94 24.19 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.206 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -75.32 141.69 26.03 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.011 1.141 . . . . 0.0 110.631 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.501 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 7.5 p -159.74 162.91 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.329 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.501 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 9.7 mt-10 -129.44 114.82 16.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.9 mt -76.54 88.23 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.097 0.475 . . . . 0.0 111.73 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -74.37 113.49 11.65 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.6 mt -118.55 135.94 57.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.004 0.431 . . . . 0.0 111.401 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.642 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -110.17 147.72 33.18 Favored 'General case' 0 C--O 1.253 1.274 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.27 176.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.706 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -53.48 -22.55 8.19 Favored 'General case' 0 C--N 1.346 0.423 0 O-C-N 124.985 1.428 . . . . 0.0 112.177 -175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -63.43 8.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.706 ' H ' ' C ' ' A' ' 61' ' ' ALA . 89.0 mtm180 59.7 72.33 0.53 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.992 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.478 ' CB ' ' CE2' ' A' ' 60' ' ' TYR . 1.4 m -149.96 147.56 28.03 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.604 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.648 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -124.48 106.56 10.27 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.284 0.365 . . . . 0.0 111.452 -177.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.599 ' OG1' ' OH ' ' A' ' 60' ' ' TYR . 15.3 m -94.11 122.09 36.27 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 4.0 p90 177.1 -151.78 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 47.3 t 80.69 159.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.202 0 O-C-N 124.006 0.816 . . . . 0.0 110.344 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.64 119.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.033 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.541 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -148.73 147.83 29.3 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.292 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.48 ' OG1' ' C ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER 173.7 141.6 0.16 Allowed Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.359 177.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.71 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 10.8 Cg_endo -72.62 169.38 22.02 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.588 0.859 . . . . 0.0 111.955 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 72' ' ' PRO . 12.1 Cg_exo -46.61 -157.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.814 2.343 . . . . 0.0 112.359 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.718 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -36.31 -34.01 0.05 Allowed 'General case' 0 C--O 1.255 1.364 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -40.15 -10.35 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.123 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.718 ' N ' ' O ' ' A' ' 74' ' ' ALA . 31.1 m-85 -32.76 -81.55 0.01 OUTLIER 'General case' 0 C--N 1.35 0.628 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.759 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -108.49 -5.35 16.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 82' ' ' ALA . 6.5 mm -63.08 -42.42 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.347 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -52.2 -36.58 52.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.17 -66.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.842 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.62 -13.98 0.46 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.726 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 78' ' ' ILE . . . -89.83 -77.06 0.4 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.637 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.75 37.86 0.49 Allowed Glycine 0 N--CA 1.466 0.648 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.2 mt -90.68 104.88 17.42 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.44 -45.27 13.85 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.742 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -174.66 157.36 2.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.91 147.4 21.54 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -179.58 -2.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.022 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -59.9 -46.49 89.17 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.563 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -165.51 152.15 9.02 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.628 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.77 145.8 48.23 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.961 1.108 . . . . 0.0 111.679 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.76 58.3 0.11 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -162.4 -85.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -171.81 -66.57 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.027 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -141.6 137.0 31.59 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -158.86 151.25 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.167 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.88 84.3 0.59 Allowed Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -141.82 103.15 4.3 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.086 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.5 pt -106.56 159.91 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.36 152.01 19.4 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.257 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.43 ' O ' ' CG2' ' A' ' 104' ' ' VAL . 70.4 t-105 -60.32 -51.26 70.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.778 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.85 -41.93 92.5 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 120.62 -1.3 . . . . 0.0 111.751 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.22 -44.51 95.11 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.105 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 101' ' ' TRP . 17.5 m -62.92 -33.71 62.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 118.257 -1.377 . . . . 0.0 109.411 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 108' ' ' ALA . 96.2 mt -61.47 -72.21 0.13 Allowed 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.19 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -43.77 -56.23 3.96 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.488 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.482 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 95.1 mt -50.61 -25.68 3.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.879 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -88.89 -44.6 10.34 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.604 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -43.9 -68.32 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.373 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.751 ' N ' HE21 ' A' ' 110' ' ' GLN . 0.0 OUTLIER -57.32 -66.37 0.47 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.328 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -47.16 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.973 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.561 ' N ' ' O ' ' A' ' 110' ' ' GLN . 37.6 mtt -157.51 51.34 0.48 Allowed Pre-proline 0 C--O 1.234 0.248 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.664 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 112' ' ' MET . 10.7 Cg_endo -66.05 -33.37 41.53 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 120.748 0.965 . . . . 0.0 111.867 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 115' ' ' LEU . 63.9 m-20 -160.75 -77.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.942 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 115' ' ' LEU . 3.9 mm? 44.0 -169.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.296 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.532 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -121.98 35.56 4.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.762 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.3 p -135.83 168.41 19.35 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.395 0.617 . . . . 0.0 111.902 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.443 ' OG1' ' N ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -138.67 -85.52 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.511 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.443 ' N ' ' OG1' ' A' ' 118' ' ' THR . 97.7 m-20 -55.42 164.22 1.04 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 124' ' ' ALA . 4.4 mm? -61.66 -40.62 95.57 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-O 121.469 0.652 . . . . 0.0 110.42 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -50.31 -46.08 55.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.129 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.73 -66.27 0.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.174 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.05 -48.02 44.31 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.928 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -47.06 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' A' ' 129' ' ' GLY . 42.2 ttm180 -42.15 -37.63 1.49 Allowed 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.498 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.2 tmm? -54.9 -73.48 0.05 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.484 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.1 mt -51.77 -51.71 26.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.847 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -62.81 -70.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.16 -42.39 3.12 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 133' ' ' SER . 23.9 m -57.49 -46.16 84.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -51.28 -50.29 59.57 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.571 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -49.97 -36.03 26.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.2 t -63.23 -71.15 0.17 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 81.3 mtp -47.65 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.82 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.626 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 80.43 55.68 3.38 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 39.8 t -138.15 161.72 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.449 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 76.3 mt-10 -133.01 159.35 40.28 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.921 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.2 t -99.49 156.99 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 p -84.48 -3.33 7.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.651 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -133.69 94.36 0.27 Allowed Glycine 0 CA--C 1.519 0.286 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.43 67.94 5.69 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.154 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.35 145.15 98.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.47 1.447 . . . . 0.0 112.1 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -155.72 23.71 0.39 Allowed 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.013 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 69.5 t -130.11 130.75 66.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt 47.98 -166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 146' ' ' ASP . 40.2 p-10 -80.63 112.99 18.51 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.009 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.374 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 5' ' ' VAL . 98.9 mttt . . . . . 0 C--O 1.223 -0.323 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 4' ' ' VAL . 12.4 p -42.22 121.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 3' ' ' LYS . 12.7 m -113.92 -24.76 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.09 129.68 24.29 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.978 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.715 ' O ' HG13 ' A' ' 7' ' ' VAL . 9.0 p -120.8 109.78 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.577 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG12 ' CD2' ' A' ' 10' ' ' LEU . 2.4 t -88.45 89.82 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.015 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -84.6 117.31 23.66 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 124.073 0.858 . . . . 0.0 109.704 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -179.92 -178.66 0.44 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.649 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -91.8 160.43 15.32 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.556 HD23 ' HD2' ' A' ' 13' ' ' PRO . 2.2 mt -151.53 133.93 8.5 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.556 ' HD2' HD23 ' A' ' 12' ' ' LEU . 45.1 Cg_endo -80.79 119.04 3.54 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.108 1.074 . . . . 0.0 114.213 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.926 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -51.97 137.9 25.9 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 53.56 -154.03 7.65 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 -176.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 15' ' ' GLY . 40.7 tttp 40.73 22.55 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.369 1.085 . . . . 0.0 111.008 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -96.84 159.58 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.13 167.31 8.73 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.144 -178.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.37 40.26 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.464 1.443 . . . . 0.0 112.159 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.561 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -146.14 53.31 1.76 Allowed Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.708 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 34.8 Cg_endo -80.17 165.6 21.29 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 120.901 1.067 . . . . 0.0 112.043 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -61.41 -24.88 79.21 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 120.827 1.018 . . . . 0.0 111.099 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.533 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.7 t -83.72 -66.66 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.676 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.02 -98.75 0.01 OUTLIER Glycine 0 N--CA 1.468 0.799 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 27' ' ' LEU . 2.7 Cg_endo -53.1 -57.17 2.16 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 CA-C-N 120.698 2.249 . . . . 0.0 110.334 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -43.29 -16.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 -178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 25' ' ' PRO . 1.3 tp -112.2 -38.02 4.86 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.09 -49.71 75.57 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.682 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -41.19 -29.49 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.022 0.911 . . . . 0.0 110.662 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.448 ' CD2' HG21 ' A' ' 59' ' ' ILE . 24.6 m80 -44.76 -37.43 3.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.551 0.691 . . . . 0.0 109.379 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 99.56 -23.23 37.02 Favored Glycine 0 C--O 1.225 -0.41 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.574 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -47.1 -135.94 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.223 0.609 . . . . 0.0 112.492 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -137.46 106.89 6.11 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.72 -0.613 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 37' ' ' PHE . 4.6 mm -52.52 -70.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 34' ' ' ILE . 10.0 tpt -39.56 -40.45 0.87 Allowed 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.2 -0.312 . . . . 0.0 110.498 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.28 -46.92 88.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' ILE . 57.5 t80 -50.7 -65.06 0.62 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 122.371 1.082 . . . . 0.0 109.504 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 42' ' ' ASN . 97.4 t -57.42 -44.29 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.169 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -46.27 -64.8 0.66 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.9 -38.94 70.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.249 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.856 ' CZ ' HG21 ' A' ' 45' ' ' THR . 68.1 t80 -64.2 -76.38 0.07 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 38' ' ' VAL . 20.4 t-20 -41.06 -45.49 2.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.586 0.708 . . . . 0.0 112.035 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.5 -35.99 73.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.305 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.21 -43.02 13.33 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.702 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.856 HG21 ' CZ ' ' A' ' 41' ' ' PHE . 47.1 p -67.47 -21.23 65.54 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -82.45 -37.51 25.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -65.51 -21.57 66.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.446 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.4 ptm -107.5 -29.27 9.31 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 117.62 171.04 15.35 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 51.1 p-10 -75.63 142.28 42.65 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.926 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -174.34 -150.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.903 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.701 HD13 ' N ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -139.87 135.81 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.701 ' N ' HD13 ' A' ' 52' ' ' ILE . 18.1 t -144.27 133.28 11.26 Favored Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.905 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.24 131.96 12.19 Favored 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 120.766 0.978 . . . . 0.0 109.646 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 1.5 p -140.53 156.98 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.862 0.839 . . . . 0.0 111.928 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 21.5 mt-10 -131.34 82.37 2.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.331 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 57' ' ' ILE . 21.9 mt -53.04 95.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.282 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.41 101.94 5.76 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.448 HG21 ' CD2' ' A' ' 30' ' ' HIS . 45.4 mt -104.38 123.67 58.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.45 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -99.98 144.3 29.18 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.666 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -54.65 -22.29 13.18 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.042 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -66.03 6.42 0.39 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.666 ' H ' ' C ' ' A' ' 61' ' ' ALA . 84.0 mtm180 64.44 71.02 0.48 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.921 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 t -147.92 126.24 12.3 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.526 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -103.58 102.31 12.19 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -90.49 123.91 34.56 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER 173.47 118.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.565 -177.673 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -151.2 131.92 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.694 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.5 p -135.23 150.89 50.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.473 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 71' ' ' THR . 46.5 pttt -174.27 -158.3 0.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.504 ' O ' ' O ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER 80.34 60.0 0.14 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.912 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 71' ' ' THR . 19.7 Cg_exo -43.53 177.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.747 1.631 . . . . 0.0 112.916 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -54.67 -55.37 3.35 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.398 1.399 . . . . 0.0 114.924 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.811 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . -146.54 -66.63 0.28 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.0 p -36.64 -20.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.891 0.377 . . . . 0.0 110.43 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.646 ' N ' ' O ' ' A' ' 74' ' ' ALA . 1.8 t80 -40.29 -67.11 0.25 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.276 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.915 HD23 ' O ' ' A' ' 77' ' ' LEU . 6.9 tt -110.15 -19.94 12.85 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.811 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.2 mt -55.67 -42.21 68.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.031 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -44.54 -39.27 4.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.592 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -81.89 -60.42 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.49 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.73 13.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.43 . . . . 0.0 110.766 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -85.43 -78.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.39 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.34 41.43 0.23 Allowed Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 mt -94.59 112.86 24.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 . . . . . 0 C--N 1.33 -0.28 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.499 -179.649 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.2 mttp . . . . . 0 N--CA 1.462 0.154 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.454 HG22 ' N ' ' A' ' 97' ' ' GLY . 11.6 p -138.84 159.01 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.733 0.302 . . . . 0.0 110.25 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.454 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 104.54 84.38 1.76 Allowed Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.507 ' HE ' HG23 ' A' ' 139' ' ' VAL . 43.5 ttt180 -135.77 104.77 5.87 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.142 0.496 . . . . 0.0 111.219 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.512 HD12 ' CG1' ' A' ' 104' ' ' VAL . 3.1 pt -109.41 148.51 13.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.521 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.8 OUTLIER -89.1 160.28 17.11 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.164 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.79 ' NE1' HD11 ' A' ' 105' ' ' LEU . 76.0 t-105 -60.4 -54.17 48.85 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.605 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -59.97 -43.5 95.04 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.913 -1.117 . . . . 0.0 111.388 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -59.1 -45.53 90.64 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.978 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.512 ' CG1' HD12 ' A' ' 99' ' ' ILE . 29.8 m -64.88 -31.66 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 118.249 -1.381 . . . . 0.0 109.672 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.79 HD11 ' NE1' ' A' ' 101' ' ' TRP . 76.1 mt -61.74 -67.32 0.42 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.662 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -44.38 -41.59 6.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.198 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.52 HD11 HD22 ' A' ' 77' ' ' LEU . 97.3 mt -67.13 -29.12 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.104 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -91.77 -3.3 56.34 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.749 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 111' ' ' LYS . 44.1 mtpt -85.74 -72.73 0.48 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.866 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.58 -0.89 0.3 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.027 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.591 ' NZ ' ' HB2' ' A' ' 123' ' ' ALA . 1.4 pptp? -68.9 -16.72 63.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.616 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.481 ' SD ' ' NZ ' ' A' ' 111' ' ' LYS . 5.9 ptt? -123.91 70.15 48.85 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.444 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 15.2 Cg_exo -53.84 -40.52 80.07 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 120.653 0.902 . . . . 0.0 112.082 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 113' ' ' PRO . 80.6 m-20 -149.78 14.93 0.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.58 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 115' ' ' LEU . 9.6 mp -71.32 160.53 32.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.2 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -70.56 64.72 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.096 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.0 m -162.04 140.04 8.87 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.374 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.74 -2.76 0.35 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.99 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.87 124.41 34.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.298 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 36.0 mt -62.09 -42.95 99.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.576 0.703 . . . . 0.0 110.266 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.4 -36.63 71.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.983 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.61 -69.4 0.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.591 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.591 ' HB2' ' NZ ' ' A' ' 111' ' ' LYS . . . -47.13 -33.09 4.76 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.133 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -61.13 -66.58 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.1 mtt180 -46.35 -33.78 4.08 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.793 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.465 ' O ' ' CB ' ' A' ' 130' ' ' SER . 34.4 ttp -59.57 -73.83 0.08 Allowed 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 mm -50.56 -48.31 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.739 0.304 . . . . 0.0 110.826 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -68.15 -70.82 0.24 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.05 -45.8 6.17 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 126' ' ' MET . 67.5 m -56.41 -42.45 78.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.693 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -55.85 -46.65 78.13 Favored 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.538 HH11 ' HG2' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -54.67 -44.11 73.02 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.424 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 t -51.96 -69.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 74.4 mtp -41.96 -66.39 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.674 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.22 55.05 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.693 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 49.2 t -134.6 161.14 40.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.478 ' N ' HG12 ' A' ' 136' ' ' VAL . 96.2 mt-10 -124.3 152.9 42.5 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.534 HG12 ' H ' ' A' ' 140' ' ' GLY . 8.1 t -104.07 133.37 48.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 100' ' ' THR . 1.6 p -70.37 -3.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.799 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.534 ' H ' HG12 ' A' ' 138' ' ' VAL . . . . . . . . 0 N--CA 1.463 0.452 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 tttt . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 4' ' ' VAL . 12.9 p -64.76 119.92 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.03 -24.49 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 119.211 -0.423 . . . . 0.0 109.88 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.55 134.83 27.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.588 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 7' ' ' VAL . 13.4 p -124.98 125.51 69.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.207 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.61 93.47 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 119.644 1.111 . . . . 0.0 111.556 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -84.05 118.12 23.86 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.836 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.444 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -171.41 -173.79 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.648 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -90.18 149.29 22.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.833 HD22 ' CE2' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -140.59 93.39 8.69 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 123.154 0.284 . . . . 0.0 110.315 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -67.47 123.18 10.51 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.141 1.227 . . . . 0.0 114.224 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.887 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -54.49 136.73 44.17 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 54.89 -155.78 8.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 15' ' ' GLY . 97.3 mttt 41.47 20.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.118 0.959 . . . . 0.0 111.165 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -97.04 158.52 15.39 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.61 167.68 7.89 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.245 -179.145 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.79 42.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.136 1.224 . . . . 0.0 112.024 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.539 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -150.53 55.58 1.82 Allowed Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.599 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 32.5 Cg_endo -79.47 164.8 23.57 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 120.819 1.013 . . . . 0.0 112.105 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -63.18 -24.37 72.75 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.768 0.979 . . . . 0.0 111.359 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.714 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.5 t -77.01 -64.67 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 44.04 -99.01 0.01 OUTLIER Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 28' ' ' GLY . 14.4 Cg_exo -48.95 -59.63 1.17 Allowed 'Trans proline' 0 C--N 1.32 -0.971 0 CA-C-N 119.991 1.896 . . . . 0.0 110.561 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.714 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -44.36 -24.01 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.381 -0.527 . . . . 0.0 109.886 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 39.4 tp -119.91 31.96 6.28 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.907 0.86 . . . . 0.0 109.495 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' PRO . . . -126.24 -64.34 0.16 Allowed Glycine 0 C--N 1.319 -0.363 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 28' ' ' GLY . 65.6 tp60 -42.29 -25.26 0.07 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.734 0.767 . . . . 0.0 109.699 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.483 ' N ' ' C ' ' A' ' 28' ' ' GLY . 37.6 t-80 -42.63 -39.14 2.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.44 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 97.68 -24.43 31.63 Favored Glycine 0 C--N 1.331 0.28 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -48.94 -135.68 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.093 0.557 . . . . 0.0 112.272 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -136.88 130.31 31.52 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.096 -0.377 . . . . 0.0 110.874 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 37' ' ' PHE . 3.5 mm -82.16 -72.24 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.3 tpt -39.57 -40.51 0.88 Allowed 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.14 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -60.78 -49.81 76.0 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.255 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 34' ' ' ILE . 87.6 t80 -47.02 -60.54 2.38 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.099 0.952 . . . . 0.0 109.795 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 42' ' ' ASN . 59.9 t -59.85 -44.05 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.348 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 84.5 tttt -46.66 -66.12 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.99 76.11 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.627 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.833 ' CE2' HD22 ' A' ' 12' ' ' LEU . 33.3 t80 -62.97 -75.8 0.07 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' VAL . 6.3 t-20 -40.53 -45.33 2.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.389 0.614 . . . . 0.0 111.974 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.596 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . -57.44 -34.84 69.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.037 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.42 -44.79 12.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.371 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 49' ' ' GLY . 45.8 p -65.36 -21.61 66.71 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -77.0 -45.15 28.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 43' ' ' ALA . 4.1 m-80 -62.48 -16.11 53.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.4 mmm -106.8 -70.92 0.77 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.268 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 160.15 -162.22 33.04 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 40.0 p-10 -99.86 122.3 42.59 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.887 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -156.8 -153.14 0.4 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.28 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mm -137.71 127.79 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.708 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.7 t -144.26 124.97 7.69 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.774 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -73.94 147.93 39.68 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 120.745 0.963 . . . . 0.0 110.639 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.675 HG21 HD12 ' A' ' 12' ' ' LEU . 34.0 m -143.19 160.83 17.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.257 0.551 . . . . 0.0 111.246 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 58' ' ' THR . 93.8 mt-10 -129.38 76.74 1.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.5 mt -50.87 86.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.874 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -72.99 95.17 1.96 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.462 HG21 ' NE2' ' A' ' 30' ' ' HIS . 60.8 mt -95.6 125.13 48.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.693 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 63' ' ' ARG . 3.4 m-85 -100.63 140.35 35.03 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.625 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.63 -23.33 2.52 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 124.584 1.178 . . . . 0.0 112.366 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -66.89 5.82 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.625 ' H ' ' C ' ' A' ' 61' ' ' ALA . 59.8 mtp180 63.88 69.69 0.53 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.341 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.9 p -146.47 127.55 14.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.959 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -105.04 103.44 13.0 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.622 -177.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.512 ' O ' ' OG1' ' A' ' 58' ' ' THR . 41.1 p -95.21 122.91 38.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.56 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.5 p90 176.32 -152.74 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 48.9 t 80.35 117.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 124.408 1.067 . . . . 0.0 111.381 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -124.58 127.56 47.56 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -143.8 -170.33 3.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.701 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 m 66.0 52.07 0.83 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.586 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.701 ' HD3' ' N ' ' A' ' 71' ' ' THR . 1.4 Cg_endo -73.73 162.57 39.26 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 120.859 1.039 . . . . 0.0 112.553 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -73.75 91.24 0.91 Allowed 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.552 1.502 . . . . 0.0 113.189 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.818 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . . . 179.69 -171.53 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.511 ' OG ' ' NH1' ' A' ' 79' ' ' ARG . 2.5 m -38.91 -17.32 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.818 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 74.9 m-85 -45.69 -42.24 11.43 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.297 0.373 . . . . 0.0 110.392 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.845 HD22 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -130.74 -13.98 3.64 Favored 'General case' 0 C--O 1.254 1.318 0 CA-C-O 122.304 1.049 . . . . 0.0 108.891 178.284 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.845 ' N ' HD22 ' A' ' 77' ' ' LEU . 17.4 mt -65.34 -41.74 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.987 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.603 HH11 ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -51.76 -41.61 61.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.661 179.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -63.21 -63.18 1.27 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.27 69.6 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.491 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -79.52 -83.84 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.553 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 137.6 -76.87 0.35 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.9 mt 42.34 -160.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 C--N 1.329 -0.292 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.466 178.854 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.427 0.156 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -144.96 150.61 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 137' ' ' GLU . . . 82.4 75.96 1.12 Allowed Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -131.0 116.94 18.49 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.621 0.248 . . . . 0.0 110.624 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 mt -109.71 150.11 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.0 p -82.0 149.35 28.18 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.912 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.629 ' NE1' HD11 ' A' ' 105' ' ' LEU . 66.8 t-105 -57.7 -52.05 67.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.092 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -58.77 -40.94 85.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.329 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -60.62 -48.47 81.63 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.9 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.87 -32.78 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.658 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.629 HD11 ' NE1' ' A' ' 101' ' ' TRP . 50.5 mt -59.5 -68.37 0.29 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.655 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -44.59 -46.2 9.89 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.284 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.57 -29.24 38.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.946 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.753 ' HB2' HD12 ' A' ' 127' ' ' ILE . . . -101.66 -8.23 21.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.651 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 105' ' ' LEU . 75.0 tttt -77.6 -75.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.007 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -59.58 -20.96 59.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.631 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -97.75 102.02 13.67 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.721 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 115' ' ' LEU . 6.6 mmt -140.05 55.34 6.35 Favored Pre-proline 0 C--O 1.236 0.373 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.129 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 112' ' ' MET . 14.5 Cg_exo -50.57 -54.8 4.85 Favored 'Trans proline' 0 N--CA 1.488 1.206 0 C-N-CA 120.671 0.914 . . . . 0.0 112.067 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -126.92 -29.27 2.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.345 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.537 ' H ' HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -75.14 38.99 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.072 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.458 ' C ' ' H ' ' A' ' 118' ' ' THR . 35.1 p-10 -84.85 46.82 1.3 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.704 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.446 ' OG1' ' HB3' ' A' ' 122' ' ' ALA . 5.5 p -73.33 32.54 0.07 Allowed 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.855 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 116' ' ' ASN . 9.8 t 39.43 29.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.26 0.35 . . . . 0.0 110.73 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 117' ' ' THR . 74.9 m-20 -150.95 125.37 9.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.458 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 83.8 mt -62.95 -34.47 77.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.258 0.552 . . . . 0.0 110.788 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.67 -37.17 62.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.512 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.446 ' HB3' ' OG1' ' A' ' 117' ' ' THR . . . -72.39 -69.4 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.056 -1.058 . . . . 0.0 109.35 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.696 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -50.6 -32.72 19.61 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.192 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -60.91 -70.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 129' ' ' GLY . 62.7 ttt180 -42.95 -30.78 0.44 Allowed 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.508 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 4.7 tmm? -58.38 -73.08 0.08 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.753 HD12 ' HB2' ' A' ' 108' ' ' ALA . 88.0 mt -50.69 -51.3 20.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.023 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -63.66 -71.55 0.17 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.73 -45.76 4.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.508 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 67.2 m -58.75 -44.65 90.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.626 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -51.59 -47.83 63.42 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -55.26 -42.28 73.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.4 t -55.26 -72.13 0.07 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.4 mtm -42.17 -34.71 0.79 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.773 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.38 49.11 0.57 Allowed Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.626 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 43.0 t -136.05 164.93 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.541 ' N ' HG12 ' A' ' 136' ' ' VAL . 81.9 tt0 -130.13 158.72 38.9 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.54 ' C ' ' H ' ' A' ' 140' ' ' GLY . 53.9 t -111.56 160.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.5 ' N ' HG12 ' A' ' 138' ' ' VAL . 9.8 p -64.48 8.45 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.091 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.7 tptm . . . . . 0 C--O 1.233 0.205 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.63 138.23 19.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 m -118.82 -25.44 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.188 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.44 143.04 29.82 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.853 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 7' ' ' VAL . 15.0 p -133.84 133.03 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.563 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.42 92.67 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 120.067 1.303 . . . . 0.0 111.757 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -82.81 116.07 21.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -167.85 -173.78 2.22 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.536 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -90.76 143.78 26.38 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.615 HD12 ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -123.68 86.84 52.73 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -65.71 114.91 3.12 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.54 1.493 . . . . 0.0 114.642 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.751 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -74.9 146.54 41.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 174.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.73 58.33 10.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt 173.61 -24.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.91 150.29 45.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -160.39 167.54 13.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.115 -178.167 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -59.32 48.07 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.618 1.546 . . . . 0.0 112.711 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -169.53 53.87 0.23 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.504 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 20' ' ' ALA . 18.2 Cg_endo -68.1 166.1 26.12 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.032 1.155 . . . . 0.0 112.247 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -65.33 -22.18 60.41 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.803 1.002 . . . . 0.0 111.239 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.545 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.7 t -72.49 -64.32 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.554 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 25' ' ' PRO . . . 59.2 -137.48 50.23 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 118.619 -1.753 . . . . 0.0 109.485 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.688 ' C ' ' H ' ' A' ' 27' ' ' LEU . 28.2 Cg_exo -38.23 -41.32 1.35 Allowed 'Trans proline' 0 N--CA 1.486 1.06 0 CA-C-N 120.607 2.204 . . . . 0.0 110.853 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.545 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -57.47 13.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.811 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.688 ' H ' ' C ' ' A' ' 25' ' ' PRO . 3.5 tt -172.27 -48.7 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.579 ' N ' HD23 ' A' ' 27' ' ' LEU . . . -59.01 -48.9 83.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -73.96 35.55 0.09 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.471 0.653 . . . . 0.0 110.272 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.63 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -84.88 -19.93 31.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.258 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 106.2 -43.85 1.59 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -49.35 -131.32 0.0 OUTLIER 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.335 0.654 . . . . 0.0 111.79 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -137.91 143.44 40.83 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.762 -0.586 . . . . 0.0 110.525 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' PHE . 6.7 mt -88.88 -70.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.1 tpt -40.85 -39.6 1.17 Allowed 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -57.11 -49.32 76.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.631 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 64.2 t80 -48.78 -59.89 3.19 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.452 1.12 . . . . 0.0 109.501 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' ASN . 57.4 t -61.59 -42.73 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 113.391 -1.731 . . . . 0.0 111.281 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.0 tppp? -46.25 -57.9 4.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.65 95.08 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 119.921 -0.711 . . . . 0.0 110.127 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 12' ' ' LEU . 2.0 t80 -62.81 -74.78 0.09 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -40.01 -43.32 1.54 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 121.558 0.694 . . . . 0.0 111.779 -177.412 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -59.09 -36.39 75.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.261 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.12 -46.8 10.09 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.113 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.649 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 82.5 p -60.87 -37.77 83.28 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -65.22 -36.74 85.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -63.88 -18.6 64.34 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.756 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -103.79 -42.98 5.45 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.634 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 116.75 74.29 0.53 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.399 -0.667 . . . . 0.0 111.868 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.634 ' O ' ' O ' ' A' ' 49' ' ' GLY . 2.9 p30 44.93 159.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.883 0.373 . . . . 0.0 111.482 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.751 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 170.81 -163.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.293 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.5 mt -141.06 131.23 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.99 125.52 4.94 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.833 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.42 149.78 31.49 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 CA-C-N 119.485 0.852 . . . . 0.0 110.86 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.553 ' CG2' HD23 ' A' ' 12' ' ' LEU . 35.0 m -144.64 161.92 14.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.434 0.635 . . . . 0.0 111.416 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 58' ' ' THR . 95.2 mt-10 -127.33 80.93 1.99 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.407 ' H ' HG13 ' A' ' 57' ' ' ILE . 44.1 mt -54.04 88.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.043 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -66.21 110.53 3.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.402 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.4 mt -107.91 125.0 64.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.363 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -104.12 140.13 38.22 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.627 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.73 -21.78 1.79 Allowed 'General case' 0 C--N 1.341 0.232 0 O-C-N 124.226 0.954 . . . . 0.0 112.218 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -68.33 6.12 0.85 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.627 ' H ' ' C ' ' A' ' 61' ' ' ALA . 87.4 mtm180 64.62 67.8 0.55 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.355 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.7 m -143.21 127.14 17.29 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.854 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -108.39 102.49 11.59 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.606 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.4 p -93.95 126.06 38.93 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.631 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 5.6 p90 -174.96 130.99 0.31 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.918 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 69' ' ' THR . 44.5 t -137.05 156.06 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.404 ' N ' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -177.71 121.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.949 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -177.51 -179.65 0.85 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.317 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.513 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 21.9 p 55.93 61.01 8.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.054 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 71' ' ' THR . 3.7 Cg_endo -75.27 164.1 33.5 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 120.897 1.065 . . . . 0.0 112.418 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.67 ' HA ' HD11 ' A' ' 77' ' ' LEU . 13.8 Cg_endo -72.2 176.51 8.43 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 121.899 1.732 . . . . 0.0 112.178 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.731 ' O ' HD12 ' A' ' 77' ' ' LEU . . . 79.56 -174.54 0.06 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.909 0.322 . . . . 0.0 111.051 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.549 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.7 OUTLIER -39.99 -19.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.088 -178.109 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.552 ' N ' ' O ' ' A' ' 74' ' ' ALA . 10.1 m-85 -45.48 -35.95 4.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.697 0.623 . . . . 0.0 111.057 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.84 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.91 -25.52 1.83 Allowed 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.8 0.81 . . . . 0.0 109.021 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 73.7 mt -55.5 -35.47 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.666 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -53.73 -43.96 69.5 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.223 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -64.55 -65.34 0.69 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.35 -13.45 0.56 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.979 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.67 -76.62 0.39 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.765 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.48 48.84 0.58 Allowed Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.0 mt -98.7 124.05 43.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.3 mttm . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -145.24 144.13 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.634 0.254 . . . . 0.0 110.35 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 46.95 87.18 0.01 OUTLIER Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -116.39 106.25 13.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.977 0.418 . . . . 0.0 111.23 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.703 HD12 HG11 ' A' ' 104' ' ' VAL . 7.4 pt -100.94 144.91 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -85.45 156.87 20.64 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.439 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.6 ' NE1' HD11 ' A' ' 105' ' ' LEU . 49.3 t-105 -63.73 -51.06 66.64 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.615 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.23 -43.4 98.95 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.152 -0.967 . . . . 0.0 111.533 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -61.33 -46.96 88.08 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.696 -0.801 . . . . 0.0 111.227 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.703 HG11 HD12 ' A' ' 99' ' ' ILE . 35.5 m -65.2 -33.56 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 118.235 -1.386 . . . . 0.0 109.414 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.6 HD11 ' NE1' ' A' ' 101' ' ' TRP . 40.8 mt -59.48 -65.69 0.63 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.392 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -44.86 -51.15 9.87 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.049 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.34 -31.46 46.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.787 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.536 ' HB1' ' HB1' ' A' ' 123' ' ' ALA . . . -91.55 -8.07 48.48 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.675 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 105' ' ' LEU . 45.3 tttm -85.56 -71.57 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 109.919 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.63 -40.72 60.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.395 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -69.89 66.08 0.24 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.384 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.436 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 38.8 mtm -157.65 54.84 0.84 Allowed Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.568 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 112' ' ' MET . 9.8 Cg_endo -65.13 -55.7 0.45 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 120.805 1.003 . . . . 0.0 111.85 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 113' ' ' PRO . 57.5 m-20 -160.01 15.5 0.14 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.398 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.9 mt -46.61 -86.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.319 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -170.8 -18.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.25 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 70.1 p -83.33 167.51 17.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.1 0.476 . . . . 0.0 111.15 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -140.59 -85.83 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.401 -178.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.516 ' H ' HG23 ' A' ' 118' ' ' THR . 90.9 m-20 -58.67 159.55 6.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.447 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 37.5 mt -61.77 -37.27 83.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 0.0 110.161 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -52.9 -37.79 61.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.281 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.17 -69.0 0.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 118.981 -1.087 . . . . 0.0 109.067 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.536 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -49.51 -35.52 20.26 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.227 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -59.09 -69.83 0.18 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.0 mtt180 -43.76 -30.57 0.67 Allowed 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.758 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.459 ' O ' ' CB ' ' A' ' 130' ' ' SER . 2.9 tmm? -59.31 -73.07 0.09 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.0 mm -51.69 -48.98 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.032 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -67.71 -70.44 0.26 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.61 -43.22 4.97 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 126' ' ' MET . 68.8 m -58.64 -42.64 88.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -56.07 -48.99 75.01 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -51.39 -41.38 60.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.546 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.6 t -54.77 -66.77 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 86.5 mtp -50.75 -4.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.812 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 91.21 -27.72 8.96 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 137' ' ' GLU . 55.1 t -47.38 164.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.556 ' N ' HG12 ' A' ' 136' ' ' VAL . 97.7 mt-10 -141.23 161.9 36.77 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.056 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 140' ' ' GLY . 83.0 t -88.09 152.44 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 139' ' ' VAL . 7.8 p -61.3 2.68 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.285 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.524 0.617 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.224 -0.259 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 4' ' ' VAL . 14.2 p -51.9 112.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.639 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.8 -24.18 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.89 132.4 23.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.102 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.7 ' O ' HG13 ' A' ' 7' ' ' VAL . 8.6 p -122.56 105.29 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.687 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.438 ' CG1' HD21 ' A' ' 10' ' ' LEU . 4.6 t -76.64 91.66 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 118.741 -1.184 . . . . 0.0 109.626 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -89.32 106.43 18.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.511 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.506 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -175.32 -173.77 0.68 Allowed 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.024 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -100.95 163.23 12.39 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.479 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.561 HD12 HG21 ' A' ' 55' ' ' VAL . 2.2 mt -153.51 137.3 10.48 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.48 ' HD2' HD23 ' A' ' 12' ' ' LEU . 57.7 Cg_endo -87.53 125.27 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 CA-C-N 120.366 1.166 . . . . 0.0 114.114 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.802 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -59.33 139.17 57.27 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . 57.79 152.8 0.01 OUTLIER Glycine 0 CA--C 1.536 1.345 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 50.4 tttt 77.34 13.97 1.91 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.797 1.799 . . . . 0.0 111.373 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 18' ' ' THR . . . -91.19 157.97 16.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.99 167.56 4.87 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.653 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.09 39.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.709 1.606 . . . . 0.0 112.61 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.544 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -146.52 54.08 1.99 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.043 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 38.9 Cg_endo -82.49 164.24 16.61 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 120.972 1.114 . . . . 0.0 112.142 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -62.33 -25.7 76.63 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 120.8 1.0 . . . . 0.0 111.024 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.04 -71.57 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.034 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 46.47 -101.24 0.03 OUTLIER Glycine 0 C--O 1.214 -1.151 0 CA-C-O 118.574 -1.125 . . . . 0.0 111.099 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.627 ' C ' ' H ' ' A' ' 27' ' ' LEU . 19.4 Cg_exo -43.57 -56.29 2.46 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 CA-C-N 121.479 2.639 . . . . 0.0 110.728 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.71 23.9 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.599 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.627 ' H ' ' C ' ' A' ' 25' ' ' PRO . 12.7 tp -169.98 -47.37 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -59.35 -51.39 59.44 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.529 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -73.57 41.28 0.11 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.014 0.907 . . . . 0.0 109.9 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -89.35 -21.29 23.18 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.89 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 106.86 -38.82 3.13 Favored Glycine 0 N--CA 1.462 0.431 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.555 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -50.87 -134.98 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -137.14 125.93 24.01 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.484 -0.76 . . . . 0.0 110.4 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.571 ' O ' ' N ' ' A' ' 37' ' ' PHE . 10.9 mm -67.92 -70.55 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.409 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -39.53 -36.93 0.43 Allowed 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.505 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -61.89 -47.1 86.51 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.64 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 59.0 t80 -51.05 -65.1 0.61 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.412 1.101 . . . . 0.0 109.201 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 42' ' ' ASN . 96.4 t -57.07 -42.45 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.276 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 88.2 tttt -49.81 -60.94 2.44 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.685 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.72 79.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.355 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.64 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 8.8 m-85 -64.9 -76.44 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' VAL . 8.9 t-20 -39.3 -49.42 1.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.358 0.599 . . . . 0.0 111.973 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -57.32 -34.01 68.31 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.864 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.83 -46.91 9.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.054 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.507 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 76.7 p -62.94 -24.01 67.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -84.89 -35.74 21.97 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -60.45 -25.63 66.14 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.476 ' CG ' ' N ' ' A' ' 49' ' ' GLY . 6.6 ptm -107.14 -55.65 2.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.383 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' A' ' 48' ' ' MET . . . 152.68 170.9 19.6 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.298 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -73.56 141.26 46.68 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 122.475 -0.426 . . . . 0.0 110.028 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.802 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -172.56 -152.26 0.06 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.155 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 13' ' ' PRO . 40.8 mm -139.07 130.5 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.3 t -145.02 134.68 11.52 Favored Pre-proline 0 C--O 1.246 0.893 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.188 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -76.1 148.5 31.25 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 120.589 0.859 . . . . 0.0 110.384 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.561 HG21 HD12 ' A' ' 12' ' ' LEU . 25.6 m -146.06 137.04 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.504 0.669 . . . . 0.0 111.967 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 78.0 mt-10 -117.76 75.07 0.97 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 57' ' ' ILE . 23.4 mt -58.26 93.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.944 -176.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.36 95.29 1.72 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.9 mt -95.12 120.99 45.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -98.15 142.02 30.36 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.626 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.33 -20.18 1.01 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.846 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 93.3 m-20 -73.23 30.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.626 ' H ' ' C ' ' A' ' 61' ' ' ALA . 5.2 ptm180 40.31 69.77 0.29 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 122.305 1.05 . . . . 0.0 110.888 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 99.4 p -144.84 125.61 14.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.052 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -102.85 101.83 11.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.382 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 1.2 p -93.77 178.08 5.79 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CB ' ' O ' ' A' ' 66' ' ' THR . 1.9 t80 82.17 -154.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -177.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.422 HG23 ' C ' ' A' ' 67' ' ' PHE . 6.3 t 82.25 72.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 123.871 0.732 . . . . 0.0 111.791 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.0 t -68.49 154.14 42.43 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.397 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -175.7 178.57 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.652 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.7 p 51.61 82.68 0.24 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.766 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.87 177.08 2.53 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.438 1.425 . . . . 0.0 112.441 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -74.98 4.6 4.58 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.398 1.399 . . . . 0.0 113.825 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -72.18 -152.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.832 0.349 . . . . 0.0 110.758 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -39.38 -15.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.691 0.397 . . . . 0.0 111.431 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.59 ' N ' ' O ' ' A' ' 74' ' ' ALA . 2.5 t80 -40.37 -47.75 2.59 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.976 0.798 . . . . 0.0 110.604 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.772 HD22 ' C ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -133.42 -14.92 2.52 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.787 0.803 . . . . 0.0 108.885 179.229 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.618 HD11 HG23 ' A' ' 127' ' ' ILE . 22.9 mt -60.45 -38.12 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.418 HH11 ' HB2' ' A' ' 84' ' ' LEU . 11.3 mmm180 -50.29 -44.66 54.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.265 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -66.42 -61.07 2.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.66 -21.7 7.42 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.089 -0.645 . . . . 0.0 110.597 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -87.49 -77.91 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.807 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.63 19.41 3.76 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.418 ' HB2' HH11 ' A' ' 79' ' ' ARG . 22.3 mt -69.11 139.05 54.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.701 -179.863 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.831 0.348 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.539 HG22 ' N ' ' A' ' 97' ' ' GLY . 13.6 p -145.36 163.31 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.23 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 88.76 75.51 1.29 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -136.82 119.29 15.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.129 0.49 . . . . 0.0 111.25 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 104' ' ' VAL . 5.6 pt -108.65 148.3 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.261 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.427 ' O ' HG13 ' A' ' 104' ' ' VAL . 1.2 p -80.73 145.86 31.33 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.454 0.645 . . . . 0.0 110.832 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.436 ' CE2' HD21 ' A' ' 105' ' ' LEU . 62.6 t-105 -53.26 -70.53 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.374 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -43.78 -38.09 3.06 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.216 -0.928 . . . . 0.0 111.482 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -61.44 -48.5 80.87 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.821 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 99' ' ' ILE . 2.0 m -63.78 -27.77 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 117.711 -1.596 . . . . 0.0 109.099 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 109' ' ' LYS . 35.9 mt -62.43 -70.86 0.18 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.654 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -45.87 -48.4 15.95 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.39 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.537 HG21 HD21 ' A' ' 77' ' ' LEU . 61.4 mt -60.88 -30.39 47.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.934 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.521 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -98.9 -2.53 37.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.026 -0.421 . . . . 0.0 110.681 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 105' ' ' LEU . 68.7 tttt -89.08 -75.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.333 . . . . 0.0 111.026 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.29 -36.6 71.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.649 0.261 . . . . 0.0 111.46 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.43 48.68 0.11 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.049 0.452 . . . . 0.0 111.745 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.521 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 1.3 ptt? -171.64 58.04 0.25 Allowed Pre-proline 0 C--N 1.322 -0.628 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.615 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 112' ' ' MET . 14.0 Cg_exo -54.13 -38.59 87.61 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 120.508 0.805 . . . . 0.0 111.808 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -168.07 34.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.994 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.565 ' O ' HD23 ' A' ' 115' ' ' LEU . 2.8 tt -61.36 -52.19 65.65 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.239 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 116' ' ' ASN . 45.0 t-20 -174.38 -6.99 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.332 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.9 p -140.61 175.21 9.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.146 0.498 . . . . 0.0 111.758 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.33 -37.56 0.42 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.432 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -76.55 145.32 39.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.985 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.504 HD21 ' HG3' ' A' ' 109' ' ' LYS . 1.1 mm? -61.24 -45.47 94.39 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 121.505 0.669 . . . . 0.0 110.254 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.48 -36.75 69.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.451 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.45 -69.08 0.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.772 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.14 -40.21 45.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.173 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -54.39 -68.99 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.2 mtt180 -44.09 -28.8 0.53 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.081 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.46 ' O ' ' CB ' ' A' ' 130' ' ' SER . 5.6 tmm? -59.83 -71.06 0.14 Allowed 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.618 HG23 HD11 ' A' ' 78' ' ' ILE . 9.5 mt -51.41 -50.48 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.728 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -64.63 -71.74 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.25 -45.27 5.16 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 126' ' ' MET . 62.5 m -60.26 -41.07 92.48 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -54.86 -47.19 74.52 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -54.5 -41.77 70.01 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 135' ' ' GLY . 1.9 t -57.01 -71.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 80.1 mtp -43.73 -13.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.329 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 90.66 46.14 4.07 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.588 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 53.2 t -137.58 142.66 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.43 167.8 10.41 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 140' ' ' GLY . 12.0 t -89.9 144.52 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.03 0.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.291 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.524 0.604 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' HG13 ' A' ' 5' ' ' VAL . 99.2 mttt . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 60' ' ' TYR . 7.0 p -40.55 124.72 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 3' ' ' LYS . 31.1 m -113.88 -24.07 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.64 135.86 32.12 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.869 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 7' ' ' VAL . 12.6 p -124.65 123.62 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.195 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.63 92.05 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.638 1.108 . . . . 0.0 111.004 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -75.16 112.93 11.94 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -170.45 -173.85 1.53 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.383 0.611 . . . . 0.0 110.583 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -99.49 157.61 16.32 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.555 HD12 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -133.8 89.05 31.19 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -58.09 135.09 66.31 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.446 1.431 . . . . 0.0 114.442 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.892 ' HB3' ' H ' ' A' ' 51' ' ' ALA . . . -91.83 144.43 25.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.59 40.84 33.03 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -170.26 8.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.237 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 18' ' ' THR . . . -91.21 150.12 21.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -158.05 164.89 19.91 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.021 -178.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -61.69 47.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.658 1.572 . . . . 0.0 112.456 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -169.85 54.17 0.23 Allowed Pre-proline 0 C--N 1.322 -0.627 0 O-C-N 122.153 -0.342 . . . . 0.0 110.696 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 22.2 Cg_endo -73.57 172.27 16.08 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 121.066 1.177 . . . . 0.0 112.24 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -57.51 -21.46 46.01 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 120.525 0.817 . . . . 0.0 111.056 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.579 ' CG1' ' HB3' ' A' ' 26' ' ' ALA . 2.2 t -82.93 -64.11 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.794 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 45.7 -100.48 0.02 OUTLIER Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.71 -1.05 . . . . 0.0 110.72 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.5 Cg_exo -50.64 -57.92 1.99 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 CA-C-N 120.678 2.239 . . . . 0.0 111.054 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.579 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.49 -17.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.596 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -113.96 -39.6 3.92 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.18 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.64 51.0 3.26 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -142.33 -13.25 0.8 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.367 0.603 . . . . 0.0 109.794 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.573 ' CE1' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.66 -15.48 62.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.938 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.604 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 100.88 -32.99 6.8 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.604 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -46.43 -133.8 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.393 0.677 . . . . 0.0 112.357 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -136.2 144.97 45.2 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.904 -0.498 . . . . 0.0 110.483 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 37' ' ' PHE . 4.5 mm -94.03 -73.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.52 ' C ' ' SD ' ' A' ' 35' ' ' MET . 3.7 ppp? -41.14 -35.82 0.64 Allowed 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.23 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -59.72 -52.64 64.64 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 90.1 t80 -47.84 -58.94 3.73 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.469 1.128 . . . . 0.0 109.241 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 42' ' ' ASN . 75.3 t -60.76 -44.65 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.156 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 35' ' ' MET . 88.3 tttt -45.21 -64.68 0.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.04 74.13 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.433 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.455 ' CE2' HG21 ' A' ' 45' ' ' THR . 48.9 t80 -62.15 -76.36 0.06 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -40.28 -43.4 1.71 Allowed 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 121.311 0.577 . . . . 0.0 111.822 -177.448 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.05 -34.17 69.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.93 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.19 -47.11 10.43 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.829 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.455 HG21 ' CE2' ' A' ' 41' ' ' PHE . 71.8 p -62.57 -32.33 73.29 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -69.17 -41.02 77.77 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -63.66 -18.49 64.02 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 70.8 mtm -107.22 -86.67 0.49 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.788 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -174.7 -165.72 31.54 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.359 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 34.1 p-10 -93.5 130.18 39.44 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.892 ' H ' ' HB3' ' A' ' 14' ' ' ALA . . . -162.41 -152.45 0.23 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.296 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.4 mt -141.99 132.1 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 69' ' ' THR . 99.1 t -124.7 108.07 28.77 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -74.02 112.09 3.46 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 120.793 0.995 . . . . 0.0 109.698 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 56' ' ' GLU . 6.5 p -144.35 164.61 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 121.488 0.661 . . . . 0.0 112.2 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.621 ' N ' HG22 ' A' ' 55' ' ' VAL . 12.7 mt-10 -123.19 115.93 22.58 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.408 HD13 ' CZ ' ' A' ' 37' ' ' PHE . 54.2 mt -74.92 94.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.917 0.389 . . . . 0.0 111.757 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -69.42 102.21 1.73 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 mt -100.73 123.62 53.81 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-O 120.844 0.354 . . . . 0.0 111.163 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 18.2 m-85 -99.3 143.17 29.86 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.505 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.64 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -53.74 -24.44 14.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 124.717 1.261 . . . . 0.0 112.375 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 41.0 t0 -67.72 7.57 0.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.64 ' H ' ' C ' ' A' ' 61' ' ' ALA . 98.5 mtt180 62.5 70.37 0.57 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.252 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 p -145.3 134.08 22.33 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.947 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -111.55 103.81 12.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.651 -178.553 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.7 p -96.8 123.22 40.44 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 5.9 p90 177.98 -150.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -175.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 53.2 t 80.56 104.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 124.344 1.028 . . . . 0.0 111.766 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' HG13 ' A' ' 53' ' ' VAL . 1.1 p -122.59 112.72 18.33 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.497 ' C ' HG22 ' A' ' 71' ' ' THR . 12.4 mmtt -143.8 -150.29 0.31 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.669 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 4.8 t 47.0 53.47 13.83 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 123.699 0.624 . . . . 0.0 110.442 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.669 ' HD3' ' N ' ' A' ' 71' ' ' THR . 6.5 Cg_endo -79.36 175.79 10.37 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 120.727 0.952 . . . . 0.0 112.399 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.725 ' HA ' HD11 ' A' ' 77' ' ' LEU . 1.7 Cg_endo -64.7 -172.22 0.19 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.608 1.538 . . . . 0.0 111.246 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 73' ' ' PRO . . . 78.99 -176.72 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.578 0.228 . . . . 0.0 110.729 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 1.6 p -40.92 -20.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.474 -0.141 . . . . 0.0 110.652 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 74' ' ' ALA . 11.9 m-85 -43.28 -44.26 5.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.366 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.956 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.58 -25.4 3.43 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 122.068 0.937 . . . . 0.0 109.018 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 82' ' ' ALA . 26.9 mt -54.05 -33.38 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.438 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 83' ' ' GLY . 19.6 mmm-85 -51.54 -48.34 63.07 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.091 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -64.74 -61.84 1.94 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.57 -21.8 4.26 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.639 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -91.68 -77.05 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.639 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 113.93 54.84 0.42 Allowed Glycine 0 N--CA 1.469 0.85 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 85' ' ' GLU . 10.0 mt -94.58 15.06 18.98 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.853 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' LEU . 64.9 tt0 . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.9 mttm . . . . . 0 N--CA 1.463 0.19 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 97' ' ' GLY . 6.3 p -136.44 157.86 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.484 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 118.35 80.78 0.73 Allowed Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -126.48 94.4 4.05 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.948 0.404 . . . . 0.0 111.962 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.545 HD12 HG11 ' A' ' 104' ' ' VAL . 12.1 pt -100.93 149.78 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.452 ' OG1' ' OE1' ' A' ' 103' ' ' GLN . 0.2 OUTLIER -90.78 156.53 17.98 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.478 0.656 . . . . 0.0 110.333 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.598 ' O ' HG22 ' A' ' 104' ' ' VAL . 61.3 t-105 -61.56 -71.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.325 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -46.46 -39.14 10.16 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 120.761 -1.212 . . . . 0.0 111.905 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.452 ' OE1' ' OG1' ' A' ' 100' ' ' THR . 32.3 mt-30 -60.8 -47.19 87.45 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.308 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 101' ' ' TRP . 15.9 m -63.62 -29.0 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.371 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 108' ' ' ALA . 59.7 mt -63.23 -72.61 0.13 Allowed 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.998 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -44.88 -45.04 10.07 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.2 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.63 -25.22 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.127 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -106.27 -1.02 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.704 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 105' ' ' LEU . 43.8 tttp -85.18 -74.68 0.39 Allowed 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.253 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -62.42 -43.61 98.4 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.548 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -76.45 76.15 3.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.799 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.449 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -135.98 54.85 10.67 Favored Pre-proline 0 N--CA 1.468 0.432 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.009 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 112' ' ' MET . 4.3 Cg_endo -59.84 -30.97 93.16 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 120.701 0.934 . . . . 0.0 111.662 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.578 ' C ' ' H ' ' A' ' 116' ' ' ASN . 36.8 t70 -154.05 -86.08 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.992 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.1 mt 51.69 0.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.634 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.578 ' H ' ' C ' ' A' ' 114' ' ' ASP . 4.0 t30 54.38 26.95 7.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.47 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.3 p -143.79 161.62 38.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.293 0.568 . . . . 0.0 111.728 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.3 -32.48 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.09 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -75.02 146.04 41.93 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.74 -45.71 93.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.355 0.598 . . . . 0.0 110.406 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 121' ' ' GLU . 5.0 pt-20 -59.19 -38.85 80.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.702 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.95 -68.98 0.34 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.016 -1.073 . . . . 0.0 108.805 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.18 -37.49 22.67 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.075 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.85 -66.25 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.1 mtt180 -46.16 -36.0 5.56 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.489 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 5.7 tmm? -55.57 -73.47 0.06 Allowed 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.544 HG23 HD11 ' A' ' 78' ' ' ILE . 6.1 mm -51.15 -50.33 26.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.962 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -62.67 -72.55 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.15 -47.41 5.41 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.489 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 66.4 m -56.79 -43.0 80.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.619 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -52.52 -46.85 66.89 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -55.55 -34.25 64.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.125 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 130' ' ' SER . 3.1 t -65.37 -76.45 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 6.7 ptm -40.2 -25.73 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.636 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 104.38 60.52 0.67 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.619 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 27.4 t -145.29 162.99 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.471 ' N ' HG12 ' A' ' 136' ' ' VAL . 98.1 mt-10 -128.94 156.22 44.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.49 ' CG2' ' HB1' ' A' ' 128' ' ' ALA . 2.1 t -87.73 152.11 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 139' ' ' VAL . 46.1 t -96.74 -11.8 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.718 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.619 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.57 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 48.4 tttt . . . . . 0 CA--C 1.506 -0.725 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.67 158.71 30.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.621 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 61' ' ' ALA . 29.2 m -117.98 -26.16 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.13 116.55 4.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 119.044 -1.062 . . . . 0.0 111.103 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.71 ' O ' HG13 ' A' ' 7' ' ' VAL . 9.4 p -110.12 112.24 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.335 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.89 90.41 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 118.563 -1.255 . . . . 0.0 110.693 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -76.26 120.17 21.16 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.456 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -173.68 -174.65 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.38 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -95.87 159.38 15.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.91 HD13 ' CZ ' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -136.61 92.89 14.6 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HA ' HD13 ' A' ' 52' ' ' ILE . 22.6 Cg_exo -59.36 146.5 94.63 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.26 1.307 . . . . 0.0 114.414 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.794 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -101.32 143.2 31.66 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.44 44.59 36.43 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' H ' ' H ' ' A' ' 17' ' ' ALA . 24.0 mttt -167.46 -6.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.238 -0.481 . . . . 0.0 109.811 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' H ' ' H ' ' A' ' 16' ' ' LYS . . . -80.09 149.62 30.57 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -158.97 168.03 13.23 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.115 -178.13 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -60.14 41.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.475 1.45 . . . . 0.0 112.427 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -172.34 58.79 0.25 Allowed Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.919 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 20.5 Cg_endo -78.75 172.21 15.44 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.218 1.279 . . . . 0.0 112.136 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -55.88 -23.82 44.4 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 120.552 0.834 . . . . 0.0 111.013 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.678 HG12 ' HB3' ' A' ' 26' ' ' ALA . 2.2 t -83.04 -64.55 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 43.43 -96.86 0.01 OUTLIER Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -47.13 -60.06 1.02 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 CA-C-N 119.927 1.863 . . . . 0.0 110.669 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.678 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -47.33 -23.84 0.65 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.847 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.681 HD23 ' HE2' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -116.96 26.88 9.49 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.48 41.32 0.63 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -141.69 -11.17 0.9 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.438 0.637 . . . . 0.0 109.619 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.681 ' HE2' HD23 ' A' ' 27' ' ' LEU . 1.4 p80 -67.18 -15.34 63.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.466 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 102.22 -26.33 24.63 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -51.37 -132.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.142 0.577 . . . . 0.0 112.089 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -133.45 -169.28 2.25 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 37' ' ' PHE . 3.4 mm -131.65 -76.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.562 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -40.2 -42.28 1.46 Allowed 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.875 179.048 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -52.81 -51.47 60.7 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.101 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 34' ' ' ILE . 2.0 t80 -50.37 -66.09 0.45 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.599 1.19 . . . . 0.0 109.845 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 42' ' ' ASN . 54.0 t -57.51 -48.61 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 112.889 -1.959 . . . . 0.0 110.939 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 35' ' ' MET . 79.1 mttt -44.14 -58.49 2.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.43 -44.33 84.57 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.048 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.91 ' CZ ' HD13 ' A' ' 12' ' ' LEU . 1.8 t80 -61.13 -73.96 0.09 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -39.85 -41.29 1.12 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.688 0.756 . . . . 0.0 111.681 -177.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -61.9 -35.0 77.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.083 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -86.4 -43.49 12.78 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.749 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 49' ' ' GLY . 70.4 p -63.61 -34.93 78.92 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -67.96 -42.07 81.45 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -62.95 -20.14 64.95 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.0 ttp -106.08 -85.28 0.5 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.954 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 170.78 170.3 34.84 Favored Glycine 0 N--CA 1.465 0.617 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.108 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 47.7 p-10 -65.39 137.05 57.24 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.794 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -176.09 -154.0 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.857 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 13' ' ' PRO . 33.7 mm -141.68 130.99 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.88 127.93 16.47 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.626 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -71.05 148.62 57.14 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.804 1.003 . . . . 0.0 110.751 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 12' ' ' LEU . 7.2 p -153.68 160.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.485 0.659 . . . . 0.0 111.434 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 55' ' ' VAL . 65.3 mt-10 -139.47 103.17 4.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.423 HD13 HD11 ' A' ' 27' ' ' LEU . 21.1 mt -68.17 87.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.582 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 m -70.99 103.16 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 mt -103.74 126.0 58.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.173 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 3' ' ' LYS . 4.4 m-85 -104.07 141.09 36.82 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.892 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -51.09 -22.11 2.26 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 124.18 0.925 . . . . 0.0 112.079 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -67.51 9.12 0.27 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.651 ' H ' ' C ' ' A' ' 61' ' ' ALA . 99.5 mtt180 60.96 68.97 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.923 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -146.22 132.36 19.37 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.135 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -109.56 102.39 11.25 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.161 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 8.4 m -95.56 119.66 34.44 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.576 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER 172.19 115.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 O-C-N 124.4 1.062 . . . . 0.0 111.092 -176.662 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.8 t -154.43 136.6 6.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 p -141.47 147.05 37.25 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -141.76 171.06 14.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.251 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -40.17 98.08 0.16 Allowed Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.793 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.493 ' O ' ' O ' ' A' ' 71' ' ' THR . 16.2 Cg_exo -43.26 177.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 121.256 1.304 . . . . 0.0 113.119 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 17.2 Cg_exo -51.14 113.54 1.15 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.427 1.418 . . . . 0.0 112.759 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 172.38 -152.0 0.01 OUTLIER 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.721 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 80.2 p -36.94 -22.96 0.01 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.985 0.421 . . . . 0.0 110.44 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.604 ' N ' ' O ' ' A' ' 74' ' ' ALA . 11.6 t80 -47.37 -36.75 10.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.68 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.9 -34.22 3.98 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.67 0.747 . . . . 0.0 109.884 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.721 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 69.0 mt -48.2 -38.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.418 ' NH1' ' O ' ' A' ' 84' ' ' LEU . 13.1 mmm180 -51.67 -45.99 63.63 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.329 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -66.54 -63.31 1.1 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.33 -19.27 2.0 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.293 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -89.96 -77.62 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.607 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.33 45.1 0.63 Allowed Glycine 0 N--CA 1.47 0.902 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.418 ' O ' ' NH1' ' A' ' 79' ' ' ARG . 24.5 mt -98.89 115.36 28.67 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.753 0.311 . . . . 0.0 110.559 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.532 0.206 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 97' ' ' GLY . 5.4 p -145.18 155.93 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.247 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 60.53 82.48 0.07 OUTLIER Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.408 ' NE ' HG23 ' A' ' 139' ' ' VAL . 22.8 ttt180 -135.1 104.19 5.84 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.599 HD12 ' CG1' ' A' ' 104' ' ' VAL . 4.8 pt -104.37 150.21 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.8 p -87.96 155.72 19.69 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.397 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.782 ' NE1' HD11 ' A' ' 105' ' ' LEU . 74.0 t-105 -60.97 -54.59 43.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.083 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 1.3 tp10 -59.1 -40.37 85.1 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.059 -1.025 . . . . 0.0 111.123 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -59.38 -47.14 86.55 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.811 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.599 ' CG1' HD12 ' A' ' 99' ' ' ILE . 20.4 m -65.52 -29.06 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 118.494 -1.282 . . . . 0.0 109.467 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.782 HD11 ' NE1' ' A' ' 101' ' ' TRP . 64.7 mt -64.52 -74.03 0.11 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.522 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -44.2 -48.76 9.3 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.464 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.6 -25.28 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.107 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -105.54 -0.34 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.479 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.9 tmtt? -89.2 -74.74 0.46 Allowed 'General case' 0 N--CA 1.461 0.083 0 CA-C-O 120.751 0.31 . . . . 0.0 110.187 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -72.53 -40.99 66.35 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.843 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -74.85 73.59 2.11 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.57 61.71 0.17 Allowed Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.407 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -52.75 -43.15 58.07 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 120.594 0.863 . . . . 0.0 112.051 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 116' ' ' ASN . 27.0 t70 -142.4 -61.79 0.44 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.272 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 tt 45.64 -85.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.933 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 114' ' ' ASP . 12.6 t-20 -174.77 9.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.943 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 46.5 p -141.83 171.19 14.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.401 0.619 . . . . 0.0 111.749 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.37 -40.86 0.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.894 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -83.48 153.31 24.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.524 HD21 ' HG2' ' A' ' 109' ' ' LYS . 35.8 mt -60.24 -46.18 90.66 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.314 0.578 . . . . 0.0 109.931 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -54.81 -42.09 71.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.916 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.56 -66.84 0.53 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.116 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.63 36.67 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.941 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -53.03 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.602 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.4 mtt180 -43.3 -31.22 0.6 Allowed 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.001 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 130' ' ' SER . 5.5 ttp -59.33 -73.48 0.08 Allowed 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 127' ' ' ILE . 1.9 mp -48.99 -49.39 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.581 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -65.98 -71.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.34 -49.29 5.64 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 126' ' ' MET . 49.5 m -54.47 -42.99 71.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.719 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -56.05 -47.8 77.21 Favored 'General case' 0 C--O 1.228 -0.069 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -55.14 -41.51 71.86 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 t -53.31 -71.26 0.07 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.1 mtm -41.58 -62.07 0.95 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.942 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.18 50.0 0.04 OUTLIER Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.719 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 54.4 t -133.92 164.82 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.551 ' N ' HG12 ' A' ' 136' ' ' VAL . 98.0 mt-10 -133.78 159.27 41.1 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 140' ' ' GLY . 6.2 t -96.34 155.12 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.408 HG23 ' NE ' ' A' ' 98' ' ' ARG . 3.0 p -83.44 -2.71 6.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.647 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.418 ' H ' HG12 ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.518 0.261 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.5 mptm? . . . . . 0 C--O 1.223 -0.333 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.91 121.67 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 3' ' ' LYS . 17.3 m -113.33 -25.32 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.778 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.94 135.59 39.74 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.271 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.578 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.4 p -126.37 126.95 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.226 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.96 91.03 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.826 1.194 . . . . 0.0 111.539 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -82.15 116.32 21.66 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.49 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -168.47 -171.51 1.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.403 -178.633 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -94.44 154.16 17.58 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.963 HD12 ' CZ ' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -135.66 92.35 17.14 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -71.65 114.32 3.91 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.264 1.309 . . . . 0.0 114.775 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.789 ' HB3' ' H ' ' A' ' 51' ' ' ALA . . . -61.94 143.83 55.9 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . 61.49 150.53 0.02 OUTLIER Glycine 0 C--N 1.336 0.57 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.4 tttp 72.88 10.52 5.4 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.126 0.963 . . . . 0.0 110.564 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 18' ' ' THR . . . -92.15 151.93 20.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.6 170.81 3.97 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.041 -178.443 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -58.79 42.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.363 1.375 . . . . 0.0 112.23 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -160.91 54.26 0.55 Allowed Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-O 120.474 0.178 . . . . 0.0 110.533 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 25.6 Cg_endo -77.07 168.37 23.43 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.091 1.194 . . . . 0.0 112.21 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -56.51 -31.37 86.02 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 120.639 0.893 . . . . 0.0 111.284 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.796 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.7 t -75.02 -61.28 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 44.48 -99.61 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -47.87 -60.31 0.92 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 CA-C-N 119.816 1.808 . . . . 0.0 110.998 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.796 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -45.9 -26.83 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.366 -0.533 . . . . 0.0 109.824 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 25.6 tp -119.69 23.06 11.34 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.603 0.716 . . . . 0.0 109.172 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -152.56 37.93 0.77 Allowed Glycine 0 C--N 1.322 -0.221 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.668 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.442 ' O ' ' OE1' ' A' ' 29' ' ' GLN . 0.8 OUTLIER -141.57 -3.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.567 ' ND1' ' N ' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -78.5 -11.96 59.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.264 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.588 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 97.83 -26.1 24.72 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.588 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -47.66 -134.37 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.987 0.515 . . . . 0.0 112.287 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -136.76 143.58 43.33 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 122.093 -0.38 . . . . 0.0 111.015 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.6 mm -93.14 -73.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -39.72 -39.44 0.77 Allowed 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -59.49 -52.44 65.57 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.822 -0.751 . . . . 0.0 108.993 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' A' ' 34' ' ' ILE . 90.2 t80 -47.11 -62.43 1.42 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.165 0.983 . . . . 0.0 109.724 177.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 42' ' ' ASN . 86.9 t -58.71 -44.02 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 113.309 -1.769 . . . . 0.0 111.178 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.42 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 88.4 tttt -45.44 -67.79 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.75 -41.02 66.67 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.491 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.963 ' CZ ' HD12 ' A' ' 12' ' ' LEU . 54.9 t80 -62.9 -77.03 0.06 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.29 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -40.24 -44.73 1.94 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.314 0.578 . . . . 0.0 112.182 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.06 -34.81 70.52 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.113 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.17 -46.05 11.45 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.618 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 49' ' ' GLY . 32.4 p -63.76 -31.69 72.94 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -70.03 -41.02 74.82 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -62.4 -20.02 64.03 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.2 mtm -106.51 -78.85 0.57 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.259 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 169.17 166.49 28.29 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.362 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 36.9 p-10 -62.63 125.51 24.17 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.789 ' H ' ' HB3' ' A' ' 14' ' ' ALA . . . -162.41 -153.88 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.285 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 99.3 mt -142.03 132.15 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.72 120.46 6.03 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.249 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -65.37 140.71 65.03 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 120.746 0.964 . . . . 0.0 110.862 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.412 ' CG2' HD23 ' A' ' 12' ' ' LEU . 25.4 m -137.53 159.62 34.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.234 0.54 . . . . 0.0 110.861 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 58' ' ' THR . 32.4 tt0 -129.89 85.7 2.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 57' ' ' ILE . 4.6 mt -60.36 82.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.216 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -72.74 97.16 2.15 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.2 mt -97.31 126.25 50.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.008 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -98.86 144.65 27.83 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.664 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -54.25 -24.12 17.46 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.44 1.088 . . . . 0.0 112.331 -176.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -68.45 10.44 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.664 ' H ' ' C ' ' A' ' 61' ' ' ALA . 87.2 mtm180 61.27 69.2 0.68 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.496 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.3 m -142.9 126.94 17.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.843 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -107.58 103.76 13.15 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.058 -177.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.483 ' O ' ' OG1' ' A' ' 58' ' ' THR . 77.3 p -95.71 121.58 37.57 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.586 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.4 p90 176.46 -152.54 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 51.7 t 80.69 152.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.304 0 O-C-N 124.329 1.018 . . . . 0.0 110.564 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t -146.68 173.36 12.43 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.453 ' C ' HG22 ' A' ' 71' ' ' THR . 58.0 pttt -170.6 -159.85 0.19 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.585 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 t 43.25 56.38 11.84 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.956 0.408 . . . . 0.0 111.431 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 71' ' ' THR . 9.8 Cg_endo -77.82 157.57 31.35 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 C-N-CA 120.064 0.509 . . . . 0.0 112.04 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.683 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 11.3 Cg_endo -70.13 176.2 7.38 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 121.952 1.768 . . . . 0.0 112.293 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 73' ' ' PRO . . . 79.71 -177.24 0.08 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.897 0.317 . . . . 0.0 110.279 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.635 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.1 OUTLIER -40.51 -20.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.312 -0.242 . . . . 0.0 110.521 -179.031 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.542 ' HD2' ' O ' ' A' ' 73' ' ' PRO . 26.0 m-85 -42.73 -35.96 1.3 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.651 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.812 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -133.51 -25.55 1.7 Allowed 'General case' 0 C--O 1.253 1.253 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.635 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 45.6 mt -54.56 -35.02 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.573 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -53.37 -42.84 67.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.277 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.434 ' C ' ' N ' ' A' ' 82' ' ' ALA . 3.1 tmtm? -67.84 -65.32 0.71 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.9 -11.64 0.25 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.999 -0.681 . . . . 0.0 110.65 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.42 -77.63 0.33 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.851 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 137.74 63.09 0.05 OUTLIER Glycine 0 N--CA 1.464 0.537 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.9 mt -115.06 135.87 53.74 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.233 0.214 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.461 HG22 ' N ' ' A' ' 97' ' ' GLY . 14.3 p -144.61 159.5 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.461 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 93.68 68.19 1.07 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.28 99.29 6.27 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.706 0.253 . . . . 0.0 111.034 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.669 HD12 HG11 ' A' ' 104' ' ' VAL . 13.7 pt -95.63 139.29 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.492 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -81.61 155.99 25.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.753 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.632 ' O ' HG22 ' A' ' 104' ' ' VAL . 57.2 t-105 -61.75 -69.13 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -48.29 -42.17 30.07 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 120.916 -1.115 . . . . 0.0 112.147 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -59.86 -46.08 90.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.451 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.669 HG11 HD12 ' A' ' 99' ' ' ILE . 19.2 m -63.44 -29.78 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 118.286 -1.366 . . . . 0.0 109.283 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 108' ' ' ALA . 36.7 mt -62.38 -70.68 0.19 Allowed 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.339 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -43.63 -46.29 7.21 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.568 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.46 -26.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.378 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.554 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -101.66 -2.39 30.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.364 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.517 ' O ' ' SD ' ' A' ' 112' ' ' MET . 87.5 tttt -88.76 -75.45 0.43 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.857 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.4 -40.3 73.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.04 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.15 84.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.456 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.554 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 3.1 ptt? -179.51 58.24 0.1 OUTLIER Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.505 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 112' ' ' MET . 13.6 Cg_endo -75.81 -55.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 120.618 0.879 . . . . 0.0 112.337 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -88.85 -31.45 18.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.772 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 117' ' ' THR . 10.3 mt -45.42 134.07 7.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -65.98 70.24 0.06 Allowed 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.298 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LEU . 82.6 p -143.71 159.35 42.65 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.212 0.53 . . . . 0.0 111.994 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.64 -43.32 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.935 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -91.94 148.35 22.27 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.8 OUTLIER -59.27 -46.82 87.5 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.689 0.757 . . . . 0.0 110.124 -178.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.65 -35.68 68.66 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.66 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.92 -64.73 0.81 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.937 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.87 -22.92 27.97 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.923 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.95 -73.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.2 mtt180 -43.09 -31.95 0.63 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.658 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 130' ' ' SER . 38.9 ttp -57.36 -72.95 0.08 Allowed 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.448 HG23 HD11 ' A' ' 78' ' ' ILE . 50.0 mm -51.33 -50.28 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.328 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -64.28 -72.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.13 -45.58 3.99 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 126' ' ' MET . 67.7 m -56.74 -44.69 81.95 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.582 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -56.22 -50.43 71.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -48.88 -42.88 38.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.399 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.586 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.4 t -54.13 -65.07 0.64 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.8 mtp -52.45 -2.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.605 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.1 -29.27 6.61 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.582 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 68.1 t -46.05 164.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 79.2 mt-10 -143.05 164.76 29.22 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.093 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 140' ' ' GLY . 3.5 t -85.23 155.03 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 100' ' ' THR . 1.0 OUTLIER -100.18 -7.54 9.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.703 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.507 -0.464 0 CA-C-O 119.131 -0.816 . . . . 0.0 111.553 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.418 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 17.9 ttmt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.775 0.322 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 4' ' ' VAL . 7.7 p -70.59 126.39 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -112.07 -24.77 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.41 119.6 14.61 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.292 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.6 p -111.6 104.82 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.842 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.68 92.41 2.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 117.985 -1.486 . . . . 0.0 110.295 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -85.23 109.49 18.37 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.437 0.461 . . . . 0.0 110.304 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -171.89 -174.51 1.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.191 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -102.18 173.57 6.32 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.61 139.31 5.93 Favored Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.974 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -82.2 149.54 15.3 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.125 1.217 . . . . 0.0 114.722 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.827 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -90.33 144.73 25.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.17 58.86 8.95 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.404 ' H ' ' H ' ' A' ' 17' ' ' ALA . 2.1 mmtm 172.63 21.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.336 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 16' ' ' LYS . . . -98.16 150.68 21.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -162.42 168.54 10.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.075 -178.794 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -62.23 42.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.29 1.327 . . . . 0.0 111.963 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -155.53 59.31 2.13 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.994 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 27.8 Cg_endo -79.72 166.47 21.57 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.286 1.324 . . . . 0.0 111.888 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.37 -30.71 88.83 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 120.8 1.0 . . . . 0.0 111.102 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.665 ' CG1' ' HB3' ' A' ' 26' ' ' ALA . 2.4 t -70.98 -58.06 6.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.812 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 41.08 -99.64 0.01 OUTLIER Glycine 0 C--O 1.207 -1.555 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.3 Cg_exo -48.41 -62.49 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 CA-C-N 120.308 2.054 . . . . 0.0 110.789 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.665 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -42.95 -16.82 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.059 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.614 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 29.5 tp -117.53 -27.56 6.3 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.699 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -57.59 -54.83 34.18 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -88.99 43.22 1.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.565 0.697 . . . . 0.0 110.496 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.614 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -86.87 -31.74 20.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 109.86 -48.83 0.9 Allowed Glycine 0 N--CA 1.472 1.085 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.546 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -50.33 -131.23 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.973 0.509 . . . . 0.0 111.865 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -138.71 128.33 24.76 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.89 -0.506 . . . . 0.0 111.205 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.9 mm -71.96 -72.25 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.453 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -38.55 -39.44 0.48 Allowed 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -58.93 -48.94 79.68 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.074 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 60.7 t80 -48.42 -65.66 0.53 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.527 1.156 . . . . 0.0 109.622 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 42' ' ' ASN . 89.8 t -56.87 -44.03 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.383 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -47.06 -53.03 13.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.87 -37.8 87.12 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.227 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 7.8 m-85 -65.43 -74.11 0.11 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 41' ' ' PHE . 0.6 OUTLIER -37.16 -45.69 0.65 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.516 0.674 . . . . 0.0 111.514 -177.722 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.17 79.31 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.55 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -88.73 -45.23 9.96 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.519 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 42' ' ' ASN . 52.3 p -60.63 -18.54 53.92 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -86.69 -42.72 13.15 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -60.23 -17.04 38.88 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.786 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.595 ' SD ' ' HB1' ' A' ' 14' ' ' ALA . 1.7 ppp? -120.11 126.41 50.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.132 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.501 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -40.93 161.9 0.01 OUTLIER Glycine 0 CA--C 1.543 1.835 0 C-N-CA 119.533 -1.317 . . . . 0.0 111.584 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 53.6 p-10 -62.6 151.46 37.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.06 0.93 . . . . 0.0 109.928 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.827 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 179.6 -150.48 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.809 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.0 mt -143.24 134.9 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 m -147.43 145.83 23.0 Favored Pre-proline 0 C--O 1.243 0.723 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.3 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -76.42 149.09 30.69 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 121.064 1.176 . . . . 0.0 110.961 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 m -142.54 143.28 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.133 0.492 . . . . 0.0 111.017 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.71 85.6 2.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 mt -64.52 83.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.916 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 m -69.23 93.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.8 mt -93.56 125.72 46.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.218 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.418 ' CD2' ' C ' ' A' ' 3' ' ' LYS . 7.7 m-85 -100.27 142.66 31.44 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.659 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.7 -22.87 2.29 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 124.651 1.219 . . . . 0.0 112.165 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.25 5.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.659 ' H ' ' C ' ' A' ' 61' ' ' ALA . 51.2 mtp180 62.54 72.78 0.48 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.104 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.1 p -152.45 132.36 13.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.314 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -101.36 101.69 12.38 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.41 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.7 132.0 41.36 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.527 ' O ' ' CD2' ' A' ' 67' ' ' PHE . 51.5 p90 -172.26 123.54 0.49 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.479 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 69' ' ' THR . 72.8 t -107.32 108.01 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.523 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 25.6 p -156.21 -164.27 1.65 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 69' ' ' THR . 9.3 pttt 76.78 -178.95 0.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.511 ' CG2' ' CE2' ' A' ' 76' ' ' TYR . 6.4 m 64.9 68.61 0.73 Allowed Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.558 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.531 ' O ' ' CD1' ' A' ' 76' ' ' TYR . 10.8 Cg_endo -78.53 155.5 28.04 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 120.934 1.089 . . . . 0.0 112.289 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.562 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 10.0 Cg_endo -68.46 112.67 2.89 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.699 1.599 . . . . 0.0 112.367 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 169.61 -167.46 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.672 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -41.51 -16.19 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 O-C-N 122.0 -0.437 . . . . 0.0 110.571 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.659 ' CE1' HD22 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -43.97 -30.12 0.67 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.208 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.947 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -140.7 -27.14 0.73 Allowed 'General case' 0 C--O 1.255 1.358 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.025 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.947 ' N ' HD23 ' A' ' 77' ' ' LEU . 66.4 mt -51.67 -35.59 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.455 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -53.51 -45.37 69.68 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.702 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.07 -63.63 1.19 Allowed 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.32 -19.44 5.42 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.725 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.19 -78.75 0.25 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.069 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 134.03 23.52 0.68 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.17 132.64 36.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 . . . . . 0 C--N 1.333 -0.139 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.306 -179.838 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 CA--C 1.53 0.202 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.4 p -159.8 152.95 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.308 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.88 82.86 0.14 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.647 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -140.35 123.06 16.33 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 121.035 0.445 . . . . 0.0 111.003 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.617 HD12 ' CG1' ' A' ' 104' ' ' VAL . 1.6 pt -128.8 157.28 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 p -91.01 166.79 12.82 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.134 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.621 ' NE1' HD11 ' A' ' 105' ' ' LEU . 55.9 t-105 -59.34 -54.39 47.33 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.27 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -55.73 -40.94 73.15 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.585 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -61.03 -47.86 84.48 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.858 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.617 ' CG1' HD12 ' A' ' 99' ' ' ILE . 16.0 m -66.42 -28.63 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 118.414 -1.314 . . . . 0.0 109.783 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.621 HD11 ' NE1' ' A' ' 101' ' ' TRP . 53.0 mt -63.1 -71.47 0.16 Allowed 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.521 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -43.79 -47.45 8.03 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.141 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.83 -27.48 41.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.244 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.566 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -104.63 0.62 28.69 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.693 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 105' ' ' LEU . 77.8 tttt -84.91 -73.78 0.42 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.541 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -57.18 -35.98 70.24 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -70.59 48.74 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.456 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.566 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 91.9 mtp -143.32 54.1 2.95 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.411 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 112' ' ' MET . 3.5 Cg_endo -57.8 -46.67 25.04 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 120.651 0.901 . . . . 0.0 112.088 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -173.93 26.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.9 mt -43.42 -73.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.454 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -172.1 0.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.226 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.6 p -141.73 177.53 8.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 111.903 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.2 p -141.6 -22.26 0.73 Allowed 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.996 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -82.07 143.06 31.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.198 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.2 -40.72 97.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 110.876 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -56.1 -35.16 66.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.18 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.77 -68.88 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.861 -1.136 . . . . 0.0 108.967 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.06 -39.08 26.19 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.976 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.38 -66.55 0.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 129' ' ' GLY . 98.8 mtt180 -44.27 -31.91 1.14 Allowed 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.479 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 4.4 tmm? -59.24 -72.35 0.1 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.6 mm -51.1 -50.34 25.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.218 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -66.26 -70.82 0.22 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.39 -44.4 3.99 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.479 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 66.4 m -58.71 -44.85 90.51 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.557 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -54.62 -50.32 68.39 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.55 HH11 ' HG2' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -49.36 -44.59 44.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.5 t -52.47 -65.72 0.51 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 83.5 mtp -51.82 -5.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.303 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.57 -25.56 12.87 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.557 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 45.7 t -47.64 163.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 136' ' ' VAL . 75.8 mt-10 -131.62 153.24 50.13 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 140' ' ' GLY . 65.2 t -117.25 130.49 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 139' ' ' VAL . 38.7 t -94.76 -4.88 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.487 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.508 ' H ' HG12 ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.538 0.208 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 4' ' ' VAL . 8.2 p -58.05 123.07 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 61' ' ' ALA . 64.5 t -114.36 -24.09 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.03 130.05 18.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.608 0.718 . . . . 0.0 111.101 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.4 t -119.92 103.56 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.058 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.25 93.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 118.164 -1.415 . . . . 0.0 110.045 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -76.01 110.81 10.78 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -169.91 -172.6 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.944 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 11' ' ' GLN . 26.4 mp0 -109.59 171.94 7.15 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.699 HD13 ' CE1' ' A' ' 41' ' ' PHE . 8.0 mt -143.15 136.02 13.73 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -82.49 159.85 17.02 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.222 1.281 . . . . 0.0 113.722 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.751 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -118.35 142.53 47.43 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.66 35.53 38.15 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -177.38 59.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.896 -0.652 . . . . 0.0 110.468 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.07 156.24 47.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -167.68 169.02 5.81 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.286 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.84 39.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.357 1.371 . . . . 0.0 112.171 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.578 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -147.0 52.57 1.39 Allowed Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.629 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 31.2 Cg_endo -79.78 166.28 21.6 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.027 1.151 . . . . 0.0 111.885 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.08 -29.2 86.3 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 120.93 1.087 . . . . 0.0 111.087 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.601 ' CG1' ' HB3' ' A' ' 26' ' ' ALA . 2.4 t -80.62 -63.49 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 42.97 -99.58 0.01 OUTLIER Glycine 0 C--O 1.212 -1.252 0 CA-C-O 118.58 -1.122 . . . . 0.0 110.418 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.3 Cg_exo -47.55 -60.51 0.85 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 CA-C-N 120.968 2.384 . . . . 0.0 110.986 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.601 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.48 -16.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.429 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.632 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -117.82 -38.23 3.29 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 110.901 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -56.68 -52.01 53.2 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -76.5 42.19 0.28 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.382 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.632 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -92.35 -30.38 15.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.726 177.718 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.596 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . 109.27 -43.19 1.76 Allowed Glycine 0 N--CA 1.464 0.529 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -51.44 -132.01 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.103 0.561 . . . . 0.0 111.849 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -138.68 123.73 19.01 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.909 -0.495 . . . . 0.0 110.736 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.6 mm -63.18 -71.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.416 ' O ' ' N ' ' A' ' 39' ' ' LYS . 96.7 mmm -39.43 -43.19 1.19 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.26 -48.26 79.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.272 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 34' ' ' ILE . 29.5 t80 -50.05 -67.67 0.24 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 122.364 1.078 . . . . 0.0 109.358 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 42' ' ' ASN . 93.8 t -56.93 -42.51 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.174 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 88.4 tttt -48.59 -60.69 2.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.52 -41.32 80.65 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.683 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.699 ' CE1' HD13 ' A' ' 12' ' ' LEU . 10.3 m-85 -62.97 -76.0 0.07 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 46' ' ' ALA . 8.0 t-20 -39.29 -46.34 1.54 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.524 0.678 . . . . 0.0 111.744 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -57.8 -35.24 70.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.302 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -88.07 -44.42 10.97 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.983 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 49' ' ' GLY . 14.8 p -65.26 -21.12 66.69 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -87.82 -33.66 18.53 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 47' ' ' ASN . 62.4 t-20 -64.45 -24.53 67.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.486 ' CG ' ' N ' ' A' ' 49' ' ' GLY . 7.1 ptt? -105.65 -47.2 3.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.644 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.486 ' N ' ' CG ' ' A' ' 48' ' ' MET . . . 142.62 178.57 18.69 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 40.7 p-10 -74.82 147.98 40.69 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.751 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.04 -154.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.754 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.1 mm -143.3 136.46 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.5 131.13 12.7 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.741 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -72.26 153.23 56.39 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 120.76 0.974 . . . . 0.0 110.369 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.551 HG11 HD12 ' A' ' 12' ' ' LEU . 5.3 p -155.52 145.53 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.426 0.632 . . . . 0.0 111.897 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -121.93 95.68 4.76 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.4 mt -69.72 89.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.712 -175.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.24 98.93 1.81 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 59' ' ' ILE . 40.9 mt -99.28 131.44 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.806 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 63' ' ' ARG . 4.1 m-85 -106.83 142.15 36.93 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.55 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.91 -27.34 7.31 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 124.388 1.055 . . . . 0.0 111.841 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -60.33 -5.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' A' ' 61' ' ' ALA . 25.7 ttm180 76.79 70.01 0.06 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.212 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.0 p -144.77 125.33 14.05 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.237 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -104.64 103.28 12.91 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.556 0.217 . . . . 0.0 110.555 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.7 p -95.55 134.46 38.4 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.559 ' CZ ' ' O ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -124.73 175.34 7.3 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.226 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.97 86.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.9 t -177.15 139.03 0.26 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.211 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.585 ' O ' ' O ' ' A' ' 71' ' ' THR . 0.6 OUTLIER -176.92 117.25 0.11 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.672 0.749 . . . . 0.0 110.336 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.585 ' O ' ' O ' ' A' ' 70' ' ' LYS . 49.8 p 51.85 140.45 0.02 OUTLIER Pre-proline 0 C--N 1.292 -1.914 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.468 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -78.21 168.57 21.56 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 120.551 1.232 . . . . 0.0 112.821 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.46 90.67 0.33 Allowed 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.983 1.789 . . . . 0.0 111.959 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.72 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -176.7 -143.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.634 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.5 OUTLIER -37.25 -14.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.72 ' N ' ' O ' ' A' ' 74' ' ' ALA . 3.2 t80 -46.52 -41.27 13.95 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 123.53 0.518 . . . . 0.0 110.385 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.86 ' N ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -130.1 -15.25 3.79 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.819 ' N ' HD22 ' A' ' 77' ' ' LEU . 26.2 mt -65.02 -40.68 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.997 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -50.25 -41.82 50.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.063 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -71.58 -61.19 1.87 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.313 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.18 -22.43 6.55 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.319 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -86.61 -78.08 0.3 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.765 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.39 56.61 0.77 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.8 mt -92.48 114.49 27.06 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 C--N 1.331 -0.22 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.648 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 97' ' ' GLY . 12.5 p -152.64 164.56 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 88.59 84.55 1.25 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -138.81 128.39 24.66 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.07 0.462 . . . . 0.0 110.88 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 104' ' ' VAL . 15.0 pt -119.19 151.61 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.6 p -78.72 154.78 29.79 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.237 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.717 ' NE1' HD11 ' A' ' 105' ' ' LEU . 65.4 t-105 -58.49 -54.63 44.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.019 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -58.31 -42.8 87.5 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 121.439 -0.788 . . . . 0.0 111.396 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -58.33 -46.11 86.83 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.638 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.543 HG23 ' CG2' ' A' ' 127' ' ' ILE . 7.7 p -66.9 -30.6 50.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.044 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.717 HD11 ' NE1' ' A' ' 101' ' ' TRP . 58.3 mt -61.69 -71.77 0.14 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.153 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -45.66 -49.77 14.1 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.39 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.501 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 93.1 mt -57.53 -26.69 27.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -105.64 2.44 28.16 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.398 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 105' ' ' LEU . 77.3 tttt -86.16 -73.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -65.52 -40.51 93.06 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.725 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 107' ' ' ILE . 49.7 mmtt -60.43 93.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.712 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.422 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 48.8 mtt -154.82 56.0 1.35 Allowed Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.403 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 112' ' ' MET . 14.7 Cg_exo -50.46 -46.67 28.17 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 120.778 0.985 . . . . 0.0 112.154 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 66.8 t0 -170.92 40.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.245 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.562 HD22 ' N ' ' A' ' 115' ' ' LEU . 3.6 mm? -74.41 143.66 44.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.74 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.563 ' ND2' ' O ' ' A' ' 116' ' ' ASN . 10.2 t30 -69.37 35.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.444 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 115' ' ' LEU . 69.5 p -139.46 162.79 34.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.228 0.537 . . . . 0.0 111.756 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.7 p -142.46 -45.07 0.32 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.779 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -72.5 151.51 42.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 35.9 mt -59.3 -42.19 90.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.358 0.599 . . . . 0.0 109.948 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.85 -44.53 86.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.093 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.85 -71.23 0.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.279 -0.969 . . . . 0.0 108.528 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.596 ' O ' ' HG3' ' A' ' 126' ' ' MET . . . -44.22 -55.0 5.17 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.896 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -44.69 -62.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.295 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 129' ' ' GLY . 64.8 ttt180 -44.41 -32.36 1.34 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.791 ' HG3' ' H ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER -58.95 -66.71 0.46 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.791 ' H ' ' HG3' ' A' ' 126' ' ' MET . 4.9 mm -56.11 -48.68 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.317 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -66.84 -69.83 0.28 Allowed 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.09 -47.43 5.35 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 126' ' ' MET . 70.3 m -57.82 -42.84 85.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.619 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -53.86 -48.18 70.28 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.532 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -50.75 -41.1 56.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.393 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 135' ' ' GLY . 2.3 t -59.57 -72.64 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 4.3 ptm -45.27 -13.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.527 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 89.31 66.17 1.26 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.619 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 37.1 t -157.16 141.61 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -116.17 172.44 7.18 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 140' ' ' GLY . 7.3 t -96.33 149.02 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 p -62.08 4.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.313 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.523 0.588 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt . . . . . 0 CA--C 1.521 -0.142 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.697 HG21 HG22 ' A' ' 58' ' ' THR . 1.0 OUTLIER -55.01 104.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.213 178.775 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 6' ' ' ALA . 29.6 m -80.79 -46.33 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.204 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 5' ' ' VAL . . . -100.84 142.1 32.79 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.263 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.7 p -132.58 99.91 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.595 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.12 90.34 3.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.031 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -78.99 117.2 19.84 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.493 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -170.67 -173.91 1.49 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.537 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -98.25 162.7 13.06 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.474 HD12 HG11 ' A' ' 55' ' ' VAL . 1.1 mt -148.88 96.83 3.73 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.484 ' HA ' HD13 ' A' ' 52' ' ' ILE . 26.5 Cg_exo -54.23 147.88 43.36 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.239 1.292 . . . . 0.0 114.769 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.832 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -94.61 142.45 27.44 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 45.06 31.38 2.9 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -154.07 34.34 0.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.145 -0.527 . . . . 0.0 110.522 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.82 151.55 36.28 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.546 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -156.32 167.98 13.27 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.121 -178.078 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -61.5 36.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.305 1.337 . . . . 0.0 112.207 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -159.33 57.39 1.04 Allowed Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.687 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 23.4 Cg_endo -80.22 169.62 17.26 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.157 1.238 . . . . 0.0 112.123 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -55.01 -28.41 59.65 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 120.705 0.936 . . . . 0.0 111.146 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.747 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.6 t -84.7 -61.9 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 43.25 -98.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.809 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -47.15 -60.71 0.78 Allowed 'Trans proline' 0 C--N 1.317 -1.106 0 CA-C-N 119.736 1.768 . . . . 0.0 110.559 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.747 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -48.49 -26.29 2.07 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.834 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 36.8 tp -113.23 26.35 10.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 122.124 0.964 . . . . 0.0 109.354 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.42 42.38 0.5 Allowed Glycine 0 C--N 1.313 -0.73 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.259 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -141.13 -16.28 0.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.186 0.517 . . . . 0.0 109.638 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.497 ' O ' ' ND1' ' A' ' 30' ' ' HIS . 16.2 t-80 -59.01 -11.11 3.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.197 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.99 -15.81 58.99 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.39 -131.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.304 0.642 . . . . 0.0 112.071 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -134.09 -165.56 1.66 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mm -138.46 -74.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.3 tpt -41.4 -37.41 1.03 Allowed 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -59.83 -54.36 47.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 68.7 t80 -45.38 -58.15 3.53 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 122.863 1.315 . . . . 0.0 109.755 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 42' ' ' ASN . 48.8 t -63.19 -43.4 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.577 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -44.64 -58.67 2.9 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.41 95.83 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.342 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -62.12 -74.22 0.09 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.646 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -39.74 -44.58 1.58 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.72 0.772 . . . . 0.0 111.738 -177.299 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.17 72.92 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.219 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.51 ' HB1' ' HG3' ' A' ' 70' ' ' LYS . . . -87.71 -46.09 9.8 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.186 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.8 p -62.76 -19.46 64.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -89.12 -34.14 16.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -61.41 -26.05 67.6 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.592 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -106.08 -85.87 0.49 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.067 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.592 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -176.2 169.23 41.75 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.338 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 42.9 p-10 -69.48 137.66 52.77 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.832 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -174.93 -150.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.861 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 13' ' ' PRO . 35.4 mm -138.19 125.0 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.603 HG11 HG23 ' A' ' 69' ' ' THR . 84.4 t -125.9 120.94 24.19 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.206 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -75.32 141.69 26.03 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.011 1.141 . . . . 0.0 110.631 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.618 HG22 ' N ' ' A' ' 56' ' ' GLU . 7.5 p -159.74 162.91 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.329 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.618 ' N ' HG22 ' A' ' 55' ' ' VAL . 9.7 mt-10 -129.44 114.82 16.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.9 mt -76.54 88.23 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.097 0.475 . . . . 0.0 111.73 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.697 HG22 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -74.37 113.49 11.65 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.6 mt -118.55 135.94 57.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.004 0.431 . . . . 0.0 111.401 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.642 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -110.17 147.72 33.18 Favored 'General case' 0 C--O 1.253 1.274 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.27 176.665 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.713 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -53.48 -22.55 8.19 Favored 'General case' 0 C--N 1.346 0.423 0 O-C-N 124.985 1.428 . . . . 0.0 112.177 -175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -63.43 8.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.713 ' H ' ' C ' ' A' ' 61' ' ' ALA . 89.0 mtm180 59.7 72.33 0.53 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.992 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.479 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 1.4 m -149.96 147.56 28.03 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.604 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -124.48 106.56 10.27 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.284 0.365 . . . . 0.0 111.452 -177.551 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.594 ' OG1' ' OH ' ' A' ' 60' ' ' TYR . 15.3 m -94.11 122.09 36.27 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 4.0 p90 177.1 -151.78 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 47.3 t 80.69 159.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.202 0 O-C-N 124.006 0.816 . . . . 0.0 110.344 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.603 HG23 HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER 175.64 119.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.033 179.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HD3' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -148.73 147.83 29.3 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.292 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.48 ' OG1' ' C ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER 173.7 141.6 0.16 Allowed Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.359 177.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.71 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 10.8 Cg_endo -72.62 169.38 22.02 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.588 0.859 . . . . 0.0 111.955 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 72' ' ' PRO . 12.1 Cg_exo -46.61 -157.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.814 2.343 . . . . 0.0 112.359 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.718 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -36.31 -34.01 0.05 Allowed 'General case' 0 C--O 1.255 1.364 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -40.15 -10.35 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.123 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.718 ' N ' ' O ' ' A' ' 74' ' ' ALA . 31.1 m-85 -32.76 -81.55 0.01 OUTLIER 'General case' 0 C--N 1.35 0.628 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.861 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -108.49 -5.35 16.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.771 HD11 ' CG2' ' A' ' 127' ' ' ILE . 6.5 mm -63.08 -42.42 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.347 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -52.2 -36.58 52.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.17 -66.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.842 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.62 -13.98 0.46 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.726 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 78' ' ' ILE . . . -89.83 -77.06 0.4 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.637 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.75 37.86 0.49 Allowed Glycine 0 N--CA 1.466 0.648 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.2 mt -90.68 104.88 17.42 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 C--N 1.33 -0.241 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.742 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.2 mttt . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -158.86 151.25 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.167 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.88 84.3 0.59 Allowed Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -141.82 103.15 4.3 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.086 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.606 HD12 ' CG1' ' A' ' 104' ' ' VAL . 3.5 pt -106.56 159.91 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.36 152.01 19.4 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.257 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.488 ' O ' HG22 ' A' ' 104' ' ' VAL . 70.4 t-105 -60.32 -51.26 70.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.778 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.85 -41.93 92.5 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 120.62 -1.3 . . . . 0.0 111.751 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.22 -44.51 95.11 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.105 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.606 ' CG1' HD12 ' A' ' 99' ' ' ILE . 17.5 m -62.92 -33.71 62.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 118.257 -1.377 . . . . 0.0 109.411 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 108' ' ' ALA . 96.2 mt -61.47 -72.21 0.13 Allowed 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.19 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.46 ' CG ' ' NE2' ' A' ' 110' ' ' GLN . 82.9 tt0 -43.77 -56.23 3.96 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.488 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.482 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 95.1 mt -50.61 -25.68 3.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.879 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -88.89 -44.6 10.34 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.604 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.434 ' HG3' HD11 ' A' ' 120' ' ' LEU . 47.7 mtpt -43.9 -68.32 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.373 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 112' ' ' MET . 0.2 OUTLIER -57.32 -66.37 0.47 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.328 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -47.16 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.973 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.561 ' N ' ' O ' ' A' ' 110' ' ' GLN . 37.6 mtt -157.51 51.34 0.48 Allowed Pre-proline 0 C--O 1.234 0.248 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.664 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 112' ' ' MET . 10.7 Cg_endo -66.05 -33.37 41.53 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 120.748 0.965 . . . . 0.0 111.867 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 115' ' ' LEU . 63.9 m-20 -160.75 -77.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.942 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.558 HD22 ' H ' ' A' ' 115' ' ' LEU . 3.9 mm? 44.0 -169.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.296 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -121.98 35.56 4.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.762 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.3 p -135.83 168.41 19.35 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.395 0.617 . . . . 0.0 111.902 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -138.67 -85.52 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.511 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.505 ' H ' HG23 ' A' ' 118' ' ' THR . 97.7 m-20 -55.42 164.22 1.04 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 124' ' ' ALA . 4.4 mm? -61.66 -40.62 95.57 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-O 121.469 0.652 . . . . 0.0 110.42 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -50.31 -46.08 55.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.129 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.73 -66.27 0.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.174 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 126' ' ' MET . . . -49.05 -48.02 44.31 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.928 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -47.06 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 129' ' ' GLY . 42.2 ttm180 -42.15 -37.63 1.49 Allowed 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.418 ' SD ' ' C ' ' A' ' 126' ' ' MET . 3.2 tmm? -54.9 -73.48 0.05 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.484 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.771 ' CG2' HD11 ' A' ' 78' ' ' ILE . 34.1 mt -51.77 -51.71 26.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.847 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -62.81 -70.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.16 -42.39 3.12 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 133' ' ' SER . 23.9 m -57.49 -46.16 84.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.637 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -51.28 -50.29 59.57 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.579 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -49.97 -36.03 26.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.4 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.58 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.2 t -63.23 -71.15 0.17 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.644 ' SD ' ' HB3' ' A' ' 74' ' ' ALA . 81.3 mtp -47.65 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.82 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 80.43 55.68 3.38 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.637 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 39.8 t -138.15 161.72 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.47 ' N ' HG12 ' A' ' 136' ' ' VAL . 76.3 mt-10 -133.01 159.35 40.28 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.921 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.441 HG12 ' H ' ' A' ' 140' ' ' GLY . 11.2 t -99.49 156.99 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 p -84.48 -3.33 7.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.651 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.441 ' H ' HG12 ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.519 0.286 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.91 -167.64 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.831 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 5' ' ' VAL . 98.9 mttt -62.54 -161.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 4' ' ' VAL . 12.4 p -42.22 121.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 3' ' ' LYS . 12.7 m -113.92 -24.76 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.09 129.68 24.29 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.978 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.715 ' O ' HG13 ' A' ' 7' ' ' VAL . 9.0 p -120.8 109.78 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.577 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG12 ' CD2' ' A' ' 10' ' ' LEU . 2.4 t -88.45 89.82 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.015 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -84.6 117.31 23.66 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 124.073 0.858 . . . . 0.0 109.704 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -179.92 -178.66 0.44 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.649 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -91.8 160.43 15.32 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.556 HD23 ' HD2' ' A' ' 13' ' ' PRO . 2.2 mt -151.53 133.93 8.5 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.556 ' HD2' HD23 ' A' ' 12' ' ' LEU . 45.1 Cg_endo -80.79 119.04 3.54 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.108 1.074 . . . . 0.0 114.213 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.926 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -51.97 137.9 25.9 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 53.56 -154.03 7.65 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 -176.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 15' ' ' GLY . 40.7 tttp 40.73 22.55 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.369 1.085 . . . . 0.0 111.008 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -96.84 159.58 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.13 167.31 8.73 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.144 -178.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.37 40.26 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.464 1.443 . . . . 0.0 112.159 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.561 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -146.14 53.31 1.76 Allowed Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.708 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 34.8 Cg_endo -80.17 165.6 21.29 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 120.901 1.067 . . . . 0.0 112.043 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -61.41 -24.88 79.21 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 120.827 1.018 . . . . 0.0 111.099 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.533 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.7 t -83.72 -66.66 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.676 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.02 -98.75 0.01 OUTLIER Glycine 0 N--CA 1.468 0.799 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 27' ' ' LEU . 2.7 Cg_endo -53.1 -57.17 2.16 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 CA-C-N 120.698 2.249 . . . . 0.0 110.334 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -43.29 -16.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 -178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 25' ' ' PRO . 1.3 tp -112.2 -38.02 4.86 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.09 -49.71 75.57 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.682 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -41.19 -29.49 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.022 0.911 . . . . 0.0 110.662 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.448 ' CD2' HG21 ' A' ' 59' ' ' ILE . 24.6 m80 -44.76 -37.43 3.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.551 0.691 . . . . 0.0 109.379 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 99.56 -23.23 37.02 Favored Glycine 0 C--O 1.225 -0.41 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.574 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -47.1 -135.94 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.223 0.609 . . . . 0.0 112.492 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -137.46 106.89 6.11 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.72 -0.613 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 37' ' ' PHE . 4.6 mm -52.52 -70.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 34' ' ' ILE . 10.0 tpt -39.56 -40.45 0.87 Allowed 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.2 -0.312 . . . . 0.0 110.498 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.28 -46.92 88.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' ILE . 57.5 t80 -50.7 -65.06 0.62 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 122.371 1.082 . . . . 0.0 109.504 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 42' ' ' ASN . 97.4 t -57.42 -44.29 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.169 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -46.27 -64.8 0.66 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.9 -38.94 70.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.249 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.856 ' CZ ' HG21 ' A' ' 45' ' ' THR . 68.1 t80 -64.2 -76.38 0.07 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 38' ' ' VAL . 20.4 t-20 -41.06 -45.49 2.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.586 0.708 . . . . 0.0 112.035 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.5 -35.99 73.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.305 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.21 -43.02 13.33 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.702 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.856 HG21 ' CZ ' ' A' ' 41' ' ' PHE . 47.1 p -67.47 -21.23 65.54 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -82.45 -37.51 25.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -65.51 -21.57 66.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.446 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.4 ptm -107.5 -29.27 9.31 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 117.62 171.04 15.35 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 51.1 p-10 -75.63 142.28 42.65 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.926 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -174.34 -150.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.903 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.701 HD13 ' N ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -139.87 135.81 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.701 ' N ' HD13 ' A' ' 52' ' ' ILE . 18.1 t -144.27 133.28 11.26 Favored Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.905 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.24 131.96 12.19 Favored 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 120.766 0.978 . . . . 0.0 109.646 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 1.5 p -140.53 156.98 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.862 0.839 . . . . 0.0 111.928 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 21.5 mt-10 -131.34 82.37 2.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.331 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 57' ' ' ILE . 21.9 mt -53.04 95.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.282 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.41 101.94 5.76 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.448 HG21 ' CD2' ' A' ' 30' ' ' HIS . 45.4 mt -104.38 123.67 58.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.45 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -99.98 144.3 29.18 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.666 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -54.65 -22.29 13.18 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.042 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -66.03 6.42 0.39 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.666 ' H ' ' C ' ' A' ' 61' ' ' ALA . 84.0 mtm180 64.44 71.02 0.48 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.921 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 t -147.92 126.24 12.3 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.526 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -103.58 102.31 12.19 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -90.49 123.91 34.56 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER 173.47 118.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.565 -177.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -151.2 131.92 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.694 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.5 p -135.23 150.89 50.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.473 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 71' ' ' THR . 46.5 pttt -174.27 -158.3 0.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.504 ' O ' ' O ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER 80.34 60.0 0.14 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.912 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 71' ' ' THR . 19.7 Cg_exo -43.53 177.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.747 1.631 . . . . 0.0 112.916 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -54.67 -55.37 3.35 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.398 1.399 . . . . 0.0 114.924 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.811 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . -146.54 -66.63 0.28 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.0 p -36.64 -20.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.891 0.377 . . . . 0.0 110.43 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.646 ' N ' ' O ' ' A' ' 74' ' ' ALA . 1.8 t80 -40.29 -67.11 0.25 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.276 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.915 HD23 ' O ' ' A' ' 77' ' ' LEU . 6.9 tt -110.15 -19.94 12.85 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.811 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.2 mt -55.67 -42.21 68.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.031 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -44.54 -39.27 4.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.592 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -81.89 -60.42 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.49 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.73 13.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.43 . . . . 0.0 110.766 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -85.43 -78.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.39 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.34 41.43 0.23 Allowed Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 mt -94.59 112.86 24.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -91.18 -85.21 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.499 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -63.38 -43.72 96.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.861 0.362 . . . . 0.0 110.282 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 131.59 -155.41 21.37 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.5 158.7 20.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -158.05 -173.13 4.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.103 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -49.66 154.35 1.73 Allowed Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.97 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.84 144.51 35.12 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.656 0.904 . . . . 0.0 111.786 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -151.79 164.27 30.29 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -96.13 5.73 50.41 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.595 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 94' ' ' GLU . 1.5 pm0 -65.55 -35.46 80.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.39 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 94' ' ' GLU . 58.2 mttp 56.49 114.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.454 HG22 ' N ' ' A' ' 97' ' ' GLY . 11.6 p -138.84 159.01 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.733 0.302 . . . . 0.0 110.25 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.454 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 104.54 84.38 1.76 Allowed Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.507 ' HE ' HG23 ' A' ' 139' ' ' VAL . 43.5 ttt180 -135.77 104.77 5.87 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.142 0.496 . . . . 0.0 111.219 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.512 HD12 ' CG1' ' A' ' 104' ' ' VAL . 3.1 pt -109.41 148.51 13.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.521 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.8 OUTLIER -89.1 160.28 17.11 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.164 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.79 ' NE1' HD11 ' A' ' 105' ' ' LEU . 76.0 t-105 -60.4 -54.17 48.85 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.605 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -59.97 -43.5 95.04 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.913 -1.117 . . . . 0.0 111.388 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -59.1 -45.53 90.64 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.978 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.512 ' CG1' HD12 ' A' ' 99' ' ' ILE . 29.8 m -64.88 -31.66 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 118.249 -1.381 . . . . 0.0 109.672 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.79 HD11 ' NE1' ' A' ' 101' ' ' TRP . 76.1 mt -61.74 -67.32 0.42 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.662 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -44.38 -41.59 6.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.198 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.52 HD11 HD22 ' A' ' 77' ' ' LEU . 97.3 mt -67.13 -29.12 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.104 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -91.77 -3.3 56.34 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.749 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 111' ' ' LYS . 44.1 mtpt -85.74 -72.73 0.48 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.866 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.58 -0.89 0.3 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.027 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.591 ' NZ ' ' HB2' ' A' ' 123' ' ' ALA . 1.4 pptp? -68.9 -16.72 63.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.616 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.481 ' SD ' ' NZ ' ' A' ' 111' ' ' LYS . 5.9 ptt? -123.91 70.15 48.85 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.444 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 15.2 Cg_exo -53.84 -40.52 80.07 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 120.653 0.902 . . . . 0.0 112.082 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 113' ' ' PRO . 80.6 m-20 -149.78 14.93 0.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.58 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 115' ' ' LEU . 9.6 mp -71.32 160.53 32.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.2 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -70.56 64.72 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.096 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.0 m -162.04 140.04 8.87 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.374 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.74 -2.76 0.35 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.99 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.87 124.41 34.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.298 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 36.0 mt -62.09 -42.95 99.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.576 0.703 . . . . 0.0 110.266 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.4 -36.63 71.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.983 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.61 -69.4 0.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.591 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.591 ' HB2' ' NZ ' ' A' ' 111' ' ' LYS . . . -47.13 -33.09 4.76 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.133 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -61.13 -66.58 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.1 mtt180 -46.35 -33.78 4.08 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.793 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.465 ' O ' ' CB ' ' A' ' 130' ' ' SER . 34.4 ttp -59.57 -73.83 0.08 Allowed 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 mm -50.56 -48.31 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.739 0.304 . . . . 0.0 110.826 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -68.15 -70.82 0.24 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.05 -45.8 6.17 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 126' ' ' MET . 67.5 m -56.41 -42.45 78.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.693 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -55.85 -46.65 78.13 Favored 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.538 HH11 ' HG2' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -54.67 -44.11 73.02 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 t -51.96 -69.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 74.4 mtp -41.96 -66.39 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.674 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.22 55.05 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.693 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 49.2 t -134.6 161.14 40.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.478 ' N ' HG12 ' A' ' 136' ' ' VAL . 96.2 mt-10 -124.3 152.9 42.5 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.534 HG12 ' H ' ' A' ' 140' ' ' GLY . 8.1 t -104.07 133.37 48.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 100' ' ' THR . 1.6 p -70.37 -3.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.799 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.534 ' H ' HG12 ' A' ' 138' ' ' VAL . . . -131.58 112.31 1.18 Allowed Glycine 0 N--CA 1.463 0.452 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -179.59 68.37 0.17 Allowed Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -55.57 133.44 58.08 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.029 1.153 . . . . 0.0 111.804 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 174.74 23.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.899 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.55 133.6 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.774 0.321 . . . . 0.0 110.619 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -74.35 142.88 45.08 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -85.16 -2.04 57.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.683 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.9 -179.76 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.443 ' SD ' ' HB1' ' A' ' 61' ' ' ALA . 19.1 mmt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -153.06 130.52 11.4 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 tttt 71.75 -164.65 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 4' ' ' VAL . 12.9 p -64.76 119.92 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.03 -24.49 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 119.211 -0.423 . . . . 0.0 109.88 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.55 134.83 27.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.588 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 7' ' ' VAL . 13.4 p -124.98 125.51 69.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.207 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.61 93.47 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 119.644 1.111 . . . . 0.0 111.556 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -84.05 118.12 23.86 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.836 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.444 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -171.41 -173.79 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.648 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -90.18 149.29 22.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.833 HD22 ' CE2' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -140.59 93.39 8.69 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 123.154 0.284 . . . . 0.0 110.315 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -67.47 123.18 10.51 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.141 1.227 . . . . 0.0 114.224 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.887 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -54.49 136.73 44.17 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 54.89 -155.78 8.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 15' ' ' GLY . 97.3 mttt 41.47 20.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.118 0.959 . . . . 0.0 111.165 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -97.04 158.52 15.39 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.61 167.68 7.89 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.245 -179.145 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.79 42.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.136 1.224 . . . . 0.0 112.024 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.539 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -150.53 55.58 1.82 Allowed Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.599 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 32.5 Cg_endo -79.47 164.8 23.57 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 120.819 1.013 . . . . 0.0 112.105 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -63.18 -24.37 72.75 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.768 0.979 . . . . 0.0 111.359 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.714 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.5 t -77.01 -64.67 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 44.04 -99.01 0.01 OUTLIER Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 28' ' ' GLY . 14.4 Cg_exo -48.95 -59.63 1.17 Allowed 'Trans proline' 0 C--N 1.32 -0.971 0 CA-C-N 119.991 1.896 . . . . 0.0 110.561 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.714 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -44.36 -24.01 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.381 -0.527 . . . . 0.0 109.886 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 39.4 tp -119.91 31.96 6.28 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.907 0.86 . . . . 0.0 109.495 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' PRO . . . -126.24 -64.34 0.16 Allowed Glycine 0 C--N 1.319 -0.363 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 28' ' ' GLY . 65.6 tp60 -42.29 -25.26 0.07 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.734 0.767 . . . . 0.0 109.699 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.483 ' N ' ' C ' ' A' ' 28' ' ' GLY . 37.6 t-80 -42.63 -39.14 2.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.44 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 97.68 -24.43 31.63 Favored Glycine 0 C--N 1.331 0.28 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -48.94 -135.68 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.093 0.557 . . . . 0.0 112.272 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -136.88 130.31 31.52 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.096 -0.377 . . . . 0.0 110.874 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 37' ' ' PHE . 3.5 mm -82.16 -72.24 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.3 tpt -39.57 -40.51 0.88 Allowed 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.14 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -60.78 -49.81 76.0 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.255 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 34' ' ' ILE . 87.6 t80 -47.02 -60.54 2.38 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.099 0.952 . . . . 0.0 109.795 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 42' ' ' ASN . 59.9 t -59.85 -44.05 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.348 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 84.5 tttt -46.66 -66.12 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.99 76.11 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.627 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.833 ' CE2' HD22 ' A' ' 12' ' ' LEU . 33.3 t80 -62.97 -75.8 0.07 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' VAL . 6.3 t-20 -40.53 -45.33 2.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.389 0.614 . . . . 0.0 111.974 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.596 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . -57.44 -34.84 69.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.037 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.42 -44.79 12.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.371 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 49' ' ' GLY . 45.8 p -65.36 -21.61 66.71 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -77.0 -45.15 28.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 43' ' ' ALA . 4.1 m-80 -62.48 -16.11 53.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.4 mmm -106.8 -70.92 0.77 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.268 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 160.15 -162.22 33.04 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 40.0 p-10 -99.86 122.3 42.59 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.887 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -156.8 -153.14 0.4 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.28 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mm -137.71 127.79 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.708 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.7 t -144.26 124.97 7.69 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.774 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -73.94 147.93 39.68 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 120.745 0.963 . . . . 0.0 110.639 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.675 HG21 HD12 ' A' ' 12' ' ' LEU . 34.0 m -143.19 160.83 17.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.257 0.551 . . . . 0.0 111.246 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 58' ' ' THR . 93.8 mt-10 -129.38 76.74 1.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.5 mt -50.87 86.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.874 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -72.99 95.17 1.96 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.462 HG21 ' NE2' ' A' ' 30' ' ' HIS . 60.8 mt -95.6 125.13 48.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.693 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 63' ' ' ARG . 3.4 m-85 -100.63 140.35 35.03 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.625 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.63 -23.33 2.52 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 124.584 1.178 . . . . 0.0 112.366 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -66.89 5.82 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.625 ' H ' ' C ' ' A' ' 61' ' ' ALA . 59.8 mtp180 63.88 69.69 0.53 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.341 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.9 p -146.47 127.55 14.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.959 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -105.04 103.44 13.0 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.622 -177.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.512 ' O ' ' OG1' ' A' ' 58' ' ' THR . 41.1 p -95.21 122.91 38.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.56 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.5 p90 176.32 -152.74 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 48.9 t 80.35 117.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 124.408 1.067 . . . . 0.0 111.381 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -124.58 127.56 47.56 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -143.8 -170.33 3.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.701 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 m 66.0 52.07 0.83 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.586 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.701 ' HD3' ' N ' ' A' ' 71' ' ' THR . 1.4 Cg_endo -73.73 162.57 39.26 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 120.859 1.039 . . . . 0.0 112.553 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -73.75 91.24 0.91 Allowed 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.552 1.502 . . . . 0.0 113.189 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.818 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . . . 179.69 -171.53 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.511 ' OG ' ' NH1' ' A' ' 79' ' ' ARG . 2.5 m -38.91 -17.32 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.818 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 74.9 m-85 -45.69 -42.24 11.43 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.297 0.373 . . . . 0.0 110.392 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.845 HD22 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -130.74 -13.98 3.64 Favored 'General case' 0 C--O 1.254 1.318 0 CA-C-O 122.304 1.049 . . . . 0.0 108.891 178.284 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.845 ' N ' HD22 ' A' ' 77' ' ' LEU . 17.4 mt -65.34 -41.74 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.987 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.603 HH11 ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -51.76 -41.61 61.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.661 179.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -63.21 -63.18 1.27 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.27 69.6 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.491 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -79.52 -83.84 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.553 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 137.6 -76.87 0.35 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.9 mt 42.34 -160.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -164.37 -87.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.466 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -145.38 106.87 4.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.57 -100.0 0.02 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -163.75 121.4 1.83 Allowed 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.534 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -72.7 -63.4 1.17 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.446 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -142.31 151.27 57.79 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.639 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.11 142.44 54.81 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 120.747 0.964 . . . . 0.0 111.436 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.39 -118.06 2.46 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -139.22 -86.77 0.23 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.642 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -178.98 67.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.875 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -155.71 54.97 0.61 Allowed 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.157 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -144.96 150.61 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 137' ' ' GLU . . . 82.4 75.96 1.12 Allowed Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -131.0 116.94 18.49 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.621 0.248 . . . . 0.0 110.624 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 mt -109.71 150.11 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.0 p -82.0 149.35 28.18 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.912 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.629 ' NE1' HD11 ' A' ' 105' ' ' LEU . 66.8 t-105 -57.7 -52.05 67.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.092 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -58.77 -40.94 85.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.329 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -60.62 -48.47 81.63 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.9 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.87 -32.78 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.658 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.629 HD11 ' NE1' ' A' ' 101' ' ' TRP . 50.5 mt -59.5 -68.37 0.29 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.655 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -44.59 -46.2 9.89 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.284 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.57 -29.24 38.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.946 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.753 ' HB2' HD12 ' A' ' 127' ' ' ILE . . . -101.66 -8.23 21.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.651 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 105' ' ' LEU . 75.0 tttt -77.6 -75.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.007 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -59.58 -20.96 59.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.631 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -97.75 102.02 13.67 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.721 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 115' ' ' LEU . 6.6 mmt -140.05 55.34 6.35 Favored Pre-proline 0 C--O 1.236 0.373 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.129 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 112' ' ' MET . 14.5 Cg_exo -50.57 -54.8 4.85 Favored 'Trans proline' 0 N--CA 1.488 1.206 0 C-N-CA 120.671 0.914 . . . . 0.0 112.067 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -126.92 -29.27 2.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.345 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.537 ' H ' HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -75.14 38.99 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.072 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.458 ' C ' ' H ' ' A' ' 118' ' ' THR . 35.1 p-10 -84.85 46.82 1.3 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.704 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.446 ' OG1' ' HB3' ' A' ' 122' ' ' ALA . 5.5 p -73.33 32.54 0.07 Allowed 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.855 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 116' ' ' ASN . 9.8 t 39.43 29.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.26 0.35 . . . . 0.0 110.73 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 117' ' ' THR . 74.9 m-20 -150.95 125.37 9.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.458 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 83.8 mt -62.95 -34.47 77.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.258 0.552 . . . . 0.0 110.788 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.67 -37.17 62.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.512 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' HB3' ' OG1' ' A' ' 117' ' ' THR . . . -72.39 -69.4 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.056 -1.058 . . . . 0.0 109.35 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.696 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -50.6 -32.72 19.61 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.192 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -60.91 -70.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 129' ' ' GLY . 62.7 ttt180 -42.95 -30.78 0.44 Allowed 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.508 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 4.7 tmm? -58.38 -73.08 0.08 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.753 HD12 ' HB2' ' A' ' 108' ' ' ALA . 88.0 mt -50.69 -51.3 20.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.023 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -63.66 -71.55 0.17 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.73 -45.76 4.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.508 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 67.2 m -58.75 -44.65 90.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.626 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -51.59 -47.83 63.42 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -55.26 -42.28 73.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.4 t -55.26 -72.13 0.07 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.4 mtm -42.17 -34.71 0.79 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.773 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.38 49.11 0.57 Allowed Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.626 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 43.0 t -136.05 164.93 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.541 ' N ' HG12 ' A' ' 136' ' ' VAL . 81.9 tt0 -130.13 158.72 38.9 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.54 ' C ' ' H ' ' A' ' 140' ' ' GLY . 53.9 t -111.56 160.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.5 ' N ' HG12 ' A' ' 138' ' ' VAL . 9.8 p -64.48 8.45 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.091 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . 61.03 157.33 0.06 OUTLIER Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.91 71.1 56.96 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 117.087 0.443 . . . . 0.0 110.818 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -63.91 154.41 70.08 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.33 1.354 . . . . 0.0 111.849 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -54.15 -177.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.51 ' O ' ' O ' ' A' ' 145' ' ' LYS . 2.8 t -137.17 109.3 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 144' ' ' VAL . 97.7 mttt 53.95 117.22 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.139 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 147' ' ' ALA . 31.9 p30 -63.71 -30.26 71.39 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.904 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.524 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.647 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptp . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 67.9 mttm -94.71 41.87 1.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.379 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 7.7 tptm 74.61 175.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.63 138.23 19.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 m -118.82 -25.44 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.188 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.44 143.04 29.82 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.853 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 7' ' ' VAL . 15.0 p -133.84 133.03 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.563 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.42 92.67 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 120.067 1.303 . . . . 0.0 111.757 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -82.81 116.07 21.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -167.85 -173.78 2.22 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.536 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -90.76 143.78 26.38 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.615 HD12 ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -123.68 86.84 52.73 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -65.71 114.91 3.12 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.54 1.493 . . . . 0.0 114.642 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.751 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -74.9 146.54 41.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 174.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.73 58.33 10.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt 173.61 -24.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.91 150.29 45.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -160.39 167.54 13.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.115 -178.167 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -59.32 48.07 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.618 1.546 . . . . 0.0 112.711 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -169.53 53.87 0.23 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.504 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 20' ' ' ALA . 18.2 Cg_endo -68.1 166.1 26.12 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.032 1.155 . . . . 0.0 112.247 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -65.33 -22.18 60.41 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.803 1.002 . . . . 0.0 111.239 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.545 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.7 t -72.49 -64.32 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.554 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 25' ' ' PRO . . . 59.2 -137.48 50.23 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 118.619 -1.753 . . . . 0.0 109.485 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.688 ' C ' ' H ' ' A' ' 27' ' ' LEU . 28.2 Cg_exo -38.23 -41.32 1.35 Allowed 'Trans proline' 0 N--CA 1.486 1.06 0 CA-C-N 120.607 2.204 . . . . 0.0 110.853 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.545 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -57.47 13.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.811 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.688 ' H ' ' C ' ' A' ' 25' ' ' PRO . 3.5 tt -172.27 -48.7 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.579 ' N ' HD23 ' A' ' 27' ' ' LEU . . . -59.01 -48.9 83.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -73.96 35.55 0.09 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.471 0.653 . . . . 0.0 110.272 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.63 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -84.88 -19.93 31.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.258 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 106.2 -43.85 1.59 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -49.35 -131.32 0.0 OUTLIER 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.335 0.654 . . . . 0.0 111.79 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -137.91 143.44 40.83 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.762 -0.586 . . . . 0.0 110.525 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' PHE . 6.7 mt -88.88 -70.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.1 tpt -40.85 -39.6 1.17 Allowed 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -57.11 -49.32 76.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.631 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 64.2 t80 -48.78 -59.89 3.19 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.452 1.12 . . . . 0.0 109.501 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' ASN . 57.4 t -61.59 -42.73 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 113.391 -1.731 . . . . 0.0 111.281 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.0 tppp? -46.25 -57.9 4.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.65 95.08 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 119.921 -0.711 . . . . 0.0 110.127 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 12' ' ' LEU . 2.0 t80 -62.81 -74.78 0.09 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -40.01 -43.32 1.54 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 121.558 0.694 . . . . 0.0 111.779 -177.412 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -59.09 -36.39 75.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.261 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.12 -46.8 10.09 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.113 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.649 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 82.5 p -60.87 -37.77 83.28 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -65.22 -36.74 85.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -63.88 -18.6 64.34 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.756 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -103.79 -42.98 5.45 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.634 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 116.75 74.29 0.53 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.399 -0.667 . . . . 0.0 111.868 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.634 ' O ' ' O ' ' A' ' 49' ' ' GLY . 2.9 p30 44.93 159.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.883 0.373 . . . . 0.0 111.482 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.751 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 170.81 -163.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.293 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.5 mt -141.06 131.23 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.99 125.52 4.94 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.833 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.42 149.78 31.49 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 CA-C-N 119.485 0.852 . . . . 0.0 110.86 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.553 ' CG2' HD23 ' A' ' 12' ' ' LEU . 35.0 m -144.64 161.92 14.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.434 0.635 . . . . 0.0 111.416 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 58' ' ' THR . 95.2 mt-10 -127.33 80.93 1.99 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.407 ' H ' HG13 ' A' ' 57' ' ' ILE . 44.1 mt -54.04 88.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.043 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -66.21 110.53 3.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.402 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.4 mt -107.91 125.0 64.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.363 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -104.12 140.13 38.22 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.627 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.73 -21.78 1.79 Allowed 'General case' 0 C--N 1.341 0.232 0 O-C-N 124.226 0.954 . . . . 0.0 112.218 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -68.33 6.12 0.85 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.627 ' H ' ' C ' ' A' ' 61' ' ' ALA . 87.4 mtm180 64.62 67.8 0.55 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.355 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.7 m -143.21 127.14 17.29 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.854 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -108.39 102.49 11.59 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.606 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.4 p -93.95 126.06 38.93 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.631 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 5.6 p90 -174.96 130.99 0.31 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.918 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 69' ' ' THR . 44.5 t -137.05 156.06 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.404 ' N ' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -177.71 121.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.949 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -177.51 -179.65 0.85 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.317 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.513 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 21.9 p 55.93 61.01 8.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.054 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 71' ' ' THR . 3.7 Cg_endo -75.27 164.1 33.5 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 120.897 1.065 . . . . 0.0 112.418 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.67 ' HA ' HD11 ' A' ' 77' ' ' LEU . 13.8 Cg_endo -72.2 176.51 8.43 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 121.899 1.732 . . . . 0.0 112.178 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.731 ' O ' HD12 ' A' ' 77' ' ' LEU . . . 79.56 -174.54 0.06 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.909 0.322 . . . . 0.0 111.051 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.549 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.7 OUTLIER -39.99 -19.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.088 -178.109 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.552 ' N ' ' O ' ' A' ' 74' ' ' ALA . 10.1 m-85 -45.48 -35.95 4.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.697 0.623 . . . . 0.0 111.057 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.84 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.91 -25.52 1.83 Allowed 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.8 0.81 . . . . 0.0 109.021 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 73.7 mt -55.5 -35.47 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.666 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -53.73 -43.96 69.5 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.223 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -64.55 -65.34 0.69 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.35 -13.45 0.56 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.979 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.67 -76.62 0.39 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.765 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.48 48.84 0.58 Allowed Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.0 mt -98.7 124.05 43.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -100.85 118.8 37.62 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 45.57 32.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.522 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.09 -135.23 40.11 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.85 59.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.937 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -59.3 -41.99 90.29 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.627 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -87.06 147.05 41.82 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.685 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -62.15 142.17 91.0 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 120.599 0.866 . . . . 0.0 111.848 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -111.26 -121.36 4.11 Favored Glycine 0 N--CA 1.465 0.601 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.4 mtt-85 -136.68 -86.83 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.651 0.262 . . . . 0.0 110.639 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -150.07 176.96 10.33 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.3 mttm 54.94 100.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.936 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -145.24 144.13 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.634 0.254 . . . . 0.0 110.35 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 46.95 87.18 0.01 OUTLIER Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -116.39 106.25 13.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.977 0.418 . . . . 0.0 111.23 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.703 HD12 HG11 ' A' ' 104' ' ' VAL . 7.4 pt -100.94 144.91 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -85.45 156.87 20.64 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.439 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.6 ' NE1' HD11 ' A' ' 105' ' ' LEU . 49.3 t-105 -63.73 -51.06 66.64 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.615 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.23 -43.4 98.95 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.152 -0.967 . . . . 0.0 111.533 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -61.33 -46.96 88.08 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.696 -0.801 . . . . 0.0 111.227 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.703 HG11 HD12 ' A' ' 99' ' ' ILE . 35.5 m -65.2 -33.56 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 118.235 -1.386 . . . . 0.0 109.414 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.6 HD11 ' NE1' ' A' ' 101' ' ' TRP . 40.8 mt -59.48 -65.69 0.63 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.392 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -44.86 -51.15 9.87 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.049 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.34 -31.46 46.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.787 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.536 ' HB1' ' HB1' ' A' ' 123' ' ' ALA . . . -91.55 -8.07 48.48 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.675 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 105' ' ' LEU . 45.3 tttm -85.56 -71.57 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 109.919 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.63 -40.72 60.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.395 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -69.89 66.08 0.24 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.384 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.436 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 38.8 mtm -157.65 54.84 0.84 Allowed Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.568 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 112' ' ' MET . 9.8 Cg_endo -65.13 -55.7 0.45 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 120.805 1.003 . . . . 0.0 111.85 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 113' ' ' PRO . 57.5 m-20 -160.01 15.5 0.14 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.398 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.9 mt -46.61 -86.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.319 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -170.8 -18.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.25 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 70.1 p -83.33 167.51 17.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.1 0.476 . . . . 0.0 111.15 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -140.59 -85.83 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.401 -178.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.516 ' H ' HG23 ' A' ' 118' ' ' THR . 90.9 m-20 -58.67 159.55 6.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.447 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 37.5 mt -61.77 -37.27 83.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 0.0 110.161 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -52.9 -37.79 61.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.281 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.17 -69.0 0.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 118.981 -1.087 . . . . 0.0 109.067 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.536 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -49.51 -35.52 20.26 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.227 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -59.09 -69.83 0.18 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.0 mtt180 -43.76 -30.57 0.67 Allowed 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.758 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.459 ' O ' ' CB ' ' A' ' 130' ' ' SER . 2.9 tmm? -59.31 -73.07 0.09 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.0 mm -51.69 -48.98 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.032 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -67.71 -70.44 0.26 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.61 -43.22 4.97 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 126' ' ' MET . 68.8 m -58.64 -42.64 88.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -56.07 -48.99 75.01 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -51.39 -41.38 60.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.546 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.6 t -54.77 -66.77 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 86.5 mtp -50.75 -4.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.812 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 91.21 -27.72 8.96 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 137' ' ' GLU . 55.1 t -47.38 164.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.556 ' N ' HG12 ' A' ' 136' ' ' VAL . 97.7 mt-10 -141.23 161.9 36.77 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.056 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 140' ' ' GLY . 83.0 t -88.09 152.44 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 139' ' ' VAL . 7.8 p -61.3 2.68 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.285 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . 113.9 154.23 11.17 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -141.92 68.02 23.16 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.69 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.067 1.178 . . . . 0.0 112.048 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -173.7 23.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.776 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.8 t -137.45 134.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.216 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -88.24 130.51 35.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -145.75 -55.71 0.29 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.993 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.104 -0.95 . . . . 0.0 110.324 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 ptt? . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 3' ' ' LYS . 50.5 tttt -171.05 177.96 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' H ' ' HG2' ' A' ' 2' ' ' LYS . 98.4 mttt 52.34 -162.41 0.09 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.143 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 4' ' ' VAL . 14.2 p -51.9 112.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.639 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.8 -24.18 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.89 132.4 23.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.102 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.7 ' O ' HG13 ' A' ' 7' ' ' VAL . 8.6 p -122.56 105.29 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.687 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.438 ' CG1' HD21 ' A' ' 10' ' ' LEU . 4.6 t -76.64 91.66 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 118.741 -1.184 . . . . 0.0 109.626 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -89.32 106.43 18.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.511 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.506 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -175.32 -173.77 0.68 Allowed 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.024 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -100.95 163.23 12.39 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.479 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.561 HD12 HG21 ' A' ' 55' ' ' VAL . 2.2 mt -153.51 137.3 10.48 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.48 ' HD2' HD23 ' A' ' 12' ' ' LEU . 57.7 Cg_endo -87.53 125.27 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 CA-C-N 120.366 1.166 . . . . 0.0 114.114 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.802 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -59.33 139.17 57.27 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . 57.79 152.8 0.01 OUTLIER Glycine 0 CA--C 1.536 1.345 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 50.4 tttt 77.34 13.97 1.91 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.797 1.799 . . . . 0.0 111.373 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 18' ' ' THR . . . -91.19 157.97 16.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.99 167.56 4.87 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.653 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.09 39.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.709 1.606 . . . . 0.0 112.61 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.544 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -146.52 54.08 1.99 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.043 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 38.9 Cg_endo -82.49 164.24 16.61 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 120.972 1.114 . . . . 0.0 112.142 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -62.33 -25.7 76.63 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 120.8 1.0 . . . . 0.0 111.024 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.04 -71.57 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.034 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 46.47 -101.24 0.03 OUTLIER Glycine 0 C--O 1.214 -1.151 0 CA-C-O 118.574 -1.125 . . . . 0.0 111.099 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.627 ' C ' ' H ' ' A' ' 27' ' ' LEU . 19.4 Cg_exo -43.57 -56.29 2.46 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 CA-C-N 121.479 2.639 . . . . 0.0 110.728 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.71 23.9 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.599 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.627 ' H ' ' C ' ' A' ' 25' ' ' PRO . 12.7 tp -169.98 -47.37 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -59.35 -51.39 59.44 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.529 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -73.57 41.28 0.11 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.014 0.907 . . . . 0.0 109.9 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -89.35 -21.29 23.18 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 106.86 -38.82 3.13 Favored Glycine 0 N--CA 1.462 0.431 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.555 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -50.87 -134.98 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -137.14 125.93 24.01 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.484 -0.76 . . . . 0.0 110.4 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.571 ' O ' ' N ' ' A' ' 37' ' ' PHE . 10.9 mm -67.92 -70.55 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.409 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -39.53 -36.93 0.43 Allowed 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.505 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -61.89 -47.1 86.51 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.64 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 59.0 t80 -51.05 -65.1 0.61 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.412 1.101 . . . . 0.0 109.201 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 42' ' ' ASN . 96.4 t -57.07 -42.45 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.276 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 88.2 tttt -49.81 -60.94 2.44 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.685 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.72 79.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.355 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.64 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 8.8 m-85 -64.9 -76.44 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' VAL . 8.9 t-20 -39.3 -49.42 1.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.358 0.599 . . . . 0.0 111.973 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -57.32 -34.01 68.31 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.864 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.83 -46.91 9.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.054 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.507 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 76.7 p -62.94 -24.01 67.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -84.89 -35.74 21.97 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -60.45 -25.63 66.14 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.476 ' CG ' ' N ' ' A' ' 49' ' ' GLY . 6.6 ptm -107.14 -55.65 2.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.383 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' A' ' 48' ' ' MET . . . 152.68 170.9 19.6 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.298 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -73.56 141.26 46.68 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 122.475 -0.426 . . . . 0.0 110.028 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.802 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -172.56 -152.26 0.06 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.155 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 13' ' ' PRO . 40.8 mm -139.07 130.5 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.3 t -145.02 134.68 11.52 Favored Pre-proline 0 C--O 1.246 0.893 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.188 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -76.1 148.5 31.25 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 120.589 0.859 . . . . 0.0 110.384 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.561 HG21 HD12 ' A' ' 12' ' ' LEU . 25.6 m -146.06 137.04 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.504 0.669 . . . . 0.0 111.967 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 78.0 mt-10 -117.76 75.07 0.97 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 57' ' ' ILE . 23.4 mt -58.26 93.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.944 -176.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.36 95.29 1.72 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.9 mt -95.12 120.99 45.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -98.15 142.02 30.36 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.626 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.33 -20.18 1.01 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.846 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 93.3 m-20 -73.23 30.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.626 ' H ' ' C ' ' A' ' 61' ' ' ALA . 5.2 ptm180 40.31 69.77 0.29 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 122.305 1.05 . . . . 0.0 110.888 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 99.4 p -144.84 125.61 14.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.052 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -102.85 101.83 11.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.382 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 1.2 p -93.77 178.08 5.79 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CB ' ' O ' ' A' ' 66' ' ' THR . 1.9 t80 82.17 -154.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -177.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.422 HG23 ' C ' ' A' ' 67' ' ' PHE . 6.3 t 82.25 72.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 123.871 0.732 . . . . 0.0 111.791 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.0 t -68.49 154.14 42.43 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.397 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -175.7 178.57 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.652 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.7 p 51.61 82.68 0.24 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.766 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.87 177.08 2.53 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.438 1.425 . . . . 0.0 112.441 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -74.98 4.6 4.58 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.398 1.399 . . . . 0.0 113.825 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -72.18 -152.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.832 0.349 . . . . 0.0 110.758 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -39.38 -15.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.691 0.397 . . . . 0.0 111.431 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.59 ' N ' ' O ' ' A' ' 74' ' ' ALA . 2.5 t80 -40.37 -47.75 2.59 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.976 0.798 . . . . 0.0 110.604 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.772 HD22 ' C ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -133.42 -14.92 2.52 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.787 0.803 . . . . 0.0 108.885 179.229 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.618 HD11 HG23 ' A' ' 127' ' ' ILE . 22.9 mt -60.45 -38.12 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.418 HH11 ' HB2' ' A' ' 84' ' ' LEU . 11.3 mmm180 -50.29 -44.66 54.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.265 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -66.42 -61.07 2.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.66 -21.7 7.42 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.089 -0.645 . . . . 0.0 110.597 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -87.49 -77.91 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.807 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.63 19.41 3.76 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.418 ' HB2' HH11 ' A' ' 79' ' ' ARG . 22.3 mt -69.11 139.05 54.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -94.02 -45.48 7.57 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.701 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -173.17 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.018 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.26 40.79 54.85 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.11 72.25 1.25 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 110.651 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -151.46 162.95 40.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.919 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -55.31 154.2 11.89 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.172 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -53.42 144.67 49.38 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 120.491 0.794 . . . . 0.0 111.787 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -147.05 -75.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.3 110.75 6.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.718 0.294 . . . . 0.0 110.608 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -74.59 76.3 2.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.139 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -164.62 71.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.871 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.539 HG22 ' N ' ' A' ' 97' ' ' GLY . 13.6 p -145.36 163.31 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.23 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 88.76 75.51 1.29 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -136.82 119.29 15.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.129 0.49 . . . . 0.0 111.25 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 104' ' ' VAL . 5.6 pt -108.65 148.3 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.261 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.427 ' O ' HG13 ' A' ' 104' ' ' VAL . 1.2 p -80.73 145.86 31.33 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.454 0.645 . . . . 0.0 110.832 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.436 ' CE2' HD21 ' A' ' 105' ' ' LEU . 62.6 t-105 -53.26 -70.53 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.374 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -43.78 -38.09 3.06 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.216 -0.928 . . . . 0.0 111.482 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -61.44 -48.5 80.87 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.821 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 99' ' ' ILE . 2.0 m -63.78 -27.77 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 117.711 -1.596 . . . . 0.0 109.099 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 109' ' ' LYS . 35.9 mt -62.43 -70.86 0.18 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.654 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -45.87 -48.4 15.95 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.39 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.537 HG21 HD21 ' A' ' 77' ' ' LEU . 61.4 mt -60.88 -30.39 47.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.934 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.521 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -98.9 -2.53 37.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.026 -0.421 . . . . 0.0 110.681 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 105' ' ' LEU . 68.7 tttt -89.08 -75.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.333 . . . . 0.0 111.026 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.29 -36.6 71.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.649 0.261 . . . . 0.0 111.46 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.43 48.68 0.11 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.049 0.452 . . . . 0.0 111.745 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.521 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 1.3 ptt? -171.64 58.04 0.25 Allowed Pre-proline 0 C--N 1.322 -0.628 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.615 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 112' ' ' MET . 14.0 Cg_exo -54.13 -38.59 87.61 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 120.508 0.805 . . . . 0.0 111.808 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -168.07 34.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.994 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.565 ' O ' HD23 ' A' ' 115' ' ' LEU . 2.8 tt -61.36 -52.19 65.65 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.239 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 116' ' ' ASN . 45.0 t-20 -174.38 -6.99 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.332 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.9 p -140.61 175.21 9.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.146 0.498 . . . . 0.0 111.758 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.33 -37.56 0.42 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.432 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -76.55 145.32 39.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.985 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.504 HD21 ' HG3' ' A' ' 109' ' ' LYS . 1.1 mm? -61.24 -45.47 94.39 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 121.505 0.669 . . . . 0.0 110.254 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.48 -36.75 69.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.451 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.45 -69.08 0.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.772 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.14 -40.21 45.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.173 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -54.39 -68.99 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.2 mtt180 -44.09 -28.8 0.53 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.081 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.46 ' O ' ' CB ' ' A' ' 130' ' ' SER . 5.6 tmm? -59.83 -71.06 0.14 Allowed 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.618 HG23 HD11 ' A' ' 78' ' ' ILE . 9.5 mt -51.41 -50.48 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.728 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -64.63 -71.74 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.25 -45.27 5.16 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 126' ' ' MET . 62.5 m -60.26 -41.07 92.48 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -54.86 -47.19 74.52 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -54.5 -41.77 70.01 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 135' ' ' GLY . 1.9 t -57.01 -71.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 80.1 mtp -43.73 -13.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.329 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 90.66 46.14 4.07 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.588 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 53.2 t -137.58 142.66 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.43 167.8 10.41 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 140' ' ' GLY . 12.0 t -89.9 144.52 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.03 0.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.291 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . 99.15 156.82 29.03 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -133.8 72.45 73.16 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 117.033 0.417 . . . . 0.0 110.798 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.97 149.16 91.36 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.444 1.429 . . . . 0.0 112.099 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 143' ' ' GLU . 0.7 OUTLIER -168.57 37.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.82 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.7 t -136.95 159.1 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.416 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.73 98.92 3.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.3 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 146' ' ' ASP . 44.9 p-10 -172.18 134.32 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.559 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.255 179.671 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtm . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt 51.98 -166.51 0.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.304 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' HG13 ' A' ' 5' ' ' VAL . 99.2 mttt -104.32 -159.12 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 60' ' ' TYR . 7.0 p -40.55 124.72 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 3' ' ' LYS . 31.1 m -113.88 -24.07 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.64 135.86 32.12 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.869 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 7' ' ' VAL . 12.6 p -124.65 123.62 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.195 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.63 92.05 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.638 1.108 . . . . 0.0 111.004 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -75.16 112.93 11.94 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -170.45 -173.85 1.53 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.383 0.611 . . . . 0.0 110.583 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -99.49 157.61 16.32 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.555 HD12 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -133.8 89.05 31.19 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -58.09 135.09 66.31 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.446 1.431 . . . . 0.0 114.442 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.892 ' HB3' ' H ' ' A' ' 51' ' ' ALA . . . -91.83 144.43 25.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.59 40.84 33.03 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -170.26 8.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.237 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 18' ' ' THR . . . -91.21 150.12 21.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -158.05 164.89 19.91 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.021 -178.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -61.69 47.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.658 1.572 . . . . 0.0 112.456 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -169.85 54.17 0.23 Allowed Pre-proline 0 C--N 1.322 -0.627 0 O-C-N 122.153 -0.342 . . . . 0.0 110.696 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 22.2 Cg_endo -73.57 172.27 16.08 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 121.066 1.177 . . . . 0.0 112.24 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -57.51 -21.46 46.01 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 120.525 0.817 . . . . 0.0 111.056 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.579 ' CG1' ' HB3' ' A' ' 26' ' ' ALA . 2.2 t -82.93 -64.11 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.794 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 45.7 -100.48 0.02 OUTLIER Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.71 -1.05 . . . . 0.0 110.72 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.5 Cg_exo -50.64 -57.92 1.99 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 CA-C-N 120.678 2.239 . . . . 0.0 111.054 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.579 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.49 -17.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.596 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -113.96 -39.6 3.92 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.18 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.64 51.0 3.26 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -142.33 -13.25 0.8 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.367 0.603 . . . . 0.0 109.794 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.573 ' CE1' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.66 -15.48 62.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.938 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.604 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 100.88 -32.99 6.8 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.604 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -46.43 -133.8 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.393 0.677 . . . . 0.0 112.357 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -136.2 144.97 45.2 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.904 -0.498 . . . . 0.0 110.483 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 37' ' ' PHE . 4.5 mm -94.03 -73.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.52 ' C ' ' SD ' ' A' ' 35' ' ' MET . 3.7 ppp? -41.14 -35.82 0.64 Allowed 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.23 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -59.72 -52.64 64.64 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 90.1 t80 -47.84 -58.94 3.73 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.469 1.128 . . . . 0.0 109.241 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 42' ' ' ASN . 75.3 t -60.76 -44.65 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.156 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 35' ' ' MET . 88.3 tttt -45.21 -64.68 0.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.04 74.13 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.433 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.455 ' CE2' HG21 ' A' ' 45' ' ' THR . 48.9 t80 -62.15 -76.36 0.06 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -40.28 -43.4 1.71 Allowed 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 121.311 0.577 . . . . 0.0 111.822 -177.448 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.05 -34.17 69.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.93 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.19 -47.11 10.43 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.829 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.455 HG21 ' CE2' ' A' ' 41' ' ' PHE . 71.8 p -62.57 -32.33 73.29 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -69.17 -41.02 77.77 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -63.66 -18.49 64.02 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 70.8 mtm -107.22 -86.67 0.49 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.788 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -174.7 -165.72 31.54 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.359 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 34.1 p-10 -93.5 130.18 39.44 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.892 ' H ' ' HB3' ' A' ' 14' ' ' ALA . . . -162.41 -152.45 0.23 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.296 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.4 mt -141.99 132.1 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 69' ' ' THR . 99.1 t -124.7 108.07 28.77 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -74.02 112.09 3.46 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 120.793 0.995 . . . . 0.0 109.698 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 56' ' ' GLU . 6.5 p -144.35 164.61 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 121.488 0.661 . . . . 0.0 112.2 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.621 ' N ' HG22 ' A' ' 55' ' ' VAL . 12.7 mt-10 -123.19 115.93 22.58 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.408 HD13 ' CZ ' ' A' ' 37' ' ' PHE . 54.2 mt -74.92 94.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.917 0.389 . . . . 0.0 111.757 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -69.42 102.21 1.73 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 mt -100.73 123.62 53.81 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-O 120.844 0.354 . . . . 0.0 111.163 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 18.2 m-85 -99.3 143.17 29.86 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.505 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.64 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -53.74 -24.44 14.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 124.717 1.261 . . . . 0.0 112.375 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 41.0 t0 -67.72 7.57 0.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.64 ' H ' ' C ' ' A' ' 61' ' ' ALA . 98.5 mtt180 62.5 70.37 0.57 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.252 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 p -145.3 134.08 22.33 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.947 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -111.55 103.81 12.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.651 -178.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.7 p -96.8 123.22 40.44 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 5.9 p90 177.98 -150.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -175.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 53.2 t 80.56 104.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 124.344 1.028 . . . . 0.0 111.766 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' HG13 ' A' ' 53' ' ' VAL . 1.1 p -122.59 112.72 18.33 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.497 ' C ' HG22 ' A' ' 71' ' ' THR . 12.4 mmtt -143.8 -150.29 0.31 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.669 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 4.8 t 47.0 53.47 13.83 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 123.699 0.624 . . . . 0.0 110.442 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.669 ' HD3' ' N ' ' A' ' 71' ' ' THR . 6.5 Cg_endo -79.36 175.79 10.37 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 120.727 0.952 . . . . 0.0 112.399 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.725 ' HA ' HD11 ' A' ' 77' ' ' LEU . 1.7 Cg_endo -64.7 -172.22 0.19 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.608 1.538 . . . . 0.0 111.246 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 73' ' ' PRO . . . 78.99 -176.72 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.578 0.228 . . . . 0.0 110.729 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 1.6 p -40.92 -20.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.474 -0.141 . . . . 0.0 110.652 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 74' ' ' ALA . 11.9 m-85 -43.28 -44.26 5.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.366 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.956 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.58 -25.4 3.43 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 122.068 0.937 . . . . 0.0 109.018 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 82' ' ' ALA . 26.9 mt -54.05 -33.38 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.438 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 83' ' ' GLY . 19.6 mmm-85 -51.54 -48.34 63.07 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.091 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -64.74 -61.84 1.94 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.57 -21.8 4.26 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.639 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -91.68 -77.05 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.639 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 113.93 54.84 0.42 Allowed Glycine 0 N--CA 1.469 0.85 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 85' ' ' GLU . 10.0 mt -94.58 15.06 18.98 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.853 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' LEU . 64.9 tt0 -44.26 164.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.458 ' CG ' ' N ' ' A' ' 87' ' ' GLY . 18.9 ptmt -48.49 -42.76 33.79 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.505 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.458 ' N ' ' CG ' ' A' ' 86' ' ' LYS . . . 144.03 170.03 13.27 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 90' ' ' LYS . . . -108.03 109.74 21.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 66.33 -67.36 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -148.91 152.32 36.66 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.81 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -52.39 140.08 53.98 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 120.76 0.974 . . . . 0.0 111.647 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.48 -77.45 1.35 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -140.19 151.18 45.01 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 95' ' ' LYS . 96.0 mt-10 -60.32 -165.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 94' ' ' GLU . 61.9 mttm 52.95 105.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.013 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 97' ' ' GLY . 6.3 p -136.44 157.86 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.484 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 118.35 80.78 0.73 Allowed Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -126.48 94.4 4.05 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.948 0.404 . . . . 0.0 111.962 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.545 HD12 HG11 ' A' ' 104' ' ' VAL . 12.1 pt -100.93 149.78 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.452 ' OG1' ' OE1' ' A' ' 103' ' ' GLN . 0.2 OUTLIER -90.78 156.53 17.98 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.478 0.656 . . . . 0.0 110.333 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.598 ' O ' HG22 ' A' ' 104' ' ' VAL . 61.3 t-105 -61.56 -71.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.325 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -46.46 -39.14 10.16 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 120.761 -1.212 . . . . 0.0 111.905 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.452 ' OE1' ' OG1' ' A' ' 100' ' ' THR . 32.3 mt-30 -60.8 -47.19 87.45 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.308 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 101' ' ' TRP . 15.9 m -63.62 -29.0 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.371 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 108' ' ' ALA . 59.7 mt -63.23 -72.61 0.13 Allowed 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.998 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -44.88 -45.04 10.07 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.2 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.63 -25.22 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.127 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -106.27 -1.02 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.704 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 105' ' ' LEU . 43.8 tttp -85.18 -74.68 0.39 Allowed 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.253 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -62.42 -43.61 98.4 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.548 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -76.45 76.15 3.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.799 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.449 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -135.98 54.85 10.67 Favored Pre-proline 0 N--CA 1.468 0.432 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.009 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 112' ' ' MET . 4.3 Cg_endo -59.84 -30.97 93.16 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 120.701 0.934 . . . . 0.0 111.662 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.578 ' C ' ' H ' ' A' ' 116' ' ' ASN . 36.8 t70 -154.05 -86.08 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.992 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.1 mt 51.69 0.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.634 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.578 ' H ' ' C ' ' A' ' 114' ' ' ASP . 4.0 t30 54.38 26.95 7.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.47 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.3 p -143.79 161.62 38.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.293 0.568 . . . . 0.0 111.728 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.3 -32.48 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.09 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -75.02 146.04 41.93 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.74 -45.71 93.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.355 0.598 . . . . 0.0 110.406 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 121' ' ' GLU . 5.0 pt-20 -59.19 -38.85 80.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.702 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.95 -68.98 0.34 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.016 -1.073 . . . . 0.0 108.805 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.18 -37.49 22.67 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.075 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.85 -66.25 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.1 mtt180 -46.16 -36.0 5.56 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.489 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 5.7 tmm? -55.57 -73.47 0.06 Allowed 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.544 HG23 HD11 ' A' ' 78' ' ' ILE . 6.1 mm -51.15 -50.33 26.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.962 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -62.67 -72.55 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.15 -47.41 5.41 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.489 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 66.4 m -56.79 -43.0 80.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.619 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -52.52 -46.85 66.89 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -55.55 -34.25 64.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.125 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 130' ' ' SER . 3.1 t -65.37 -76.45 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 6.7 ptm -40.2 -25.73 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.636 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 104.38 60.52 0.67 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.619 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 27.4 t -145.29 162.99 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.471 ' N ' HG12 ' A' ' 136' ' ' VAL . 98.1 mt-10 -128.94 156.22 44.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.49 ' CG2' ' HB1' ' A' ' 128' ' ' ALA . 2.1 t -87.73 152.11 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 139' ' ' VAL . 46.1 t -96.74 -11.8 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.718 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -131.54 69.22 0.54 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.12 69.56 18.15 Favored Pre-proline 0 CA--C 1.532 0.256 0 O-C-N 122.793 -0.24 . . . . 0.0 110.502 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.8 148.16 93.69 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.344 1.363 . . . . 0.0 111.976 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.54 151.26 47.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 145' ' ' LYS . 12.7 m -90.56 31.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.734 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 144' ' ' VAL . 98.3 mttt 48.35 -174.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -152.57 -85.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.587 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.194 179.787 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptp . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 14.3 mptt -97.39 -179.89 4.65 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.57 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 48.4 tttt 71.97 173.72 0.3 Allowed 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.884 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.67 158.71 30.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.621 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 61' ' ' ALA . 29.2 m -117.98 -26.16 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.13 116.55 4.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 119.044 -1.062 . . . . 0.0 111.103 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.71 ' O ' HG13 ' A' ' 7' ' ' VAL . 9.4 p -110.12 112.24 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.335 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.89 90.41 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 118.563 -1.255 . . . . 0.0 110.693 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -76.26 120.17 21.16 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.456 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -173.68 -174.65 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.38 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -95.87 159.38 15.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.91 HD13 ' CZ ' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -136.61 92.89 14.6 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HA ' HD13 ' A' ' 52' ' ' ILE . 22.6 Cg_exo -59.36 146.5 94.63 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.26 1.307 . . . . 0.0 114.414 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.794 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -101.32 143.2 31.66 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.44 44.59 36.43 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' H ' ' H ' ' A' ' 17' ' ' ALA . 24.0 mttt -167.46 -6.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.238 -0.481 . . . . 0.0 109.811 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' H ' ' H ' ' A' ' 16' ' ' LYS . . . -80.09 149.62 30.57 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -158.97 168.03 13.23 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.115 -178.13 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -60.14 41.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.475 1.45 . . . . 0.0 112.427 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -172.34 58.79 0.25 Allowed Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.919 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 20.5 Cg_endo -78.75 172.21 15.44 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.218 1.279 . . . . 0.0 112.136 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -55.88 -23.82 44.4 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 120.552 0.834 . . . . 0.0 111.013 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.678 HG12 ' HB3' ' A' ' 26' ' ' ALA . 2.2 t -83.04 -64.55 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 43.43 -96.86 0.01 OUTLIER Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -47.13 -60.06 1.02 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 CA-C-N 119.927 1.863 . . . . 0.0 110.669 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.678 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -47.33 -23.84 0.65 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.847 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.681 HD23 ' HE2' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -116.96 26.88 9.49 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.48 41.32 0.63 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -141.69 -11.17 0.9 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.438 0.637 . . . . 0.0 109.619 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.681 ' HE2' HD23 ' A' ' 27' ' ' LEU . 1.4 p80 -67.18 -15.34 63.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.466 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 102.22 -26.33 24.63 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -51.37 -132.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.142 0.577 . . . . 0.0 112.089 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -133.45 -169.28 2.25 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 37' ' ' PHE . 3.4 mm -131.65 -76.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.562 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -40.2 -42.28 1.46 Allowed 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.875 179.048 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -52.81 -51.47 60.7 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.101 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 34' ' ' ILE . 2.0 t80 -50.37 -66.09 0.45 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.599 1.19 . . . . 0.0 109.845 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 42' ' ' ASN . 54.0 t -57.51 -48.61 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 112.889 -1.959 . . . . 0.0 110.939 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 35' ' ' MET . 79.1 mttt -44.14 -58.49 2.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.43 -44.33 84.57 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.048 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.91 ' CZ ' HD13 ' A' ' 12' ' ' LEU . 1.8 t80 -61.13 -73.96 0.09 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -39.85 -41.29 1.12 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.688 0.756 . . . . 0.0 111.681 -177.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -61.9 -35.0 77.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.083 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -86.4 -43.49 12.78 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.749 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 49' ' ' GLY . 70.4 p -63.61 -34.93 78.92 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -67.96 -42.07 81.45 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -62.95 -20.14 64.95 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.0 ttp -106.08 -85.28 0.5 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.954 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 170.78 170.3 34.84 Favored Glycine 0 N--CA 1.465 0.617 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.108 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 47.7 p-10 -65.39 137.05 57.24 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.794 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -176.09 -154.0 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.857 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 13' ' ' PRO . 33.7 mm -141.68 130.99 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.88 127.93 16.47 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.626 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -71.05 148.62 57.14 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.804 1.003 . . . . 0.0 110.751 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 12' ' ' LEU . 7.2 p -153.68 160.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.485 0.659 . . . . 0.0 111.434 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 55' ' ' VAL . 65.3 mt-10 -139.47 103.17 4.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.423 HD13 HD11 ' A' ' 27' ' ' LEU . 21.1 mt -68.17 87.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.582 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 m -70.99 103.16 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 mt -103.74 126.0 58.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.173 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 3' ' ' LYS . 4.4 m-85 -104.07 141.09 36.82 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.892 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -51.09 -22.11 2.26 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 124.18 0.925 . . . . 0.0 112.079 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -67.51 9.12 0.27 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.651 ' H ' ' C ' ' A' ' 61' ' ' ALA . 99.5 mtt180 60.96 68.97 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.923 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -146.22 132.36 19.37 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.135 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.601 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -109.56 102.39 11.25 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.161 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 8.4 m -95.56 119.66 34.44 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.576 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER 172.19 115.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 O-C-N 124.4 1.062 . . . . 0.0 111.092 -176.662 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.8 t -154.43 136.6 6.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 p -141.47 147.05 37.25 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -141.76 171.06 14.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.251 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -40.17 98.08 0.16 Allowed Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.793 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.493 ' O ' ' O ' ' A' ' 71' ' ' THR . 16.2 Cg_exo -43.26 177.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 121.256 1.304 . . . . 0.0 113.119 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 17.2 Cg_exo -51.14 113.54 1.15 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.427 1.418 . . . . 0.0 112.759 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 172.38 -152.0 0.01 OUTLIER 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.721 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 80.2 p -36.94 -22.96 0.01 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.985 0.421 . . . . 0.0 110.44 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.604 ' N ' ' O ' ' A' ' 74' ' ' ALA . 11.6 t80 -47.37 -36.75 10.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.68 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.9 -34.22 3.98 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.67 0.747 . . . . 0.0 109.884 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.721 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 69.0 mt -48.2 -38.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.418 ' NH1' ' O ' ' A' ' 84' ' ' LEU . 13.1 mmm180 -51.67 -45.99 63.63 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.329 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -66.54 -63.31 1.1 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.33 -19.27 2.0 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.293 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -89.96 -77.62 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.607 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.33 45.1 0.63 Allowed Glycine 0 N--CA 1.47 0.902 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.418 ' O ' ' NH1' ' A' ' 79' ' ' ARG . 24.5 mt -98.89 115.36 28.67 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -89.92 -46.06 8.8 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.753 0.311 . . . . 0.0 110.559 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.467 ' HG3' ' H ' ' A' ' 88' ' ' ALA . 21.1 ptmt -149.81 152.08 34.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.085 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.07 -6.07 3.66 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.467 ' H ' ' HG3' ' A' ' 86' ' ' LYS . . . 53.59 -179.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 88' ' ' ALA . 71.7 m80 -154.09 -60.53 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -80.45 147.41 63.81 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.333 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.36 146.74 49.74 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.808 1.006 . . . . 0.0 111.766 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.92 -101.46 0.33 Allowed Glycine 0 N--CA 1.466 0.64 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.41 ' C ' ' H ' ' A' ' 95' ' ' LYS . 7.4 tpt180 -97.62 135.22 39.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -77.88 29.36 0.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.817 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 93' ' ' ARG . 52.8 mtmt -144.81 101.27 3.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.557 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 97' ' ' GLY . 5.4 p -145.18 155.93 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.247 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 60.53 82.48 0.07 OUTLIER Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.408 ' NE ' HG23 ' A' ' 139' ' ' VAL . 22.8 ttt180 -135.1 104.19 5.84 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.599 HD12 ' CG1' ' A' ' 104' ' ' VAL . 4.8 pt -104.37 150.21 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.8 p -87.96 155.72 19.69 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.397 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.782 ' NE1' HD11 ' A' ' 105' ' ' LEU . 74.0 t-105 -60.97 -54.59 43.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.083 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 1.3 tp10 -59.1 -40.37 85.1 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.059 -1.025 . . . . 0.0 111.123 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -59.38 -47.14 86.55 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.811 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.599 ' CG1' HD12 ' A' ' 99' ' ' ILE . 20.4 m -65.52 -29.06 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 118.494 -1.282 . . . . 0.0 109.467 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.782 HD11 ' NE1' ' A' ' 101' ' ' TRP . 64.7 mt -64.52 -74.03 0.11 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.522 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -44.2 -48.76 9.3 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.464 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.6 -25.28 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.107 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -105.54 -0.34 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.479 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.9 tmtt? -89.2 -74.74 0.46 Allowed 'General case' 0 N--CA 1.461 0.083 0 CA-C-O 120.751 0.31 . . . . 0.0 110.187 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -72.53 -40.99 66.35 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.843 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -74.85 73.59 2.11 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.57 61.71 0.17 Allowed Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.407 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -52.75 -43.15 58.07 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 120.594 0.863 . . . . 0.0 112.051 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 116' ' ' ASN . 27.0 t70 -142.4 -61.79 0.44 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.272 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 tt 45.64 -85.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.933 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 114' ' ' ASP . 12.6 t-20 -174.77 9.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.943 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 46.5 p -141.83 171.19 14.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.401 0.619 . . . . 0.0 111.749 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.37 -40.86 0.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.894 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -83.48 153.31 24.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.524 HD21 ' HG2' ' A' ' 109' ' ' LYS . 35.8 mt -60.24 -46.18 90.66 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.314 0.578 . . . . 0.0 109.931 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -54.81 -42.09 71.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.916 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.56 -66.84 0.53 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.116 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.63 36.67 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.941 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -53.03 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.602 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.4 mtt180 -43.3 -31.22 0.6 Allowed 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.001 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 130' ' ' SER . 5.5 ttp -59.33 -73.48 0.08 Allowed 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 127' ' ' ILE . 1.9 mp -48.99 -49.39 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.581 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -65.98 -71.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.34 -49.29 5.64 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 126' ' ' MET . 49.5 m -54.47 -42.99 71.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.719 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -56.05 -47.8 77.21 Favored 'General case' 0 C--O 1.228 -0.069 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -55.14 -41.51 71.86 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 t -53.31 -71.26 0.07 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.1 mtm -41.58 -62.07 0.95 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.942 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.18 50.0 0.04 OUTLIER Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.719 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 54.4 t -133.92 164.82 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.551 ' N ' HG12 ' A' ' 136' ' ' VAL . 98.0 mt-10 -133.78 159.27 41.1 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 140' ' ' GLY . 6.2 t -96.34 155.12 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.408 HG23 ' NE ' ' A' ' 98' ' ' ARG . 3.0 p -83.44 -2.71 6.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.647 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.418 ' H ' HG12 ' A' ' 138' ' ' VAL . . . -152.12 103.21 0.24 Allowed Glycine 0 CA--C 1.518 0.261 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -157.76 68.11 3.89 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.489 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -60.28 143.73 99.5 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.276 1.318 . . . . 0.0 111.804 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -82.63 152.94 25.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 145' ' ' LYS . 10.5 t -75.26 121.91 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 144' ' ' VAL . 68.4 mttm 51.08 178.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -152.59 -85.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.644 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.921 179.637 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 3' ' ' LYS . 22.4 tptt -93.48 -163.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.5 mptm? -64.59 -164.05 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.91 121.67 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 3' ' ' LYS . 17.3 m -113.33 -25.32 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.778 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.94 135.59 39.74 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.271 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.578 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.4 p -126.37 126.95 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.226 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.96 91.03 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.826 1.194 . . . . 0.0 111.539 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -82.15 116.32 21.66 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.49 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -168.47 -171.51 1.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.403 -178.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -94.44 154.16 17.58 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.963 HD12 ' CZ ' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -135.66 92.35 17.14 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -71.65 114.32 3.91 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.264 1.309 . . . . 0.0 114.775 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.789 ' HB3' ' H ' ' A' ' 51' ' ' ALA . . . -61.94 143.83 55.9 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . 61.49 150.53 0.02 OUTLIER Glycine 0 C--N 1.336 0.57 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.4 tttp 72.88 10.52 5.4 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.126 0.963 . . . . 0.0 110.564 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 18' ' ' THR . . . -92.15 151.93 20.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.6 170.81 3.97 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.041 -178.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -58.79 42.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.363 1.375 . . . . 0.0 112.23 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -160.91 54.26 0.55 Allowed Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-O 120.474 0.178 . . . . 0.0 110.533 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 25.6 Cg_endo -77.07 168.37 23.43 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.091 1.194 . . . . 0.0 112.21 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -56.51 -31.37 86.02 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 120.639 0.893 . . . . 0.0 111.284 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.796 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.7 t -75.02 -61.28 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 44.48 -99.61 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -47.87 -60.31 0.92 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 CA-C-N 119.816 1.808 . . . . 0.0 110.998 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.796 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -45.9 -26.83 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.366 -0.533 . . . . 0.0 109.824 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 25.6 tp -119.69 23.06 11.34 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.603 0.716 . . . . 0.0 109.172 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -152.56 37.93 0.77 Allowed Glycine 0 C--N 1.322 -0.221 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.668 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.442 ' O ' ' OE1' ' A' ' 29' ' ' GLN . 0.8 OUTLIER -141.57 -3.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.567 ' ND1' ' N ' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -78.5 -11.96 59.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.264 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.588 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 97.83 -26.1 24.72 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.588 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -47.66 -134.37 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.987 0.515 . . . . 0.0 112.287 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -136.76 143.58 43.33 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 122.093 -0.38 . . . . 0.0 111.015 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.6 mm -93.14 -73.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -39.72 -39.44 0.77 Allowed 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -59.49 -52.44 65.57 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.822 -0.751 . . . . 0.0 108.993 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' A' ' 34' ' ' ILE . 90.2 t80 -47.11 -62.43 1.42 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.165 0.983 . . . . 0.0 109.724 177.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 42' ' ' ASN . 86.9 t -58.71 -44.02 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 113.309 -1.769 . . . . 0.0 111.178 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.42 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 88.4 tttt -45.44 -67.79 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.75 -41.02 66.67 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.491 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.963 ' CZ ' HD12 ' A' ' 12' ' ' LEU . 54.9 t80 -62.9 -77.03 0.06 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.29 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -40.24 -44.73 1.94 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.314 0.578 . . . . 0.0 112.182 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.06 -34.81 70.52 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.113 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.17 -46.05 11.45 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.618 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 49' ' ' GLY . 32.4 p -63.76 -31.69 72.94 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -70.03 -41.02 74.82 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -62.4 -20.02 64.03 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.2 mtm -106.51 -78.85 0.57 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.259 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 169.17 166.49 28.29 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.362 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 36.9 p-10 -62.63 125.51 24.17 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.789 ' H ' ' HB3' ' A' ' 14' ' ' ALA . . . -162.41 -153.88 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.285 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 99.3 mt -142.03 132.15 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.72 120.46 6.03 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.249 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -65.37 140.71 65.03 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 120.746 0.964 . . . . 0.0 110.862 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.412 ' CG2' HD23 ' A' ' 12' ' ' LEU . 25.4 m -137.53 159.62 34.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.234 0.54 . . . . 0.0 110.861 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 58' ' ' THR . 32.4 tt0 -129.89 85.7 2.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 57' ' ' ILE . 4.6 mt -60.36 82.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.216 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -72.74 97.16 2.15 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.2 mt -97.31 126.25 50.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.008 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -98.86 144.65 27.83 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.664 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -54.25 -24.12 17.46 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.44 1.088 . . . . 0.0 112.331 -176.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -68.45 10.44 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.664 ' H ' ' C ' ' A' ' 61' ' ' ALA . 87.2 mtm180 61.27 69.2 0.68 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.496 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.3 m -142.9 126.94 17.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.843 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -107.58 103.76 13.15 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.058 -177.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.483 ' O ' ' OG1' ' A' ' 58' ' ' THR . 77.3 p -95.71 121.58 37.57 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.586 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.4 p90 176.46 -152.54 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 51.7 t 80.69 152.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.304 0 O-C-N 124.329 1.018 . . . . 0.0 110.564 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t -146.68 173.36 12.43 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.453 ' C ' HG22 ' A' ' 71' ' ' THR . 58.0 pttt -170.6 -159.85 0.19 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.585 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 t 43.25 56.38 11.84 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.956 0.408 . . . . 0.0 111.431 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 71' ' ' THR . 9.8 Cg_endo -77.82 157.57 31.35 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 C-N-CA 120.064 0.509 . . . . 0.0 112.04 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.683 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 11.3 Cg_endo -70.13 176.2 7.38 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 121.952 1.768 . . . . 0.0 112.293 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 73' ' ' PRO . . . 79.71 -177.24 0.08 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.897 0.317 . . . . 0.0 110.279 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.635 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.1 OUTLIER -40.51 -20.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.312 -0.242 . . . . 0.0 110.521 -179.031 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.542 ' HD2' ' O ' ' A' ' 73' ' ' PRO . 26.0 m-85 -42.73 -35.96 1.3 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.651 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.812 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -133.51 -25.55 1.7 Allowed 'General case' 0 C--O 1.253 1.253 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.635 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 45.6 mt -54.56 -35.02 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.573 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -53.37 -42.84 67.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.277 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.434 ' C ' ' N ' ' A' ' 82' ' ' ALA . 3.1 tmtm? -67.84 -65.32 0.71 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.9 -11.64 0.25 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.999 -0.681 . . . . 0.0 110.65 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.42 -77.63 0.33 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.851 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 137.74 63.09 0.05 OUTLIER Glycine 0 N--CA 1.464 0.537 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.9 mt -115.06 135.87 53.74 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -140.92 -175.3 4.25 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.83 126.36 26.61 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.91 -143.36 11.84 Favored Glycine 0 N--CA 1.466 0.646 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 51.29 31.25 6.75 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.586 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -79.44 -83.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.271 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -89.21 153.57 48.85 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.332 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -53.45 142.51 58.44 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 120.842 1.028 . . . . 0.0 111.667 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.47 -107.85 0.2 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -71.43 149.12 46.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -127.31 57.82 1.48 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.687 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -139.66 74.13 1.46 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.492 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.461 HG22 ' N ' ' A' ' 97' ' ' GLY . 14.3 p -144.61 159.5 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.461 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 93.68 68.19 1.07 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.28 99.29 6.27 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.706 0.253 . . . . 0.0 111.034 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.669 HD12 HG11 ' A' ' 104' ' ' VAL . 13.7 pt -95.63 139.29 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.492 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -81.61 155.99 25.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.753 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.632 ' O ' HG22 ' A' ' 104' ' ' VAL . 57.2 t-105 -61.75 -69.13 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -48.29 -42.17 30.07 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 120.916 -1.115 . . . . 0.0 112.147 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -59.86 -46.08 90.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.451 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.669 HG11 HD12 ' A' ' 99' ' ' ILE . 19.2 m -63.44 -29.78 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 118.286 -1.366 . . . . 0.0 109.283 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 108' ' ' ALA . 36.7 mt -62.38 -70.68 0.19 Allowed 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.339 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -43.63 -46.29 7.21 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.568 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.46 -26.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.378 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.554 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -101.66 -2.39 30.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.364 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.517 ' O ' ' SD ' ' A' ' 112' ' ' MET . 87.5 tttt -88.76 -75.45 0.43 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.857 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.4 -40.3 73.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.04 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.15 84.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.456 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.554 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 3.1 ptt? -179.51 58.24 0.1 OUTLIER Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.505 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 112' ' ' MET . 13.6 Cg_endo -75.81 -55.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 120.618 0.879 . . . . 0.0 112.337 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -88.85 -31.45 18.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.772 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 117' ' ' THR . 10.3 mt -45.42 134.07 7.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -65.98 70.24 0.06 Allowed 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.298 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LEU . 82.6 p -143.71 159.35 42.65 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.212 0.53 . . . . 0.0 111.994 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.64 -43.32 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.935 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -91.94 148.35 22.27 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.8 OUTLIER -59.27 -46.82 87.5 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.689 0.757 . . . . 0.0 110.124 -178.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.65 -35.68 68.66 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.66 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.92 -64.73 0.81 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.937 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.87 -22.92 27.97 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.923 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.95 -73.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.2 mtt180 -43.09 -31.95 0.63 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.658 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 130' ' ' SER . 38.9 ttp -57.36 -72.95 0.08 Allowed 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.448 HG23 HD11 ' A' ' 78' ' ' ILE . 50.0 mm -51.33 -50.28 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.328 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -64.28 -72.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.13 -45.58 3.99 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 126' ' ' MET . 67.7 m -56.74 -44.69 81.95 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.582 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -56.22 -50.43 71.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -48.88 -42.88 38.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.399 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.586 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.4 t -54.13 -65.07 0.64 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.8 mtp -52.45 -2.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.605 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.1 -29.27 6.61 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.582 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 68.1 t -46.05 164.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 79.2 mt-10 -143.05 164.76 29.22 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.093 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 140' ' ' GLY . 3.5 t -85.23 155.03 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 100' ' ' THR . 1.0 OUTLIER -100.18 -7.54 9.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.703 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 138' ' ' VAL . . . -115.48 -22.28 4.83 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-O 119.131 -0.816 . . . . 0.0 111.553 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 138' ' ' VAL . . . -35.74 91.1 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 124.045 0.497 . . . . 0.0 110.197 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.5 ' N ' ' O ' ' A' ' 140' ' ' GLY . 2.9 Cg_exo -63.2 149.85 90.23 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.36 1.373 . . . . 0.0 111.895 -177.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' ' 145' ' ' LYS . 72.2 tt0 -59.36 132.1 52.98 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 145' ' ' LYS . 4.9 m -66.8 -6.12 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.894 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.534 ' H ' ' HG2' ' A' ' 143' ' ' GLU . 2.5 tmtp? 54.16 104.89 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -131.6 116.12 16.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.601 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.851 -179.808 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptt? . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? 49.62 91.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.884 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 17.9 ttmt -107.84 178.03 4.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.775 0.322 . . . . 0.0 110.455 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 4' ' ' VAL . 7.7 p -70.59 126.39 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -112.07 -24.77 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.41 119.6 14.61 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.292 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.6 p -111.6 104.82 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.842 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.68 92.41 2.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 117.985 -1.486 . . . . 0.0 110.295 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -85.23 109.49 18.37 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.437 0.461 . . . . 0.0 110.304 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -171.89 -174.51 1.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.191 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -102.18 173.57 6.32 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.61 139.31 5.93 Favored Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.974 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -82.2 149.54 15.3 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.125 1.217 . . . . 0.0 114.722 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.827 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -90.33 144.73 25.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.17 58.86 8.95 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.404 ' H ' ' H ' ' A' ' 17' ' ' ALA . 2.1 mmtm 172.63 21.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.336 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 16' ' ' LYS . . . -98.16 150.68 21.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -162.42 168.54 10.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.075 -178.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -62.23 42.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.29 1.327 . . . . 0.0 111.963 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -155.53 59.31 2.13 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.994 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 27.8 Cg_endo -79.72 166.47 21.57 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.286 1.324 . . . . 0.0 111.888 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.37 -30.71 88.83 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 120.8 1.0 . . . . 0.0 111.102 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.665 ' CG1' ' HB3' ' A' ' 26' ' ' ALA . 2.4 t -70.98 -58.06 6.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.812 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 41.08 -99.64 0.01 OUTLIER Glycine 0 C--O 1.207 -1.555 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.3 Cg_exo -48.41 -62.49 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 CA-C-N 120.308 2.054 . . . . 0.0 110.789 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.665 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -42.95 -16.82 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.059 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.614 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 29.5 tp -117.53 -27.56 6.3 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.699 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -57.59 -54.83 34.18 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -88.99 43.22 1.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.565 0.697 . . . . 0.0 110.496 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.614 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -86.87 -31.74 20.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 109.86 -48.83 0.9 Allowed Glycine 0 N--CA 1.472 1.085 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.546 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -50.33 -131.23 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.973 0.509 . . . . 0.0 111.865 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -138.71 128.33 24.76 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.89 -0.506 . . . . 0.0 111.205 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.9 mm -71.96 -72.25 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.453 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -38.55 -39.44 0.48 Allowed 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -58.93 -48.94 79.68 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.074 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 60.7 t80 -48.42 -65.66 0.53 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.527 1.156 . . . . 0.0 109.622 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 42' ' ' ASN . 89.8 t -56.87 -44.03 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.383 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -47.06 -53.03 13.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.87 -37.8 87.12 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.227 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 7.8 m-85 -65.43 -74.11 0.11 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 41' ' ' PHE . 0.6 OUTLIER -37.16 -45.69 0.65 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.516 0.674 . . . . 0.0 111.514 -177.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.17 79.31 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.55 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -88.73 -45.23 9.96 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.519 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 42' ' ' ASN . 52.3 p -60.63 -18.54 53.92 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -86.69 -42.72 13.15 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -60.23 -17.04 38.88 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.786 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.595 ' SD ' ' HB1' ' A' ' 14' ' ' ALA . 1.7 ppp? -120.11 126.41 50.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.132 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.501 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -40.93 161.9 0.01 OUTLIER Glycine 0 CA--C 1.543 1.835 0 C-N-CA 119.533 -1.317 . . . . 0.0 111.584 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 53.6 p-10 -62.6 151.46 37.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.06 0.93 . . . . 0.0 109.928 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.827 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 179.6 -150.48 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.809 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.0 mt -143.24 134.9 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 m -147.43 145.83 23.0 Favored Pre-proline 0 C--O 1.243 0.723 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.3 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -76.42 149.09 30.69 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 121.064 1.176 . . . . 0.0 110.961 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 m -142.54 143.28 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.133 0.492 . . . . 0.0 111.017 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.71 85.6 2.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 mt -64.52 83.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.916 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 m -69.23 93.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.8 mt -93.56 125.72 46.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.218 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.418 ' CD2' ' C ' ' A' ' 3' ' ' LYS . 7.7 m-85 -100.27 142.66 31.44 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.659 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.7 -22.87 2.29 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 124.651 1.219 . . . . 0.0 112.165 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.25 5.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.659 ' H ' ' C ' ' A' ' 61' ' ' ALA . 51.2 mtp180 62.54 72.78 0.48 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.104 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.1 p -152.45 132.36 13.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.314 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -101.36 101.69 12.38 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.41 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.7 132.0 41.36 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.527 ' O ' ' CD2' ' A' ' 67' ' ' PHE . 51.5 p90 -172.26 123.54 0.49 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.479 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 69' ' ' THR . 72.8 t -107.32 108.01 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.523 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 25.6 p -156.21 -164.27 1.65 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 69' ' ' THR . 9.3 pttt 76.78 -178.95 0.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.511 ' CG2' ' CE2' ' A' ' 76' ' ' TYR . 6.4 m 64.9 68.61 0.73 Allowed Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.558 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.531 ' O ' ' CD1' ' A' ' 76' ' ' TYR . 10.8 Cg_endo -78.53 155.5 28.04 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 120.934 1.089 . . . . 0.0 112.289 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.562 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 10.0 Cg_endo -68.46 112.67 2.89 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.699 1.599 . . . . 0.0 112.367 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 169.61 -167.46 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.672 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -41.51 -16.19 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 O-C-N 122.0 -0.437 . . . . 0.0 110.571 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.659 ' CE1' HD22 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -43.97 -30.12 0.67 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.208 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.947 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -140.7 -27.14 0.73 Allowed 'General case' 0 C--O 1.255 1.358 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.025 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.947 ' N ' HD23 ' A' ' 77' ' ' LEU . 66.4 mt -51.67 -35.59 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.455 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -53.51 -45.37 69.68 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.702 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.07 -63.63 1.19 Allowed 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.32 -19.44 5.42 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.725 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.19 -78.75 0.25 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.069 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 134.03 23.52 0.68 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.17 132.64 36.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -88.49 -80.39 0.28 Allowed 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.306 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -144.48 -19.34 0.54 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.709 0.29 . . . . 0.0 111.012 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.06 -137.74 2.29 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.05 0.38 0.1 Allowed 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.191 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 49.49 -173.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -48.97 154.18 1.34 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.096 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.09 141.87 46.52 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 120.909 1.072 . . . . 0.0 111.714 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.61 -103.9 0.22 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -86.02 135.13 33.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -94.18 8.94 39.87 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.939 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -91.54 97.82 11.29 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.4 p -159.8 152.95 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.308 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.88 82.86 0.14 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.647 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -140.35 123.06 16.33 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 121.035 0.445 . . . . 0.0 111.003 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.617 HD12 ' CG1' ' A' ' 104' ' ' VAL . 1.6 pt -128.8 157.28 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 p -91.01 166.79 12.82 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.134 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.621 ' NE1' HD11 ' A' ' 105' ' ' LEU . 55.9 t-105 -59.34 -54.39 47.33 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.27 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -55.73 -40.94 73.15 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.585 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -61.03 -47.86 84.48 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.858 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.617 ' CG1' HD12 ' A' ' 99' ' ' ILE . 16.0 m -66.42 -28.63 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 118.414 -1.314 . . . . 0.0 109.783 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.621 HD11 ' NE1' ' A' ' 101' ' ' TRP . 53.0 mt -63.1 -71.47 0.16 Allowed 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.521 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -43.79 -47.45 8.03 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.141 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.83 -27.48 41.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.244 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.566 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -104.63 0.62 28.69 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.693 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 105' ' ' LEU . 77.8 tttt -84.91 -73.78 0.42 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.541 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -57.18 -35.98 70.24 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -70.59 48.74 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.456 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.566 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 91.9 mtp -143.32 54.1 2.95 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.411 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 112' ' ' MET . 3.5 Cg_endo -57.8 -46.67 25.04 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 120.651 0.901 . . . . 0.0 112.088 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -173.93 26.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.9 mt -43.42 -73.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.454 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -172.1 0.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.226 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.6 p -141.73 177.53 8.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 111.903 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.2 p -141.6 -22.26 0.73 Allowed 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.996 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -82.07 143.06 31.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.198 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.2 -40.72 97.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 110.876 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -56.1 -35.16 66.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.18 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.77 -68.88 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.861 -1.136 . . . . 0.0 108.967 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.06 -39.08 26.19 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.976 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.38 -66.55 0.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 129' ' ' GLY . 98.8 mtt180 -44.27 -31.91 1.14 Allowed 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.479 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 4.4 tmm? -59.24 -72.35 0.1 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.6 mm -51.1 -50.34 25.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.218 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -66.26 -70.82 0.22 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.39 -44.4 3.99 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.479 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 66.4 m -58.71 -44.85 90.51 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.557 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -54.62 -50.32 68.39 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.55 HH11 ' HG2' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -49.36 -44.59 44.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.5 t -52.47 -65.72 0.51 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 83.5 mtp -51.82 -5.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.303 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.57 -25.56 12.87 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.557 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 45.7 t -47.64 163.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 136' ' ' VAL . 75.8 mt-10 -131.62 153.24 50.13 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 140' ' ' GLY . 65.2 t -117.25 130.49 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 139' ' ' VAL . 38.7 t -94.76 -4.88 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.487 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.609 ' O ' ' HB3' ' A' ' 141' ' ' ALA . . . -59.33 156.11 26.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 140' ' ' GLY . . . 73.68 64.32 0.31 Allowed Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 117.403 0.602 . . . . 0.0 110.186 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 9.5 Cg_endo -71.85 178.41 5.86 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.339 1.359 . . . . 0.0 111.759 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.1 140.16 56.13 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 75.7 t -126.19 127.75 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -140.15 141.66 36.04 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -103.19 -76.03 0.6 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.616 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.106 -0.949 . . . . 0.0 110.505 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 ttp . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.67 139.77 53.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -145.29 168.59 20.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.482 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 4' ' ' VAL . 8.2 p -58.05 123.07 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 61' ' ' ALA . 64.5 t -114.36 -24.09 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.03 130.05 18.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.608 0.718 . . . . 0.0 111.101 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.4 t -119.92 103.56 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.058 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.25 93.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 118.164 -1.415 . . . . 0.0 110.045 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -76.01 110.81 10.78 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -169.91 -172.6 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.944 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 11' ' ' GLN . 26.4 mp0 -109.59 171.94 7.15 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.699 HD13 ' CE1' ' A' ' 41' ' ' PHE . 8.0 mt -143.15 136.02 13.73 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -82.49 159.85 17.02 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.222 1.281 . . . . 0.0 113.722 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.751 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -118.35 142.53 47.43 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.66 35.53 38.15 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -177.38 59.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.896 -0.652 . . . . 0.0 110.468 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.07 156.24 47.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -167.68 169.02 5.81 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.286 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.84 39.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.357 1.371 . . . . 0.0 112.171 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.578 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -147.0 52.57 1.39 Allowed Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.629 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 31.2 Cg_endo -79.78 166.28 21.6 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.027 1.151 . . . . 0.0 111.885 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.08 -29.2 86.3 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 120.93 1.087 . . . . 0.0 111.087 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.601 ' CG1' ' HB3' ' A' ' 26' ' ' ALA . 2.4 t -80.62 -63.49 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 42.97 -99.58 0.01 OUTLIER Glycine 0 C--O 1.212 -1.252 0 CA-C-O 118.58 -1.122 . . . . 0.0 110.418 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.3 Cg_exo -47.55 -60.51 0.85 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 CA-C-N 120.968 2.384 . . . . 0.0 110.986 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.601 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.48 -16.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.429 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.632 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -117.82 -38.23 3.29 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 110.901 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -56.68 -52.01 53.2 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -76.5 42.19 0.28 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.382 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.632 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -92.35 -30.38 15.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.726 177.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.596 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . 109.27 -43.19 1.76 Allowed Glycine 0 N--CA 1.464 0.529 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -51.44 -132.01 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.103 0.561 . . . . 0.0 111.849 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -138.68 123.73 19.01 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.909 -0.495 . . . . 0.0 110.736 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.6 mm -63.18 -71.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.416 ' O ' ' N ' ' A' ' 39' ' ' LYS . 96.7 mmm -39.43 -43.19 1.19 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.26 -48.26 79.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.272 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 34' ' ' ILE . 29.5 t80 -50.05 -67.67 0.24 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 122.364 1.078 . . . . 0.0 109.358 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 42' ' ' ASN . 93.8 t -56.93 -42.51 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.174 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 88.4 tttt -48.59 -60.69 2.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.52 -41.32 80.65 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.683 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.699 ' CE1' HD13 ' A' ' 12' ' ' LEU . 10.3 m-85 -62.97 -76.0 0.07 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 46' ' ' ALA . 8.0 t-20 -39.29 -46.34 1.54 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.524 0.678 . . . . 0.0 111.744 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -57.8 -35.24 70.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.302 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -88.07 -44.42 10.97 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.983 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 49' ' ' GLY . 14.8 p -65.26 -21.12 66.69 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -87.82 -33.66 18.53 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 47' ' ' ASN . 62.4 t-20 -64.45 -24.53 67.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.486 ' CG ' ' N ' ' A' ' 49' ' ' GLY . 7.1 ptt? -105.65 -47.2 3.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.644 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.486 ' N ' ' CG ' ' A' ' 48' ' ' MET . . . 142.62 178.57 18.69 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 40.7 p-10 -74.82 147.98 40.69 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.751 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.04 -154.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.754 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.1 mm -143.3 136.46 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.5 131.13 12.7 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.741 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -72.26 153.23 56.39 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 120.76 0.974 . . . . 0.0 110.369 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.551 HG11 HD12 ' A' ' 12' ' ' LEU . 5.3 p -155.52 145.53 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.426 0.632 . . . . 0.0 111.897 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -121.93 95.68 4.76 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.4 mt -69.72 89.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.712 -175.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.24 98.93 1.81 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 59' ' ' ILE . 40.9 mt -99.28 131.44 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.806 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 63' ' ' ARG . 4.1 m-85 -106.83 142.15 36.93 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.55 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.91 -27.34 7.31 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 124.388 1.055 . . . . 0.0 111.841 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -60.33 -5.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' A' ' 61' ' ' ALA . 25.7 ttm180 76.79 70.01 0.06 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.212 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.0 p -144.77 125.33 14.05 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.237 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -104.64 103.28 12.91 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.556 0.217 . . . . 0.0 110.555 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.7 p -95.55 134.46 38.4 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.559 ' CZ ' ' O ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -124.73 175.34 7.3 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.226 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.97 86.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.9 t -177.15 139.03 0.26 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.211 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.585 ' O ' ' O ' ' A' ' 71' ' ' THR . 0.6 OUTLIER -176.92 117.25 0.11 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.672 0.749 . . . . 0.0 110.336 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.585 ' O ' ' O ' ' A' ' 70' ' ' LYS . 49.8 p 51.85 140.45 0.02 OUTLIER Pre-proline 0 C--N 1.292 -1.914 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.468 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -78.21 168.57 21.56 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 120.551 1.232 . . . . 0.0 112.821 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.46 90.67 0.33 Allowed 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.983 1.789 . . . . 0.0 111.959 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.72 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -176.7 -143.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.634 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.5 OUTLIER -37.25 -14.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.72 ' N ' ' O ' ' A' ' 74' ' ' ALA . 3.2 t80 -46.52 -41.27 13.95 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 123.53 0.518 . . . . 0.0 110.385 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.86 ' N ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -130.1 -15.25 3.79 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.819 ' N ' HD22 ' A' ' 77' ' ' LEU . 26.2 mt -65.02 -40.68 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.997 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -50.25 -41.82 50.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.063 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -71.58 -61.19 1.87 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.313 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.18 -22.43 6.55 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.319 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -86.61 -78.08 0.3 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.765 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.39 56.61 0.77 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.8 mt -92.48 114.49 27.06 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -81.52 -178.97 7.18 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -79.65 144.67 33.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.06 106.64 0.65 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.22 3.05 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.305 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -64.38 -47.28 79.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.37 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -88.11 148.09 42.13 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.669 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.31 142.92 67.27 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 120.628 0.886 . . . . 0.0 111.616 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.08 136.44 4.13 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 62.26 -175.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 95' ' ' LYS . 79.8 mm-40 -90.5 84.96 6.01 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.189 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 94' ' ' GLU . 58.4 mttp 53.52 169.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 97' ' ' GLY . 12.5 p -152.64 164.56 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 88.59 84.55 1.25 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -138.81 128.39 24.66 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.07 0.462 . . . . 0.0 110.88 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 104' ' ' VAL . 15.0 pt -119.19 151.61 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.6 p -78.72 154.78 29.79 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.237 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.717 ' NE1' HD11 ' A' ' 105' ' ' LEU . 65.4 t-105 -58.49 -54.63 44.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.019 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -58.31 -42.8 87.5 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 121.439 -0.788 . . . . 0.0 111.396 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -58.33 -46.11 86.83 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.638 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.543 HG23 ' CG2' ' A' ' 127' ' ' ILE . 7.7 p -66.9 -30.6 50.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.044 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.717 HD11 ' NE1' ' A' ' 101' ' ' TRP . 58.3 mt -61.69 -71.77 0.14 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.153 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -45.66 -49.77 14.1 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.39 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.501 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 93.1 mt -57.53 -26.69 27.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -105.64 2.44 28.16 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.398 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 105' ' ' LEU . 77.3 tttt -86.16 -73.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -65.52 -40.51 93.06 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.725 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 107' ' ' ILE . 49.7 mmtt -60.43 93.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.712 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.422 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 48.8 mtt -154.82 56.0 1.35 Allowed Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.403 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 112' ' ' MET . 14.7 Cg_exo -50.46 -46.67 28.17 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 120.778 0.985 . . . . 0.0 112.154 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 66.8 t0 -170.92 40.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.245 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.562 HD22 ' N ' ' A' ' 115' ' ' LEU . 3.6 mm? -74.41 143.66 44.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.74 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.563 ' ND2' ' O ' ' A' ' 116' ' ' ASN . 10.2 t30 -69.37 35.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.444 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 115' ' ' LEU . 69.5 p -139.46 162.79 34.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.228 0.537 . . . . 0.0 111.756 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.7 p -142.46 -45.07 0.32 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.779 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -72.5 151.51 42.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 35.9 mt -59.3 -42.19 90.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.358 0.599 . . . . 0.0 109.948 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.85 -44.53 86.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.093 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.85 -71.23 0.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.279 -0.969 . . . . 0.0 108.528 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.596 ' O ' ' HG3' ' A' ' 126' ' ' MET . . . -44.22 -55.0 5.17 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.896 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -44.69 -62.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.295 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 129' ' ' GLY . 64.8 ttt180 -44.41 -32.36 1.34 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.791 ' HG3' ' H ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER -58.95 -66.71 0.46 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.791 ' H ' ' HG3' ' A' ' 126' ' ' MET . 4.9 mm -56.11 -48.68 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.317 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -66.84 -69.83 0.28 Allowed 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.09 -47.43 5.35 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 126' ' ' MET . 70.3 m -57.82 -42.84 85.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.619 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -53.86 -48.18 70.28 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.532 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -50.75 -41.1 56.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 135' ' ' GLY . 2.3 t -59.57 -72.64 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 4.3 ptm -45.27 -13.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.527 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 89.31 66.17 1.26 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.619 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 37.1 t -157.16 141.61 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -116.17 172.44 7.18 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 140' ' ' GLY . 7.3 t -96.33 149.02 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 p -62.08 4.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.313 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . 100.27 155.41 27.75 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -145.73 67.87 12.78 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.868 0.334 . . . . 0.0 110.4 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.57 150.74 69.73 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.383 1.388 . . . . 0.0 112.114 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.439 ' O ' ' OE1' ' A' ' 143' ' ' GLU . 1.2 tm-20 -169.91 24.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.242 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.9 t -132.9 133.42 58.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -105.21 83.3 1.95 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -162.63 93.83 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.713 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.451 179.63 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.525 ' N ' ' CB ' ' A' ' 61' ' ' ALA . 7.7 ptt? . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.478 ' H ' ' CG ' ' A' ' 1' ' ' MET . 89.0 tttt -173.58 159.4 3.59 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt 62.09 153.11 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.262 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.697 HG21 HG22 ' A' ' 58' ' ' THR . 1.0 OUTLIER -55.01 104.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.213 178.775 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 6' ' ' ALA . 29.6 m -80.79 -46.33 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.204 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 5' ' ' VAL . . . -100.84 142.1 32.79 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.263 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.7 p -132.58 99.91 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.595 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.12 90.34 3.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.031 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -78.99 117.2 19.84 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.493 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -170.67 -173.91 1.49 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.537 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -98.25 162.7 13.06 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.474 HD12 HG11 ' A' ' 55' ' ' VAL . 1.1 mt -148.88 96.83 3.73 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.484 ' HA ' HD13 ' A' ' 52' ' ' ILE . 26.5 Cg_exo -54.23 147.88 43.36 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.239 1.292 . . . . 0.0 114.769 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.832 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -94.61 142.45 27.44 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 45.06 31.38 2.9 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -154.07 34.34 0.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.145 -0.527 . . . . 0.0 110.522 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.82 151.55 36.28 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.546 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -156.32 167.98 13.27 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.121 -178.078 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -61.5 36.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.305 1.337 . . . . 0.0 112.207 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -159.33 57.39 1.04 Allowed Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.687 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 23.4 Cg_endo -80.22 169.62 17.26 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.157 1.238 . . . . 0.0 112.123 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -55.01 -28.41 59.65 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 120.705 0.936 . . . . 0.0 111.146 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.747 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.6 t -84.7 -61.9 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 43.25 -98.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.809 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -47.15 -60.71 0.78 Allowed 'Trans proline' 0 C--N 1.317 -1.106 0 CA-C-N 119.736 1.768 . . . . 0.0 110.559 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.747 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -48.49 -26.29 2.07 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.834 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 36.8 tp -113.23 26.35 10.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 122.124 0.964 . . . . 0.0 109.354 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.42 42.38 0.5 Allowed Glycine 0 C--N 1.313 -0.73 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.259 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -141.13 -16.28 0.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.186 0.517 . . . . 0.0 109.638 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.497 ' O ' ' ND1' ' A' ' 30' ' ' HIS . 16.2 t-80 -59.01 -11.11 3.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.197 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.99 -15.81 58.99 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.39 -131.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.304 0.642 . . . . 0.0 112.071 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -134.09 -165.56 1.66 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mm -138.46 -74.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.3 tpt -41.4 -37.41 1.03 Allowed 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -59.83 -54.36 47.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 68.7 t80 -45.38 -58.15 3.53 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 122.863 1.315 . . . . 0.0 109.755 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 42' ' ' ASN . 48.8 t -63.19 -43.4 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.577 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -44.64 -58.67 2.9 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.41 95.83 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.342 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -62.12 -74.22 0.09 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.646 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -39.74 -44.58 1.58 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.72 0.772 . . . . 0.0 111.738 -177.299 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.17 72.92 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.219 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.51 ' HB1' ' HG3' ' A' ' 70' ' ' LYS . . . -87.71 -46.09 9.8 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.186 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.8 p -62.76 -19.46 64.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -89.12 -34.14 16.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -61.41 -26.05 67.6 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.592 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -106.08 -85.87 0.49 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.067 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.592 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -176.2 169.23 41.75 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.338 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 42.9 p-10 -69.48 137.66 52.77 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.832 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -174.93 -150.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.861 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 13' ' ' PRO . 35.4 mm -138.19 125.0 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.603 HG11 HG23 ' A' ' 69' ' ' THR . 84.4 t -125.9 120.94 24.19 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.206 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -75.32 141.69 26.03 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.011 1.141 . . . . 0.0 110.631 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.618 HG22 ' N ' ' A' ' 56' ' ' GLU . 7.5 p -159.74 162.91 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.329 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.618 ' N ' HG22 ' A' ' 55' ' ' VAL . 9.7 mt-10 -129.44 114.82 16.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.9 mt -76.54 88.23 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.097 0.475 . . . . 0.0 111.73 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.697 HG22 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -74.37 113.49 11.65 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.6 mt -118.55 135.94 57.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.004 0.431 . . . . 0.0 111.401 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.642 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -110.17 147.72 33.18 Favored 'General case' 0 C--O 1.253 1.274 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.27 176.665 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.713 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -53.48 -22.55 8.19 Favored 'General case' 0 C--N 1.346 0.423 0 O-C-N 124.985 1.428 . . . . 0.0 112.177 -175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -63.43 8.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.713 ' H ' ' C ' ' A' ' 61' ' ' ALA . 89.0 mtm180 59.7 72.33 0.53 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.992 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.479 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 1.4 m -149.96 147.56 28.03 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.604 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -124.48 106.56 10.27 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.284 0.365 . . . . 0.0 111.452 -177.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.594 ' OG1' ' OH ' ' A' ' 60' ' ' TYR . 15.3 m -94.11 122.09 36.27 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 4.0 p90 177.1 -151.78 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 47.3 t 80.69 159.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.202 0 O-C-N 124.006 0.816 . . . . 0.0 110.344 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.603 HG23 HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER 175.64 119.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.033 179.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HD3' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -148.73 147.83 29.3 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.292 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.48 ' OG1' ' C ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER 173.7 141.6 0.16 Allowed Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.359 177.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.71 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 10.8 Cg_endo -72.62 169.38 22.02 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.588 0.859 . . . . 0.0 111.955 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 72' ' ' PRO . 12.1 Cg_exo -46.61 -157.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.814 2.343 . . . . 0.0 112.359 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.718 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -36.31 -34.01 0.05 Allowed 'General case' 0 C--O 1.255 1.364 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -40.15 -10.35 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.123 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.718 ' N ' ' O ' ' A' ' 74' ' ' ALA . 31.1 m-85 -32.76 -81.55 0.01 OUTLIER 'General case' 0 C--N 1.35 0.628 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.861 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -108.49 -5.35 16.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.771 HD11 ' CG2' ' A' ' 127' ' ' ILE . 6.5 mm -63.08 -42.42 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.347 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -52.2 -36.58 52.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.17 -66.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.842 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.62 -13.98 0.46 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.726 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 78' ' ' ILE . . . -89.83 -77.06 0.4 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.637 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.75 37.86 0.49 Allowed Glycine 0 N--CA 1.466 0.648 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.2 mt -90.68 104.88 17.42 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.44 -45.27 13.85 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.742 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -174.66 157.36 2.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.91 147.4 21.54 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -179.58 -2.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.022 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -59.9 -46.49 89.17 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.563 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -165.51 152.15 9.02 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.628 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.77 145.8 48.23 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.961 1.108 . . . . 0.0 111.679 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.76 58.3 0.11 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -162.4 -85.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -171.81 -66.57 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.027 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -141.6 137.0 31.59 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -158.86 151.25 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.167 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.88 84.3 0.59 Allowed Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -141.82 103.15 4.3 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.086 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.606 HD12 ' CG1' ' A' ' 104' ' ' VAL . 3.5 pt -106.56 159.91 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.36 152.01 19.4 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.257 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.488 ' O ' HG22 ' A' ' 104' ' ' VAL . 70.4 t-105 -60.32 -51.26 70.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.778 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.85 -41.93 92.5 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 120.62 -1.3 . . . . 0.0 111.751 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.22 -44.51 95.11 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.105 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.606 ' CG1' HD12 ' A' ' 99' ' ' ILE . 17.5 m -62.92 -33.71 62.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 118.257 -1.377 . . . . 0.0 109.411 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 108' ' ' ALA . 96.2 mt -61.47 -72.21 0.13 Allowed 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.19 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.46 ' CG ' ' NE2' ' A' ' 110' ' ' GLN . 82.9 tt0 -43.77 -56.23 3.96 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.488 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.482 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 95.1 mt -50.61 -25.68 3.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.879 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -88.89 -44.6 10.34 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.604 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.434 ' HG3' HD11 ' A' ' 120' ' ' LEU . 47.7 mtpt -43.9 -68.32 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.373 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 112' ' ' MET . 0.2 OUTLIER -57.32 -66.37 0.47 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.328 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -47.16 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.973 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.561 ' N ' ' O ' ' A' ' 110' ' ' GLN . 37.6 mtt -157.51 51.34 0.48 Allowed Pre-proline 0 C--O 1.234 0.248 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.664 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 112' ' ' MET . 10.7 Cg_endo -66.05 -33.37 41.53 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 120.748 0.965 . . . . 0.0 111.867 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 115' ' ' LEU . 63.9 m-20 -160.75 -77.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.942 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.558 HD22 ' H ' ' A' ' 115' ' ' LEU . 3.9 mm? 44.0 -169.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.296 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -121.98 35.56 4.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.762 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.3 p -135.83 168.41 19.35 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.395 0.617 . . . . 0.0 111.902 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -138.67 -85.52 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.511 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.505 ' H ' HG23 ' A' ' 118' ' ' THR . 97.7 m-20 -55.42 164.22 1.04 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 124' ' ' ALA . 4.4 mm? -61.66 -40.62 95.57 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-O 121.469 0.652 . . . . 0.0 110.42 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -50.31 -46.08 55.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.129 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.73 -66.27 0.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.174 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 126' ' ' MET . . . -49.05 -48.02 44.31 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.928 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -47.06 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 129' ' ' GLY . 42.2 ttm180 -42.15 -37.63 1.49 Allowed 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.418 ' SD ' ' C ' ' A' ' 126' ' ' MET . 3.2 tmm? -54.9 -73.48 0.05 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.484 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.771 ' CG2' HD11 ' A' ' 78' ' ' ILE . 34.1 mt -51.77 -51.71 26.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.847 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -62.81 -70.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.16 -42.39 3.12 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 133' ' ' SER . 23.9 m -57.49 -46.16 84.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.637 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -51.28 -50.29 59.57 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.579 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -49.97 -36.03 26.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.4 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.58 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.2 t -63.23 -71.15 0.17 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.644 ' SD ' ' HB3' ' A' ' 74' ' ' ALA . 81.3 mtp -47.65 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.82 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 80.43 55.68 3.38 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.637 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 39.8 t -138.15 161.72 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.47 ' N ' HG12 ' A' ' 136' ' ' VAL . 76.3 mt-10 -133.01 159.35 40.28 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.921 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.441 HG12 ' H ' ' A' ' 140' ' ' GLY . 11.2 t -99.49 156.99 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 p -84.48 -3.33 7.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.651 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.441 ' H ' HG12 ' A' ' 138' ' ' VAL . . . -133.69 94.36 0.27 Allowed Glycine 0 CA--C 1.519 0.286 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.43 67.94 5.69 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.154 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.35 145.15 98.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.47 1.447 . . . . 0.0 112.1 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' O ' ' OE1' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -155.72 23.71 0.39 Allowed 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.013 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 69.5 t -130.11 130.75 66.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt 47.98 -166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 146' ' ' ASP . 40.2 p-10 -80.63 112.99 18.51 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.009 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.374 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 5' ' ' VAL . 98.9 mttt . . . . . 0 C--O 1.223 -0.323 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 4' ' ' VAL . 12.4 p -42.22 121.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 3' ' ' LYS . 12.7 m -113.92 -24.76 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.09 129.68 24.29 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.978 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.715 ' O ' HG13 ' A' ' 7' ' ' VAL . 9.0 p -120.8 109.78 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.577 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG12 ' CD2' ' A' ' 10' ' ' LEU . 2.4 t -88.45 89.82 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.015 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -84.6 117.31 23.66 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 124.073 0.858 . . . . 0.0 109.704 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -179.92 -178.66 0.44 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.649 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.434 ' N ' ' NE2' ' A' ' 11' ' ' GLN . 0.7 OUTLIER -91.8 160.43 15.32 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.556 HD23 ' HD2' ' A' ' 13' ' ' PRO . 2.2 mt -151.53 133.93 8.5 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.556 ' HD2' HD23 ' A' ' 12' ' ' LEU . 45.1 Cg_endo -80.79 119.04 3.54 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.108 1.074 . . . . 0.0 114.213 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.926 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -51.97 137.9 25.9 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 53.56 -154.03 7.65 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 -176.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 15' ' ' GLY . 40.7 tttp 40.73 22.55 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.369 1.085 . . . . 0.0 111.008 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -96.84 159.58 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.13 167.31 8.73 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.144 -178.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.37 40.26 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.464 1.443 . . . . 0.0 112.159 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.561 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -146.14 53.31 1.76 Allowed Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.708 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 34.8 Cg_endo -80.17 165.6 21.29 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 120.901 1.067 . . . . 0.0 112.043 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -61.41 -24.88 79.21 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 120.827 1.018 . . . . 0.0 111.099 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.533 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.7 t -83.72 -66.66 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.676 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.02 -98.75 0.01 OUTLIER Glycine 0 N--CA 1.468 0.799 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 27' ' ' LEU . 2.7 Cg_endo -53.1 -57.17 2.16 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 CA-C-N 120.698 2.249 . . . . 0.0 110.334 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -43.29 -16.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 -178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 25' ' ' PRO . 1.3 tp -112.2 -38.02 4.86 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.09 -49.71 75.57 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.682 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -41.19 -29.49 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.022 0.911 . . . . 0.0 110.662 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -44.76 -37.43 3.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.551 0.691 . . . . 0.0 109.379 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 99.56 -23.23 37.02 Favored Glycine 0 C--O 1.225 -0.41 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.574 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -47.1 -135.94 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.223 0.609 . . . . 0.0 112.492 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -137.46 106.89 6.11 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.72 -0.613 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 37' ' ' PHE . 4.6 mm -52.52 -70.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 34' ' ' ILE . 10.0 tpt -39.56 -40.45 0.87 Allowed 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.2 -0.312 . . . . 0.0 110.498 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.28 -46.92 88.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' ILE . 57.5 t80 -50.7 -65.06 0.62 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 122.371 1.082 . . . . 0.0 109.504 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 42' ' ' ASN . 97.4 t -57.42 -44.29 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.169 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -46.27 -64.8 0.66 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.9 -38.94 70.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.249 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.856 ' CZ ' HG21 ' A' ' 45' ' ' THR . 68.1 t80 -64.2 -76.38 0.07 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 38' ' ' VAL . 20.4 t-20 -41.06 -45.49 2.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.586 0.708 . . . . 0.0 112.035 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.5 -35.99 73.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.305 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.21 -43.02 13.33 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.702 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.856 HG21 ' CZ ' ' A' ' 41' ' ' PHE . 47.1 p -67.47 -21.23 65.54 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -82.45 -37.51 25.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -65.51 -21.57 66.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.446 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.4 ptm -107.5 -29.27 9.31 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 117.62 171.04 15.35 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 51.1 p-10 -75.63 142.28 42.65 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.926 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -174.34 -150.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.903 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.701 HD13 ' N ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -139.87 135.81 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.701 ' N ' HD13 ' A' ' 52' ' ' ILE . 18.1 t -144.27 133.28 11.26 Favored Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.905 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.24 131.96 12.19 Favored 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 120.766 0.978 . . . . 0.0 109.646 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 1.5 p -140.53 156.98 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.862 0.839 . . . . 0.0 111.928 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 21.5 mt-10 -131.34 82.37 2.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.331 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 57' ' ' ILE . 21.9 mt -53.04 95.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.282 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.41 101.94 5.76 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.38 123.67 58.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.45 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -99.98 144.3 29.18 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.666 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -54.65 -22.29 13.18 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.042 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -66.03 6.42 0.39 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.666 ' H ' ' C ' ' A' ' 61' ' ' ALA . 84.0 mtm180 64.44 71.02 0.48 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.921 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 t -147.92 126.24 12.3 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.526 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -103.58 102.31 12.19 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -90.49 123.91 34.56 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER 173.47 118.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.565 -177.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -151.2 131.92 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.694 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.5 p -135.23 150.89 50.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.473 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 71' ' ' THR . 46.5 pttt -174.27 -158.3 0.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.504 ' O ' ' O ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER 80.34 60.0 0.14 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.912 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 71' ' ' THR . 19.7 Cg_exo -43.53 177.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.747 1.631 . . . . 0.0 112.916 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -54.67 -55.37 3.35 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.398 1.399 . . . . 0.0 114.924 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.811 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . -146.54 -66.63 0.28 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.0 p -36.64 -20.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.891 0.377 . . . . 0.0 110.43 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.646 ' N ' ' O ' ' A' ' 74' ' ' ALA . 1.8 t80 -40.29 -67.11 0.25 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.276 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.915 HD23 ' O ' ' A' ' 77' ' ' LEU . 6.9 tt -110.15 -19.94 12.85 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.811 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.2 mt -55.67 -42.21 68.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.031 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -44.54 -39.27 4.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.592 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -81.89 -60.42 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.49 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.73 13.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.43 . . . . 0.0 110.766 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -85.43 -78.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.39 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.34 41.43 0.23 Allowed Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 mt -94.59 112.86 24.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 . . . . . 0 C--N 1.33 -0.28 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.499 -179.649 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.2 mttp . . . . . 0 N--CA 1.462 0.154 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.454 HG22 ' N ' ' A' ' 97' ' ' GLY . 11.6 p -138.84 159.01 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.733 0.302 . . . . 0.0 110.25 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.454 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 104.54 84.38 1.76 Allowed Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.507 ' HE ' HG23 ' A' ' 139' ' ' VAL . 43.5 ttt180 -135.77 104.77 5.87 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.142 0.496 . . . . 0.0 111.219 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.512 HD12 ' CG1' ' A' ' 104' ' ' VAL . 3.1 pt -109.41 148.51 13.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.521 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.8 OUTLIER -89.1 160.28 17.11 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.164 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.79 ' NE1' HD11 ' A' ' 105' ' ' LEU . 76.0 t-105 -60.4 -54.17 48.85 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.605 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -59.97 -43.5 95.04 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.913 -1.117 . . . . 0.0 111.388 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -59.1 -45.53 90.64 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.978 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.512 ' CG1' HD12 ' A' ' 99' ' ' ILE . 29.8 m -64.88 -31.66 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 118.249 -1.381 . . . . 0.0 109.672 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.79 HD11 ' NE1' ' A' ' 101' ' ' TRP . 76.1 mt -61.74 -67.32 0.42 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.662 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -44.38 -41.59 6.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.198 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.52 HD11 HD22 ' A' ' 77' ' ' LEU . 97.3 mt -67.13 -29.12 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.104 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -91.77 -3.3 56.34 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.749 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 111' ' ' LYS . 44.1 mtpt -85.74 -72.73 0.48 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.866 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.58 -0.89 0.3 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.027 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.591 ' NZ ' ' HB2' ' A' ' 123' ' ' ALA . 1.4 pptp? -68.9 -16.72 63.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.616 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.481 ' SD ' ' NZ ' ' A' ' 111' ' ' LYS . 5.9 ptt? -123.91 70.15 48.85 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.444 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 15.2 Cg_exo -53.84 -40.52 80.07 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 120.653 0.902 . . . . 0.0 112.082 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 113' ' ' PRO . 80.6 m-20 -149.78 14.93 0.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.58 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 115' ' ' LEU . 9.6 mp -71.32 160.53 32.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.2 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.57 ' C ' HD22 ' A' ' 116' ' ' ASN . 0.2 OUTLIER -70.56 64.72 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.096 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.0 m -162.04 140.04 8.87 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.374 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.74 -2.76 0.35 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.99 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.87 124.41 34.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.298 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 36.0 mt -62.09 -42.95 99.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.576 0.703 . . . . 0.0 110.266 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.4 -36.63 71.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.983 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.61 -69.4 0.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.591 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.591 ' HB2' ' NZ ' ' A' ' 111' ' ' LYS . . . -47.13 -33.09 4.76 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.133 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -61.13 -66.58 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.1 mtt180 -46.35 -33.78 4.08 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.793 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.465 ' O ' ' CB ' ' A' ' 130' ' ' SER . 34.4 ttp -59.57 -73.83 0.08 Allowed 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 mm -50.56 -48.31 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.739 0.304 . . . . 0.0 110.826 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -68.15 -70.82 0.24 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.05 -45.8 6.17 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 126' ' ' MET . 67.5 m -56.41 -42.45 78.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.693 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -55.85 -46.65 78.13 Favored 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.538 ' HG2' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -54.67 -44.11 73.02 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 t -51.96 -69.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 74.4 mtp -41.96 -66.39 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.674 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.22 55.05 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.693 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 49.2 t -134.6 161.14 40.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.478 ' N ' HG12 ' A' ' 136' ' ' VAL . 96.2 mt-10 -124.3 152.9 42.5 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.534 HG12 ' H ' ' A' ' 140' ' ' GLY . 8.1 t -104.07 133.37 48.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 100' ' ' THR . 1.6 p -70.37 -3.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.799 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.534 ' H ' HG12 ' A' ' 138' ' ' VAL . . . . . . . . 0 N--CA 1.463 0.452 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 tttt . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 4' ' ' VAL . 12.9 p -64.76 119.92 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.03 -24.49 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 119.211 -0.423 . . . . 0.0 109.88 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.55 134.83 27.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.588 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 7' ' ' VAL . 13.4 p -124.98 125.51 69.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.207 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.61 93.47 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 119.644 1.111 . . . . 0.0 111.556 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -84.05 118.12 23.86 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.836 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.444 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -171.41 -173.79 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.648 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -90.18 149.29 22.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.833 HD22 ' CE2' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -140.59 93.39 8.69 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 123.154 0.284 . . . . 0.0 110.315 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -67.47 123.18 10.51 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.141 1.227 . . . . 0.0 114.224 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.887 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -54.49 136.73 44.17 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 54.89 -155.78 8.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 15' ' ' GLY . 97.3 mttt 41.47 20.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.118 0.959 . . . . 0.0 111.165 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -97.04 158.52 15.39 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.61 167.68 7.89 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.245 -179.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.79 42.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.136 1.224 . . . . 0.0 112.024 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.539 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -150.53 55.58 1.82 Allowed Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.599 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 32.5 Cg_endo -79.47 164.8 23.57 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 120.819 1.013 . . . . 0.0 112.105 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -63.18 -24.37 72.75 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.768 0.979 . . . . 0.0 111.359 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.714 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.5 t -77.01 -64.67 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 44.04 -99.01 0.01 OUTLIER Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 28' ' ' GLY . 14.4 Cg_exo -48.95 -59.63 1.17 Allowed 'Trans proline' 0 C--N 1.32 -0.971 0 CA-C-N 119.991 1.896 . . . . 0.0 110.561 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.714 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -44.36 -24.01 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.381 -0.527 . . . . 0.0 109.886 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 39.4 tp -119.91 31.96 6.28 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.907 0.86 . . . . 0.0 109.495 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' PRO . . . -126.24 -64.34 0.16 Allowed Glycine 0 C--N 1.319 -0.363 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 28' ' ' GLY . 65.6 tp60 -42.29 -25.26 0.07 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.734 0.767 . . . . 0.0 109.699 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.483 ' N ' ' C ' ' A' ' 28' ' ' GLY . 37.6 t-80 -42.63 -39.14 2.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.44 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 97.68 -24.43 31.63 Favored Glycine 0 C--N 1.331 0.28 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -48.94 -135.68 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.093 0.557 . . . . 0.0 112.272 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -136.88 130.31 31.52 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.096 -0.377 . . . . 0.0 110.874 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 37' ' ' PHE . 3.5 mm -82.16 -72.24 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.3 tpt -39.57 -40.51 0.88 Allowed 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.14 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -60.78 -49.81 76.0 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.255 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 34' ' ' ILE . 87.6 t80 -47.02 -60.54 2.38 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.099 0.952 . . . . 0.0 109.795 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 42' ' ' ASN . 59.9 t -59.85 -44.05 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.348 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 84.5 tttt -46.66 -66.12 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.99 76.11 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.627 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.833 ' CE2' HD22 ' A' ' 12' ' ' LEU . 33.3 t80 -62.97 -75.8 0.07 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' VAL . 6.3 t-20 -40.53 -45.33 2.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.389 0.614 . . . . 0.0 111.974 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.446 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -57.44 -34.84 69.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.037 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.42 -44.79 12.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.371 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 49' ' ' GLY . 45.8 p -65.36 -21.61 66.71 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -77.0 -45.15 28.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 43' ' ' ALA . 5.1 m120 -62.48 -16.11 53.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.4 mmm -106.8 -70.92 0.77 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.268 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 160.15 -162.22 33.04 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 40.0 p-10 -99.86 122.3 42.59 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.887 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -156.8 -153.14 0.4 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.28 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mm -137.71 127.79 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.708 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.7 t -144.26 124.97 7.69 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.774 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -73.94 147.93 39.68 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 120.745 0.963 . . . . 0.0 110.639 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.675 HG21 HD12 ' A' ' 12' ' ' LEU . 34.0 m -143.19 160.83 17.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.257 0.551 . . . . 0.0 111.246 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 58' ' ' THR . 93.8 mt-10 -129.38 76.74 1.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.5 mt -50.87 86.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.874 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -72.99 95.17 1.96 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.462 HG21 ' NE2' ' A' ' 30' ' ' HIS . 60.8 mt -95.6 125.13 48.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.693 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 63' ' ' ARG . 3.4 m-85 -100.63 140.35 35.03 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.625 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.63 -23.33 2.52 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 124.584 1.178 . . . . 0.0 112.366 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -66.89 5.82 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.625 ' H ' ' C ' ' A' ' 61' ' ' ALA . 59.8 mtp180 63.88 69.69 0.53 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.341 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.9 p -146.47 127.55 14.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.959 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -105.04 103.44 13.0 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.622 -177.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.512 ' O ' ' OG1' ' A' ' 58' ' ' THR . 41.1 p -95.21 122.91 38.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.56 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.5 p90 176.32 -152.74 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 48.9 t 80.35 117.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 124.408 1.067 . . . . 0.0 111.381 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -124.58 127.56 47.56 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -143.8 -170.33 3.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.701 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 m 66.0 52.07 0.83 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.586 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.701 ' HD3' ' N ' ' A' ' 71' ' ' THR . 1.4 Cg_endo -73.73 162.57 39.26 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 120.859 1.039 . . . . 0.0 112.553 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -73.75 91.24 0.91 Allowed 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.552 1.502 . . . . 0.0 113.189 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.818 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . . . 179.69 -171.53 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.511 ' OG ' ' NH1' ' A' ' 79' ' ' ARG . 2.5 m -38.91 -17.32 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.818 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 74.9 m-85 -45.69 -42.24 11.43 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.297 0.373 . . . . 0.0 110.392 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.845 HD22 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -130.74 -13.98 3.64 Favored 'General case' 0 C--O 1.254 1.318 0 CA-C-O 122.304 1.049 . . . . 0.0 108.891 178.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.845 ' N ' HD22 ' A' ' 77' ' ' LEU . 17.4 mt -65.34 -41.74 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.987 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.603 ' HG2' HH11 ' A' ' 79' ' ' ARG . 0.0 OUTLIER -51.76 -41.61 61.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.661 179.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -63.21 -63.18 1.27 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.27 69.6 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.491 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -79.52 -83.84 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.553 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 137.6 -76.87 0.35 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.9 mt 42.34 -160.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 C--N 1.329 -0.292 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.466 178.854 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.427 0.156 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -144.96 150.61 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 137' ' ' GLU . . . 82.4 75.96 1.12 Allowed Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -131.0 116.94 18.49 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.621 0.248 . . . . 0.0 110.624 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 mt -109.71 150.11 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.468 HG21 ' NE2' ' A' ' 103' ' ' GLN . 3.0 p -82.0 149.35 28.18 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.912 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.629 ' NE1' HD11 ' A' ' 105' ' ' LEU . 66.8 t-105 -57.7 -52.05 67.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.092 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -58.77 -40.94 85.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.329 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.468 ' NE2' HG21 ' A' ' 100' ' ' THR . 58.3 mt-30 -60.62 -48.47 81.63 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.9 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.87 -32.78 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.658 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.629 HD11 ' NE1' ' A' ' 101' ' ' TRP . 50.5 mt -59.5 -68.37 0.29 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.655 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -44.59 -46.2 9.89 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.284 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.57 -29.24 38.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.946 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.753 ' HB2' HD12 ' A' ' 127' ' ' ILE . . . -101.66 -8.23 21.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.651 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 105' ' ' LEU . 75.0 tttt -77.6 -75.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.007 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -59.58 -20.96 59.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.631 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -97.75 102.02 13.67 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.721 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 115' ' ' LEU . 6.6 mmt -140.05 55.34 6.35 Favored Pre-proline 0 C--O 1.236 0.373 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.129 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 112' ' ' MET . 14.5 Cg_exo -50.57 -54.8 4.85 Favored 'Trans proline' 0 N--CA 1.488 1.206 0 C-N-CA 120.671 0.914 . . . . 0.0 112.067 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -126.92 -29.27 2.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.345 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -75.14 38.99 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.072 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.69 HD22 ' N ' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -84.85 46.82 1.3 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.704 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.446 ' OG1' ' HB3' ' A' ' 122' ' ' ALA . 5.5 p -73.33 32.54 0.07 Allowed 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.855 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 116' ' ' ASN . 9.8 t 39.43 29.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.26 0.35 . . . . 0.0 110.73 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 117' ' ' THR . 74.9 m-20 -150.95 125.37 9.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.458 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 83.8 mt -62.95 -34.47 77.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.258 0.552 . . . . 0.0 110.788 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.67 -37.17 62.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.512 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.446 ' HB3' ' OG1' ' A' ' 117' ' ' THR . . . -72.39 -69.4 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.056 -1.058 . . . . 0.0 109.35 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.696 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -50.6 -32.72 19.61 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.192 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -60.91 -70.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 129' ' ' GLY . 62.7 ttt180 -42.95 -30.78 0.44 Allowed 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.508 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 4.7 tmm? -58.38 -73.08 0.08 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.753 HD12 ' HB2' ' A' ' 108' ' ' ALA . 88.0 mt -50.69 -51.3 20.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.023 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -63.66 -71.55 0.17 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.73 -45.76 4.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.508 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 67.2 m -58.75 -44.65 90.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.626 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -51.59 -47.83 63.42 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -55.26 -42.28 73.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.4 t -55.26 -72.13 0.07 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.4 mtm -42.17 -34.71 0.79 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.773 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.38 49.11 0.57 Allowed Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.626 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 43.0 t -136.05 164.93 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.541 ' N ' HG12 ' A' ' 136' ' ' VAL . 81.9 tt0 -130.13 158.72 38.9 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.54 ' C ' ' H ' ' A' ' 140' ' ' GLY . 53.9 t -111.56 160.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.5 ' N ' HG12 ' A' ' 138' ' ' VAL . 9.8 p -64.48 8.45 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.091 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.7 tptm . . . . . 0 C--O 1.233 0.205 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.63 138.23 19.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 m -118.82 -25.44 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.188 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.44 143.04 29.82 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.853 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 7' ' ' VAL . 15.0 p -133.84 133.03 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.563 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.42 92.67 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 120.067 1.303 . . . . 0.0 111.757 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -82.81 116.07 21.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -167.85 -173.78 2.22 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.536 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -90.76 143.78 26.38 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.615 HD12 ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -123.68 86.84 52.73 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -65.71 114.91 3.12 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.54 1.493 . . . . 0.0 114.642 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.751 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -74.9 146.54 41.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 174.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.73 58.33 10.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt 173.61 -24.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.91 150.29 45.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -160.39 167.54 13.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.115 -178.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -59.32 48.07 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.618 1.546 . . . . 0.0 112.711 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -169.53 53.87 0.23 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.504 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 20' ' ' ALA . 18.2 Cg_endo -68.1 166.1 26.12 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.032 1.155 . . . . 0.0 112.247 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -65.33 -22.18 60.41 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.803 1.002 . . . . 0.0 111.239 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.545 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.7 t -72.49 -64.32 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.554 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 25' ' ' PRO . . . 59.2 -137.48 50.23 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 118.619 -1.753 . . . . 0.0 109.485 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.688 ' C ' ' H ' ' A' ' 27' ' ' LEU . 28.2 Cg_exo -38.23 -41.32 1.35 Allowed 'Trans proline' 0 N--CA 1.486 1.06 0 CA-C-N 120.607 2.204 . . . . 0.0 110.853 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.545 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -57.47 13.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.811 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.688 ' H ' ' C ' ' A' ' 25' ' ' PRO . 3.5 tt -172.27 -48.7 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.579 ' N ' HD23 ' A' ' 27' ' ' LEU . . . -59.01 -48.9 83.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -73.96 35.55 0.09 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.471 0.653 . . . . 0.0 110.272 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.63 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -84.88 -19.93 31.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.258 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 106.2 -43.85 1.59 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -49.35 -131.32 0.0 OUTLIER 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.335 0.654 . . . . 0.0 111.79 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -137.91 143.44 40.83 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.762 -0.586 . . . . 0.0 110.525 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' PHE . 6.7 mt -88.88 -70.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.1 tpt -40.85 -39.6 1.17 Allowed 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -57.11 -49.32 76.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.631 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 64.2 t80 -48.78 -59.89 3.19 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.452 1.12 . . . . 0.0 109.501 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' ASN . 57.4 t -61.59 -42.73 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 113.391 -1.731 . . . . 0.0 111.281 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.0 tppp? -46.25 -57.9 4.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.65 95.08 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 119.921 -0.711 . . . . 0.0 110.127 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 12' ' ' LEU . 2.0 t80 -62.81 -74.78 0.09 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -40.01 -43.32 1.54 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 121.558 0.694 . . . . 0.0 111.779 -177.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -59.09 -36.39 75.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.261 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.12 -46.8 10.09 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.113 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.649 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 82.5 p -60.87 -37.77 83.28 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -65.22 -36.74 85.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -63.88 -18.6 64.34 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.756 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -103.79 -42.98 5.45 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.634 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 116.75 74.29 0.53 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.399 -0.667 . . . . 0.0 111.868 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.634 ' O ' ' O ' ' A' ' 49' ' ' GLY . 2.9 p30 44.93 159.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.883 0.373 . . . . 0.0 111.482 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.751 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 170.81 -163.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.293 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.5 mt -141.06 131.23 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.99 125.52 4.94 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.833 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.42 149.78 31.49 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 CA-C-N 119.485 0.852 . . . . 0.0 110.86 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.553 ' CG2' HD23 ' A' ' 12' ' ' LEU . 35.0 m -144.64 161.92 14.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.434 0.635 . . . . 0.0 111.416 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 58' ' ' THR . 95.2 mt-10 -127.33 80.93 1.99 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.407 ' H ' HG13 ' A' ' 57' ' ' ILE . 44.1 mt -54.04 88.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.043 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -66.21 110.53 3.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.4 mt -107.91 125.0 64.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.363 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -104.12 140.13 38.22 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.627 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.73 -21.78 1.79 Allowed 'General case' 0 C--N 1.341 0.232 0 O-C-N 124.226 0.954 . . . . 0.0 112.218 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -68.33 6.12 0.85 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.627 ' H ' ' C ' ' A' ' 61' ' ' ALA . 87.4 mtm180 64.62 67.8 0.55 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.355 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.7 m -143.21 127.14 17.29 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.854 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -108.39 102.49 11.59 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.606 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.4 p -93.95 126.06 38.93 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.631 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 5.6 p90 -174.96 130.99 0.31 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.918 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 69' ' ' THR . 44.5 t -137.05 156.06 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.404 ' N ' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -177.71 121.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.949 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -177.51 -179.65 0.85 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.317 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.513 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 21.9 p 55.93 61.01 8.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.054 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 71' ' ' THR . 3.7 Cg_endo -75.27 164.1 33.5 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 120.897 1.065 . . . . 0.0 112.418 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.67 ' HA ' HD11 ' A' ' 77' ' ' LEU . 13.8 Cg_endo -72.2 176.51 8.43 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 121.899 1.732 . . . . 0.0 112.178 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.731 ' O ' HD12 ' A' ' 77' ' ' LEU . . . 79.56 -174.54 0.06 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.909 0.322 . . . . 0.0 111.051 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.549 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.7 OUTLIER -39.99 -19.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.088 -178.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.552 ' N ' ' O ' ' A' ' 74' ' ' ALA . 10.1 m-85 -45.48 -35.95 4.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.697 0.623 . . . . 0.0 111.057 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.84 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.91 -25.52 1.83 Allowed 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.8 0.81 . . . . 0.0 109.021 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 73.7 mt -55.5 -35.47 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.666 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -53.73 -43.96 69.5 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.223 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -64.55 -65.34 0.69 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.35 -13.45 0.56 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.979 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.67 -76.62 0.39 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.765 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.48 48.84 0.58 Allowed Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.0 mt -98.7 124.05 43.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.3 mttm . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -145.24 144.13 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.634 0.254 . . . . 0.0 110.35 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 46.95 87.18 0.01 OUTLIER Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -116.39 106.25 13.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.977 0.418 . . . . 0.0 111.23 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.703 HD12 HG11 ' A' ' 104' ' ' VAL . 7.4 pt -100.94 144.91 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -85.45 156.87 20.64 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.439 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.6 ' NE1' HD11 ' A' ' 105' ' ' LEU . 49.3 t-105 -63.73 -51.06 66.64 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.615 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.23 -43.4 98.95 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.152 -0.967 . . . . 0.0 111.533 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -61.33 -46.96 88.08 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.696 -0.801 . . . . 0.0 111.227 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.703 HG11 HD12 ' A' ' 99' ' ' ILE . 35.5 m -65.2 -33.56 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 118.235 -1.386 . . . . 0.0 109.414 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.6 HD11 ' NE1' ' A' ' 101' ' ' TRP . 40.8 mt -59.48 -65.69 0.63 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.392 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -44.86 -51.15 9.87 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.049 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.34 -31.46 46.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.787 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.536 ' HB1' ' HB1' ' A' ' 123' ' ' ALA . . . -91.55 -8.07 48.48 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.675 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 105' ' ' LEU . 45.3 tttm -85.56 -71.57 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 109.919 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.63 -40.72 60.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.395 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -69.89 66.08 0.24 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.384 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.436 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 38.8 mtm -157.65 54.84 0.84 Allowed Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.568 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 112' ' ' MET . 9.8 Cg_endo -65.13 -55.7 0.45 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 120.805 1.003 . . . . 0.0 111.85 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 113' ' ' PRO . 57.5 m-20 -160.01 15.5 0.14 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.398 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.9 mt -46.61 -86.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.319 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -170.8 -18.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.25 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 70.1 p -83.33 167.51 17.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.1 0.476 . . . . 0.0 111.15 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -140.59 -85.83 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.401 -178.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.516 ' H ' HG23 ' A' ' 118' ' ' THR . 90.9 m-20 -58.67 159.55 6.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.447 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 37.5 mt -61.77 -37.27 83.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 0.0 110.161 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -52.9 -37.79 61.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.281 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.17 -69.0 0.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 118.981 -1.087 . . . . 0.0 109.067 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.536 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -49.51 -35.52 20.26 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.227 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -59.09 -69.83 0.18 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.0 mtt180 -43.76 -30.57 0.67 Allowed 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.758 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.459 ' O ' ' CB ' ' A' ' 130' ' ' SER . 2.9 tmm? -59.31 -73.07 0.09 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.0 mm -51.69 -48.98 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.032 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -67.71 -70.44 0.26 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.61 -43.22 4.97 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 126' ' ' MET . 68.8 m -58.64 -42.64 88.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -56.07 -48.99 75.01 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -51.39 -41.38 60.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.546 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.6 t -54.77 -66.77 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 86.5 mtp -50.75 -4.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.812 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 91.21 -27.72 8.96 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 137' ' ' GLU . 55.1 t -47.38 164.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.556 ' N ' HG12 ' A' ' 136' ' ' VAL . 97.7 mt-10 -141.23 161.9 36.77 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.056 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 140' ' ' GLY . 83.0 t -88.09 152.44 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 139' ' ' VAL . 7.8 p -61.3 2.68 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.285 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.524 0.617 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.224 -0.259 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 4' ' ' VAL . 14.2 p -51.9 112.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.639 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.8 -24.18 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.89 132.4 23.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.102 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.7 ' O ' HG13 ' A' ' 7' ' ' VAL . 8.6 p -122.56 105.29 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.687 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.438 ' CG1' HD21 ' A' ' 10' ' ' LEU . 4.6 t -76.64 91.66 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 118.741 -1.184 . . . . 0.0 109.626 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -89.32 106.43 18.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.511 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.506 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -175.32 -173.77 0.68 Allowed 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.024 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -100.95 163.23 12.39 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.479 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.561 HD12 HG21 ' A' ' 55' ' ' VAL . 2.2 mt -153.51 137.3 10.48 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.48 ' HD2' HD23 ' A' ' 12' ' ' LEU . 57.7 Cg_endo -87.53 125.27 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 CA-C-N 120.366 1.166 . . . . 0.0 114.114 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.802 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -59.33 139.17 57.27 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . 57.79 152.8 0.01 OUTLIER Glycine 0 CA--C 1.536 1.345 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 50.4 tttt 77.34 13.97 1.91 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.797 1.799 . . . . 0.0 111.373 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 18' ' ' THR . . . -91.19 157.97 16.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.99 167.56 4.87 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.653 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.09 39.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.709 1.606 . . . . 0.0 112.61 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.544 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -146.52 54.08 1.99 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.043 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 38.9 Cg_endo -82.49 164.24 16.61 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 120.972 1.114 . . . . 0.0 112.142 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -62.33 -25.7 76.63 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 120.8 1.0 . . . . 0.0 111.024 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.04 -71.57 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.034 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 46.47 -101.24 0.03 OUTLIER Glycine 0 C--O 1.214 -1.151 0 CA-C-O 118.574 -1.125 . . . . 0.0 111.099 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.627 ' C ' ' H ' ' A' ' 27' ' ' LEU . 19.4 Cg_exo -43.57 -56.29 2.46 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 CA-C-N 121.479 2.639 . . . . 0.0 110.728 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.71 23.9 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.599 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.627 ' H ' ' C ' ' A' ' 25' ' ' PRO . 12.7 tp -169.98 -47.37 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -59.35 -51.39 59.44 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.529 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -73.57 41.28 0.11 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.014 0.907 . . . . 0.0 109.9 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -89.35 -21.29 23.18 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 106.86 -38.82 3.13 Favored Glycine 0 N--CA 1.462 0.431 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.555 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -50.87 -134.98 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -137.14 125.93 24.01 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.484 -0.76 . . . . 0.0 110.4 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.571 ' O ' ' N ' ' A' ' 37' ' ' PHE . 10.9 mm -67.92 -70.55 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.409 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -39.53 -36.93 0.43 Allowed 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.505 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -61.89 -47.1 86.51 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.64 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 59.0 t80 -51.05 -65.1 0.61 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.412 1.101 . . . . 0.0 109.201 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 42' ' ' ASN . 96.4 t -57.07 -42.45 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.276 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 88.2 tttt -49.81 -60.94 2.44 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.685 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.72 79.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.355 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.64 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 8.8 m-85 -64.9 -76.44 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' VAL . 8.9 t-20 -39.3 -49.42 1.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.358 0.599 . . . . 0.0 111.973 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -57.32 -34.01 68.31 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.864 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.83 -46.91 9.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.054 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.507 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 76.7 p -62.94 -24.01 67.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -84.89 -35.74 21.97 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -60.45 -25.63 66.14 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.476 ' CG ' ' N ' ' A' ' 49' ' ' GLY . 6.6 ptm -107.14 -55.65 2.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.383 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' A' ' 48' ' ' MET . . . 152.68 170.9 19.6 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.298 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -73.56 141.26 46.68 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 122.475 -0.426 . . . . 0.0 110.028 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.802 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -172.56 -152.26 0.06 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.155 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 13' ' ' PRO . 40.8 mm -139.07 130.5 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.3 t -145.02 134.68 11.52 Favored Pre-proline 0 C--O 1.246 0.893 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.188 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -76.1 148.5 31.25 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 120.589 0.859 . . . . 0.0 110.384 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.561 HG21 HD12 ' A' ' 12' ' ' LEU . 25.6 m -146.06 137.04 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.504 0.669 . . . . 0.0 111.967 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 78.0 mt-10 -117.76 75.07 0.97 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 57' ' ' ILE . 23.4 mt -58.26 93.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.944 -176.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.36 95.29 1.72 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.9 mt -95.12 120.99 45.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -98.15 142.02 30.36 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.626 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.33 -20.18 1.01 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.846 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 93.3 m-20 -73.23 30.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.626 ' H ' ' C ' ' A' ' 61' ' ' ALA . 5.2 ptm180 40.31 69.77 0.29 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 122.305 1.05 . . . . 0.0 110.888 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 99.4 p -144.84 125.61 14.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.052 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -102.85 101.83 11.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.382 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 1.2 p -93.77 178.08 5.79 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CB ' ' O ' ' A' ' 66' ' ' THR . 1.9 t80 82.17 -154.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -177.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.422 HG23 ' C ' ' A' ' 67' ' ' PHE . 6.3 t 82.25 72.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 123.871 0.732 . . . . 0.0 111.791 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.0 t -68.49 154.14 42.43 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.397 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -175.7 178.57 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.652 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.7 p 51.61 82.68 0.24 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.766 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.87 177.08 2.53 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.438 1.425 . . . . 0.0 112.441 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -74.98 4.6 4.58 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.398 1.399 . . . . 0.0 113.825 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -72.18 -152.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.832 0.349 . . . . 0.0 110.758 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -39.38 -15.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.691 0.397 . . . . 0.0 111.431 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.59 ' N ' ' O ' ' A' ' 74' ' ' ALA . 2.5 t80 -40.37 -47.75 2.59 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.976 0.798 . . . . 0.0 110.604 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.772 ' C ' HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -133.42 -14.92 2.52 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.787 0.803 . . . . 0.0 108.885 179.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.618 HD11 HG23 ' A' ' 127' ' ' ILE . 22.9 mt -60.45 -38.12 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.418 HH11 ' HB2' ' A' ' 84' ' ' LEU . 11.3 mmm180 -50.29 -44.66 54.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.265 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -66.42 -61.07 2.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.66 -21.7 7.42 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.089 -0.645 . . . . 0.0 110.597 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -87.49 -77.91 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.807 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.63 19.41 3.76 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.418 ' HB2' HH11 ' A' ' 79' ' ' ARG . 22.3 mt -69.11 139.05 54.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.701 -179.863 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.831 0.348 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.539 HG22 ' N ' ' A' ' 97' ' ' GLY . 13.6 p -145.36 163.31 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.23 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 88.76 75.51 1.29 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -136.82 119.29 15.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.129 0.49 . . . . 0.0 111.25 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 104' ' ' VAL . 5.6 pt -108.65 148.3 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.261 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.479 HG21 ' NE2' ' A' ' 103' ' ' GLN . 1.2 p -80.73 145.86 31.33 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.454 0.645 . . . . 0.0 110.832 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.436 ' CE2' HD21 ' A' ' 105' ' ' LEU . 62.6 t-105 -53.26 -70.53 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.374 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -43.78 -38.09 3.06 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.216 -0.928 . . . . 0.0 111.482 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.479 ' NE2' HG21 ' A' ' 100' ' ' THR . 42.1 mt-30 -61.44 -48.5 80.87 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.821 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 99' ' ' ILE . 2.0 m -63.78 -27.77 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 117.711 -1.596 . . . . 0.0 109.099 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 109' ' ' LYS . 35.9 mt -62.43 -70.86 0.18 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.654 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -45.87 -48.4 15.95 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.39 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.537 HG21 HD21 ' A' ' 77' ' ' LEU . 61.4 mt -60.88 -30.39 47.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.934 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.521 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -98.9 -2.53 37.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.026 -0.421 . . . . 0.0 110.681 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 105' ' ' LEU . 68.7 tttt -89.08 -75.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.333 . . . . 0.0 111.026 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.29 -36.6 71.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.649 0.261 . . . . 0.0 111.46 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.43 48.68 0.11 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.049 0.452 . . . . 0.0 111.745 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.521 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 1.3 ptt? -171.64 58.04 0.25 Allowed Pre-proline 0 C--N 1.322 -0.628 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.615 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 112' ' ' MET . 14.0 Cg_exo -54.13 -38.59 87.61 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 120.508 0.805 . . . . 0.0 111.808 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -168.07 34.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.994 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.565 HD23 ' O ' ' A' ' 115' ' ' LEU . 2.8 tt -61.36 -52.19 65.65 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.239 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.547 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -174.38 -6.99 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.332 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.9 p -140.61 175.21 9.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.146 0.498 . . . . 0.0 111.758 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.33 -37.56 0.42 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.432 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -76.55 145.32 39.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.985 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.504 HD21 ' HG3' ' A' ' 109' ' ' LYS . 1.1 mm? -61.24 -45.47 94.39 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 121.505 0.669 . . . . 0.0 110.254 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.48 -36.75 69.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.451 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.45 -69.08 0.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.772 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.14 -40.21 45.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.173 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -54.39 -68.99 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.2 mtt180 -44.09 -28.8 0.53 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.081 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.46 ' O ' ' CB ' ' A' ' 130' ' ' SER . 5.6 tmm? -59.83 -71.06 0.14 Allowed 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.618 HG23 HD11 ' A' ' 78' ' ' ILE . 9.5 mt -51.41 -50.48 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.728 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -64.63 -71.74 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.25 -45.27 5.16 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 126' ' ' MET . 62.5 m -60.26 -41.07 92.48 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -54.86 -47.19 74.52 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -54.5 -41.77 70.01 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 135' ' ' GLY . 1.9 t -57.01 -71.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 80.1 mtp -43.73 -13.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.329 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 90.66 46.14 4.07 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.588 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 53.2 t -137.58 142.66 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.43 167.8 10.41 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 140' ' ' GLY . 12.0 t -89.9 144.52 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.03 0.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.291 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.524 0.604 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' HG13 ' A' ' 5' ' ' VAL . 99.2 mttt . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 60' ' ' TYR . 7.0 p -40.55 124.72 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 3' ' ' LYS . 31.1 m -113.88 -24.07 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.64 135.86 32.12 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.869 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 7' ' ' VAL . 12.6 p -124.65 123.62 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.195 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.63 92.05 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.638 1.108 . . . . 0.0 111.004 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -75.16 112.93 11.94 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -170.45 -173.85 1.53 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.383 0.611 . . . . 0.0 110.583 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -99.49 157.61 16.32 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.555 HD12 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -133.8 89.05 31.19 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -58.09 135.09 66.31 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.446 1.431 . . . . 0.0 114.442 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.892 ' HB3' ' H ' ' A' ' 51' ' ' ALA . . . -91.83 144.43 25.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.59 40.84 33.03 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -170.26 8.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.237 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 18' ' ' THR . . . -91.21 150.12 21.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -158.05 164.89 19.91 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.021 -178.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -61.69 47.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.658 1.572 . . . . 0.0 112.456 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -169.85 54.17 0.23 Allowed Pre-proline 0 C--N 1.322 -0.627 0 O-C-N 122.153 -0.342 . . . . 0.0 110.696 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 22.2 Cg_endo -73.57 172.27 16.08 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 121.066 1.177 . . . . 0.0 112.24 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -57.51 -21.46 46.01 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 120.525 0.817 . . . . 0.0 111.056 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.579 ' CG1' ' HB3' ' A' ' 26' ' ' ALA . 2.2 t -82.93 -64.11 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.794 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 45.7 -100.48 0.02 OUTLIER Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.71 -1.05 . . . . 0.0 110.72 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.5 Cg_exo -50.64 -57.92 1.99 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 CA-C-N 120.678 2.239 . . . . 0.0 111.054 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.579 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.49 -17.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.596 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -113.96 -39.6 3.92 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.18 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.64 51.0 3.26 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -142.33 -13.25 0.8 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.367 0.603 . . . . 0.0 109.794 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.573 ' CE1' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.66 -15.48 62.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.938 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.604 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 100.88 -32.99 6.8 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.604 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -46.43 -133.8 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.393 0.677 . . . . 0.0 112.357 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -136.2 144.97 45.2 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.904 -0.498 . . . . 0.0 110.483 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 37' ' ' PHE . 4.5 mm -94.03 -73.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.52 ' C ' ' SD ' ' A' ' 35' ' ' MET . 3.7 ppp? -41.14 -35.82 0.64 Allowed 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.23 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -59.72 -52.64 64.64 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 90.1 t80 -47.84 -58.94 3.73 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.469 1.128 . . . . 0.0 109.241 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 42' ' ' ASN . 75.3 t -60.76 -44.65 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.156 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 35' ' ' MET . 88.3 tttt -45.21 -64.68 0.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.04 74.13 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.433 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.455 ' CE2' HG21 ' A' ' 45' ' ' THR . 48.9 t80 -62.15 -76.36 0.06 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -40.28 -43.4 1.71 Allowed 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 121.311 0.577 . . . . 0.0 111.822 -177.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.05 -34.17 69.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.93 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.19 -47.11 10.43 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.829 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.455 HG21 ' CE2' ' A' ' 41' ' ' PHE . 71.8 p -62.57 -32.33 73.29 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -69.17 -41.02 77.77 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -63.66 -18.49 64.02 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 70.8 mtm -107.22 -86.67 0.49 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.788 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -174.7 -165.72 31.54 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.359 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 34.1 p-10 -93.5 130.18 39.44 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.892 ' H ' ' HB3' ' A' ' 14' ' ' ALA . . . -162.41 -152.45 0.23 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.296 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.4 mt -141.99 132.1 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 69' ' ' THR . 99.1 t -124.7 108.07 28.77 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -74.02 112.09 3.46 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 120.793 0.995 . . . . 0.0 109.698 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 56' ' ' GLU . 6.5 p -144.35 164.61 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 121.488 0.661 . . . . 0.0 112.2 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.621 ' N ' HG22 ' A' ' 55' ' ' VAL . 12.7 mt-10 -123.19 115.93 22.58 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.408 HD13 ' CZ ' ' A' ' 37' ' ' PHE . 54.2 mt -74.92 94.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.917 0.389 . . . . 0.0 111.757 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -69.42 102.21 1.73 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 mt -100.73 123.62 53.81 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-O 120.844 0.354 . . . . 0.0 111.163 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 18.2 m-85 -99.3 143.17 29.86 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.505 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.64 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -53.74 -24.44 14.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 124.717 1.261 . . . . 0.0 112.375 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 41.0 t0 -67.72 7.57 0.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.64 ' H ' ' C ' ' A' ' 61' ' ' ALA . 98.5 mtt180 62.5 70.37 0.57 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.252 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 p -145.3 134.08 22.33 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.947 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -111.55 103.81 12.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.651 -178.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.7 p -96.8 123.22 40.44 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 5.9 p90 177.98 -150.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -175.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 53.2 t 80.56 104.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 124.344 1.028 . . . . 0.0 111.766 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' HG13 ' A' ' 53' ' ' VAL . 1.1 p -122.59 112.72 18.33 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.497 ' C ' HG22 ' A' ' 71' ' ' THR . 12.4 mmtt -143.8 -150.29 0.31 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.669 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 4.8 t 47.0 53.47 13.83 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 123.699 0.624 . . . . 0.0 110.442 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.669 ' HD3' ' N ' ' A' ' 71' ' ' THR . 6.5 Cg_endo -79.36 175.79 10.37 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 120.727 0.952 . . . . 0.0 112.399 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.725 ' HA ' HD11 ' A' ' 77' ' ' LEU . 1.7 Cg_endo -64.7 -172.22 0.19 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.608 1.538 . . . . 0.0 111.246 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 73' ' ' PRO . . . 78.99 -176.72 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.578 0.228 . . . . 0.0 110.729 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 1.6 p -40.92 -20.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.474 -0.141 . . . . 0.0 110.652 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 74' ' ' ALA . 11.9 m-85 -43.28 -44.26 5.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.366 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.956 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.58 -25.4 3.43 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 122.068 0.937 . . . . 0.0 109.018 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 82' ' ' ALA . 26.9 mt -54.05 -33.38 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.438 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 83' ' ' GLY . 19.6 mmm-85 -51.54 -48.34 63.07 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.091 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -64.74 -61.84 1.94 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.57 -21.8 4.26 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.639 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -91.68 -77.05 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.639 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 113.93 54.84 0.42 Allowed Glycine 0 N--CA 1.469 0.85 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 85' ' ' GLU . 10.0 mt -94.58 15.06 18.98 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.853 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' LEU . 64.9 tt0 . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.9 mttm . . . . . 0 N--CA 1.463 0.19 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 97' ' ' GLY . 6.3 p -136.44 157.86 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.484 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 118.35 80.78 0.73 Allowed Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -126.48 94.4 4.05 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.948 0.404 . . . . 0.0 111.962 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.545 HD12 HG11 ' A' ' 104' ' ' VAL . 12.1 pt -100.93 149.78 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.452 ' OG1' ' OE1' ' A' ' 103' ' ' GLN . 0.2 OUTLIER -90.78 156.53 17.98 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.478 0.656 . . . . 0.0 110.333 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.598 ' O ' HG22 ' A' ' 104' ' ' VAL . 61.3 t-105 -61.56 -71.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.325 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -46.46 -39.14 10.16 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 120.761 -1.212 . . . . 0.0 111.905 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.452 ' OE1' ' OG1' ' A' ' 100' ' ' THR . 32.3 mt-30 -60.8 -47.19 87.45 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.308 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 101' ' ' TRP . 15.9 m -63.62 -29.0 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.371 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 108' ' ' ALA . 59.7 mt -63.23 -72.61 0.13 Allowed 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.998 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -44.88 -45.04 10.07 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.2 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.63 -25.22 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.127 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -106.27 -1.02 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.704 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 105' ' ' LEU . 43.8 tttp -85.18 -74.68 0.39 Allowed 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.253 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -62.42 -43.61 98.4 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.548 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -76.45 76.15 3.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.799 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.449 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -135.98 54.85 10.67 Favored Pre-proline 0 N--CA 1.468 0.432 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.009 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 112' ' ' MET . 4.3 Cg_endo -59.84 -30.97 93.16 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 120.701 0.934 . . . . 0.0 111.662 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.578 ' C ' ' H ' ' A' ' 116' ' ' ASN . 36.8 t70 -154.05 -86.08 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.992 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.1 mt 51.69 0.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.634 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.578 ' H ' ' C ' ' A' ' 114' ' ' ASP . 4.0 t30 54.38 26.95 7.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.47 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.3 p -143.79 161.62 38.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.293 0.568 . . . . 0.0 111.728 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.3 -32.48 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.09 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -75.02 146.04 41.93 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.74 -45.71 93.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.355 0.598 . . . . 0.0 110.406 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 121' ' ' GLU . 5.0 pt-20 -59.19 -38.85 80.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.702 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.95 -68.98 0.34 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.016 -1.073 . . . . 0.0 108.805 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.18 -37.49 22.67 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.075 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.85 -66.25 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.1 mtt180 -46.16 -36.0 5.56 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.489 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 5.7 tmm? -55.57 -73.47 0.06 Allowed 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.544 HG23 HD11 ' A' ' 78' ' ' ILE . 6.1 mm -51.15 -50.33 26.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.962 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -62.67 -72.55 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.15 -47.41 5.41 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.489 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 66.4 m -56.79 -43.0 80.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.619 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -52.52 -46.85 66.89 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.564 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -55.55 -34.25 64.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 130' ' ' SER . 3.1 t -65.37 -76.45 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 6.7 ptm -40.2 -25.73 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.636 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 104.38 60.52 0.67 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.619 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 27.4 t -145.29 162.99 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.471 ' N ' HG12 ' A' ' 136' ' ' VAL . 98.1 mt-10 -128.94 156.22 44.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.49 ' CG2' ' HB1' ' A' ' 128' ' ' ALA . 2.1 t -87.73 152.11 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 139' ' ' VAL . 46.1 t -96.74 -11.8 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.718 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.619 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.57 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 48.4 tttt . . . . . 0 CA--C 1.506 -0.725 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.67 158.71 30.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.621 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 61' ' ' ALA . 29.2 m -117.98 -26.16 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.13 116.55 4.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 119.044 -1.062 . . . . 0.0 111.103 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.71 ' O ' HG13 ' A' ' 7' ' ' VAL . 9.4 p -110.12 112.24 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.335 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.89 90.41 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 118.563 -1.255 . . . . 0.0 110.693 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -76.26 120.17 21.16 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.456 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -173.68 -174.65 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.38 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.414 ' N ' ' NE2' ' A' ' 11' ' ' GLN . 2.7 mp0 -95.87 159.38 15.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.91 HD13 ' CZ ' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -136.61 92.89 14.6 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HA ' HD13 ' A' ' 52' ' ' ILE . 22.6 Cg_exo -59.36 146.5 94.63 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.26 1.307 . . . . 0.0 114.414 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.794 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -101.32 143.2 31.66 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.44 44.59 36.43 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' H ' ' H ' ' A' ' 17' ' ' ALA . 24.0 mttt -167.46 -6.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.238 -0.481 . . . . 0.0 109.811 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' H ' ' H ' ' A' ' 16' ' ' LYS . . . -80.09 149.62 30.57 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -158.97 168.03 13.23 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.115 -178.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -60.14 41.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.475 1.45 . . . . 0.0 112.427 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -172.34 58.79 0.25 Allowed Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.919 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 20.5 Cg_endo -78.75 172.21 15.44 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.218 1.279 . . . . 0.0 112.136 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -55.88 -23.82 44.4 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 120.552 0.834 . . . . 0.0 111.013 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.678 HG12 ' HB3' ' A' ' 26' ' ' ALA . 2.2 t -83.04 -64.55 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 43.43 -96.86 0.01 OUTLIER Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -47.13 -60.06 1.02 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 CA-C-N 119.927 1.863 . . . . 0.0 110.669 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.678 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -47.33 -23.84 0.65 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.847 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.681 HD23 ' HE2' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -116.96 26.88 9.49 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.48 41.32 0.63 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -141.69 -11.17 0.9 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.438 0.637 . . . . 0.0 109.619 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.681 ' HE2' HD23 ' A' ' 27' ' ' LEU . 1.4 p80 -67.18 -15.34 63.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.466 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 102.22 -26.33 24.63 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -51.37 -132.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.142 0.577 . . . . 0.0 112.089 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -133.45 -169.28 2.25 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 37' ' ' PHE . 3.4 mm -131.65 -76.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.562 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -40.2 -42.28 1.46 Allowed 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.875 179.048 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -52.81 -51.47 60.7 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.101 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 34' ' ' ILE . 2.0 t80 -50.37 -66.09 0.45 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.599 1.19 . . . . 0.0 109.845 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 42' ' ' ASN . 54.0 t -57.51 -48.61 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 112.889 -1.959 . . . . 0.0 110.939 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 35' ' ' MET . 79.1 mttt -44.14 -58.49 2.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.43 -44.33 84.57 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.048 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.91 ' CZ ' HD13 ' A' ' 12' ' ' LEU . 1.8 t80 -61.13 -73.96 0.09 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -39.85 -41.29 1.12 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.688 0.756 . . . . 0.0 111.681 -177.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -61.9 -35.0 77.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.083 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -86.4 -43.49 12.78 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.749 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 49' ' ' GLY . 70.4 p -63.61 -34.93 78.92 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -67.96 -42.07 81.45 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -62.95 -20.14 64.95 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.0 ttp -106.08 -85.28 0.5 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.954 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 170.78 170.3 34.84 Favored Glycine 0 N--CA 1.465 0.617 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.108 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 47.7 p-10 -65.39 137.05 57.24 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.794 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -176.09 -154.0 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.857 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 13' ' ' PRO . 33.7 mm -141.68 130.99 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.88 127.93 16.47 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.626 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -71.05 148.62 57.14 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.804 1.003 . . . . 0.0 110.751 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 12' ' ' LEU . 7.2 p -153.68 160.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.485 0.659 . . . . 0.0 111.434 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 55' ' ' VAL . 65.3 mt-10 -139.47 103.17 4.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.423 HD13 HD11 ' A' ' 27' ' ' LEU . 21.1 mt -68.17 87.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.582 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 m -70.99 103.16 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 mt -103.74 126.0 58.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.173 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 3' ' ' LYS . 4.4 m-85 -104.07 141.09 36.82 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.892 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -51.09 -22.11 2.26 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 124.18 0.925 . . . . 0.0 112.079 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -67.51 9.12 0.27 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.651 ' H ' ' C ' ' A' ' 61' ' ' ALA . 99.5 mtt180 60.96 68.97 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.923 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -146.22 132.36 19.37 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.135 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -109.56 102.39 11.25 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.161 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 8.4 m -95.56 119.66 34.44 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER 172.19 115.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 O-C-N 124.4 1.062 . . . . 0.0 111.092 -176.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.8 t -154.43 136.6 6.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 p -141.47 147.05 37.25 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -141.76 171.06 14.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.251 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -40.17 98.08 0.16 Allowed Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.793 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.493 ' O ' ' O ' ' A' ' 71' ' ' THR . 16.2 Cg_exo -43.26 177.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 121.256 1.304 . . . . 0.0 113.119 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 17.2 Cg_exo -51.14 113.54 1.15 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.427 1.418 . . . . 0.0 112.759 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 172.38 -152.0 0.01 OUTLIER 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.721 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 80.2 p -36.94 -22.96 0.01 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.985 0.421 . . . . 0.0 110.44 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.604 ' N ' ' O ' ' A' ' 74' ' ' ALA . 11.6 t80 -47.37 -36.75 10.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.68 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.9 -34.22 3.98 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.67 0.747 . . . . 0.0 109.884 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.721 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 69.0 mt -48.2 -38.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.418 ' NH1' ' O ' ' A' ' 84' ' ' LEU . 13.1 mmm180 -51.67 -45.99 63.63 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.329 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -66.54 -63.31 1.1 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.33 -19.27 2.0 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.293 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -89.96 -77.62 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.607 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.33 45.1 0.63 Allowed Glycine 0 N--CA 1.47 0.902 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.418 ' O ' ' NH1' ' A' ' 79' ' ' ARG . 24.5 mt -98.89 115.36 28.67 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.753 0.311 . . . . 0.0 110.559 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.532 0.206 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 97' ' ' GLY . 5.4 p -145.18 155.93 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.247 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 60.53 82.48 0.07 OUTLIER Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.408 ' NE ' HG23 ' A' ' 139' ' ' VAL . 22.8 ttt180 -135.1 104.19 5.84 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.599 HD12 ' CG1' ' A' ' 104' ' ' VAL . 4.8 pt -104.37 150.21 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.517 HG21 ' NE2' ' A' ' 103' ' ' GLN . 1.8 p -87.96 155.72 19.69 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.397 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.782 ' NE1' HD11 ' A' ' 105' ' ' LEU . 74.0 t-105 -60.97 -54.59 43.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.083 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 1.3 tp10 -59.1 -40.37 85.1 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.059 -1.025 . . . . 0.0 111.123 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.517 ' NE2' HG21 ' A' ' 100' ' ' THR . 41.0 mt-30 -59.38 -47.14 86.55 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.811 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.599 ' CG1' HD12 ' A' ' 99' ' ' ILE . 20.4 m -65.52 -29.06 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 118.494 -1.282 . . . . 0.0 109.467 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.782 HD11 ' NE1' ' A' ' 101' ' ' TRP . 64.7 mt -64.52 -74.03 0.11 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.522 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -44.2 -48.76 9.3 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.464 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.6 -25.28 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.107 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -105.54 -0.34 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.479 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.9 tmtt? -89.2 -74.74 0.46 Allowed 'General case' 0 N--CA 1.461 0.083 0 CA-C-O 120.751 0.31 . . . . 0.0 110.187 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -72.53 -40.99 66.35 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.843 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -74.85 73.59 2.11 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.57 61.71 0.17 Allowed Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.407 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -52.75 -43.15 58.07 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 120.594 0.863 . . . . 0.0 112.051 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 116' ' ' ASN . 27.0 t70 -142.4 -61.79 0.44 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.272 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 tt 45.64 -85.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.933 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 114' ' ' ASP . 4.3 t30 -174.77 9.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.943 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 46.5 p -141.83 171.19 14.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.401 0.619 . . . . 0.0 111.749 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.37 -40.86 0.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.894 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -83.48 153.31 24.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.524 HD21 ' HG2' ' A' ' 109' ' ' LYS . 35.8 mt -60.24 -46.18 90.66 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.314 0.578 . . . . 0.0 109.931 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -54.81 -42.09 71.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.916 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.56 -66.84 0.53 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.116 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.63 36.67 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.941 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -53.03 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.602 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.4 mtt180 -43.3 -31.22 0.6 Allowed 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.001 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 130' ' ' SER . 5.5 ttp -59.33 -73.48 0.08 Allowed 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 127' ' ' ILE . 1.9 mp -48.99 -49.39 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.581 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -65.98 -71.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.34 -49.29 5.64 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 126' ' ' MET . 49.5 m -54.47 -42.99 71.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.719 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -56.05 -47.8 77.21 Favored 'General case' 0 C--O 1.228 -0.069 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -55.14 -41.51 71.86 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 t -53.31 -71.26 0.07 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.1 mtm -41.58 -62.07 0.95 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.942 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.18 50.0 0.04 OUTLIER Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.719 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 54.4 t -133.92 164.82 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.551 ' N ' HG12 ' A' ' 136' ' ' VAL . 98.0 mt-10 -133.78 159.27 41.1 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 140' ' ' GLY . 6.2 t -96.34 155.12 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.408 HG23 ' NE ' ' A' ' 98' ' ' ARG . 3.0 p -83.44 -2.71 6.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.647 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.418 ' H ' HG12 ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.518 0.261 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.5 mptm? . . . . . 0 C--O 1.223 -0.333 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.91 121.67 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 3' ' ' LYS . 17.3 m -113.33 -25.32 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.778 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.94 135.59 39.74 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.271 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.578 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.4 p -126.37 126.95 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.226 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.96 91.03 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.826 1.194 . . . . 0.0 111.539 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -82.15 116.32 21.66 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.49 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -168.47 -171.51 1.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.403 -178.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -94.44 154.16 17.58 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.963 HD12 ' CZ ' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -135.66 92.35 17.14 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -71.65 114.32 3.91 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.264 1.309 . . . . 0.0 114.775 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.789 ' HB3' ' H ' ' A' ' 51' ' ' ALA . . . -61.94 143.83 55.9 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . 61.49 150.53 0.02 OUTLIER Glycine 0 C--N 1.336 0.57 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.4 tttp 72.88 10.52 5.4 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.126 0.963 . . . . 0.0 110.564 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 18' ' ' THR . . . -92.15 151.93 20.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.6 170.81 3.97 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.041 -178.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -58.79 42.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.363 1.375 . . . . 0.0 112.23 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -160.91 54.26 0.55 Allowed Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-O 120.474 0.178 . . . . 0.0 110.533 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 25.6 Cg_endo -77.07 168.37 23.43 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.091 1.194 . . . . 0.0 112.21 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -56.51 -31.37 86.02 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 120.639 0.893 . . . . 0.0 111.284 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.796 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.7 t -75.02 -61.28 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 44.48 -99.61 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -47.87 -60.31 0.92 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 CA-C-N 119.816 1.808 . . . . 0.0 110.998 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.796 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -45.9 -26.83 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.366 -0.533 . . . . 0.0 109.824 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 25.6 tp -119.69 23.06 11.34 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.603 0.716 . . . . 0.0 109.172 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -152.56 37.93 0.77 Allowed Glycine 0 C--N 1.322 -0.221 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.668 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 29' ' ' GLN . 0.8 OUTLIER -141.57 -3.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.567 ' N ' ' ND1' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -78.5 -11.96 59.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.264 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.588 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 97.83 -26.1 24.72 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.588 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -47.66 -134.37 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.987 0.515 . . . . 0.0 112.287 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -136.76 143.58 43.33 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 122.093 -0.38 . . . . 0.0 111.015 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.6 mm -93.14 -73.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -39.72 -39.44 0.77 Allowed 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -59.49 -52.44 65.57 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.822 -0.751 . . . . 0.0 108.993 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' A' ' 34' ' ' ILE . 90.2 t80 -47.11 -62.43 1.42 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.165 0.983 . . . . 0.0 109.724 177.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 42' ' ' ASN . 86.9 t -58.71 -44.02 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 113.309 -1.769 . . . . 0.0 111.178 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.42 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 88.4 tttt -45.44 -67.79 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.75 -41.02 66.67 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.491 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.963 ' CZ ' HD12 ' A' ' 12' ' ' LEU . 54.9 t80 -62.9 -77.03 0.06 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.29 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -40.24 -44.73 1.94 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.314 0.578 . . . . 0.0 112.182 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.06 -34.81 70.52 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.113 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.17 -46.05 11.45 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.618 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 49' ' ' GLY . 32.4 p -63.76 -31.69 72.94 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -70.03 -41.02 74.82 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -62.4 -20.02 64.03 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.2 mtm -106.51 -78.85 0.57 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.259 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 169.17 166.49 28.29 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.362 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 36.9 p-10 -62.63 125.51 24.17 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.789 ' H ' ' HB3' ' A' ' 14' ' ' ALA . . . -162.41 -153.88 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.285 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 99.3 mt -142.03 132.15 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.72 120.46 6.03 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.249 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -65.37 140.71 65.03 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 120.746 0.964 . . . . 0.0 110.862 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.412 ' CG2' HD23 ' A' ' 12' ' ' LEU . 25.4 m -137.53 159.62 34.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.234 0.54 . . . . 0.0 110.861 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 58' ' ' THR . 32.4 tt0 -129.89 85.7 2.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 57' ' ' ILE . 4.6 mt -60.36 82.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.216 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -72.74 97.16 2.15 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.2 mt -97.31 126.25 50.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.008 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -98.86 144.65 27.83 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.664 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -54.25 -24.12 17.46 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.44 1.088 . . . . 0.0 112.331 -176.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -68.45 10.44 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.664 ' H ' ' C ' ' A' ' 61' ' ' ALA . 87.2 mtm180 61.27 69.2 0.68 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.496 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.3 m -142.9 126.94 17.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.843 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -107.58 103.76 13.15 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.058 -177.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.483 ' O ' ' OG1' ' A' ' 58' ' ' THR . 77.3 p -95.71 121.58 37.57 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.586 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.4 p90 176.46 -152.54 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 51.7 t 80.69 152.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.304 0 O-C-N 124.329 1.018 . . . . 0.0 110.564 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t -146.68 173.36 12.43 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.453 ' C ' HG22 ' A' ' 71' ' ' THR . 58.0 pttt -170.6 -159.85 0.19 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.585 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 t 43.25 56.38 11.84 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.956 0.408 . . . . 0.0 111.431 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 71' ' ' THR . 9.8 Cg_endo -77.82 157.57 31.35 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 C-N-CA 120.064 0.509 . . . . 0.0 112.04 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.683 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 11.3 Cg_endo -70.13 176.2 7.38 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 121.952 1.768 . . . . 0.0 112.293 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 73' ' ' PRO . . . 79.71 -177.24 0.08 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.897 0.317 . . . . 0.0 110.279 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.635 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.1 OUTLIER -40.51 -20.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.312 -0.242 . . . . 0.0 110.521 -179.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.542 ' HD2' ' O ' ' A' ' 73' ' ' PRO . 26.0 m-85 -42.73 -35.96 1.3 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.651 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.812 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -133.51 -25.55 1.7 Allowed 'General case' 0 C--O 1.253 1.253 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.635 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 45.6 mt -54.56 -35.02 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.573 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -53.37 -42.84 67.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.277 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.434 ' C ' ' N ' ' A' ' 82' ' ' ALA . 3.1 tmtm? -67.84 -65.32 0.71 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.9 -11.64 0.25 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.999 -0.681 . . . . 0.0 110.65 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.42 -77.63 0.33 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.851 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 137.74 63.09 0.05 OUTLIER Glycine 0 N--CA 1.464 0.537 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.9 mt -115.06 135.87 53.74 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.233 0.214 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.461 HG22 ' N ' ' A' ' 97' ' ' GLY . 14.3 p -144.61 159.5 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.461 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 93.68 68.19 1.07 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.28 99.29 6.27 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.706 0.253 . . . . 0.0 111.034 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.669 HD12 HG11 ' A' ' 104' ' ' VAL . 13.7 pt -95.63 139.29 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.492 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -81.61 155.99 25.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.753 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.632 ' O ' HG22 ' A' ' 104' ' ' VAL . 57.2 t-105 -61.75 -69.13 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -48.29 -42.17 30.07 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 120.916 -1.115 . . . . 0.0 112.147 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -59.86 -46.08 90.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.451 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.669 HG11 HD12 ' A' ' 99' ' ' ILE . 19.2 m -63.44 -29.78 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 118.286 -1.366 . . . . 0.0 109.283 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 108' ' ' ALA . 36.7 mt -62.38 -70.68 0.19 Allowed 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.339 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -43.63 -46.29 7.21 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.568 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.46 -26.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.378 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.554 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -101.66 -2.39 30.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.364 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.517 ' O ' ' SD ' ' A' ' 112' ' ' MET . 87.5 tttt -88.76 -75.45 0.43 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.857 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.4 -40.3 73.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.04 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.15 84.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.456 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.554 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 3.1 ptt? -179.51 58.24 0.1 OUTLIER Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.505 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 112' ' ' MET . 13.6 Cg_endo -75.81 -55.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 120.618 0.879 . . . . 0.0 112.337 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -88.85 -31.45 18.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.772 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 117' ' ' THR . 10.3 mt -45.42 134.07 7.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -65.98 70.24 0.06 Allowed 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.298 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LEU . 82.6 p -143.71 159.35 42.65 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.212 0.53 . . . . 0.0 111.994 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.64 -43.32 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.935 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -91.94 148.35 22.27 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 120' ' ' LEU . 0.8 OUTLIER -59.27 -46.82 87.5 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.689 0.757 . . . . 0.0 110.124 -178.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.65 -35.68 68.66 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.66 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.92 -64.73 0.81 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.937 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.87 -22.92 27.97 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.923 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.95 -73.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.2 mtt180 -43.09 -31.95 0.63 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.658 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 130' ' ' SER . 38.9 ttp -57.36 -72.95 0.08 Allowed 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.448 HG23 HD11 ' A' ' 78' ' ' ILE . 50.0 mm -51.33 -50.28 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.328 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -64.28 -72.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.13 -45.58 3.99 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 126' ' ' MET . 67.7 m -56.74 -44.69 81.95 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.582 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -56.22 -50.43 71.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -48.88 -42.88 38.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.586 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.4 t -54.13 -65.07 0.64 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.8 mtp -52.45 -2.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.605 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.1 -29.27 6.61 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.582 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 68.1 t -46.05 164.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 79.2 mt-10 -143.05 164.76 29.22 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.093 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 140' ' ' GLY . 3.5 t -85.23 155.03 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 100' ' ' THR . 1.0 OUTLIER -100.18 -7.54 9.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.703 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.507 -0.464 0 CA-C-O 119.131 -0.816 . . . . 0.0 111.553 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.418 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 17.9 ttmt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.775 0.322 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 4' ' ' VAL . 7.7 p -70.59 126.39 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -112.07 -24.77 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.41 119.6 14.61 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.292 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.6 p -111.6 104.82 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.842 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.68 92.41 2.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 117.985 -1.486 . . . . 0.0 110.295 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -85.23 109.49 18.37 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.437 0.461 . . . . 0.0 110.304 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -171.89 -174.51 1.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.191 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -102.18 173.57 6.32 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.61 139.31 5.93 Favored Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.974 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -82.2 149.54 15.3 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.125 1.217 . . . . 0.0 114.722 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.827 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -90.33 144.73 25.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.17 58.86 8.95 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.404 ' H ' ' H ' ' A' ' 17' ' ' ALA . 2.1 mmtm 172.63 21.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.336 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 16' ' ' LYS . . . -98.16 150.68 21.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -162.42 168.54 10.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.075 -178.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -62.23 42.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.29 1.327 . . . . 0.0 111.963 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -155.53 59.31 2.13 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.994 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 27.8 Cg_endo -79.72 166.47 21.57 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.286 1.324 . . . . 0.0 111.888 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.37 -30.71 88.83 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 120.8 1.0 . . . . 0.0 111.102 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.665 ' CG1' ' HB3' ' A' ' 26' ' ' ALA . 2.4 t -70.98 -58.06 6.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.812 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 41.08 -99.64 0.01 OUTLIER Glycine 0 C--O 1.207 -1.555 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.3 Cg_exo -48.41 -62.49 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 CA-C-N 120.308 2.054 . . . . 0.0 110.789 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.665 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -42.95 -16.82 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.059 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.614 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 29.5 tp -117.53 -27.56 6.3 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.699 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -57.59 -54.83 34.18 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -88.99 43.22 1.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.565 0.697 . . . . 0.0 110.496 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.649 ' CD2' ' H ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -86.87 -31.74 20.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.649 ' H ' ' CD2' ' A' ' 30' ' ' HIS . . . 109.86 -48.83 0.9 Allowed Glycine 0 N--CA 1.472 1.085 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.546 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -50.33 -131.23 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.973 0.509 . . . . 0.0 111.865 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -138.71 128.33 24.76 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.89 -0.506 . . . . 0.0 111.205 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.9 mm -71.96 -72.25 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.453 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -38.55 -39.44 0.48 Allowed 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -58.93 -48.94 79.68 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.074 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 60.7 t80 -48.42 -65.66 0.53 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.527 1.156 . . . . 0.0 109.622 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 42' ' ' ASN . 89.8 t -56.87 -44.03 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.383 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -47.06 -53.03 13.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.87 -37.8 87.12 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.227 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 7.8 m-85 -65.43 -74.11 0.11 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 41' ' ' PHE . 0.5 OUTLIER -37.16 -45.69 0.65 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.516 0.674 . . . . 0.0 111.514 -177.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.17 79.31 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.55 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -88.73 -45.23 9.96 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.519 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 42' ' ' ASN . 52.3 p -60.63 -18.54 53.92 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -86.69 -42.72 13.15 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -60.23 -17.04 38.88 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.786 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.595 ' SD ' ' HB1' ' A' ' 14' ' ' ALA . 1.7 ppp? -120.11 126.41 50.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.132 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.501 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -40.93 161.9 0.01 OUTLIER Glycine 0 CA--C 1.543 1.835 0 C-N-CA 119.533 -1.317 . . . . 0.0 111.584 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 53.6 p-10 -62.6 151.46 37.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.06 0.93 . . . . 0.0 109.928 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.827 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 179.6 -150.48 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.809 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.0 mt -143.24 134.9 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 m -147.43 145.83 23.0 Favored Pre-proline 0 C--O 1.243 0.723 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.3 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -76.42 149.09 30.69 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 121.064 1.176 . . . . 0.0 110.961 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 m -142.54 143.28 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.133 0.492 . . . . 0.0 111.017 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.71 85.6 2.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 mt -64.52 83.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.916 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 m -69.23 93.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.8 mt -93.56 125.72 46.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.218 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.418 ' CD2' ' C ' ' A' ' 3' ' ' LYS . 7.7 m-85 -100.27 142.66 31.44 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.659 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.7 -22.87 2.29 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 124.651 1.219 . . . . 0.0 112.165 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.25 5.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.659 ' H ' ' C ' ' A' ' 61' ' ' ALA . 51.2 mtp180 62.54 72.78 0.48 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.104 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.1 p -152.45 132.36 13.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.314 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -101.36 101.69 12.38 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.41 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.7 132.0 41.36 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 67' ' ' PHE . 51.5 p90 -172.26 123.54 0.49 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.479 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 69' ' ' THR . 72.8 t -107.32 108.01 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.523 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 25.6 p -156.21 -164.27 1.65 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 69' ' ' THR . 9.3 pttt 76.78 -178.95 0.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.511 ' CG2' ' CE2' ' A' ' 76' ' ' TYR . 6.4 m 64.9 68.61 0.73 Allowed Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.558 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.531 ' O ' ' CD1' ' A' ' 76' ' ' TYR . 10.8 Cg_endo -78.53 155.5 28.04 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 120.934 1.089 . . . . 0.0 112.289 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.562 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 10.0 Cg_endo -68.46 112.67 2.89 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.699 1.599 . . . . 0.0 112.367 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 169.61 -167.46 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.672 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -41.51 -16.19 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 O-C-N 122.0 -0.437 . . . . 0.0 110.571 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.659 ' CE1' HD22 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -43.97 -30.12 0.67 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.947 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -140.7 -27.14 0.73 Allowed 'General case' 0 C--O 1.255 1.358 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.947 ' N ' HD23 ' A' ' 77' ' ' LEU . 66.4 mt -51.67 -35.59 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.455 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -53.51 -45.37 69.68 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.702 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.07 -63.63 1.19 Allowed 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.32 -19.44 5.42 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.725 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.19 -78.75 0.25 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.069 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 134.03 23.52 0.68 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.17 132.64 36.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 . . . . . 0 C--N 1.333 -0.139 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.306 -179.838 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 CA--C 1.53 0.202 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.4 p -159.8 152.95 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.308 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.88 82.86 0.14 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.647 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -140.35 123.06 16.33 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 121.035 0.445 . . . . 0.0 111.003 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.617 HD12 ' CG1' ' A' ' 104' ' ' VAL . 1.6 pt -128.8 157.28 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 p -91.01 166.79 12.82 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.134 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.621 ' NE1' HD11 ' A' ' 105' ' ' LEU . 55.9 t-105 -59.34 -54.39 47.33 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.27 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -55.73 -40.94 73.15 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.585 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -61.03 -47.86 84.48 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.858 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.617 ' CG1' HD12 ' A' ' 99' ' ' ILE . 16.0 m -66.42 -28.63 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 118.414 -1.314 . . . . 0.0 109.783 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.621 HD11 ' NE1' ' A' ' 101' ' ' TRP . 53.0 mt -63.1 -71.47 0.16 Allowed 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.521 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -43.79 -47.45 8.03 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.141 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.83 -27.48 41.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.244 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.566 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -104.63 0.62 28.69 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.693 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 105' ' ' LEU . 77.8 tttt -84.91 -73.78 0.42 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.541 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -57.18 -35.98 70.24 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -70.59 48.74 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.456 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.566 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 91.9 mtp -143.32 54.1 2.95 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.411 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 112' ' ' MET . 3.5 Cg_endo -57.8 -46.67 25.04 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 120.651 0.901 . . . . 0.0 112.088 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -173.93 26.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.9 mt -43.42 -73.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.454 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.529 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -172.1 0.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.226 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.6 p -141.73 177.53 8.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 111.903 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.2 p -141.6 -22.26 0.73 Allowed 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.996 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -82.07 143.06 31.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.198 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.2 -40.72 97.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 110.876 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -56.1 -35.16 66.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.18 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.77 -68.88 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.861 -1.136 . . . . 0.0 108.967 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.06 -39.08 26.19 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.976 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.38 -66.55 0.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 129' ' ' GLY . 98.8 mtt180 -44.27 -31.91 1.14 Allowed 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.479 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 4.4 tmm? -59.24 -72.35 0.1 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.6 mm -51.1 -50.34 25.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.218 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -66.26 -70.82 0.22 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.39 -44.4 3.99 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.479 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 66.4 m -58.71 -44.85 90.51 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.557 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -54.62 -50.32 68.39 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.55 ' HG2' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -49.36 -44.59 44.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.5 t -52.47 -65.72 0.51 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 83.5 mtp -51.82 -5.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.303 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.57 -25.56 12.87 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.557 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 45.7 t -47.64 163.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 136' ' ' VAL . 75.8 mt-10 -131.62 153.24 50.13 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 140' ' ' GLY . 65.2 t -117.25 130.49 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 139' ' ' VAL . 38.7 t -94.76 -4.88 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.487 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.508 ' H ' HG12 ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.538 0.208 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 4' ' ' VAL . 8.2 p -58.05 123.07 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 61' ' ' ALA . 64.5 t -114.36 -24.09 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.03 130.05 18.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.608 0.718 . . . . 0.0 111.101 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.4 t -119.92 103.56 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.058 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.25 93.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 118.164 -1.415 . . . . 0.0 110.045 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -76.01 110.81 10.78 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -169.91 -172.6 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.944 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 11' ' ' GLN . 26.4 mp0 -109.59 171.94 7.15 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.699 HD13 ' CE1' ' A' ' 41' ' ' PHE . 8.0 mt -143.15 136.02 13.73 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -82.49 159.85 17.02 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.222 1.281 . . . . 0.0 113.722 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.751 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -118.35 142.53 47.43 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.66 35.53 38.15 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -177.38 59.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.896 -0.652 . . . . 0.0 110.468 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.07 156.24 47.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -167.68 169.02 5.81 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.286 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.84 39.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.357 1.371 . . . . 0.0 112.171 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.578 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -147.0 52.57 1.39 Allowed Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.629 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 31.2 Cg_endo -79.78 166.28 21.6 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.027 1.151 . . . . 0.0 111.885 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.08 -29.2 86.3 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 120.93 1.087 . . . . 0.0 111.087 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.601 ' CG1' ' HB3' ' A' ' 26' ' ' ALA . 2.4 t -80.62 -63.49 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 42.97 -99.58 0.01 OUTLIER Glycine 0 C--O 1.212 -1.252 0 CA-C-O 118.58 -1.122 . . . . 0.0 110.418 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.3 Cg_exo -47.55 -60.51 0.85 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 CA-C-N 120.968 2.384 . . . . 0.0 110.986 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.601 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.48 -16.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.429 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.632 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -117.82 -38.23 3.29 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 110.901 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -56.68 -52.01 53.2 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -76.5 42.19 0.28 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.382 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.632 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -92.35 -30.38 15.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.726 177.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.596 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . 109.27 -43.19 1.76 Allowed Glycine 0 N--CA 1.464 0.529 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -51.44 -132.01 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.103 0.561 . . . . 0.0 111.849 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -138.68 123.73 19.01 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.909 -0.495 . . . . 0.0 110.736 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.6 mm -63.18 -71.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.416 ' O ' ' N ' ' A' ' 39' ' ' LYS . 96.7 mmm -39.43 -43.19 1.19 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.26 -48.26 79.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.272 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 34' ' ' ILE . 29.5 t80 -50.05 -67.67 0.24 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 122.364 1.078 . . . . 0.0 109.358 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 42' ' ' ASN . 93.8 t -56.93 -42.51 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.174 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 88.4 tttt -48.59 -60.69 2.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.52 -41.32 80.65 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.683 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.699 ' CE1' HD13 ' A' ' 12' ' ' LEU . 10.3 m-85 -62.97 -76.0 0.07 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 46' ' ' ALA . 8.0 t-20 -39.29 -46.34 1.54 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.524 0.678 . . . . 0.0 111.744 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -57.8 -35.24 70.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.302 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -88.07 -44.42 10.97 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.983 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 49' ' ' GLY . 14.8 p -65.26 -21.12 66.69 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -87.82 -33.66 18.53 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.426 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 62.4 t-20 -64.45 -24.53 67.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.486 ' CG ' ' N ' ' A' ' 49' ' ' GLY . 7.1 ptt? -105.65 -47.2 3.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.644 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.486 ' N ' ' CG ' ' A' ' 48' ' ' MET . . . 142.62 178.57 18.69 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 40.7 p-10 -74.82 147.98 40.69 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.751 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.04 -154.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.754 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.1 mm -143.3 136.46 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.5 131.13 12.7 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.741 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -72.26 153.23 56.39 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 120.76 0.974 . . . . 0.0 110.369 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.551 HG11 HD12 ' A' ' 12' ' ' LEU . 5.3 p -155.52 145.53 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.426 0.632 . . . . 0.0 111.897 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -121.93 95.68 4.76 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.4 mt -69.72 89.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.712 -175.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.24 98.93 1.81 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 59' ' ' ILE . 40.9 mt -99.28 131.44 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.806 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 63' ' ' ARG . 4.1 m-85 -106.83 142.15 36.93 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.55 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.91 -27.34 7.31 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 124.388 1.055 . . . . 0.0 111.841 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -60.33 -5.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' A' ' 61' ' ' ALA . 25.7 ttm180 76.79 70.01 0.06 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.212 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.0 p -144.77 125.33 14.05 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.237 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -104.64 103.28 12.91 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.556 0.217 . . . . 0.0 110.555 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.7 p -95.55 134.46 38.4 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.559 ' CZ ' ' O ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -124.73 175.34 7.3 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.97 86.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.9 t -177.15 139.03 0.26 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.211 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.585 ' O ' ' O ' ' A' ' 71' ' ' THR . 0.6 OUTLIER -176.92 117.25 0.11 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.672 0.749 . . . . 0.0 110.336 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.585 ' O ' ' O ' ' A' ' 70' ' ' LYS . 49.8 p 51.85 140.45 0.02 OUTLIER Pre-proline 0 C--N 1.292 -1.914 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.468 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -78.21 168.57 21.56 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 120.551 1.232 . . . . 0.0 112.821 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.46 90.67 0.33 Allowed 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.983 1.789 . . . . 0.0 111.959 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.72 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -176.7 -143.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.634 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.5 OUTLIER -37.25 -14.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.72 ' N ' ' O ' ' A' ' 74' ' ' ALA . 3.2 t80 -46.52 -41.27 13.95 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 123.53 0.518 . . . . 0.0 110.385 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.86 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -130.1 -15.25 3.79 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.819 ' N ' HD22 ' A' ' 77' ' ' LEU . 26.2 mt -65.02 -40.68 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.997 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -50.25 -41.82 50.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.063 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -71.58 -61.19 1.87 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.313 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.18 -22.43 6.55 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.319 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -86.61 -78.08 0.3 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.765 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.39 56.61 0.77 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.8 mt -92.48 114.49 27.06 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 C--N 1.331 -0.22 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.648 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 97' ' ' GLY . 12.5 p -152.64 164.56 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 88.59 84.55 1.25 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -138.81 128.39 24.66 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.07 0.462 . . . . 0.0 110.88 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 104' ' ' VAL . 15.0 pt -119.19 151.61 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.41 HG21 ' NE2' ' A' ' 103' ' ' GLN . 1.6 p -78.72 154.78 29.79 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.237 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.717 ' NE1' HD11 ' A' ' 105' ' ' LEU . 65.4 t-105 -58.49 -54.63 44.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.019 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -58.31 -42.8 87.5 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 121.439 -0.788 . . . . 0.0 111.396 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.41 ' NE2' HG21 ' A' ' 100' ' ' THR . 63.3 mt-30 -58.33 -46.11 86.83 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.638 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.543 HG23 ' CG2' ' A' ' 127' ' ' ILE . 7.7 p -66.9 -30.6 50.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.044 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.717 HD11 ' NE1' ' A' ' 101' ' ' TRP . 58.3 mt -61.69 -71.77 0.14 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.153 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -45.66 -49.77 14.1 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.39 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.501 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 93.1 mt -57.53 -26.69 27.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -105.64 2.44 28.16 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.398 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 105' ' ' LEU . 77.3 tttt -86.16 -73.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -65.52 -40.51 93.06 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.725 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 107' ' ' ILE . 49.7 mmtt -60.43 93.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.712 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.422 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 48.8 mtt -154.82 56.0 1.35 Allowed Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.403 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 112' ' ' MET . 14.7 Cg_exo -50.46 -46.67 28.17 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 120.778 0.985 . . . . 0.0 112.154 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 66.8 t0 -170.92 40.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.245 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.562 ' N ' HD22 ' A' ' 115' ' ' LEU . 3.6 mm? -74.41 143.66 44.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.74 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.563 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 10.2 t30 -69.37 35.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.444 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 115' ' ' LEU . 69.5 p -139.46 162.79 34.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.228 0.537 . . . . 0.0 111.756 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.7 p -142.46 -45.07 0.32 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.779 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -72.5 151.51 42.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 35.9 mt -59.3 -42.19 90.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.358 0.599 . . . . 0.0 109.948 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.85 -44.53 86.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.093 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.85 -71.23 0.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.279 -0.969 . . . . 0.0 108.528 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.596 ' O ' ' HG3' ' A' ' 126' ' ' MET . . . -44.22 -55.0 5.17 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.896 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -44.69 -62.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.295 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 129' ' ' GLY . 64.8 ttt180 -44.41 -32.36 1.34 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.791 ' HG3' ' H ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER -58.95 -66.71 0.46 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.791 ' H ' ' HG3' ' A' ' 126' ' ' MET . 4.9 mm -56.11 -48.68 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.317 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -66.84 -69.83 0.28 Allowed 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.09 -47.43 5.35 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 126' ' ' MET . 70.3 m -57.82 -42.84 85.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.619 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -53.86 -48.18 70.28 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.532 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -50.75 -41.1 56.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 135' ' ' GLY . 2.3 t -59.57 -72.64 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 4.3 ptm -45.27 -13.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.527 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 89.31 66.17 1.26 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.619 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 37.1 t -157.16 141.61 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -116.17 172.44 7.18 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 140' ' ' GLY . 7.3 t -96.33 149.02 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 p -62.08 4.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.313 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.523 0.588 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt . . . . . 0 CA--C 1.521 -0.142 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.697 HG21 HG22 ' A' ' 58' ' ' THR . 1.0 OUTLIER -55.01 104.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.213 178.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 6' ' ' ALA . 29.6 m -80.79 -46.33 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.204 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 5' ' ' VAL . . . -100.84 142.1 32.79 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.263 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.7 p -132.58 99.91 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.595 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.12 90.34 3.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.031 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -78.99 117.2 19.84 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.493 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -170.67 -173.91 1.49 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.537 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -98.25 162.7 13.06 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.474 HD12 HG11 ' A' ' 55' ' ' VAL . 1.1 mt -148.88 96.83 3.73 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.484 ' HA ' HD13 ' A' ' 52' ' ' ILE . 26.5 Cg_exo -54.23 147.88 43.36 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.239 1.292 . . . . 0.0 114.769 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.832 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -94.61 142.45 27.44 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 45.06 31.38 2.9 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -154.07 34.34 0.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.145 -0.527 . . . . 0.0 110.522 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.82 151.55 36.28 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.546 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -156.32 167.98 13.27 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.121 -178.078 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -61.5 36.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.305 1.337 . . . . 0.0 112.207 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -159.33 57.39 1.04 Allowed Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.687 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 23.4 Cg_endo -80.22 169.62 17.26 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.157 1.238 . . . . 0.0 112.123 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -55.01 -28.41 59.65 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 120.705 0.936 . . . . 0.0 111.146 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.747 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.6 t -84.7 -61.9 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 43.25 -98.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.809 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -47.15 -60.71 0.78 Allowed 'Trans proline' 0 C--N 1.317 -1.106 0 CA-C-N 119.736 1.768 . . . . 0.0 110.559 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.747 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -48.49 -26.29 2.07 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.834 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.585 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 36.8 tp -113.23 26.35 10.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 122.124 0.964 . . . . 0.0 109.354 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.42 42.38 0.5 Allowed Glycine 0 C--N 1.313 -0.73 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.259 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -141.13 -16.28 0.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.186 0.517 . . . . 0.0 109.638 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.497 ' ND1' ' O ' ' A' ' 30' ' ' HIS . 16.2 t-80 -59.01 -11.11 3.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.197 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.99 -15.81 58.99 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.39 -131.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.304 0.642 . . . . 0.0 112.071 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -134.09 -165.56 1.66 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mm -138.46 -74.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.3 tpt -41.4 -37.41 1.03 Allowed 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -59.83 -54.36 47.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 68.7 t80 -45.38 -58.15 3.53 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 122.863 1.315 . . . . 0.0 109.755 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 42' ' ' ASN . 48.8 t -63.19 -43.4 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.577 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -44.64 -58.67 2.9 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.41 95.83 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.342 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -62.12 -74.22 0.09 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -39.74 -44.58 1.58 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.72 0.772 . . . . 0.0 111.738 -177.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.17 72.92 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.219 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.51 ' HB1' ' HG3' ' A' ' 70' ' ' LYS . . . -87.71 -46.09 9.8 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.186 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.8 p -62.76 -19.46 64.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -89.12 -34.14 16.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -61.41 -26.05 67.6 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.592 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -106.08 -85.87 0.49 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.067 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.592 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -176.2 169.23 41.75 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.338 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 42.9 p-10 -69.48 137.66 52.77 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.832 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -174.93 -150.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.861 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 13' ' ' PRO . 35.4 mm -138.19 125.0 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.603 HG11 HG23 ' A' ' 69' ' ' THR . 84.4 t -125.9 120.94 24.19 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.206 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -75.32 141.69 26.03 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.011 1.141 . . . . 0.0 110.631 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.618 HG22 ' N ' ' A' ' 56' ' ' GLU . 7.5 p -159.74 162.91 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.329 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.618 ' N ' HG22 ' A' ' 55' ' ' VAL . 9.7 mt-10 -129.44 114.82 16.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.9 mt -76.54 88.23 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.097 0.475 . . . . 0.0 111.73 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.697 HG22 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -74.37 113.49 11.65 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.6 mt -118.55 135.94 57.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.004 0.431 . . . . 0.0 111.401 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.642 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -110.17 147.72 33.18 Favored 'General case' 0 C--O 1.253 1.274 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.27 176.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.713 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -53.48 -22.55 8.19 Favored 'General case' 0 C--N 1.346 0.423 0 O-C-N 124.985 1.428 . . . . 0.0 112.177 -175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -63.43 8.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.713 ' H ' ' C ' ' A' ' 61' ' ' ALA . 89.0 mtm180 59.7 72.33 0.53 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.992 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.479 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 1.4 m -149.96 147.56 28.03 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.604 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.648 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -124.48 106.56 10.27 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.284 0.365 . . . . 0.0 111.452 -177.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.594 ' OG1' ' OH ' ' A' ' 60' ' ' TYR . 15.3 m -94.11 122.09 36.27 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 4.0 p90 177.1 -151.78 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 47.3 t 80.69 159.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.202 0 O-C-N 124.006 0.816 . . . . 0.0 110.344 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.603 HG23 HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER 175.64 119.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.033 179.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HD3' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -148.73 147.83 29.3 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.292 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.48 ' OG1' ' C ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER 173.7 141.6 0.16 Allowed Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.359 177.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.71 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 10.8 Cg_endo -72.62 169.38 22.02 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.588 0.859 . . . . 0.0 111.955 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 72' ' ' PRO . 12.1 Cg_exo -46.61 -157.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.814 2.343 . . . . 0.0 112.359 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.718 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -36.31 -34.01 0.05 Allowed 'General case' 0 C--O 1.255 1.364 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -40.15 -10.35 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.123 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.718 ' N ' ' O ' ' A' ' 74' ' ' ALA . 31.1 m-85 -32.76 -81.55 0.01 OUTLIER 'General case' 0 C--N 1.35 0.628 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.861 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -108.49 -5.35 16.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.771 HD11 ' CG2' ' A' ' 127' ' ' ILE . 6.5 mm -63.08 -42.42 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.347 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -52.2 -36.58 52.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.17 -66.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.842 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.62 -13.98 0.46 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.726 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 78' ' ' ILE . . . -89.83 -77.06 0.4 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.637 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.75 37.86 0.49 Allowed Glycine 0 N--CA 1.466 0.648 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.2 mt -90.68 104.88 17.42 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 C--N 1.33 -0.241 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.742 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.2 mttt . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -158.86 151.25 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.167 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.88 84.3 0.59 Allowed Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -141.82 103.15 4.3 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.086 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.606 HD12 ' CG1' ' A' ' 104' ' ' VAL . 3.5 pt -106.56 159.91 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.36 152.01 19.4 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.257 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.488 ' O ' HG22 ' A' ' 104' ' ' VAL . 70.4 t-105 -60.32 -51.26 70.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.778 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.85 -41.93 92.5 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 120.62 -1.3 . . . . 0.0 111.751 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.22 -44.51 95.11 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.105 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.606 ' CG1' HD12 ' A' ' 99' ' ' ILE . 17.5 m -62.92 -33.71 62.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 118.257 -1.377 . . . . 0.0 109.411 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 108' ' ' ALA . 96.2 mt -61.47 -72.21 0.13 Allowed 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.19 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -43.77 -56.23 3.96 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.488 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.482 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 95.1 mt -50.61 -25.68 3.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.879 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -88.89 -44.6 10.34 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.604 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.434 ' HG3' HD11 ' A' ' 120' ' ' LEU . 47.7 mtpt -43.9 -68.32 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.373 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.788 ' N ' HE21 ' A' ' 110' ' ' GLN . 0.0 OUTLIER -57.32 -66.37 0.47 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.328 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -47.16 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.973 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.561 ' N ' ' O ' ' A' ' 110' ' ' GLN . 37.6 mtt -157.51 51.34 0.48 Allowed Pre-proline 0 C--O 1.234 0.248 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.664 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 112' ' ' MET . 10.7 Cg_endo -66.05 -33.37 41.53 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 120.748 0.965 . . . . 0.0 111.867 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 115' ' ' LEU . 63.9 m-20 -160.75 -77.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.942 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.558 HD22 ' H ' ' A' ' 115' ' ' LEU . 3.9 mm? 44.0 -169.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.296 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.532 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -121.98 35.56 4.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.762 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.3 p -135.83 168.41 19.35 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.395 0.617 . . . . 0.0 111.902 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -138.67 -85.52 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.511 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.505 ' H ' HG23 ' A' ' 118' ' ' THR . 97.7 m-20 -55.42 164.22 1.04 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 124' ' ' ALA . 4.4 mm? -61.66 -40.62 95.57 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-O 121.469 0.652 . . . . 0.0 110.42 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -50.31 -46.08 55.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.129 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.73 -66.27 0.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.174 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 126' ' ' MET . . . -49.05 -48.02 44.31 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.928 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -47.06 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 129' ' ' GLY . 42.2 ttm180 -42.15 -37.63 1.49 Allowed 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 126' ' ' MET . 3.2 tmm? -54.9 -73.48 0.05 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.484 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.771 ' CG2' HD11 ' A' ' 78' ' ' ILE . 34.1 mt -51.77 -51.71 26.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.847 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -62.81 -70.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.16 -42.39 3.12 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 133' ' ' SER . 23.9 m -57.49 -46.16 84.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.637 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -51.28 -50.29 59.57 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.579 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -49.97 -36.03 26.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.58 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.2 t -63.23 -71.15 0.17 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.644 ' SD ' ' HB3' ' A' ' 74' ' ' ALA . 81.3 mtp -47.65 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.82 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 80.43 55.68 3.38 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.637 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 39.8 t -138.15 161.72 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.47 ' N ' HG12 ' A' ' 136' ' ' VAL . 76.3 mt-10 -133.01 159.35 40.28 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.921 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.441 HG12 ' H ' ' A' ' 140' ' ' GLY . 11.2 t -99.49 156.99 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 p -84.48 -3.33 7.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.651 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.441 ' H ' HG12 ' A' ' 138' ' ' VAL . . . . . . . . 0 CA--C 1.519 0.286 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.91 -167.64 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.831 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.504 ' O ' HG13 ' A' ' 5' ' ' VAL . 98.9 mttt -62.54 -161.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 4' ' ' VAL . 12.4 p -42.22 121.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 3' ' ' LYS . 12.7 m -113.92 -24.76 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.09 129.68 24.29 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.978 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.715 ' O ' HG13 ' A' ' 7' ' ' VAL . 9.0 p -120.8 109.78 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.577 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG12 ' CD2' ' A' ' 10' ' ' LEU . 2.4 t -88.45 89.82 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.015 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -84.6 117.31 23.66 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 124.073 0.858 . . . . 0.0 109.704 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -179.92 -178.66 0.44 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.649 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.434 ' N ' ' NE2' ' A' ' 11' ' ' GLN . 0.7 OUTLIER -91.8 160.43 15.32 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.556 HD23 ' HD2' ' A' ' 13' ' ' PRO . 2.2 mt -151.53 133.93 8.5 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.556 ' HD2' HD23 ' A' ' 12' ' ' LEU . 45.1 Cg_endo -80.79 119.04 3.54 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.108 1.074 . . . . 0.0 114.213 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.926 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -51.97 137.9 25.9 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 53.56 -154.03 7.65 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 -176.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 15' ' ' GLY . 40.7 tttp 40.73 22.55 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.369 1.085 . . . . 0.0 111.008 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -96.84 159.58 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.13 167.31 8.73 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.144 -178.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.37 40.26 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.464 1.443 . . . . 0.0 112.159 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.561 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -146.14 53.31 1.76 Allowed Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.708 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 34.8 Cg_endo -80.17 165.6 21.29 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 120.901 1.067 . . . . 0.0 112.043 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -61.41 -24.88 79.21 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 120.827 1.018 . . . . 0.0 111.099 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.533 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.7 t -83.72 -66.66 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.676 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 46.02 -98.75 0.01 OUTLIER Glycine 0 N--CA 1.468 0.799 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 27' ' ' LEU . 2.7 Cg_endo -53.1 -57.17 2.16 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 CA-C-N 120.698 2.249 . . . . 0.0 110.334 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -43.29 -16.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 -178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 25' ' ' PRO . 1.3 tp -112.2 -38.02 4.86 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.09 -49.71 75.57 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.682 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -41.19 -29.49 0.13 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.022 0.911 . . . . 0.0 110.662 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -44.76 -37.43 3.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.551 0.691 . . . . 0.0 109.379 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.59 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 99.56 -23.23 37.02 Favored Glycine 0 C--O 1.225 -0.41 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.574 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.59 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -47.1 -135.94 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.223 0.609 . . . . 0.0 112.492 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -137.46 106.89 6.11 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.72 -0.613 . . . . 0.0 110.614 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 37' ' ' PHE . 4.6 mm -52.52 -70.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 34' ' ' ILE . 10.0 tpt -39.56 -40.45 0.87 Allowed 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.2 -0.312 . . . . 0.0 110.498 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.28 -46.92 88.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' ILE . 57.5 t80 -50.7 -65.06 0.62 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 122.371 1.082 . . . . 0.0 109.504 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 42' ' ' ASN . 97.4 t -57.42 -44.29 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.169 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -46.27 -64.8 0.66 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.9 -38.94 70.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.249 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.856 ' CZ ' HG21 ' A' ' 45' ' ' THR . 68.1 t80 -64.2 -76.38 0.07 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 38' ' ' VAL . 20.4 t-20 -41.06 -45.49 2.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.586 0.708 . . . . 0.0 112.035 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.5 -35.99 73.1 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.305 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.21 -43.02 13.33 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.702 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.856 HG21 ' CZ ' ' A' ' 41' ' ' PHE . 47.1 p -67.47 -21.23 65.54 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -82.45 -37.51 25.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -65.51 -21.57 66.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.446 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.4 ptm -107.5 -29.27 9.31 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 117.62 171.04 15.35 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 51.1 p-10 -75.63 142.28 42.65 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.926 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -174.34 -150.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.903 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.701 HD13 ' N ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -139.87 135.81 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.701 ' N ' HD13 ' A' ' 52' ' ' ILE . 18.1 t -144.27 133.28 11.26 Favored Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.905 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.24 131.96 12.19 Favored 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 120.766 0.978 . . . . 0.0 109.646 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 56' ' ' GLU . 1.5 p -140.53 156.98 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.862 0.839 . . . . 0.0 111.928 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 21.5 mt-10 -131.34 82.37 2.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.331 176.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 57' ' ' ILE . 21.9 mt -53.04 95.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.282 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.41 101.94 5.76 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.38 123.67 58.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.45 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -99.98 144.3 29.18 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.666 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -54.65 -22.29 13.18 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.042 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -66.03 6.42 0.39 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.666 ' H ' ' C ' ' A' ' 61' ' ' ALA . 84.0 mtm180 64.44 71.02 0.48 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.921 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.5 t -147.92 126.24 12.3 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.526 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -103.58 102.31 12.19 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -90.49 123.91 34.56 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER 173.47 118.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.565 -177.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -151.2 131.92 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.694 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.5 p -135.23 150.89 50.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.473 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 71' ' ' THR . 46.5 pttt -174.27 -158.3 0.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.504 ' O ' ' O ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER 80.34 60.0 0.14 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.912 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 71' ' ' THR . 19.7 Cg_exo -43.53 177.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.747 1.631 . . . . 0.0 112.916 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -54.67 -55.37 3.35 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.398 1.399 . . . . 0.0 114.924 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.811 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . -146.54 -66.63 0.28 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.0 p -36.64 -20.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.891 0.377 . . . . 0.0 110.43 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.646 ' N ' ' O ' ' A' ' 74' ' ' ALA . 1.8 t80 -40.29 -67.11 0.25 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.276 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.915 HD23 ' O ' ' A' ' 77' ' ' LEU . 6.9 tt -110.15 -19.94 12.85 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.811 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.2 mt -55.67 -42.21 68.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.031 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -44.54 -39.27 4.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.592 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -81.89 -60.42 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.49 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.73 13.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.43 . . . . 0.0 110.766 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -85.43 -78.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.39 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.34 41.43 0.23 Allowed Glycine 0 N--CA 1.47 0.912 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 mt -94.59 112.86 24.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -91.18 -85.21 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.499 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -63.38 -43.72 96.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.861 0.362 . . . . 0.0 110.282 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 131.59 -155.41 21.37 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.5 158.7 20.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -158.05 -173.13 4.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.103 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -49.66 154.35 1.73 Allowed Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.97 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -51.84 144.51 35.12 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.656 0.904 . . . . 0.0 111.786 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -151.79 164.27 30.29 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -96.13 5.73 50.41 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.595 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 1.5 pm0 -65.55 -35.46 80.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.39 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 94' ' ' GLU . 58.2 mttp 56.49 114.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.454 HG22 ' N ' ' A' ' 97' ' ' GLY . 11.6 p -138.84 159.01 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.733 0.302 . . . . 0.0 110.25 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.454 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 104.54 84.38 1.76 Allowed Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.507 ' HE ' HG23 ' A' ' 139' ' ' VAL . 43.5 ttt180 -135.77 104.77 5.87 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.142 0.496 . . . . 0.0 111.219 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.512 HD12 ' CG1' ' A' ' 104' ' ' VAL . 3.1 pt -109.41 148.51 13.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.521 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.8 OUTLIER -89.1 160.28 17.11 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.164 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.79 ' NE1' HD11 ' A' ' 105' ' ' LEU . 76.0 t-105 -60.4 -54.17 48.85 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.605 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -59.97 -43.5 95.04 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.913 -1.117 . . . . 0.0 111.388 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -59.1 -45.53 90.64 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.978 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.512 ' CG1' HD12 ' A' ' 99' ' ' ILE . 29.8 m -64.88 -31.66 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 118.249 -1.381 . . . . 0.0 109.672 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.79 HD11 ' NE1' ' A' ' 101' ' ' TRP . 76.1 mt -61.74 -67.32 0.42 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.662 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -44.38 -41.59 6.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.198 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.52 HD11 HD22 ' A' ' 77' ' ' LEU . 97.3 mt -67.13 -29.12 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.104 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -91.77 -3.3 56.34 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.749 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 111' ' ' LYS . 44.1 mtpt -85.74 -72.73 0.48 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.866 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.58 -0.89 0.3 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.027 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.591 ' NZ ' ' HB2' ' A' ' 123' ' ' ALA . 1.4 pptp? -68.9 -16.72 63.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.616 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.481 ' SD ' ' NZ ' ' A' ' 111' ' ' LYS . 5.9 ptt? -123.91 70.15 48.85 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.444 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 15.2 Cg_exo -53.84 -40.52 80.07 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 120.653 0.902 . . . . 0.0 112.082 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 113' ' ' PRO . 80.6 m-20 -149.78 14.93 0.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.58 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 115' ' ' LEU . 9.6 mp -71.32 160.53 32.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.2 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.57 ' C ' HD22 ' A' ' 116' ' ' ASN . 0.2 OUTLIER -70.56 64.72 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.096 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.0 m -162.04 140.04 8.87 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.374 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.74 -2.76 0.35 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.99 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.87 124.41 34.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.298 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 36.0 mt -62.09 -42.95 99.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.576 0.703 . . . . 0.0 110.266 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.4 -36.63 71.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.983 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.61 -69.4 0.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.591 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.591 ' HB2' ' NZ ' ' A' ' 111' ' ' LYS . . . -47.13 -33.09 4.76 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.133 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -61.13 -66.58 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.1 mtt180 -46.35 -33.78 4.08 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.793 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.465 ' O ' ' CB ' ' A' ' 130' ' ' SER . 34.4 ttp -59.57 -73.83 0.08 Allowed 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 mm -50.56 -48.31 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.739 0.304 . . . . 0.0 110.826 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -68.15 -70.82 0.24 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.05 -45.8 6.17 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 126' ' ' MET . 67.5 m -56.41 -42.45 78.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.693 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -55.85 -46.65 78.13 Favored 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.538 ' HG2' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -54.67 -44.11 73.02 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 t -51.96 -69.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 74.4 mtp -41.96 -66.39 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.674 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.22 55.05 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.693 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 49.2 t -134.6 161.14 40.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.478 ' N ' HG12 ' A' ' 136' ' ' VAL . 96.2 mt-10 -124.3 152.9 42.5 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.534 HG12 ' H ' ' A' ' 140' ' ' GLY . 8.1 t -104.07 133.37 48.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 100' ' ' THR . 1.6 p -70.37 -3.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.799 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.534 ' H ' HG12 ' A' ' 138' ' ' VAL . . . -131.58 112.31 1.18 Allowed Glycine 0 N--CA 1.463 0.452 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -179.59 68.37 0.17 Allowed Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -55.57 133.44 58.08 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.029 1.153 . . . . 0.0 111.804 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 174.74 23.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.899 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.55 133.6 59.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.774 0.321 . . . . 0.0 110.619 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -74.35 142.88 45.08 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -85.16 -2.04 57.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.683 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.9 -179.76 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.443 ' SD ' ' HB1' ' A' ' 61' ' ' ALA . 19.1 mmt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -153.06 130.52 11.4 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.6 tttt 71.75 -164.65 0.13 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 4' ' ' VAL . 12.9 p -64.76 119.92 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.03 -24.49 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 119.211 -0.423 . . . . 0.0 109.88 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.55 134.83 27.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.588 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 7' ' ' VAL . 13.4 p -124.98 125.51 69.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.207 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.61 93.47 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 119.644 1.111 . . . . 0.0 111.556 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -84.05 118.12 23.86 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.836 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.444 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -171.41 -173.79 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.648 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -90.18 149.29 22.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.833 HD22 ' CE2' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -140.59 93.39 8.69 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 123.154 0.284 . . . . 0.0 110.315 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -67.47 123.18 10.51 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.141 1.227 . . . . 0.0 114.224 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.887 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -54.49 136.73 44.17 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 54.89 -155.78 8.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 15' ' ' GLY . 97.3 mttt 41.47 20.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.118 0.959 . . . . 0.0 111.165 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -97.04 158.52 15.39 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.61 167.68 7.89 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.245 -179.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.79 42.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.136 1.224 . . . . 0.0 112.024 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.539 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -150.53 55.58 1.82 Allowed Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.599 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 32.5 Cg_endo -79.47 164.8 23.57 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 120.819 1.013 . . . . 0.0 112.105 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -63.18 -24.37 72.75 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.768 0.979 . . . . 0.0 111.359 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.714 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.5 t -77.01 -64.67 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 44.04 -99.01 0.01 OUTLIER Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 28' ' ' GLY . 14.4 Cg_exo -48.95 -59.63 1.17 Allowed 'Trans proline' 0 C--N 1.32 -0.971 0 CA-C-N 119.991 1.896 . . . . 0.0 110.561 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.714 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -44.36 -24.01 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.381 -0.527 . . . . 0.0 109.886 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 39.4 tp -119.91 31.96 6.28 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.907 0.86 . . . . 0.0 109.495 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' PRO . . . -126.24 -64.34 0.16 Allowed Glycine 0 C--N 1.319 -0.363 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 28' ' ' GLY . 65.6 tp60 -42.29 -25.26 0.07 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.734 0.767 . . . . 0.0 109.699 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.483 ' N ' ' C ' ' A' ' 28' ' ' GLY . 37.6 t-80 -42.63 -39.14 2.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.44 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 97.68 -24.43 31.63 Favored Glycine 0 C--N 1.331 0.28 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -48.94 -135.68 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.093 0.557 . . . . 0.0 112.272 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -136.88 130.31 31.52 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.096 -0.377 . . . . 0.0 110.874 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 37' ' ' PHE . 3.5 mm -82.16 -72.24 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.3 tpt -39.57 -40.51 0.88 Allowed 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.14 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -60.78 -49.81 76.0 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.255 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 34' ' ' ILE . 87.6 t80 -47.02 -60.54 2.38 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.099 0.952 . . . . 0.0 109.795 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 42' ' ' ASN . 59.9 t -59.85 -44.05 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.348 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 84.5 tttt -46.66 -66.12 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.99 76.11 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.627 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.833 ' CE2' HD22 ' A' ' 12' ' ' LEU . 33.3 t80 -62.97 -75.8 0.07 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' VAL . 6.3 t-20 -40.53 -45.33 2.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.389 0.614 . . . . 0.0 111.974 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.446 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -57.44 -34.84 69.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.037 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.42 -44.79 12.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.371 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 49' ' ' GLY . 45.8 p -65.36 -21.61 66.71 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -77.0 -45.15 28.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 43' ' ' ALA . 5.1 m120 -62.48 -16.11 53.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.4 mmm -106.8 -70.92 0.77 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.268 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 160.15 -162.22 33.04 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 40.0 p-10 -99.86 122.3 42.59 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.887 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -156.8 -153.14 0.4 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.28 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mm -137.71 127.79 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.708 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.7 t -144.26 124.97 7.69 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.774 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -73.94 147.93 39.68 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 120.745 0.963 . . . . 0.0 110.639 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.675 HG21 HD12 ' A' ' 12' ' ' LEU . 34.0 m -143.19 160.83 17.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.257 0.551 . . . . 0.0 111.246 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 58' ' ' THR . 93.8 mt-10 -129.38 76.74 1.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.5 mt -50.87 86.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.874 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -72.99 95.17 1.96 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.462 HG21 ' NE2' ' A' ' 30' ' ' HIS . 60.8 mt -95.6 125.13 48.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.693 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 63' ' ' ARG . 3.4 m-85 -100.63 140.35 35.03 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.625 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.63 -23.33 2.52 Favored 'General case' 0 C--N 1.345 0.384 0 O-C-N 124.584 1.178 . . . . 0.0 112.366 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -66.89 5.82 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.625 ' H ' ' C ' ' A' ' 61' ' ' ALA . 59.8 mtp180 63.88 69.69 0.53 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.341 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.9 p -146.47 127.55 14.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.959 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -105.04 103.44 13.0 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.622 -177.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.512 ' O ' ' OG1' ' A' ' 58' ' ' THR . 41.1 p -95.21 122.91 38.39 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.56 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.5 p90 176.32 -152.74 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 48.9 t 80.35 117.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 124.408 1.067 . . . . 0.0 111.381 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -124.58 127.56 47.56 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -143.8 -170.33 3.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.701 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 m 66.0 52.07 0.83 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.586 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.701 ' HD3' ' N ' ' A' ' 71' ' ' THR . 1.4 Cg_endo -73.73 162.57 39.26 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 120.859 1.039 . . . . 0.0 112.553 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -73.75 91.24 0.91 Allowed 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.552 1.502 . . . . 0.0 113.189 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.818 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . . . 179.69 -171.53 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.511 ' OG ' ' NH1' ' A' ' 79' ' ' ARG . 2.5 m -38.91 -17.32 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.818 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 74.9 m-85 -45.69 -42.24 11.43 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.297 0.373 . . . . 0.0 110.392 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.845 HD22 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -130.74 -13.98 3.64 Favored 'General case' 0 C--O 1.254 1.318 0 CA-C-O 122.304 1.049 . . . . 0.0 108.891 178.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.845 ' N ' HD22 ' A' ' 77' ' ' LEU . 17.4 mt -65.34 -41.74 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.987 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.603 ' HG2' HH11 ' A' ' 79' ' ' ARG . 0.0 OUTLIER -51.76 -41.61 61.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.661 179.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -63.21 -63.18 1.27 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.27 69.6 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.491 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -79.52 -83.84 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.553 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 137.6 -76.87 0.35 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.9 mt 42.34 -160.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -164.37 -87.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.466 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -145.38 106.87 4.22 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.57 -100.0 0.02 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -163.75 121.4 1.83 Allowed 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.534 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -72.7 -63.4 1.17 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.446 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -142.31 151.27 57.79 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.639 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -53.11 142.44 54.81 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 120.747 0.964 . . . . 0.0 111.436 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -122.39 -118.06 2.46 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -139.22 -86.77 0.23 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.642 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -178.98 67.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.875 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -155.71 54.97 0.61 Allowed 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.157 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -144.96 150.61 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 137' ' ' GLU . . . 82.4 75.96 1.12 Allowed Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -131.0 116.94 18.49 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.621 0.248 . . . . 0.0 110.624 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.6 mt -109.71 150.11 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.468 HG21 ' NE2' ' A' ' 103' ' ' GLN . 3.0 p -82.0 149.35 28.18 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.912 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.629 ' NE1' HD11 ' A' ' 105' ' ' LEU . 66.8 t-105 -57.7 -52.05 67.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.092 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -58.77 -40.94 85.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.329 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.468 ' NE2' HG21 ' A' ' 100' ' ' THR . 58.3 mt-30 -60.62 -48.47 81.63 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.9 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.87 -32.78 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.658 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.629 HD11 ' NE1' ' A' ' 101' ' ' TRP . 50.5 mt -59.5 -68.37 0.29 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.655 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -44.59 -46.2 9.89 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.284 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.57 -29.24 38.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.946 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.753 ' HB2' HD12 ' A' ' 127' ' ' ILE . . . -101.66 -8.23 21.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.651 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 105' ' ' LEU . 75.0 tttt -77.6 -75.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.007 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -59.58 -20.96 59.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.631 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -97.75 102.02 13.67 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.721 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' A' ' 115' ' ' LEU . 6.6 mmt -140.05 55.34 6.35 Favored Pre-proline 0 C--O 1.236 0.373 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.129 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 112' ' ' MET . 14.5 Cg_exo -50.57 -54.8 4.85 Favored 'Trans proline' 0 N--CA 1.488 1.206 0 C-N-CA 120.671 0.914 . . . . 0.0 112.067 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -126.92 -29.27 2.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.345 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -75.14 38.99 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.072 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.69 HD22 ' N ' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -84.85 46.82 1.3 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.704 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.446 ' OG1' ' HB3' ' A' ' 122' ' ' ALA . 5.5 p -73.33 32.54 0.07 Allowed 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.855 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 116' ' ' ASN . 9.8 t 39.43 29.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.26 0.35 . . . . 0.0 110.73 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 117' ' ' THR . 74.9 m-20 -150.95 125.37 9.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.458 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 83.8 mt -62.95 -34.47 77.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.258 0.552 . . . . 0.0 110.788 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.67 -37.17 62.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.512 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' HB3' ' OG1' ' A' ' 117' ' ' THR . . . -72.39 -69.4 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.056 -1.058 . . . . 0.0 109.35 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.696 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -50.6 -32.72 19.61 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.192 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -60.91 -70.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 129' ' ' GLY . 62.7 ttt180 -42.95 -30.78 0.44 Allowed 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.508 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 4.7 tmm? -58.38 -73.08 0.08 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.753 HD12 ' HB2' ' A' ' 108' ' ' ALA . 88.0 mt -50.69 -51.3 20.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.023 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -63.66 -71.55 0.17 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.73 -45.76 4.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.508 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 67.2 m -58.75 -44.65 90.6 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.626 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -51.59 -47.83 63.42 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -55.26 -42.28 73.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.4 t -55.26 -72.13 0.07 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.4 mtm -42.17 -34.71 0.79 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.773 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.38 49.11 0.57 Allowed Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.626 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 43.0 t -136.05 164.93 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.541 ' N ' HG12 ' A' ' 136' ' ' VAL . 81.9 tt0 -130.13 158.72 38.9 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.54 ' C ' ' H ' ' A' ' 140' ' ' GLY . 53.9 t -111.56 160.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.5 ' N ' HG12 ' A' ' 138' ' ' VAL . 9.8 p -64.48 8.45 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.091 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . 61.03 157.33 0.06 OUTLIER Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.91 71.1 56.96 Favored Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 117.087 0.443 . . . . 0.0 110.818 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -63.91 154.41 70.08 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.33 1.354 . . . . 0.0 111.849 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -54.15 -177.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.51 ' O ' ' O ' ' A' ' 145' ' ' LYS . 2.8 t -137.17 109.3 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 144' ' ' VAL . 97.7 mttt 53.95 117.22 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.139 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 147' ' ' ALA . 31.9 p30 -63.71 -30.26 71.39 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.904 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.524 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.647 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptp . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 67.9 mttm -94.71 41.87 1.09 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.379 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 7.7 tptm 74.61 175.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.63 138.23 19.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 m -118.82 -25.44 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.188 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.44 143.04 29.82 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.853 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 7' ' ' VAL . 15.0 p -133.84 133.03 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.563 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.42 92.67 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 120.067 1.303 . . . . 0.0 111.757 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -82.81 116.07 21.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -167.85 -173.78 2.22 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.536 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -90.76 143.78 26.38 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.615 HD12 ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -123.68 86.84 52.73 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -65.71 114.91 3.12 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.54 1.493 . . . . 0.0 114.642 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.751 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -74.9 146.54 41.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 174.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.73 58.33 10.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt 173.61 -24.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.91 150.29 45.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -160.39 167.54 13.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.115 -178.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -59.32 48.07 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.618 1.546 . . . . 0.0 112.711 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -169.53 53.87 0.23 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.504 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 20' ' ' ALA . 18.2 Cg_endo -68.1 166.1 26.12 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.032 1.155 . . . . 0.0 112.247 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -65.33 -22.18 60.41 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.803 1.002 . . . . 0.0 111.239 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.545 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.7 t -72.49 -64.32 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.228 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.554 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 25' ' ' PRO . . . 59.2 -137.48 50.23 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 118.619 -1.753 . . . . 0.0 109.485 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.688 ' C ' ' H ' ' A' ' 27' ' ' LEU . 28.2 Cg_exo -38.23 -41.32 1.35 Allowed 'Trans proline' 0 N--CA 1.486 1.06 0 CA-C-N 120.607 2.204 . . . . 0.0 110.853 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.545 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -57.47 13.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.811 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.688 ' H ' ' C ' ' A' ' 25' ' ' PRO . 3.5 tt -172.27 -48.7 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.579 ' N ' HD23 ' A' ' 27' ' ' LEU . . . -59.01 -48.9 83.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -73.96 35.55 0.09 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.471 0.653 . . . . 0.0 110.272 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.63 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -84.88 -19.93 31.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.258 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 106.2 -43.85 1.59 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -49.35 -131.32 0.0 OUTLIER 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.335 0.654 . . . . 0.0 111.79 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -137.91 143.44 40.83 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.762 -0.586 . . . . 0.0 110.525 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' PHE . 6.7 mt -88.88 -70.15 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.1 tpt -40.85 -39.6 1.17 Allowed 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -57.11 -49.32 76.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.631 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 64.2 t80 -48.78 -59.89 3.19 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.452 1.12 . . . . 0.0 109.501 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 42' ' ' ASN . 57.4 t -61.59 -42.73 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 113.391 -1.731 . . . . 0.0 111.281 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.0 tppp? -46.25 -57.9 4.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.65 95.08 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 119.921 -0.711 . . . . 0.0 110.127 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 12' ' ' LEU . 2.0 t80 -62.81 -74.78 0.09 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -40.01 -43.32 1.54 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 121.558 0.694 . . . . 0.0 111.779 -177.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -59.09 -36.39 75.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.261 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.12 -46.8 10.09 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.113 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.649 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 82.5 p -60.87 -37.77 83.28 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -65.22 -36.74 85.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -63.88 -18.6 64.34 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.756 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -103.79 -42.98 5.45 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.634 ' O ' ' O ' ' A' ' 50' ' ' ASP . . . 116.75 74.29 0.53 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.399 -0.667 . . . . 0.0 111.868 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.634 ' O ' ' O ' ' A' ' 49' ' ' GLY . 2.9 p30 44.93 159.73 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.883 0.373 . . . . 0.0 111.482 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.751 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 170.81 -163.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.293 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.5 mt -141.06 131.23 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.99 125.52 4.94 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.833 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.42 149.78 31.49 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 CA-C-N 119.485 0.852 . . . . 0.0 110.86 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.553 ' CG2' HD23 ' A' ' 12' ' ' LEU . 35.0 m -144.64 161.92 14.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.434 0.635 . . . . 0.0 111.416 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 58' ' ' THR . 95.2 mt-10 -127.33 80.93 1.99 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.407 ' H ' HG13 ' A' ' 57' ' ' ILE . 44.1 mt -54.04 88.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.043 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -66.21 110.53 3.05 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -178.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.4 mt -107.91 125.0 64.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.363 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -104.12 140.13 38.22 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.627 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.73 -21.78 1.79 Allowed 'General case' 0 C--N 1.341 0.232 0 O-C-N 124.226 0.954 . . . . 0.0 112.218 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -68.33 6.12 0.85 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.627 ' H ' ' C ' ' A' ' 61' ' ' ALA . 87.4 mtm180 64.62 67.8 0.55 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.355 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.7 m -143.21 127.14 17.29 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.854 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -108.39 102.49 11.59 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.606 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.4 p -93.95 126.06 38.93 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.631 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 5.6 p90 -174.96 130.99 0.31 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.918 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 69' ' ' THR . 44.5 t -137.05 156.06 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.404 ' N ' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -177.71 121.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.949 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -177.51 -179.65 0.85 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.317 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.513 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 21.9 p 55.93 61.01 8.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.054 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 71' ' ' THR . 3.7 Cg_endo -75.27 164.1 33.5 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 120.897 1.065 . . . . 0.0 112.418 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.67 ' HA ' HD11 ' A' ' 77' ' ' LEU . 13.8 Cg_endo -72.2 176.51 8.43 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 121.899 1.732 . . . . 0.0 112.178 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.731 ' O ' HD12 ' A' ' 77' ' ' LEU . . . 79.56 -174.54 0.06 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.909 0.322 . . . . 0.0 111.051 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.549 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.7 OUTLIER -39.99 -19.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.088 -178.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.552 ' N ' ' O ' ' A' ' 74' ' ' ALA . 10.1 m-85 -45.48 -35.95 4.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.697 0.623 . . . . 0.0 111.057 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.84 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.91 -25.52 1.83 Allowed 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.8 0.81 . . . . 0.0 109.021 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 73.7 mt -55.5 -35.47 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.666 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -53.73 -43.96 69.5 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.223 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -64.55 -65.34 0.69 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.35 -13.45 0.56 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.979 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.67 -76.62 0.39 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.765 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.48 48.84 0.58 Allowed Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.0 mt -98.7 124.05 43.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -100.85 118.8 37.62 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 45.57 32.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.522 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.09 -135.23 40.11 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.85 59.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.937 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -59.3 -41.99 90.29 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.627 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -87.06 147.05 41.82 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.685 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -62.15 142.17 91.0 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 120.599 0.866 . . . . 0.0 111.848 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -111.26 -121.36 4.11 Favored Glycine 0 N--CA 1.465 0.601 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 61.4 mtt-85 -136.68 -86.83 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.651 0.262 . . . . 0.0 110.639 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -150.07 176.96 10.33 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.3 mttm 54.94 100.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.936 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -145.24 144.13 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.634 0.254 . . . . 0.0 110.35 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 46.95 87.18 0.01 OUTLIER Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -116.39 106.25 13.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.977 0.418 . . . . 0.0 111.23 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.703 HD12 HG11 ' A' ' 104' ' ' VAL . 7.4 pt -100.94 144.91 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 p -85.45 156.87 20.64 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.439 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.6 ' NE1' HD11 ' A' ' 105' ' ' LEU . 49.3 t-105 -63.73 -51.06 66.64 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.615 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.23 -43.4 98.95 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.152 -0.967 . . . . 0.0 111.533 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -61.33 -46.96 88.08 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.696 -0.801 . . . . 0.0 111.227 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.703 HG11 HD12 ' A' ' 99' ' ' ILE . 35.5 m -65.2 -33.56 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 118.235 -1.386 . . . . 0.0 109.414 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.6 HD11 ' NE1' ' A' ' 101' ' ' TRP . 40.8 mt -59.48 -65.69 0.63 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.392 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -44.86 -51.15 9.87 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.049 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.34 -31.46 46.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.787 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.536 ' HB1' ' HB1' ' A' ' 123' ' ' ALA . . . -91.55 -8.07 48.48 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.675 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 105' ' ' LEU . 45.3 tttm -85.56 -71.57 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 109.919 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.63 -40.72 60.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.395 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -69.89 66.08 0.24 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.384 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.436 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 38.8 mtm -157.65 54.84 0.84 Allowed Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.568 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 112' ' ' MET . 9.8 Cg_endo -65.13 -55.7 0.45 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 120.805 1.003 . . . . 0.0 111.85 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 113' ' ' PRO . 57.5 m-20 -160.01 15.5 0.14 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.398 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.9 mt -46.61 -86.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.319 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -170.8 -18.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.25 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 70.1 p -83.33 167.51 17.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.1 0.476 . . . . 0.0 111.15 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -140.59 -85.83 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.401 -178.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.516 ' H ' HG23 ' A' ' 118' ' ' THR . 90.9 m-20 -58.67 159.55 6.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.447 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 37.5 mt -61.77 -37.27 83.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 0.0 110.161 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -52.9 -37.79 61.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.281 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.17 -69.0 0.45 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 118.981 -1.087 . . . . 0.0 109.067 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.536 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -49.51 -35.52 20.26 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.227 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -59.09 -69.83 0.18 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.0 mtt180 -43.76 -30.57 0.67 Allowed 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.758 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.459 ' O ' ' CB ' ' A' ' 130' ' ' SER . 2.9 tmm? -59.31 -73.07 0.09 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.0 mm -51.69 -48.98 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.032 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -67.71 -70.44 0.26 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.61 -43.22 4.97 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 126' ' ' MET . 68.8 m -58.64 -42.64 88.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -56.07 -48.99 75.01 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -51.39 -41.38 60.66 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.546 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.6 t -54.77 -66.77 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 86.5 mtp -50.75 -4.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.812 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 91.21 -27.72 8.96 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 137' ' ' GLU . 55.1 t -47.38 164.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.556 ' N ' HG12 ' A' ' 136' ' ' VAL . 97.7 mt-10 -141.23 161.9 36.77 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.056 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 140' ' ' GLY . 83.0 t -88.09 152.44 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 139' ' ' VAL . 7.8 p -61.3 2.68 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.285 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . 113.9 154.23 11.17 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -141.92 68.02 23.16 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.69 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.067 1.178 . . . . 0.0 112.048 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -173.7 23.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.776 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.8 t -137.45 134.65 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.216 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -88.24 130.51 35.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -145.75 -55.71 0.29 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.993 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.104 -0.95 . . . . 0.0 110.324 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 ptt? . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 3' ' ' LYS . 50.5 tttt -171.05 177.96 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' H ' ' HG2' ' A' ' 2' ' ' LYS . 98.4 mttt 52.34 -162.41 0.09 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.143 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 4' ' ' VAL . 14.2 p -51.9 112.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.639 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.8 -24.18 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.89 132.4 23.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.102 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.7 ' O ' HG13 ' A' ' 7' ' ' VAL . 8.6 p -122.56 105.29 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.687 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.438 ' CG1' HD21 ' A' ' 10' ' ' LEU . 4.6 t -76.64 91.66 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 118.741 -1.184 . . . . 0.0 109.626 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -89.32 106.43 18.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.511 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.506 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -175.32 -173.77 0.68 Allowed 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.024 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -100.95 163.23 12.39 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.479 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.561 HD12 HG21 ' A' ' 55' ' ' VAL . 2.2 mt -153.51 137.3 10.48 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.48 ' HD2' HD23 ' A' ' 12' ' ' LEU . 57.7 Cg_endo -87.53 125.27 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 CA-C-N 120.366 1.166 . . . . 0.0 114.114 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.802 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -59.33 139.17 57.27 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . 57.79 152.8 0.01 OUTLIER Glycine 0 CA--C 1.536 1.345 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 50.4 tttt 77.34 13.97 1.91 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.797 1.799 . . . . 0.0 111.373 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 18' ' ' THR . . . -91.19 157.97 16.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.99 167.56 4.87 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.653 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.09 39.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.709 1.606 . . . . 0.0 112.61 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.544 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -146.52 54.08 1.99 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.043 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 38.9 Cg_endo -82.49 164.24 16.61 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 120.972 1.114 . . . . 0.0 112.142 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -62.33 -25.7 76.63 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 120.8 1.0 . . . . 0.0 111.024 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.04 -71.57 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.034 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 46.47 -101.24 0.03 OUTLIER Glycine 0 C--O 1.214 -1.151 0 CA-C-O 118.574 -1.125 . . . . 0.0 111.099 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.627 ' C ' ' H ' ' A' ' 27' ' ' LEU . 19.4 Cg_exo -43.57 -56.29 2.46 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 CA-C-N 121.479 2.639 . . . . 0.0 110.728 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.71 23.9 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.599 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.627 ' H ' ' C ' ' A' ' 25' ' ' PRO . 12.7 tp -169.98 -47.37 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -59.35 -51.39 59.44 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.529 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -73.57 41.28 0.11 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.014 0.907 . . . . 0.0 109.9 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -89.35 -21.29 23.18 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 106.86 -38.82 3.13 Favored Glycine 0 N--CA 1.462 0.431 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.555 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -50.87 -134.98 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -137.14 125.93 24.01 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.484 -0.76 . . . . 0.0 110.4 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.571 ' O ' ' N ' ' A' ' 37' ' ' PHE . 10.9 mm -67.92 -70.55 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.409 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -39.53 -36.93 0.43 Allowed 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.505 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -61.89 -47.1 86.51 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.64 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 59.0 t80 -51.05 -65.1 0.61 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.412 1.101 . . . . 0.0 109.201 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 42' ' ' ASN . 96.4 t -57.07 -42.45 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.276 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 88.2 tttt -49.81 -60.94 2.44 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.685 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.72 79.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.355 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.64 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 8.8 m-85 -64.9 -76.44 0.07 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 38' ' ' VAL . 8.9 t-20 -39.3 -49.42 1.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.358 0.599 . . . . 0.0 111.973 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -57.32 -34.01 68.31 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.864 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.83 -46.91 9.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.054 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.507 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 76.7 p -62.94 -24.01 67.67 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -84.89 -35.74 21.97 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -60.45 -25.63 66.14 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.476 ' CG ' ' N ' ' A' ' 49' ' ' GLY . 6.6 ptm -107.14 -55.65 2.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.383 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.476 ' N ' ' CG ' ' A' ' 48' ' ' MET . . . 152.68 170.9 19.6 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.298 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -73.56 141.26 46.68 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 122.475 -0.426 . . . . 0.0 110.028 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.802 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -172.56 -152.26 0.06 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.155 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 13' ' ' PRO . 40.8 mm -139.07 130.5 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.3 t -145.02 134.68 11.52 Favored Pre-proline 0 C--O 1.246 0.893 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.188 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -76.1 148.5 31.25 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 120.589 0.859 . . . . 0.0 110.384 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.561 HG21 HD12 ' A' ' 12' ' ' LEU . 25.6 m -146.06 137.04 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.504 0.669 . . . . 0.0 111.967 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 78.0 mt-10 -117.76 75.07 0.97 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 57' ' ' ILE . 23.4 mt -58.26 93.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.944 -176.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.36 95.29 1.72 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.9 mt -95.12 120.99 45.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -98.15 142.02 30.36 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.626 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.33 -20.18 1.01 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.846 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 93.3 m-20 -73.23 30.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.626 ' H ' ' C ' ' A' ' 61' ' ' ALA . 5.2 ptm180 40.31 69.77 0.29 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 122.305 1.05 . . . . 0.0 110.888 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 99.4 p -144.84 125.61 14.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.052 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -102.85 101.83 11.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.382 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 1.2 p -93.77 178.08 5.79 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CB ' ' O ' ' A' ' 66' ' ' THR . 1.9 t80 82.17 -154.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -177.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.422 HG23 ' C ' ' A' ' 67' ' ' PHE . 6.3 t 82.25 72.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 123.871 0.732 . . . . 0.0 111.791 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.0 t -68.49 154.14 42.43 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.397 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -175.7 178.57 1.53 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.652 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.7 p 51.61 82.68 0.24 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.766 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -64.87 177.08 2.53 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.438 1.425 . . . . 0.0 112.441 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -74.98 4.6 4.58 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.398 1.399 . . . . 0.0 113.825 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -72.18 -152.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.832 0.349 . . . . 0.0 110.758 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -39.38 -15.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.691 0.397 . . . . 0.0 111.431 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.59 ' N ' ' O ' ' A' ' 74' ' ' ALA . 2.5 t80 -40.37 -47.75 2.59 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 123.976 0.798 . . . . 0.0 110.604 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.772 ' C ' HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -133.42 -14.92 2.52 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.787 0.803 . . . . 0.0 108.885 179.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.618 HD11 HG23 ' A' ' 127' ' ' ILE . 22.9 mt -60.45 -38.12 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.418 HH11 ' HB2' ' A' ' 84' ' ' LEU . 11.3 mmm180 -50.29 -44.66 54.05 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.265 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -66.42 -61.07 2.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.66 -21.7 7.42 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.089 -0.645 . . . . 0.0 110.597 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -87.49 -77.91 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.807 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 120.63 19.41 3.76 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.418 ' HB2' HH11 ' A' ' 79' ' ' ARG . 22.3 mt -69.11 139.05 54.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -94.02 -45.48 7.57 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.701 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -173.17 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.018 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.26 40.79 54.85 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.11 72.25 1.25 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 110.651 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -151.46 162.95 40.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.919 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -55.31 154.2 11.89 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.172 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -53.42 144.67 49.38 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 120.491 0.794 . . . . 0.0 111.787 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -147.05 -75.63 0.02 OUTLIER Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.3 110.75 6.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.718 0.294 . . . . 0.0 110.608 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -74.59 76.3 2.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.139 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -164.62 71.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.871 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.539 HG22 ' N ' ' A' ' 97' ' ' GLY . 13.6 p -145.36 163.31 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.23 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 88.76 75.51 1.29 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -136.82 119.29 15.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.129 0.49 . . . . 0.0 111.25 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 104' ' ' VAL . 5.6 pt -108.65 148.3 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.261 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.479 HG21 ' NE2' ' A' ' 103' ' ' GLN . 1.2 p -80.73 145.86 31.33 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.454 0.645 . . . . 0.0 110.832 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.436 ' CE2' HD21 ' A' ' 105' ' ' LEU . 62.6 t-105 -53.26 -70.53 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.374 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -43.78 -38.09 3.06 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.216 -0.928 . . . . 0.0 111.482 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.479 ' NE2' HG21 ' A' ' 100' ' ' THR . 42.1 mt-30 -61.44 -48.5 80.87 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.821 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 99' ' ' ILE . 2.0 m -63.78 -27.77 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 117.711 -1.596 . . . . 0.0 109.099 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 109' ' ' LYS . 35.9 mt -62.43 -70.86 0.18 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.654 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -45.87 -48.4 15.95 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.39 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.537 HG21 HD21 ' A' ' 77' ' ' LEU . 61.4 mt -60.88 -30.39 47.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.934 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.521 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -98.9 -2.53 37.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.026 -0.421 . . . . 0.0 110.681 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 105' ' ' LEU . 68.7 tttt -89.08 -75.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.333 . . . . 0.0 111.026 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.29 -36.6 71.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.649 0.261 . . . . 0.0 111.46 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.43 48.68 0.11 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.049 0.452 . . . . 0.0 111.745 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.521 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 1.3 ptt? -171.64 58.04 0.25 Allowed Pre-proline 0 C--N 1.322 -0.628 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.615 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 112' ' ' MET . 14.0 Cg_exo -54.13 -38.59 87.61 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 120.508 0.805 . . . . 0.0 111.808 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -168.07 34.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.994 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.565 HD23 ' O ' ' A' ' 115' ' ' LEU . 2.8 tt -61.36 -52.19 65.65 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.239 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.547 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -174.38 -6.99 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.332 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.9 p -140.61 175.21 9.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.146 0.498 . . . . 0.0 111.758 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.33 -37.56 0.42 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.432 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -76.55 145.32 39.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.985 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.504 HD21 ' HG3' ' A' ' 109' ' ' LYS . 1.1 mm? -61.24 -45.47 94.39 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 121.505 0.669 . . . . 0.0 110.254 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.48 -36.75 69.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.451 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.45 -69.08 0.4 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.772 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -50.14 -40.21 45.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.173 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -54.39 -68.99 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.2 mtt180 -44.09 -28.8 0.53 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.081 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.46 ' O ' ' CB ' ' A' ' 130' ' ' SER . 5.6 tmm? -59.83 -71.06 0.14 Allowed 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.618 HG23 HD11 ' A' ' 78' ' ' ILE . 9.5 mt -51.41 -50.48 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.728 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -64.63 -71.74 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.25 -45.27 5.16 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 126' ' ' MET . 62.5 m -60.26 -41.07 92.48 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -54.86 -47.19 74.52 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -54.5 -41.77 70.01 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 135' ' ' GLY . 1.9 t -57.01 -71.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 80.1 mtp -43.73 -13.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.329 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 90.66 46.14 4.07 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.588 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 53.2 t -137.58 142.66 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.43 167.8 10.41 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 140' ' ' GLY . 12.0 t -89.9 144.52 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.03 0.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.291 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . 99.15 156.82 29.03 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -133.8 72.45 73.16 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 117.033 0.417 . . . . 0.0 110.798 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.97 149.16 91.36 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.444 1.429 . . . . 0.0 112.099 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 143' ' ' GLU . 0.7 OUTLIER -168.57 37.69 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.82 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.7 t -136.95 159.1 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.416 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.73 98.92 3.58 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.3 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 146' ' ' ASP . 44.9 p-10 -172.18 134.32 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.559 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.255 179.671 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtm . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt 51.98 -166.51 0.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.304 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' HG13 ' A' ' 5' ' ' VAL . 99.2 mttt -104.32 -159.12 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 60' ' ' TYR . 7.0 p -40.55 124.72 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 3' ' ' LYS . 31.1 m -113.88 -24.07 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.64 135.86 32.12 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.869 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 7' ' ' VAL . 12.6 p -124.65 123.62 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.195 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.63 92.05 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.638 1.108 . . . . 0.0 111.004 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -75.16 112.93 11.94 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -170.45 -173.85 1.53 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.383 0.611 . . . . 0.0 110.583 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -99.49 157.61 16.32 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.768 -0.826 . . . . 0.0 108.768 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.555 HD12 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -133.8 89.05 31.19 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -58.09 135.09 66.31 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.446 1.431 . . . . 0.0 114.442 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.892 ' HB3' ' H ' ' A' ' 51' ' ' ALA . . . -91.83 144.43 25.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.59 40.84 33.03 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -170.26 8.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.237 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 18' ' ' THR . . . -91.21 150.12 21.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -158.05 164.89 19.91 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.021 -178.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -61.69 47.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.658 1.572 . . . . 0.0 112.456 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -169.85 54.17 0.23 Allowed Pre-proline 0 C--N 1.322 -0.627 0 O-C-N 122.153 -0.342 . . . . 0.0 110.696 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 22.2 Cg_endo -73.57 172.27 16.08 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 121.066 1.177 . . . . 0.0 112.24 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -57.51 -21.46 46.01 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 120.525 0.817 . . . . 0.0 111.056 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.579 ' CG1' ' HB3' ' A' ' 26' ' ' ALA . 2.2 t -82.93 -64.11 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.794 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 45.7 -100.48 0.02 OUTLIER Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.71 -1.05 . . . . 0.0 110.72 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.5 Cg_exo -50.64 -57.92 1.99 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 CA-C-N 120.678 2.239 . . . . 0.0 111.054 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.579 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.49 -17.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.596 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' O ' ' CE1' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -113.96 -39.6 3.92 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.18 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.64 51.0 3.26 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -142.33 -13.25 0.8 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.367 0.603 . . . . 0.0 109.794 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.573 ' CE1' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -70.66 -15.48 62.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.938 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.604 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 100.88 -32.99 6.8 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.604 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -46.43 -133.8 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.393 0.677 . . . . 0.0 112.357 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -136.2 144.97 45.2 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.904 -0.498 . . . . 0.0 110.483 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 37' ' ' PHE . 4.5 mm -94.03 -73.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.52 ' C ' ' SD ' ' A' ' 35' ' ' MET . 3.7 ppp? -41.14 -35.82 0.64 Allowed 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.23 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -59.72 -52.64 64.64 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 90.1 t80 -47.84 -58.94 3.73 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.469 1.128 . . . . 0.0 109.241 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 42' ' ' ASN . 75.3 t -60.76 -44.65 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.156 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 35' ' ' MET . 88.3 tttt -45.21 -64.68 0.66 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.04 74.13 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.433 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.455 ' CE2' HG21 ' A' ' 45' ' ' THR . 48.9 t80 -62.15 -76.36 0.06 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -40.28 -43.4 1.71 Allowed 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 121.311 0.577 . . . . 0.0 111.822 -177.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.05 -34.17 69.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.93 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.19 -47.11 10.43 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.829 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.455 HG21 ' CE2' ' A' ' 41' ' ' PHE . 71.8 p -62.57 -32.33 73.29 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -69.17 -41.02 77.77 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -63.66 -18.49 64.02 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 70.8 mtm -107.22 -86.67 0.49 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.788 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -174.7 -165.72 31.54 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.359 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 34.1 p-10 -93.5 130.18 39.44 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.892 ' H ' ' HB3' ' A' ' 14' ' ' ALA . . . -162.41 -152.45 0.23 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.296 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.4 mt -141.99 132.1 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 69' ' ' THR . 99.1 t -124.7 108.07 28.77 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -74.02 112.09 3.46 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 120.793 0.995 . . . . 0.0 109.698 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 56' ' ' GLU . 6.5 p -144.35 164.61 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-O 121.488 0.661 . . . . 0.0 112.2 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.621 ' N ' HG22 ' A' ' 55' ' ' VAL . 12.7 mt-10 -123.19 115.93 22.58 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.408 HD13 ' CZ ' ' A' ' 37' ' ' PHE . 54.2 mt -74.92 94.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.917 0.389 . . . . 0.0 111.757 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -69.42 102.21 1.73 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 mt -100.73 123.62 53.81 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-O 120.844 0.354 . . . . 0.0 111.163 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 18.2 m-85 -99.3 143.17 29.86 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.505 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.64 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -53.74 -24.44 14.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 124.717 1.261 . . . . 0.0 112.375 -175.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 41.0 t0 -67.72 7.57 0.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.64 ' H ' ' C ' ' A' ' 61' ' ' ALA . 98.5 mtt180 62.5 70.37 0.57 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.252 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 p -145.3 134.08 22.33 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.947 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -111.55 103.81 12.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.651 -178.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.7 p -96.8 123.22 40.44 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 5.9 p90 177.98 -150.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -175.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 53.2 t 80.56 104.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 124.344 1.028 . . . . 0.0 111.766 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' HG13 ' A' ' 53' ' ' VAL . 1.1 p -122.59 112.72 18.33 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.497 ' C ' HG22 ' A' ' 71' ' ' THR . 12.4 mmtt -143.8 -150.29 0.31 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.669 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 4.8 t 47.0 53.47 13.83 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 123.699 0.624 . . . . 0.0 110.442 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.669 ' HD3' ' N ' ' A' ' 71' ' ' THR . 6.5 Cg_endo -79.36 175.79 10.37 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 120.727 0.952 . . . . 0.0 112.399 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.725 ' HA ' HD11 ' A' ' 77' ' ' LEU . 1.7 Cg_endo -64.7 -172.22 0.19 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.608 1.538 . . . . 0.0 111.246 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 73' ' ' PRO . . . 78.99 -176.72 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.578 0.228 . . . . 0.0 110.729 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 1.6 p -40.92 -20.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.474 -0.141 . . . . 0.0 110.652 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 74' ' ' ALA . 11.9 m-85 -43.28 -44.26 5.32 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.366 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.956 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -126.58 -25.4 3.43 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 122.068 0.937 . . . . 0.0 109.018 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 82' ' ' ALA . 26.9 mt -54.05 -33.38 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.438 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 83' ' ' GLY . 19.6 mmm-85 -51.54 -48.34 63.07 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.091 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -64.74 -61.84 1.94 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.57 -21.8 4.26 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.639 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -91.68 -77.05 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.639 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 113.93 54.84 0.42 Allowed Glycine 0 N--CA 1.469 0.85 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 85' ' ' GLU . 10.0 mt -94.58 15.06 18.98 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.853 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' LEU . 64.9 tt0 -44.26 164.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.458 ' CG ' ' N ' ' A' ' 87' ' ' GLY . 18.9 ptmt -48.49 -42.76 33.79 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.505 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.458 ' N ' ' CG ' ' A' ' 86' ' ' LYS . . . 144.03 170.03 13.27 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 90' ' ' LYS . . . -108.03 109.74 21.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 66.33 -67.36 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -148.91 152.32 36.66 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.81 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -52.39 140.08 53.98 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 120.76 0.974 . . . . 0.0 111.647 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.48 -77.45 1.35 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -140.19 151.18 45.01 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 95' ' ' LYS . 96.0 mt-10 -60.32 -165.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 94' ' ' GLU . 61.9 mttm 52.95 105.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.013 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 97' ' ' GLY . 6.3 p -136.44 157.86 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.484 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 118.35 80.78 0.73 Allowed Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -126.48 94.4 4.05 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.948 0.404 . . . . 0.0 111.962 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.545 HD12 HG11 ' A' ' 104' ' ' VAL . 12.1 pt -100.93 149.78 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.452 ' OG1' ' OE1' ' A' ' 103' ' ' GLN . 0.2 OUTLIER -90.78 156.53 17.98 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.478 0.656 . . . . 0.0 110.333 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.598 ' O ' HG22 ' A' ' 104' ' ' VAL . 61.3 t-105 -61.56 -71.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.325 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -46.46 -39.14 10.16 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 120.761 -1.212 . . . . 0.0 111.905 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.452 ' OE1' ' OG1' ' A' ' 100' ' ' THR . 32.3 mt-30 -60.8 -47.19 87.45 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.308 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 101' ' ' TRP . 15.9 m -63.62 -29.0 46.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.371 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 108' ' ' ALA . 59.7 mt -63.23 -72.61 0.13 Allowed 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.998 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -44.88 -45.04 10.07 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.2 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.63 -25.22 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.127 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -106.27 -1.02 23.94 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.704 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 105' ' ' LEU . 43.8 tttp -85.18 -74.68 0.39 Allowed 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.253 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -62.42 -43.61 98.4 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.548 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -76.45 76.15 3.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.799 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.449 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -135.98 54.85 10.67 Favored Pre-proline 0 N--CA 1.468 0.432 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.009 179.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 112' ' ' MET . 4.3 Cg_endo -59.84 -30.97 93.16 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 120.701 0.934 . . . . 0.0 111.662 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.578 ' C ' ' H ' ' A' ' 116' ' ' ASN . 36.8 t70 -154.05 -86.08 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.992 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.1 mt 51.69 0.7 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.634 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.578 ' H ' ' C ' ' A' ' 114' ' ' ASP . 4.0 t30 54.38 26.95 7.5 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.47 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.3 p -143.79 161.62 38.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.293 0.568 . . . . 0.0 111.728 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.3 -32.48 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.09 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -75.02 146.04 41.93 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 32.7 mt -60.74 -45.71 93.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.355 0.598 . . . . 0.0 110.406 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 121' ' ' GLU . 5.0 pt-20 -59.19 -38.85 80.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.702 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.95 -68.98 0.34 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.016 -1.073 . . . . 0.0 108.805 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.18 -37.49 22.67 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.075 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.85 -66.25 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.1 mtt180 -46.16 -36.0 5.56 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.489 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 5.7 tmm? -55.57 -73.47 0.06 Allowed 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.544 HG23 HD11 ' A' ' 78' ' ' ILE . 6.1 mm -51.15 -50.33 26.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.962 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -62.67 -72.55 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.15 -47.41 5.41 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.489 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 66.4 m -56.79 -43.0 80.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.619 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -52.52 -46.85 66.89 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.564 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -55.55 -34.25 64.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 130' ' ' SER . 3.1 t -65.37 -76.45 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 6.7 ptm -40.2 -25.73 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.636 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 104.38 60.52 0.67 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.619 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 27.4 t -145.29 162.99 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.471 ' N ' HG12 ' A' ' 136' ' ' VAL . 98.1 mt-10 -128.94 156.22 44.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.49 ' CG2' ' HB1' ' A' ' 128' ' ' ALA . 2.1 t -87.73 152.11 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 139' ' ' VAL . 46.1 t -96.74 -11.8 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.718 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -131.54 69.22 0.54 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.12 69.56 18.15 Favored Pre-proline 0 CA--C 1.532 0.256 0 O-C-N 122.793 -0.24 . . . . 0.0 110.502 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.8 148.16 93.69 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.344 1.363 . . . . 0.0 111.976 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.54 151.26 47.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 145' ' ' LYS . 12.7 m -90.56 31.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.734 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 144' ' ' VAL . 98.3 mttt 48.35 -174.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -152.57 -85.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.587 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.194 179.787 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptp . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 14.3 mptt -97.39 -179.89 4.65 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.57 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 48.4 tttt 71.97 173.72 0.3 Allowed 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.884 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.67 158.71 30.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.621 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 61' ' ' ALA . 29.2 m -117.98 -26.16 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.13 116.55 4.03 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 119.044 -1.062 . . . . 0.0 111.103 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.71 ' O ' HG13 ' A' ' 7' ' ' VAL . 9.4 p -110.12 112.24 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.335 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.89 90.41 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 118.563 -1.255 . . . . 0.0 110.693 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -76.26 120.17 21.16 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.456 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -173.68 -174.65 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.38 -179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.414 ' N ' ' NE2' ' A' ' 11' ' ' GLN . 2.7 mp0 -95.87 159.38 15.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.91 HD13 ' CZ ' ' A' ' 41' ' ' PHE . 0.7 OUTLIER -136.61 92.89 14.6 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HA ' HD13 ' A' ' 52' ' ' ILE . 22.6 Cg_exo -59.36 146.5 94.63 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.26 1.307 . . . . 0.0 114.414 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.794 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -101.32 143.2 31.66 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.44 44.59 36.43 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' H ' ' H ' ' A' ' 17' ' ' ALA . 24.0 mttt -167.46 -6.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.238 -0.481 . . . . 0.0 109.811 -178.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' H ' ' H ' ' A' ' 16' ' ' LYS . . . -80.09 149.62 30.57 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -158.97 168.03 13.23 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.115 -178.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -60.14 41.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.475 1.45 . . . . 0.0 112.427 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -172.34 58.79 0.25 Allowed Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.919 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 20.5 Cg_endo -78.75 172.21 15.44 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.218 1.279 . . . . 0.0 112.136 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -55.88 -23.82 44.4 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 120.552 0.834 . . . . 0.0 111.013 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.678 HG12 ' HB3' ' A' ' 26' ' ' ALA . 2.2 t -83.04 -64.55 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 43.43 -96.86 0.01 OUTLIER Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -47.13 -60.06 1.02 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 CA-C-N 119.927 1.863 . . . . 0.0 110.669 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.678 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -47.33 -23.84 0.65 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.847 -178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.681 HD23 ' HE2' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -116.96 26.88 9.49 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.48 41.32 0.63 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -141.69 -11.17 0.9 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.438 0.637 . . . . 0.0 109.619 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.681 ' HE2' HD23 ' A' ' 27' ' ' LEU . 1.4 p80 -67.18 -15.34 63.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.466 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 102.22 -26.33 24.63 Favored Glycine 0 N--CA 1.464 0.532 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -51.37 -132.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.142 0.577 . . . . 0.0 112.089 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -133.45 -169.28 2.25 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 37' ' ' PHE . 3.4 mm -131.65 -76.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.562 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -40.2 -42.28 1.46 Allowed 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.875 179.048 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -52.81 -51.47 60.7 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.101 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 34' ' ' ILE . 2.0 t80 -50.37 -66.09 0.45 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.599 1.19 . . . . 0.0 109.845 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 42' ' ' ASN . 54.0 t -57.51 -48.61 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 112.889 -1.959 . . . . 0.0 110.939 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 35' ' ' MET . 79.1 mttt -44.14 -58.49 2.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.43 -44.33 84.57 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.048 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.91 ' CZ ' HD13 ' A' ' 12' ' ' LEU . 1.8 t80 -61.13 -73.96 0.09 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.506 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -39.85 -41.29 1.12 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.688 0.756 . . . . 0.0 111.681 -177.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -61.9 -35.0 77.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.083 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -86.4 -43.49 12.78 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.749 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 49' ' ' GLY . 70.4 p -63.61 -34.93 78.92 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -67.96 -42.07 81.45 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -62.95 -20.14 64.95 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.0 ttp -106.08 -85.28 0.5 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.954 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 170.78 170.3 34.84 Favored Glycine 0 N--CA 1.465 0.617 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.108 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 47.7 p-10 -65.39 137.05 57.24 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.794 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -176.09 -154.0 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.857 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 13' ' ' PRO . 33.7 mm -141.68 130.99 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.88 127.93 16.47 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.626 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -71.05 148.62 57.14 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.804 1.003 . . . . 0.0 110.751 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 12' ' ' LEU . 7.2 p -153.68 160.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.485 0.659 . . . . 0.0 111.434 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 55' ' ' VAL . 65.3 mt-10 -139.47 103.17 4.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.423 HD13 HD11 ' A' ' 27' ' ' LEU . 21.1 mt -68.17 87.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.582 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 m -70.99 103.16 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 mt -103.74 126.0 58.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.173 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 3' ' ' LYS . 4.4 m-85 -104.07 141.09 36.82 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.892 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -51.09 -22.11 2.26 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 124.18 0.925 . . . . 0.0 112.079 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -67.51 9.12 0.27 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.651 ' H ' ' C ' ' A' ' 61' ' ' ALA . 99.5 mtt180 60.96 68.97 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.923 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -146.22 132.36 19.37 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.135 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.601 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -109.56 102.39 11.25 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.161 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 8.4 m -95.56 119.66 34.44 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER 172.19 115.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 O-C-N 124.4 1.062 . . . . 0.0 111.092 -176.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 85.8 t -154.43 136.6 6.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 p -141.47 147.05 37.25 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -141.76 171.06 14.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.251 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -40.17 98.08 0.16 Allowed Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.793 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.493 ' O ' ' O ' ' A' ' 71' ' ' THR . 16.2 Cg_exo -43.26 177.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 121.256 1.304 . . . . 0.0 113.119 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 17.2 Cg_exo -51.14 113.54 1.15 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.427 1.418 . . . . 0.0 112.759 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 172.38 -152.0 0.01 OUTLIER 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.721 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 80.2 p -36.94 -22.96 0.01 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.985 0.421 . . . . 0.0 110.44 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.604 ' N ' ' O ' ' A' ' 74' ' ' ALA . 11.6 t80 -47.37 -36.75 10.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.68 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.9 -34.22 3.98 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.67 0.747 . . . . 0.0 109.884 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.721 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 69.0 mt -48.2 -38.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.418 ' NH1' ' O ' ' A' ' 84' ' ' LEU . 13.1 mmm180 -51.67 -45.99 63.63 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.329 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -66.54 -63.31 1.1 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.33 -19.27 2.0 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.293 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -89.96 -77.62 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.607 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.33 45.1 0.63 Allowed Glycine 0 N--CA 1.47 0.902 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.418 ' O ' ' NH1' ' A' ' 79' ' ' ARG . 24.5 mt -98.89 115.36 28.67 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -89.92 -46.06 8.8 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.753 0.311 . . . . 0.0 110.559 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.467 ' HG3' ' H ' ' A' ' 88' ' ' ALA . 21.1 ptmt -149.81 152.08 34.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.085 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.07 -6.07 3.66 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.467 ' H ' ' HG3' ' A' ' 86' ' ' LYS . . . 53.59 -179.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 88' ' ' ALA . 71.7 m80 -154.09 -60.53 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -80.45 147.41 63.81 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.333 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.36 146.74 49.74 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.808 1.006 . . . . 0.0 111.766 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.92 -101.46 0.33 Allowed Glycine 0 N--CA 1.466 0.64 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.41 ' C ' ' H ' ' A' ' 95' ' ' LYS . 7.4 tpt180 -97.62 135.22 39.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -77.88 29.36 0.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.817 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 93' ' ' ARG . 52.8 mtmt -144.81 101.27 3.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.557 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 97' ' ' GLY . 5.4 p -145.18 155.93 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.247 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 60.53 82.48 0.07 OUTLIER Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.408 ' NE ' HG23 ' A' ' 139' ' ' VAL . 22.8 ttt180 -135.1 104.19 5.84 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.876 0.369 . . . . 0.0 110.914 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.599 HD12 ' CG1' ' A' ' 104' ' ' VAL . 4.8 pt -104.37 150.21 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.517 HG21 ' NE2' ' A' ' 103' ' ' GLN . 1.8 p -87.96 155.72 19.69 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.397 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.782 ' NE1' HD11 ' A' ' 105' ' ' LEU . 74.0 t-105 -60.97 -54.59 43.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.083 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 1.3 tp10 -59.1 -40.37 85.1 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.059 -1.025 . . . . 0.0 111.123 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.517 ' NE2' HG21 ' A' ' 100' ' ' THR . 41.0 mt-30 -59.38 -47.14 86.55 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.811 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.599 ' CG1' HD12 ' A' ' 99' ' ' ILE . 20.4 m -65.52 -29.06 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 118.494 -1.282 . . . . 0.0 109.467 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.782 HD11 ' NE1' ' A' ' 101' ' ' TRP . 64.7 mt -64.52 -74.03 0.11 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.522 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -44.2 -48.76 9.3 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.464 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.6 -25.28 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.107 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -105.54 -0.34 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.479 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.9 tmtt? -89.2 -74.74 0.46 Allowed 'General case' 0 N--CA 1.461 0.083 0 CA-C-O 120.751 0.31 . . . . 0.0 110.187 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -72.53 -40.99 66.35 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.843 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -74.85 73.59 2.11 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.57 61.71 0.17 Allowed Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.407 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -52.75 -43.15 58.07 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 120.594 0.863 . . . . 0.0 112.051 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 116' ' ' ASN . 27.0 t70 -142.4 -61.79 0.44 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.272 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 tt 45.64 -85.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.933 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 114' ' ' ASP . 4.3 t30 -174.77 9.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.943 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 46.5 p -141.83 171.19 14.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.401 0.619 . . . . 0.0 111.749 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.37 -40.86 0.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.894 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -83.48 153.31 24.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.524 HD21 ' HG2' ' A' ' 109' ' ' LYS . 35.8 mt -60.24 -46.18 90.66 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.314 0.578 . . . . 0.0 109.931 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -54.81 -42.09 71.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.916 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.56 -66.84 0.53 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.116 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.63 36.67 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.941 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -53.03 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.602 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.4 mtt180 -43.3 -31.22 0.6 Allowed 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.001 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 130' ' ' SER . 5.5 ttp -59.33 -73.48 0.08 Allowed 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 127' ' ' ILE . 1.9 mp -48.99 -49.39 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.581 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -65.98 -71.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.34 -49.29 5.64 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 126' ' ' MET . 49.5 m -54.47 -42.99 71.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.719 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -56.05 -47.8 77.21 Favored 'General case' 0 C--O 1.228 -0.069 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -55.14 -41.51 71.86 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 t -53.31 -71.26 0.07 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.1 mtm -41.58 -62.07 0.95 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.942 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 143.18 50.0 0.04 OUTLIER Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.719 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 54.4 t -133.92 164.82 33.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.551 ' N ' HG12 ' A' ' 136' ' ' VAL . 98.0 mt-10 -133.78 159.27 41.1 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 140' ' ' GLY . 6.2 t -96.34 155.12 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.408 HG23 ' NE ' ' A' ' 98' ' ' ARG . 3.0 p -83.44 -2.71 6.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.647 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.418 ' H ' HG12 ' A' ' 138' ' ' VAL . . . -152.12 103.21 0.24 Allowed Glycine 0 CA--C 1.518 0.261 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -157.76 68.11 3.89 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.489 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -60.28 143.73 99.5 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.276 1.318 . . . . 0.0 111.804 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -82.63 152.94 25.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 145' ' ' LYS . 10.5 t -75.26 121.91 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 144' ' ' VAL . 68.4 mttm 51.08 178.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -152.59 -85.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.644 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.921 179.637 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 3' ' ' LYS . 22.4 tptt -93.48 -163.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.5 mptm? -64.59 -164.05 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.91 121.67 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 3' ' ' LYS . 17.3 m -113.33 -25.32 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.778 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.94 135.59 39.74 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.271 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.578 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.4 p -126.37 126.95 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.226 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.96 91.03 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 119.826 1.194 . . . . 0.0 111.539 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -82.15 116.32 21.66 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.49 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -168.47 -171.51 1.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.403 -178.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -94.44 154.16 17.58 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.963 HD12 ' CZ ' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -135.66 92.35 17.14 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -71.65 114.32 3.91 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.264 1.309 . . . . 0.0 114.775 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.789 ' HB3' ' H ' ' A' ' 51' ' ' ALA . . . -61.94 143.83 55.9 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . 61.49 150.53 0.02 OUTLIER Glycine 0 C--N 1.336 0.57 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.4 tttp 72.88 10.52 5.4 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 118.126 0.963 . . . . 0.0 110.564 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 18' ' ' THR . . . -92.15 151.93 20.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.6 170.81 3.97 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.041 -178.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -58.79 42.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.363 1.375 . . . . 0.0 112.23 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -160.91 54.26 0.55 Allowed Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-O 120.474 0.178 . . . . 0.0 110.533 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 25.6 Cg_endo -77.07 168.37 23.43 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.091 1.194 . . . . 0.0 112.21 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -56.51 -31.37 86.02 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 120.639 0.893 . . . . 0.0 111.284 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.796 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.7 t -75.02 -61.28 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 44.48 -99.61 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -47.87 -60.31 0.92 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 CA-C-N 119.816 1.808 . . . . 0.0 110.998 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.796 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -45.9 -26.83 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.366 -0.533 . . . . 0.0 109.824 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 25.6 tp -119.69 23.06 11.34 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.603 0.716 . . . . 0.0 109.172 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -152.56 37.93 0.77 Allowed Glycine 0 C--N 1.322 -0.221 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.668 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 29' ' ' GLN . 0.8 OUTLIER -141.57 -3.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.567 ' N ' ' ND1' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -78.5 -11.96 59.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.264 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.588 ' O ' ' O ' ' A' ' 32' ' ' ALA . . . 97.83 -26.1 24.72 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.588 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -47.66 -134.37 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.987 0.515 . . . . 0.0 112.287 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -136.76 143.58 43.33 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 122.093 -0.38 . . . . 0.0 111.015 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.6 mm -93.14 -73.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -39.72 -39.44 0.77 Allowed 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -59.49 -52.44 65.57 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.822 -0.751 . . . . 0.0 108.993 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' A' ' 34' ' ' ILE . 90.2 t80 -47.11 -62.43 1.42 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.165 0.983 . . . . 0.0 109.724 177.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 42' ' ' ASN . 86.9 t -58.71 -44.02 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 113.309 -1.769 . . . . 0.0 111.178 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.42 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 88.4 tttt -45.44 -67.79 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.75 -41.02 66.67 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.491 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.963 ' CZ ' HD12 ' A' ' 12' ' ' LEU . 54.9 t80 -62.9 -77.03 0.06 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.29 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -40.24 -44.73 1.94 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.314 0.578 . . . . 0.0 112.182 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -58.06 -34.81 70.52 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.113 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.17 -46.05 11.45 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.618 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 49' ' ' GLY . 32.4 p -63.76 -31.69 72.94 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -70.03 -41.02 74.82 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -62.4 -20.02 64.03 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 9.2 mtm -106.51 -78.85 0.57 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.259 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 45' ' ' THR . . . 169.17 166.49 28.29 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.362 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 36.9 p-10 -62.63 125.51 24.17 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.789 ' H ' ' HB3' ' A' ' 14' ' ' ALA . . . -162.41 -153.88 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.285 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 99.3 mt -142.03 132.15 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.72 120.46 6.03 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.249 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -65.37 140.71 65.03 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 120.746 0.964 . . . . 0.0 110.862 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.412 ' CG2' HD23 ' A' ' 12' ' ' LEU . 25.4 m -137.53 159.62 34.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.234 0.54 . . . . 0.0 110.861 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 58' ' ' THR . 32.4 tt0 -129.89 85.7 2.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 57' ' ' ILE . 4.6 mt -60.36 82.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.216 -176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -72.74 97.16 2.15 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.2 mt -97.31 126.25 50.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.008 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -98.86 144.65 27.83 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.664 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -54.25 -24.12 17.46 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.44 1.088 . . . . 0.0 112.331 -176.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -68.45 10.44 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.664 ' H ' ' C ' ' A' ' 61' ' ' ALA . 87.2 mtm180 61.27 69.2 0.68 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.496 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.3 m -142.9 126.94 17.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.843 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -107.58 103.76 13.15 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.058 -177.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.483 ' O ' ' OG1' ' A' ' 58' ' ' THR . 77.3 p -95.71 121.58 37.57 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.586 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.4 p90 176.46 -152.54 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 51.7 t 80.69 152.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.304 0 O-C-N 124.329 1.018 . . . . 0.0 110.564 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t -146.68 173.36 12.43 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.453 ' C ' HG22 ' A' ' 71' ' ' THR . 58.0 pttt -170.6 -159.85 0.19 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.585 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 t 43.25 56.38 11.84 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.956 0.408 . . . . 0.0 111.431 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 71' ' ' THR . 9.8 Cg_endo -77.82 157.57 31.35 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 C-N-CA 120.064 0.509 . . . . 0.0 112.04 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.683 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 11.3 Cg_endo -70.13 176.2 7.38 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 121.952 1.768 . . . . 0.0 112.293 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 73' ' ' PRO . . . 79.71 -177.24 0.08 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.897 0.317 . . . . 0.0 110.279 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.635 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.1 OUTLIER -40.51 -20.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.312 -0.242 . . . . 0.0 110.521 -179.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.542 ' HD2' ' O ' ' A' ' 73' ' ' PRO . 26.0 m-85 -42.73 -35.96 1.3 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.651 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.812 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -133.51 -25.55 1.7 Allowed 'General case' 0 C--O 1.253 1.253 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.635 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 45.6 mt -54.56 -35.02 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.573 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -53.37 -42.84 67.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.277 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.434 ' C ' ' N ' ' A' ' 82' ' ' ALA . 3.1 tmtm? -67.84 -65.32 0.71 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.9 -11.64 0.25 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.999 -0.681 . . . . 0.0 110.65 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.42 -77.63 0.33 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.851 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 137.74 63.09 0.05 OUTLIER Glycine 0 N--CA 1.464 0.537 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.9 mt -115.06 135.87 53.74 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -140.92 -175.3 4.25 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.83 126.36 26.61 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.91 -143.36 11.84 Favored Glycine 0 N--CA 1.466 0.646 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 51.29 31.25 6.75 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.586 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -79.44 -83.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.271 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -89.21 153.57 48.85 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.332 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -53.45 142.51 58.44 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 120.842 1.028 . . . . 0.0 111.667 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.47 -107.85 0.2 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -71.43 149.12 46.23 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -127.31 57.82 1.48 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.687 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -139.66 74.13 1.46 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.492 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.461 HG22 ' N ' ' A' ' 97' ' ' GLY . 14.3 p -144.61 159.5 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.461 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 93.68 68.19 1.07 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -123.28 99.29 6.27 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.706 0.253 . . . . 0.0 111.034 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.669 HD12 HG11 ' A' ' 104' ' ' VAL . 13.7 pt -95.63 139.29 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.492 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -81.61 155.99 25.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.753 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.632 ' O ' HG22 ' A' ' 104' ' ' VAL . 57.2 t-105 -61.75 -69.13 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -48.29 -42.17 30.07 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 120.916 -1.115 . . . . 0.0 112.147 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -59.86 -46.08 90.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.451 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.669 HG11 HD12 ' A' ' 99' ' ' ILE . 19.2 m -63.44 -29.78 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 118.286 -1.366 . . . . 0.0 109.283 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 108' ' ' ALA . 36.7 mt -62.38 -70.68 0.19 Allowed 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.339 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -43.63 -46.29 7.21 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.568 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.46 -26.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.378 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.554 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -101.66 -2.39 30.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.364 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.517 ' O ' ' SD ' ' A' ' 112' ' ' MET . 87.5 tttt -88.76 -75.45 0.43 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.857 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.4 -40.3 73.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.04 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.15 84.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.456 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.554 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 3.1 ptt? -179.51 58.24 0.1 OUTLIER Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.505 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 112' ' ' MET . 13.6 Cg_endo -75.81 -55.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 120.618 0.879 . . . . 0.0 112.337 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -88.85 -31.45 18.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.772 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 117' ' ' THR . 10.3 mt -45.42 134.07 7.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -65.98 70.24 0.06 Allowed 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.298 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LEU . 82.6 p -143.71 159.35 42.65 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.212 0.53 . . . . 0.0 111.994 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.64 -43.32 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.935 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -91.94 148.35 22.27 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 120' ' ' LEU . 0.8 OUTLIER -59.27 -46.82 87.5 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.689 0.757 . . . . 0.0 110.124 -178.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.65 -35.68 68.66 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.66 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.92 -64.73 0.81 Allowed 'General case' 0 C--O 1.242 0.678 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.937 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.87 -22.92 27.97 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.923 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.95 -73.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' A' ' 129' ' ' GLY . 99.2 mtt180 -43.09 -31.95 0.63 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.658 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 130' ' ' SER . 38.9 ttp -57.36 -72.95 0.08 Allowed 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.448 HG23 HD11 ' A' ' 78' ' ' ILE . 50.0 mm -51.33 -50.28 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.328 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -64.28 -72.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.13 -45.58 3.99 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 126' ' ' MET . 67.7 m -56.74 -44.69 81.95 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.582 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -56.22 -50.43 71.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -48.88 -42.88 38.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.586 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.4 t -54.13 -65.07 0.64 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.8 mtp -52.45 -2.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.605 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.1 -29.27 6.61 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.582 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 68.1 t -46.05 164.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 79.2 mt-10 -143.05 164.76 29.22 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.093 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 140' ' ' GLY . 3.5 t -85.23 155.03 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 100' ' ' THR . 1.0 OUTLIER -100.18 -7.54 9.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.703 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 138' ' ' VAL . . . -115.48 -22.28 4.83 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-O 119.131 -0.816 . . . . 0.0 111.553 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 138' ' ' VAL . . . -35.74 91.1 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 124.045 0.497 . . . . 0.0 110.197 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.5 ' N ' ' O ' ' A' ' 140' ' ' GLY . 2.9 Cg_exo -63.2 149.85 90.23 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.36 1.373 . . . . 0.0 111.895 -177.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' ' 145' ' ' LYS . 72.2 tt0 -59.36 132.1 52.98 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 145' ' ' LYS . 4.9 m -66.8 -6.12 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.894 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.534 ' H ' ' HG2' ' A' ' 143' ' ' GLU . 2.5 tmtp? 54.16 104.89 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -131.6 116.12 16.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.601 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.851 -179.808 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptt? . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? 49.62 91.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.884 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 17.9 ttmt -107.84 178.03 4.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.775 0.322 . . . . 0.0 110.455 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 4' ' ' VAL . 7.7 p -70.59 126.39 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -112.07 -24.77 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.41 119.6 14.61 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.292 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.6 p -111.6 104.82 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.842 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.68 92.41 2.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 117.985 -1.486 . . . . 0.0 110.295 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -85.23 109.49 18.37 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.437 0.461 . . . . 0.0 110.304 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -171.89 -174.51 1.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.191 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -102.18 173.57 6.32 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.61 139.31 5.93 Favored Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.974 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -82.2 149.54 15.3 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.125 1.217 . . . . 0.0 114.722 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.827 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -90.33 144.73 25.55 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.17 58.86 8.95 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.404 ' H ' ' H ' ' A' ' 17' ' ' ALA . 2.1 mmtm 172.63 21.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.336 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 16' ' ' LYS . . . -98.16 150.68 21.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -162.42 168.54 10.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.075 -178.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -62.23 42.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.29 1.327 . . . . 0.0 111.963 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -155.53 59.31 2.13 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.994 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 27.8 Cg_endo -79.72 166.47 21.57 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.286 1.324 . . . . 0.0 111.888 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.37 -30.71 88.83 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 120.8 1.0 . . . . 0.0 111.102 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.665 ' CG1' ' HB3' ' A' ' 26' ' ' ALA . 2.4 t -70.98 -58.06 6.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.812 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 41.08 -99.64 0.01 OUTLIER Glycine 0 C--O 1.207 -1.555 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.3 Cg_exo -48.41 -62.49 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 CA-C-N 120.308 2.054 . . . . 0.0 110.789 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.665 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -42.95 -16.82 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.059 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.614 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 29.5 tp -117.53 -27.56 6.3 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.699 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -57.59 -54.83 34.18 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -88.99 43.22 1.13 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.565 0.697 . . . . 0.0 110.496 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.649 ' CD2' ' H ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -86.87 -31.74 20.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.649 ' H ' ' CD2' ' A' ' 30' ' ' HIS . . . 109.86 -48.83 0.9 Allowed Glycine 0 N--CA 1.472 1.085 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.546 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -50.33 -131.23 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.973 0.509 . . . . 0.0 111.865 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -138.71 128.33 24.76 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.89 -0.506 . . . . 0.0 111.205 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.9 mm -71.96 -72.25 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.453 ' C ' ' O ' ' A' ' 34' ' ' ILE . 11.4 tpt -38.55 -39.44 0.48 Allowed 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -58.93 -48.94 79.68 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.074 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 60.7 t80 -48.42 -65.66 0.53 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.527 1.156 . . . . 0.0 109.622 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 42' ' ' ASN . 89.8 t -56.87 -44.03 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.383 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -47.06 -53.03 13.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.87 -37.8 87.12 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.227 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.632 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 7.8 m-85 -65.43 -74.11 0.11 Allowed 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 41' ' ' PHE . 0.5 OUTLIER -37.16 -45.69 0.65 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.516 0.674 . . . . 0.0 111.514 -177.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.17 79.31 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.55 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -88.73 -45.23 9.96 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.519 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.414 ' OG1' ' HA ' ' A' ' 42' ' ' ASN . 52.3 p -60.63 -18.54 53.92 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -86.69 -42.72 13.15 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -60.23 -17.04 38.88 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.786 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.595 ' SD ' ' HB1' ' A' ' 14' ' ' ALA . 1.7 ppp? -120.11 126.41 50.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.132 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.501 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -40.93 161.9 0.01 OUTLIER Glycine 0 CA--C 1.543 1.835 0 C-N-CA 119.533 -1.317 . . . . 0.0 111.584 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 53.6 p-10 -62.6 151.46 37.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.06 0.93 . . . . 0.0 109.928 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.827 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 179.6 -150.48 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.809 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 98.0 mt -143.24 134.9 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 m -147.43 145.83 23.0 Favored Pre-proline 0 C--O 1.243 0.723 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.3 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -76.42 149.09 30.69 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 121.064 1.176 . . . . 0.0 110.961 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 m -142.54 143.28 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.133 0.492 . . . . 0.0 111.017 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.71 85.6 2.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 mt -64.52 83.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.916 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 m -69.23 93.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.8 mt -93.56 125.72 46.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.218 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.418 ' CD2' ' C ' ' A' ' 3' ' ' LYS . 7.7 m-85 -100.27 142.66 31.44 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.659 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.7 -22.87 2.29 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 124.651 1.219 . . . . 0.0 112.165 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.25 5.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.659 ' H ' ' C ' ' A' ' 61' ' ' ALA . 51.2 mtp180 62.54 72.78 0.48 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.104 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.1 p -152.45 132.36 13.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.314 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -101.36 101.69 12.38 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.41 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.7 132.0 41.36 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 67' ' ' PHE . 51.5 p90 -172.26 123.54 0.49 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.479 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 69' ' ' THR . 72.8 t -107.32 108.01 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.523 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 25.6 p -156.21 -164.27 1.65 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 69' ' ' THR . 9.3 pttt 76.78 -178.95 0.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.511 ' CG2' ' CE2' ' A' ' 76' ' ' TYR . 6.4 m 64.9 68.61 0.73 Allowed Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.558 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.531 ' O ' ' CD1' ' A' ' 76' ' ' TYR . 10.8 Cg_endo -78.53 155.5 28.04 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 120.934 1.089 . . . . 0.0 112.289 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.562 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 10.0 Cg_endo -68.46 112.67 2.89 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.699 1.599 . . . . 0.0 112.367 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 169.61 -167.46 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.672 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -41.51 -16.19 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 O-C-N 122.0 -0.437 . . . . 0.0 110.571 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.659 ' CE1' HD22 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -43.97 -30.12 0.67 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.947 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -140.7 -27.14 0.73 Allowed 'General case' 0 C--O 1.255 1.358 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.947 ' N ' HD23 ' A' ' 77' ' ' LEU . 66.4 mt -51.67 -35.59 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.455 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -53.51 -45.37 69.68 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.702 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.07 -63.63 1.19 Allowed 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.32 -19.44 5.42 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.725 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.19 -78.75 0.25 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.069 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 134.03 23.52 0.68 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.17 132.64 36.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -88.49 -80.39 0.28 Allowed 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.306 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -144.48 -19.34 0.54 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.709 0.29 . . . . 0.0 111.012 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.06 -137.74 2.29 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.05 0.38 0.1 Allowed 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.191 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 49.49 -173.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -48.97 154.18 1.34 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.096 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.09 141.87 46.52 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 120.909 1.072 . . . . 0.0 111.714 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.61 -103.9 0.22 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -86.02 135.13 33.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -94.18 8.94 39.87 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.939 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -91.54 97.82 11.29 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.4 p -159.8 152.95 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.308 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.88 82.86 0.14 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.647 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -140.35 123.06 16.33 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 121.035 0.445 . . . . 0.0 111.003 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.617 HD12 ' CG1' ' A' ' 104' ' ' VAL . 1.6 pt -128.8 157.28 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 p -91.01 166.79 12.82 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.134 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.621 ' NE1' HD11 ' A' ' 105' ' ' LEU . 55.9 t-105 -59.34 -54.39 47.33 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.27 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -55.73 -40.94 73.15 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.585 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -61.03 -47.86 84.48 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.858 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.617 ' CG1' HD12 ' A' ' 99' ' ' ILE . 16.0 m -66.42 -28.63 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 118.414 -1.314 . . . . 0.0 109.783 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.621 HD11 ' NE1' ' A' ' 101' ' ' TRP . 53.0 mt -63.1 -71.47 0.16 Allowed 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.521 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -43.79 -47.45 8.03 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.141 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.83 -27.48 41.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.244 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.566 ' O ' ' SD ' ' A' ' 112' ' ' MET . . . -104.63 0.62 28.69 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.693 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 105' ' ' LEU . 77.8 tttt -84.91 -73.78 0.42 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.541 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -57.18 -35.98 70.24 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -70.59 48.74 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.456 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.566 ' SD ' ' O ' ' A' ' 108' ' ' ALA . 91.9 mtp -143.32 54.1 2.95 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.411 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 112' ' ' MET . 3.5 Cg_endo -57.8 -46.67 25.04 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 120.651 0.901 . . . . 0.0 112.088 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -173.93 26.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.9 mt -43.42 -73.42 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.454 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.529 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -172.1 0.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.226 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.6 p -141.73 177.53 8.1 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 111.903 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.2 p -141.6 -22.26 0.73 Allowed 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.996 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -82.07 143.06 31.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.198 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.2 -40.72 97.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 110.876 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -56.1 -35.16 66.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.18 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.77 -68.88 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.861 -1.136 . . . . 0.0 108.967 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.06 -39.08 26.19 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.976 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.38 -66.55 0.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 129' ' ' GLY . 98.8 mtt180 -44.27 -31.91 1.14 Allowed 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.479 ' SD ' ' OG ' ' A' ' 130' ' ' SER . 4.4 tmm? -59.24 -72.35 0.1 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.6 mm -51.1 -50.34 25.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.218 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -66.26 -70.82 0.22 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.39 -44.4 3.99 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.479 ' OG ' ' SD ' ' A' ' 126' ' ' MET . 66.4 m -58.71 -44.85 90.51 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.557 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -54.62 -50.32 68.39 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.55 ' HG2' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -49.36 -44.59 44.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.5 t -52.47 -65.72 0.51 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 83.5 mtp -51.82 -5.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.303 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.57 -25.56 12.87 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.557 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 45.7 t -47.64 163.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 136' ' ' VAL . 75.8 mt-10 -131.62 153.24 50.13 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.508 HG12 ' H ' ' A' ' 140' ' ' GLY . 65.2 t -117.25 130.49 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 139' ' ' VAL . 38.7 t -94.76 -4.88 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.487 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.609 ' O ' ' HB3' ' A' ' 141' ' ' ALA . . . -59.33 156.11 26.64 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 140' ' ' GLY . . . 73.68 64.32 0.31 Allowed Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 117.403 0.602 . . . . 0.0 110.186 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 9.5 Cg_endo -71.85 178.41 5.86 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.339 1.359 . . . . 0.0 111.759 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.1 140.16 56.13 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 75.7 t -126.19 127.75 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -140.15 141.66 36.04 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -103.19 -76.03 0.6 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.616 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.106 -0.949 . . . . 0.0 110.505 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 ttp . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.67 139.77 53.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -145.29 168.59 20.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.482 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 4' ' ' VAL . 8.2 p -58.05 123.07 8.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 61' ' ' ALA . 64.5 t -114.36 -24.09 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.03 130.05 18.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.608 0.718 . . . . 0.0 111.101 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.4 t -119.92 103.56 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.058 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.25 93.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 118.164 -1.415 . . . . 0.0 110.045 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -76.01 110.81 10.78 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -169.91 -172.6 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.944 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 11' ' ' GLN . 26.4 mp0 -109.59 171.94 7.15 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.699 HD13 ' CE1' ' A' ' 41' ' ' PHE . 8.0 mt -143.15 136.02 13.73 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -82.49 159.85 17.02 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.222 1.281 . . . . 0.0 113.722 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.751 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -118.35 142.53 47.43 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.66 35.53 38.15 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -177.38 59.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.896 -0.652 . . . . 0.0 110.468 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.07 156.24 47.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -167.68 169.02 5.81 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.286 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.84 39.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.357 1.371 . . . . 0.0 112.171 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.578 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -147.0 52.57 1.39 Allowed Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.629 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 31.2 Cg_endo -79.78 166.28 21.6 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.027 1.151 . . . . 0.0 111.885 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.08 -29.2 86.3 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 120.93 1.087 . . . . 0.0 111.087 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.601 ' CG1' ' HB3' ' A' ' 26' ' ' ALA . 2.4 t -80.62 -63.49 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 42.97 -99.58 0.01 OUTLIER Glycine 0 C--O 1.212 -1.252 0 CA-C-O 118.58 -1.122 . . . . 0.0 110.418 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 27' ' ' LEU . 14.3 Cg_exo -47.55 -60.51 0.85 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 CA-C-N 120.968 2.384 . . . . 0.0 110.986 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.601 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.48 -16.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.429 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.632 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 0.5 OUTLIER -117.82 -38.23 3.29 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 110.901 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 24' ' ' GLY . . . -56.68 -52.01 53.2 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -76.5 42.19 0.28 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.382 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.632 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -92.35 -30.38 15.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.726 177.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.596 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . 109.27 -43.19 1.76 Allowed Glycine 0 N--CA 1.464 0.529 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 31' ' ' GLY . . . -51.44 -132.01 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.103 0.561 . . . . 0.0 111.849 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -138.68 123.73 19.01 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.909 -0.495 . . . . 0.0 110.736 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 37' ' ' PHE . 2.6 mm -63.18 -71.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.416 ' O ' ' N ' ' A' ' 39' ' ' LYS . 96.7 mmm -39.43 -43.19 1.19 Allowed 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.26 -48.26 79.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.272 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 34' ' ' ILE . 29.5 t80 -50.05 -67.67 0.24 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 122.364 1.078 . . . . 0.0 109.358 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 42' ' ' ASN . 93.8 t -56.93 -42.51 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 113.489 -1.687 . . . . 0.0 111.174 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 88.4 tttt -48.59 -60.69 2.5 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.52 -41.32 80.65 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.683 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.699 ' CE1' HD13 ' A' ' 12' ' ' LEU . 10.3 m-85 -62.97 -76.0 0.07 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 46' ' ' ALA . 8.0 t-20 -39.29 -46.34 1.54 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.524 0.678 . . . . 0.0 111.744 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -57.8 -35.24 70.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.302 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -88.07 -44.42 10.97 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.983 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 49' ' ' GLY . 14.8 p -65.26 -21.12 66.69 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -87.82 -33.66 18.53 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.426 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 62.4 t-20 -64.45 -24.53 67.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.486 ' CG ' ' N ' ' A' ' 49' ' ' GLY . 7.1 ptt? -105.65 -47.2 3.96 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.644 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.486 ' N ' ' CG ' ' A' ' 48' ' ' MET . . . 142.62 178.57 18.69 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 40.7 p-10 -74.82 147.98 40.69 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.751 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.04 -154.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.754 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.1 mm -143.3 136.46 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.5 131.13 12.7 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.741 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -72.26 153.23 56.39 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 120.76 0.974 . . . . 0.0 110.369 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.551 HG11 HD12 ' A' ' 12' ' ' LEU . 5.3 p -155.52 145.53 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.426 0.632 . . . . 0.0 111.897 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -121.93 95.68 4.76 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.4 mt -69.72 89.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.712 -175.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.24 98.93 1.81 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 59' ' ' ILE . 40.9 mt -99.28 131.44 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.806 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 63' ' ' ARG . 4.1 m-85 -106.83 142.15 36.93 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.55 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -50.91 -27.34 7.31 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 124.388 1.055 . . . . 0.0 111.841 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -60.33 -5.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' A' ' 61' ' ' ALA . 25.7 ttm180 76.79 70.01 0.06 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.212 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.0 p -144.77 125.33 14.05 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.237 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -104.64 103.28 12.91 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.556 0.217 . . . . 0.0 110.555 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.7 p -95.55 134.46 38.4 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.559 ' CZ ' ' O ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -124.73 175.34 7.3 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.97 86.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.9 t -177.15 139.03 0.26 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.211 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.585 ' O ' ' O ' ' A' ' 71' ' ' THR . 0.6 OUTLIER -176.92 117.25 0.11 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.672 0.749 . . . . 0.0 110.336 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.585 ' O ' ' O ' ' A' ' 70' ' ' LYS . 49.8 p 51.85 140.45 0.02 OUTLIER Pre-proline 0 C--N 1.292 -1.914 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.468 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -78.21 168.57 21.56 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 120.551 1.232 . . . . 0.0 112.821 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.46 90.67 0.33 Allowed 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.983 1.789 . . . . 0.0 111.959 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.72 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -176.7 -143.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.634 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 0.5 OUTLIER -37.25 -14.2 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.72 ' N ' ' O ' ' A' ' 74' ' ' ALA . 3.2 t80 -46.52 -41.27 13.95 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 123.53 0.518 . . . . 0.0 110.385 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.86 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -130.1 -15.25 3.79 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.819 ' N ' HD22 ' A' ' 77' ' ' LEU . 26.2 mt -65.02 -40.68 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.997 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -50.25 -41.82 50.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.063 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -71.58 -61.19 1.87 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.313 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.18 -22.43 6.55 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.319 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -86.61 -78.08 0.3 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.765 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.39 56.61 0.77 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.8 mt -92.48 114.49 27.06 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -81.52 -178.97 7.18 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -79.65 144.67 33.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.06 106.64 0.65 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.22 3.05 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.305 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -64.38 -47.28 79.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.37 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -88.11 148.09 42.13 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.669 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -54.31 142.92 67.27 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 120.628 0.886 . . . . 0.0 111.616 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.08 136.44 4.13 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 62.26 -175.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 95' ' ' LYS . 79.8 mm-40 -90.5 84.96 6.01 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.189 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 94' ' ' GLU . 58.4 mttp 53.52 169.46 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 97' ' ' GLY . 12.5 p -152.64 164.56 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 96' ' ' VAL . . . 88.59 84.55 1.25 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -138.81 128.39 24.66 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.07 0.462 . . . . 0.0 110.88 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 104' ' ' VAL . 15.0 pt -119.19 151.61 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.41 HG21 ' NE2' ' A' ' 103' ' ' GLN . 1.6 p -78.72 154.78 29.79 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.237 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.717 ' NE1' HD11 ' A' ' 105' ' ' LEU . 65.4 t-105 -58.49 -54.63 44.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.019 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -58.31 -42.8 87.5 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 121.439 -0.788 . . . . 0.0 111.396 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.41 ' NE2' HG21 ' A' ' 100' ' ' THR . 63.3 mt-30 -58.33 -46.11 86.83 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.638 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.543 HG23 ' CG2' ' A' ' 127' ' ' ILE . 7.7 p -66.9 -30.6 50.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.044 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.717 HD11 ' NE1' ' A' ' 101' ' ' TRP . 58.3 mt -61.69 -71.77 0.14 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.153 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -45.66 -49.77 14.1 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.39 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.501 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 93.1 mt -57.53 -26.69 27.46 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -105.64 2.44 28.16 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.398 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 105' ' ' LEU . 77.3 tttt -86.16 -73.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -65.52 -40.51 93.06 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.725 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 107' ' ' ILE . 49.7 mmtt -60.43 93.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.712 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.422 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 48.8 mtt -154.82 56.0 1.35 Allowed Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.403 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 112' ' ' MET . 14.7 Cg_exo -50.46 -46.67 28.17 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 120.778 0.985 . . . . 0.0 112.154 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 66.8 t0 -170.92 40.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.245 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.562 ' N ' HD22 ' A' ' 115' ' ' LEU . 3.6 mm? -74.41 143.66 44.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.74 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.563 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 10.2 t30 -69.37 35.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.444 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 115' ' ' LEU . 69.5 p -139.46 162.79 34.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.228 0.537 . . . . 0.0 111.756 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.7 p -142.46 -45.07 0.32 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.779 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -72.5 151.51 42.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 35.9 mt -59.3 -42.19 90.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.358 0.599 . . . . 0.0 109.948 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.85 -44.53 86.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.093 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.85 -71.23 0.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.279 -0.969 . . . . 0.0 108.528 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.596 ' O ' ' HG3' ' A' ' 126' ' ' MET . . . -44.22 -55.0 5.17 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.896 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -44.69 -62.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.295 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 129' ' ' GLY . 64.8 ttt180 -44.41 -32.36 1.34 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.791 ' HG3' ' H ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER -58.95 -66.71 0.46 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.791 ' H ' ' HG3' ' A' ' 126' ' ' MET . 4.9 mm -56.11 -48.68 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.317 -176.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -66.84 -69.83 0.28 Allowed 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.09 -47.43 5.35 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 126' ' ' MET . 70.3 m -57.82 -42.84 85.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.619 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -53.86 -48.18 70.28 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.532 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -50.75 -41.1 56.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 135' ' ' GLY . 2.3 t -59.57 -72.64 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 4.3 ptm -45.27 -13.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.527 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 89.31 66.17 1.26 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.619 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 37.1 t -157.16 141.61 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -116.17 172.44 7.18 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 140' ' ' GLY . 7.3 t -96.33 149.02 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 p -62.08 4.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.313 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . 100.27 155.41 27.75 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -145.73 67.87 12.78 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.868 0.334 . . . . 0.0 110.4 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.57 150.74 69.73 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.383 1.388 . . . . 0.0 112.114 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 143' ' ' GLU . 1.2 tm-20 -169.91 24.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.242 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.9 t -132.9 133.42 58.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -105.21 83.3 1.95 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -162.63 93.83 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.713 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.451 179.63 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.525 ' N ' ' CB ' ' A' ' 61' ' ' ALA . 7.7 ptt? . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.478 ' H ' ' CG ' ' A' ' 1' ' ' MET . 89.0 tttt -173.58 159.4 3.59 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt 62.09 153.11 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.262 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.697 HG21 HG22 ' A' ' 58' ' ' THR . 1.0 OUTLIER -55.01 104.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.213 178.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 6' ' ' ALA . 29.6 m -80.79 -46.33 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.204 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 5' ' ' VAL . . . -100.84 142.1 32.79 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.263 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.7 p -132.58 99.91 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.595 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.12 90.34 3.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.031 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -78.99 117.2 19.84 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.493 ' C ' HD12 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -170.67 -173.91 1.49 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.537 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -98.25 162.7 13.06 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.474 HD12 HG11 ' A' ' 55' ' ' VAL . 1.1 mt -148.88 96.83 3.73 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.484 ' HA ' HD13 ' A' ' 52' ' ' ILE . 26.5 Cg_exo -54.23 147.88 43.36 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.239 1.292 . . . . 0.0 114.769 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.832 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -94.61 142.45 27.44 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 45.06 31.38 2.9 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -154.07 34.34 0.43 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.145 -0.527 . . . . 0.0 110.522 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.82 151.55 36.28 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.546 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -156.32 167.98 13.27 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.121 -178.078 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -61.5 36.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.305 1.337 . . . . 0.0 112.207 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -159.33 57.39 1.04 Allowed Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.687 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 23.4 Cg_endo -80.22 169.62 17.26 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.157 1.238 . . . . 0.0 112.123 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -55.01 -28.41 59.65 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 120.705 0.936 . . . . 0.0 111.146 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.747 HG12 ' HB3' ' A' ' 26' ' ' ALA . 1.6 t -84.7 -61.9 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 43.25 -98.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.809 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -47.15 -60.71 0.78 Allowed 'Trans proline' 0 C--N 1.317 -1.106 0 CA-C-N 119.736 1.768 . . . . 0.0 110.559 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.747 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -48.49 -26.29 2.07 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.834 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.585 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 36.8 tp -113.23 26.35 10.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 122.124 0.964 . . . . 0.0 109.354 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.42 42.38 0.5 Allowed Glycine 0 C--N 1.313 -0.73 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.259 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -141.13 -16.28 0.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.186 0.517 . . . . 0.0 109.638 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.497 ' ND1' ' O ' ' A' ' 30' ' ' HIS . 16.2 t-80 -59.01 -11.11 3.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.197 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.99 -15.81 58.99 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.39 -131.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.304 0.642 . . . . 0.0 112.071 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -134.09 -165.56 1.66 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mm -138.46 -74.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.3 tpt -41.4 -37.41 1.03 Allowed 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -59.83 -54.36 47.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 68.7 t80 -45.38 -58.15 3.53 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 122.863 1.315 . . . . 0.0 109.755 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 42' ' ' ASN . 48.8 t -63.19 -43.4 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.577 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -44.64 -58.67 2.9 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.13 -40.41 95.83 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.342 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -62.12 -74.22 0.09 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -39.74 -44.58 1.58 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.72 0.772 . . . . 0.0 111.738 -177.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.17 72.92 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.219 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.51 ' HB1' ' HG3' ' A' ' 70' ' ' LYS . . . -87.71 -46.09 9.8 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.186 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.8 p -62.76 -19.46 64.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -89.12 -34.14 16.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -61.41 -26.05 67.6 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.592 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -106.08 -85.87 0.49 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.067 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.592 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -176.2 169.23 41.75 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.338 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 42.9 p-10 -69.48 137.66 52.77 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.832 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . -174.93 -150.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.861 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 13' ' ' PRO . 35.4 mm -138.19 125.0 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.603 HG11 HG23 ' A' ' 69' ' ' THR . 84.4 t -125.9 120.94 24.19 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.206 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -75.32 141.69 26.03 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.011 1.141 . . . . 0.0 110.631 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.618 HG22 ' N ' ' A' ' 56' ' ' GLU . 7.5 p -159.74 162.91 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.329 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.618 ' N ' HG22 ' A' ' 55' ' ' VAL . 9.7 mt-10 -129.44 114.82 16.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.9 mt -76.54 88.23 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.097 0.475 . . . . 0.0 111.73 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.697 HG22 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -74.37 113.49 11.65 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 68.6 mt -118.55 135.94 57.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.004 0.431 . . . . 0.0 111.401 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.642 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -110.17 147.72 33.18 Favored 'General case' 0 C--O 1.253 1.274 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.27 176.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.713 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -53.48 -22.55 8.19 Favored 'General case' 0 C--N 1.346 0.423 0 O-C-N 124.985 1.428 . . . . 0.0 112.177 -175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -63.43 8.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.713 ' H ' ' C ' ' A' ' 61' ' ' ALA . 89.0 mtm180 59.7 72.33 0.53 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.992 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.479 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . 1.4 m -149.96 147.56 28.03 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.604 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.648 ' N ' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -124.48 106.56 10.27 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.284 0.365 . . . . 0.0 111.452 -177.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.594 ' OG1' ' OH ' ' A' ' 60' ' ' TYR . 15.3 m -94.11 122.09 36.27 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CZ ' ' CE1' ' A' ' 37' ' ' PHE . 4.0 p90 177.1 -151.78 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 67' ' ' PHE . 47.3 t 80.69 159.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.202 0 O-C-N 124.006 0.816 . . . . 0.0 110.344 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.603 HG23 HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER 175.64 119.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.033 179.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HD3' ' H ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -148.73 147.83 29.3 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.292 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.48 ' OG1' ' C ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER 173.7 141.6 0.16 Allowed Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.359 177.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.71 ' O ' ' CE1' ' A' ' 76' ' ' TYR . 10.8 Cg_endo -72.62 169.38 22.02 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.588 0.859 . . . . 0.0 111.955 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.611 ' O ' ' O ' ' A' ' 72' ' ' PRO . 12.1 Cg_exo -46.61 -157.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.814 2.343 . . . . 0.0 112.359 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.718 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . -36.31 -34.01 0.05 Allowed 'General case' 0 C--O 1.255 1.364 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.475 ' O ' ' C ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -40.15 -10.35 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.123 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.718 ' N ' ' O ' ' A' ' 74' ' ' ALA . 31.1 m-85 -32.76 -81.55 0.01 OUTLIER 'General case' 0 C--N 1.35 0.628 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.861 ' H ' HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -108.49 -5.35 16.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.771 HD11 ' CG2' ' A' ' 127' ' ' ILE . 6.5 mm -63.08 -42.42 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.347 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -52.2 -36.58 52.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.17 -66.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.451 -0.499 . . . . 0.0 109.842 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.62 -13.98 0.46 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.726 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 78' ' ' ILE . . . -89.83 -77.06 0.4 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.637 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.75 37.86 0.49 Allowed Glycine 0 N--CA 1.466 0.648 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.2 mt -90.68 104.88 17.42 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.44 -45.27 13.85 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.742 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -174.66 157.36 2.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.91 147.4 21.54 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -179.58 -2.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.022 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -59.9 -46.49 89.17 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.563 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -165.51 152.15 9.02 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.628 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -53.77 145.8 48.23 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.961 1.108 . . . . 0.0 111.679 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.76 58.3 0.11 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -162.4 -85.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -171.81 -66.57 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.027 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -141.6 137.0 31.59 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -158.86 151.25 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.167 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.88 84.3 0.59 Allowed Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -141.82 103.15 4.3 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.086 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.606 HD12 ' CG1' ' A' ' 104' ' ' VAL . 3.5 pt -106.56 159.91 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.36 152.01 19.4 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.257 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.488 ' O ' HG22 ' A' ' 104' ' ' VAL . 70.4 t-105 -60.32 -51.26 70.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.778 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.85 -41.93 92.5 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 120.62 -1.3 . . . . 0.0 111.751 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.22 -44.51 95.11 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.105 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.606 ' CG1' HD12 ' A' ' 99' ' ' ILE . 17.5 m -62.92 -33.71 62.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 118.257 -1.377 . . . . 0.0 109.411 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 108' ' ' ALA . 96.2 mt -61.47 -72.21 0.13 Allowed 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.19 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -43.77 -56.23 3.96 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.488 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.482 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 95.1 mt -50.61 -25.68 3.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.879 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -88.89 -44.6 10.34 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.604 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.434 ' HG3' HD11 ' A' ' 120' ' ' LEU . 47.7 mtpt -43.9 -68.32 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.373 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.788 ' N ' HE21 ' A' ' 110' ' ' GLN . 0.0 OUTLIER -57.32 -66.37 0.47 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.328 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -47.16 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.973 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.561 ' N ' ' O ' ' A' ' 110' ' ' GLN . 37.6 mtt -157.51 51.34 0.48 Allowed Pre-proline 0 C--O 1.234 0.248 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.664 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 112' ' ' MET . 10.7 Cg_endo -66.05 -33.37 41.53 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 120.748 0.965 . . . . 0.0 111.867 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 115' ' ' LEU . 63.9 m-20 -160.75 -77.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.942 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.558 HD22 ' H ' ' A' ' 115' ' ' LEU . 3.9 mm? 44.0 -169.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.296 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.532 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -121.98 35.56 4.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.762 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.3 p -135.83 168.41 19.35 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.395 0.617 . . . . 0.0 111.902 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -138.67 -85.52 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.511 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.505 ' H ' HG23 ' A' ' 118' ' ' THR . 97.7 m-20 -55.42 164.22 1.04 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 124' ' ' ALA . 4.4 mm? -61.66 -40.62 95.57 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-O 121.469 0.652 . . . . 0.0 110.42 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -50.31 -46.08 55.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.129 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.73 -66.27 0.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.174 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 126' ' ' MET . . . -49.05 -48.02 44.31 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.928 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -47.06 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 129' ' ' GLY . 42.2 ttm180 -42.15 -37.63 1.49 Allowed 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.418 ' C ' ' SD ' ' A' ' 126' ' ' MET . 3.2 tmm? -54.9 -73.48 0.05 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.484 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.771 ' CG2' HD11 ' A' ' 78' ' ' ILE . 34.1 mt -51.77 -51.71 26.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.847 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -62.81 -70.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -41.16 -42.39 3.12 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 133' ' ' SER . 23.9 m -57.49 -46.16 84.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.637 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -51.28 -50.29 59.57 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.579 HH11 ' CG ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -49.97 -36.03 26.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.58 ' C ' ' H ' ' A' ' 135' ' ' GLY . 1.2 t -63.23 -71.15 0.17 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.644 ' SD ' ' HB3' ' A' ' 74' ' ' ALA . 81.3 mtp -47.65 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.82 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 80.43 55.68 3.38 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.637 ' HB ' ' HB1' ' A' ' 131' ' ' ALA . 39.8 t -138.15 161.72 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.47 ' N ' HG12 ' A' ' 136' ' ' VAL . 76.3 mt-10 -133.01 159.35 40.28 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.921 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.441 HG12 ' H ' ' A' ' 140' ' ' GLY . 11.2 t -99.49 156.99 3.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 p -84.48 -3.33 7.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.651 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.441 ' H ' HG12 ' A' ' 138' ' ' VAL . . . -133.69 94.36 0.27 Allowed Glycine 0 CA--C 1.519 0.286 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.43 67.94 5.69 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.154 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.35 145.15 98.75 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.47 1.447 . . . . 0.0 112.1 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 143' ' ' GLU . 0.9 OUTLIER -155.72 23.71 0.39 Allowed 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.013 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 69.5 t -130.11 130.75 66.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt 47.98 -166.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 146' ' ' ASP . 40.2 p-10 -80.63 112.99 18.51 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.009 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.374 -179.977 . . . . . . . . 0 0 . 1 stop_ save_